GOName,GOID,DiseaseName,DiseaseID,InferenceChemicalQty,InferenceChemicalNames,InferenceGeneQty,InferenceGeneSymbols
"1,2-diacyl-sn-glycero-3-phosphocholine metabolic process",GO:0006653,"Diabetes Mellitus, Type 2",MESH:D003924,1,Calcium,0,
3'-phosphoadenosine 5'-phosphosulfate metabolic process,GO:0050427,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
4-hydroxyproline biosynthetic process,GO:0019472,Diabetes Mellitus,MESH:D003920,1,Methylprednisolone,0,
4-hydroxyproline biosynthetic process,GO:0019472,"Diabetes Mellitus, Experimental",MESH:D003921,1,Fructose,0,
4-hydroxyproline biosynthetic process,GO:0019472,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
4-hydroxyproline biosynthetic process,GO:0019472,"Diabetes Mellitus, Type 2",MESH:D003924,2,Fructose|Genistein,0,
4-hydroxyproline metabolic process,GO:0019471,Diabetes Mellitus,MESH:D003920,6,Berberine|Docosahexaenoic Acids|Methylprednisolone|Particulate Matter|puerarin|Resveratrol,0,
4-hydroxyproline metabolic process,GO:0019471,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
4-hydroxyproline metabolic process,GO:0019471,"Diabetes Mellitus, Experimental",MESH:D003921,5,Berberine|Cyclophosphamide|Dietary Fats|puerarin|Resveratrol,0,
4-hydroxyproline metabolic process,GO:0019471,"Diabetes Mellitus, Type 1",MESH:D003922,2,Cyclophosphamide|Resveratrol,0,
4-hydroxyproline metabolic process,GO:0019471,"Diabetes Mellitus, Type 2",MESH:D003924,4,Berberine|Dietary Fats|Particulate Matter|Resveratrol,0,
5-methylcytosine biosynthetic process,GO:0046082,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
5-methylcytosine biosynthetic process,GO:0046082,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
5-methylcytosine biosynthetic process,GO:0046082,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
5-methylcytosine biosynthetic process,GO:0046082,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
5-methylcytosine metabolic process,GO:0019857,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
5-methylcytosine metabolic process,GO:0019857,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Vehicle Emissions,0,
5S class rRNA transcription by RNA polymerase III,GO:0042791,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
9-cis-retinoic acid biosynthetic process,GO:0042904,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
abscission,GO:0009838,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dibutyl Phthalate,0,
abscission,GO:0009838,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dibutyl Phthalate,0,
acetaldehyde biosynthetic process,GO:0046186,"Diabetes Mellitus, Type 2",MESH:D003924,2,Diethylnitrosamine|Ethanol,0,
acetaldehyde catabolic process,GO:0046187,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
acetaldehyde metabolic process,GO:0006117,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Diazinon,0,
acetate biosynthetic process,GO:0019413,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
acetate biosynthetic process,GO:0019413,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
acetate biosynthetic process,GO:0019413,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
acetate biosynthetic process,GO:0019413,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|bisphenol S|perfluorooctanoic acid,0,
acetate metabolic process,GO:0006083,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
acetate metabolic process,GO:0006083,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cholesterol|Dietary Fats,0,
acetate metabolic process,GO:0006083,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
acetylcholine biosynthetic process,GO:0008292,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Diazinon|Polychlorinated Biphenyls,0,
acetylcholine biosynthetic process,GO:0008292,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|ginsenoside Re|sodium arsenite,0,
acetylcholine biosynthetic process,GO:0008292,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
acetylcholine biosynthetic process,GO:0008292,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|ginsenoside Re|Polychlorinated Biphenyls,0,
acetylcholine catabolic process,GO:0006581,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Coumaphos,0,
acetylcholine catabolic process,GO:0006581,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
acetylcholine catabolic process in synaptic cleft,GO:0001507,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,GO:0003069,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SOD2
acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,GO:0003069,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SOD2
acetylcholine metabolic process,GO:0008291,Diabetes Mellitus,MESH:D003920,4,Arsenic|bisphenol A|Chlorpyrifos|Zinc,0,
acetylcholine metabolic process,GO:0008291,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|sodium arsenite|Vitamin E,0,
acetylcholine metabolic process,GO:0008291,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Lipopolysaccharides|sodium arsenite,0,
acetylcholine metabolic process,GO:0008291,"Diabetes Mellitus, Type 2",MESH:D003924,4,Arsenic|bisphenol A|Sitagliptin Phosphate|Zinc,0,
acetylcholine receptor signaling pathway,GO:0095500,Diabetes Mellitus,MESH:D003920,1,Parathion,0,
acetylcholine receptor signaling pathway,GO:0095500,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
acetylcholine receptor signaling pathway,GO:0095500,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
acetylcholine secretion,GO:0061526,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
acetylcholine secretion,GO:0061526,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Coconut Oil|Manganese,0,
acetylcholine secretion,GO:0061526,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
acetylcholine secretion,GO:0061526,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Manganese,0,
"acetylcholine secretion, neurotransmission",GO:0014055,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
acetyl-CoA biosynthetic process,GO:0006085,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
acetyl-CoA biosynthetic process,GO:0006085,"Diabetes Mellitus, Experimental",MESH:D003921,5,cobaltiprotoporphyrin|Dibutyl Phthalate|Diethylhexyl Phthalate|Glucose|Streptozocin,0,
acetyl-CoA biosynthetic process,GO:0006085,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
acetyl-CoA biosynthetic process,GO:0006085,"Diabetes Mellitus, Type 2",MESH:D003924,4,Dibutyl Phthalate|Diethylhexyl Phthalate|Glucose|Streptozocin,0,
acetyl-CoA biosynthetic process from pyruvate,GO:0006086,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PDK4
acetyl-CoA metabolic process,GO:0006084,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
acetyl-CoA metabolic process,GO:0006084,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,0,
acidic amino acid transport,GO:0015800,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
acinar cell differentiation,GO:0090425,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
acrosome assembly,GO:0001675,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
acrosome assembly,GO:0001675,"Diabetes Mellitus, Type 2",MESH:D003924,2,Diethylhexyl Phthalate|Malathion,0,
acrosome reaction,GO:0007340,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Chlorpromazine|puerarin,0,
acrosome reaction,GO:0007340,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|puerarin|Taurine,0,
acrosome reaction,GO:0007340,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Taurine,0,
acrosome reaction,GO:0007340,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
actin cytoskeleton organization,GO:0030036,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Mercury|Plant Extracts,1,RAC1
actin cytoskeleton organization,GO:0030036,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|pimagedine|Plant Extracts,1,S1PR2
actin cytoskeleton organization,GO:0030036,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Genistein|Mercury|Thioctic Acid,0,
actin cytoskeleton organization,GO:0030036,"Diabetes Mellitus, Type 2",MESH:D003924,10,alpha-Tocopherol|Ascorbic Acid|bisphenol A|daidzein|Genistein|Glutathione|Mercury|perfluorooctane sulfonic acid|Plant Extracts|titanium dioxide,3,AUTS2|MRAS|PTPN1
actin cytoskeleton reorganization,GO:0031532,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
actin cytoskeleton reorganization,GO:0031532,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
actin cytoskeleton reorganization,GO:0031532,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
actin cytoskeleton reorganization,GO:0031532,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
actin filament bundle assembly,GO:0051017,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
actin filament capping,GO:0051693,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorodecanoic acid,0,
actin filament depolymerization,GO:0030042,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
actin filament depolymerization,GO:0030042,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
actin filament depolymerization,GO:0030042,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
actin filament depolymerization,GO:0030042,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
actin filament organization,GO:0007015,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
actin filament organization,GO:0007015,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dronabinol|Hydrogen Peroxide,2,BCL2|CAV3
actin filament organization,GO:0007015,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorodecanoic acid,2,BCL2|INPPL1
actin filament polymerization,GO:0030041,Diabetes Mellitus,MESH:D003920,2,Resveratrol|Tetrachlorodibenzodioxin,1,RAC1
actin filament polymerization,GO:0030041,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
actin filament polymerization,GO:0030041,"Diabetes Mellitus, Type 1",MESH:D003922,4,Lipopolysaccharides|Norepinephrine|Resveratrol|Tetrachlorodibenzodioxin,0,
actin filament polymerization,GO:0030041,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Resveratrol,0,
actin filament reorganization,GO:0090527,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
actin filament reorganization,GO:0090527,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
action potential,GO:0001508,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
action potential,GO:0001508,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,2,KCNJ11|S1PR4
action potential,GO:0001508,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
action potential,GO:0001508,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
action potential,GO:0001508,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,ABCC8|KCNJ11
action potential,GO:0001508,"Diabetes Mellitus, Type 2",MESH:D003924,2,Nicotine|Particulate Matter,2,ABCC8|KCNJ11
action potential initiation,GO:0099610,Diabetes Mellitus,MESH:D003920,0,,1,SOD1
action potential initiation,GO:0099610,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SOD1
action potential initiation,GO:0099610,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SOD1
activated T cell proliferation,GO:0050798,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GPAM
activated T cell proliferation,GO:0050798,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
activated T cell proliferation,GO:0050798,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL2RA
activation-induced cell death of T cells,GO:0006924,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,FAS|GPAM
activation-induced cell death of T cells,GO:0006924,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
activation-induced cell death of T cells,GO:0006924,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL2RA
activation-induced cell death of T cells,GO:0006924,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|FAS
activation of adenylate cyclase activity,GO:0007190,"Diabetes Mellitus, Experimental",MESH:D003921,3,Dronabinol|Glucose|Manganese,0,
activation of adenylate cyclase activity,GO:0007190,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glucose|Manganese,2,EDNRA|GLP1R
activation of cysteine-type endopeptidase activity,GO:0097202,Diabetes Mellitus,MESH:D003920,4,Dichlorvos|Particulate Matter|Reactive Oxygen Species|Resveratrol,0,
activation of cysteine-type endopeptidase activity,GO:0097202,"Diabetes Mellitus, Experimental",MESH:D003921,9,"Dibutyl Phthalate|Diethylhexyl Phthalate|Dronabinol|Fatty Acids, Nonesterified|Glucose|Manganese|Resveratrol|S-allylcysteine|thymoquinone",0,
activation of cysteine-type endopeptidase activity,GO:0097202,"Diabetes Mellitus, Type 1",MESH:D003922,3,Dichlorvos|Reactive Oxygen Species|Resveratrol,0,
activation of cysteine-type endopeptidase activity,GO:0097202,"Diabetes Mellitus, Type 2",MESH:D003924,10,"Calcium|Dibutyl Phthalate|Diethylhexyl Phthalate|Fatty Acids, Nonesterified|Folic Acid|Glucose|Manganese|Particulate Matter|Reactive Oxygen Species|Resveratrol",0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,Diabetes Mellitus,MESH:D003920,7,"2,2',4,4'-tetrabromodiphenyl ether|Cadmium|Chlorpyrifos|Docosahexaenoic Acids|Lead|Resveratrol|Serotonin",0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,"Diabetes Mellitus, Experimental",MESH:D003921,10,Dibutyl Phthalate|Hydrogen Peroxide|Imatinib Mesylate|Manganese|mangiferin|Nitric Oxide|pterostilbene|Resveratrol|Sertraline|tributyltin,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,"Diabetes Mellitus, Type 1",MESH:D003922,3,Imatinib Mesylate|Nitric Oxide|Resveratrol,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,"Diabetes Mellitus, Type 2",MESH:D003924,9,Cadmium|Dibutyl Phthalate|Lead|Manganese|mangiferin|mono-(2-ethylhexyl)phthalate|perfluorooctane sulfonic acid|Resveratrol|Silver,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0008635,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0008635,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0008635,"Diabetes Mellitus, Type 2",MESH:D003924,1,Manganese,0,
activation of GTPase activity,GO:0090630,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
activation of GTPase activity,GO:0090630,"Diabetes Mellitus, Type 1",MESH:D003922,1,Norepinephrine,0,
activation of GTPase activity,GO:0090630,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT2
activation of immune response,GO:0002253,"Diabetes Mellitus, Type 1",MESH:D003922,1,decabromobiphenyl ether,0,
activation of immune response,GO:0002253,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
activation of innate immune response,GO:0002218,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP2
activation of phospholipase C activity,GO:0007202,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
activation of phospholipase C activity,GO:0007202,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
activation of phospholipase C activity,GO:0007202,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
activation of phospholipase C activity,GO:0007202,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
activation of protein kinase A activity,GO:0034199,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Lead|Resveratrol,0,
activation of protein kinase A activity,GO:0034199,"Diabetes Mellitus, Experimental",MESH:D003921,6,Aldosterone|bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate|Quercetin|Resveratrol,0,
activation of protein kinase A activity,GO:0034199,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Dehydroepiandrosterone|Resveratrol,0,
activation of protein kinase A activity,GO:0034199,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate|Lead|Resveratrol,0,
activation of protein kinase activity,GO:0032147,Diabetes Mellitus,MESH:D003920,2,Aspirin|Metformin,0,
activation of protein kinase activity,GO:0032147,"Diabetes Mellitus, Experimental",MESH:D003921,1,Metformin,2,INSR|PRKCD
activation of protein kinase activity,GO:0032147,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
activation of protein kinase activity,GO:0032147,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
activation of protein kinase activity,GO:0032147,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,2,HNF1A|SLC11A1
activation of protein kinase activity,GO:0032147,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Metformin,1,HNF1A
activation of protein kinase B activity,GO:0032148,Diabetes Mellitus,MESH:D003920,25,"2,2',4,4'-tetrabromodiphenyl ether|arsenite|Atrazine|bisphenol A|Blood Glucose|Chlordan|Chlorpyrifos|Copper|Dieldrin|Docosahexaenoic Acids|Gallic Acid|Metformin|methylarsonite|osthol|Parathion|Particulate Matter|Plant Extracts|puerarin|Pyruvaldehyde|Reactive Oxygen Species|Resveratrol|Sodium Selenite|Streptozocin|Sulpiride|Tobacco Smoke Pollution",2,INS|INS2
activation of protein kinase B activity,GO:0032148,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
activation of protein kinase B activity,GO:0032148,"Diabetes Mellitus, Experimental",MESH:D003921,25,"Anthocyanins|bisphenol A|Blood Glucose|Cholesterol|cobaltiprotoporphyrin|Dibutyl Phthalate|Dietary Fats|Dronabinol|Fructose|Gallic Acid|Glucose|honokiol|Hydrogen Peroxide|L 783281|Metformin|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|puerarin|Quercetin|Resveratrol|sodium arsenite|Sodium Selenite|Streptozocin|tributyltin",3,IGF1|INS1|INSR
activation of protein kinase B activity,GO:0032148,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
activation of protein kinase B activity,GO:0032148,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
activation of protein kinase B activity,GO:0032148,"Diabetes Mellitus, Type 1",MESH:D003922,11,bisphenol A|Calcitriol|decabromobiphenyl ether|Genistein|Lipopolysaccharides|Norepinephrine|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Warfarin,3,IGF1|INS|INS2
activation of protein kinase B activity,GO:0032148,"Diabetes Mellitus, Type 2",MESH:D003924,30,"Amino Acids|Atrazine|bisphenol A|Blood Glucose|Copper|Curcumin|daidzein|Dibutyl Phthalate|Dietary Fats|Diethylnitrosamine|Drugs, Chinese Herbal|Ethanol|Folic Acid|Fructose|fumosorinone|Genistein|Glucose|L 783281|Metformin|mono-(2-ethylhexyl)phthalate|Nickel|Nicotine|Orlistat|Particulate Matter|Plant Extracts|Reactive Oxygen Species|Resveratrol|Streptozocin|titanium dioxide|Vildagliptin",3,INS|INS1|NOTCH2
activation of protein kinase C activity,GO:1990051,Diabetes Mellitus,MESH:D003920,4,arsenite|bisphenol A|Lead|Reactive Oxygen Species,0,
activation of protein kinase C activity,GO:1990051,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Glucose|Quercetin|tributyltin,1,LEP
activation of protein kinase C activity,GO:1990051,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Reactive Oxygen Species,0,
activation of protein kinase C activity,GO:1990051,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Glucose|Lead|Reactive Oxygen Species,1,LEP
acute inflammatory response,GO:0002526,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
acute inflammatory response,GO:0002526,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
acute inflammatory response,GO:0002526,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cyclophosphamide|Dietary Fats,0,
acute inflammatory response,GO:0002526,"Diabetes Mellitus, Type 1",MESH:D003922,2,Cyclophosphamide|Lipopolysaccharides,1,HP
acute inflammatory response,GO:0002526,"Diabetes Mellitus, Type 2",MESH:D003924,2,Curcumin|Dietary Fats,1,HP
acute inflammatory response to antigenic stimulus,GO:0002438,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
acute inflammatory response to antigenic stimulus,GO:0002438,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,1,ICAM1
acute inflammatory response to antigenic stimulus,GO:0002438,"Diabetes Mellitus, Type 2",MESH:D003924,2,Diethylhexyl Phthalate|Particulate Matter,1,ICAM1
acute-phase response,GO:0006953,Diabetes Mellitus,MESH:D003920,0,,3,FN1|INS|INS2
acute-phase response,GO:0006953,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IL6|INS1
acute-phase response,GO:0006953,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
acute-phase response,GO:0006953,"Diabetes Mellitus, Type 1",MESH:D003922,0,,6,CRP|HP|IL6|INS|INS2|STAT3
acute-phase response,GO:0006953,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,HP|IL6|INS|INS1
acyl-CoA metabolic process,GO:0006637,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,2,ACOT1|GPAM
acyl-CoA metabolic process,GO:0006637,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,1,HNF4A
acylglycerol homeostasis,GO:0055090,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
acylglycerol homeostasis,GO:0055090,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
acylglycerol metabolic process,GO:0006639,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
acylglycerol metabolic process,GO:0006639,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
acylglycerol metabolic process,GO:0006639,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
acylglycerol metabolic process,GO:0006639,"Diabetes Mellitus, Type 2",MESH:D003924,2,2-palmitoylglycerol|bisphenol A,0,
adaptive immune response,GO:0002250,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
adaptive immune response,GO:0002250,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IFNG
adaptive immune response,GO:0002250,"Diabetes Mellitus, Insulin-Dependent, 12",MESH:C563326,0,,1,CTLA4
adaptive immune response,GO:0002250,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,4,CTSH|HLA-DQA1|HLA-DQB1|IFNG
adaptive immune response,GO:0002250,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,3,HLA-DRB5|PIK3CG|PRKCB
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002460,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
adaptive thermogenesis,GO:1990845,"Diabetes Mellitus, Experimental",MESH:D003921,1,Capsaicin,2,PPARGC1A|UCP2
adaptive thermogenesis,GO:1990845,"Diabetes Mellitus, Type 1",MESH:D003922,1,Norepinephrine,0,
adaptive thermogenesis,GO:1990845,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,PPARGC1A|THADA|UCP2
adenine metabolic process,GO:0046083,Diabetes Mellitus,MESH:D003920,2,Cadmium|Selenium,0,
adenine metabolic process,GO:0046083,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|perfluorooctanoic acid,0,
adenosine biosynthetic process,GO:0046086,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
adenosine biosynthetic process,GO:0046086,"Diabetes Mellitus, Experimental",MESH:D003921,3,Diethylhexyl Phthalate|sodium arsenite|Streptozocin,0,
adenosine biosynthetic process,GO:0046086,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Streptozocin,0,
adenosine biosynthetic process,GO:0046086,"Diabetes Mellitus, Type 2",MESH:D003924,2,Diethylhexyl Phthalate|Streptozocin,0,
adenosine catabolic process,GO:0006154,"Diabetes Mellitus, Experimental",MESH:D003921,1,Fructose,0,
adenosine catabolic process,GO:0006154,"Diabetes Mellitus, Type 2",MESH:D003924,1,Fructose,0,
adenosine metabolic process,GO:0046085,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
adenosine metabolic process,GO:0046085,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
adenosine metabolic process,GO:0046085,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol S|perfluorooctanoic acid,0,
adenosine transport,GO:0032238,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
adenylate cyclase-activating adrenergic receptor signaling pathway,GO:0071880,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
adenylate cyclase-activating adrenergic receptor signaling pathway,GO:0071880,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ADRA1A|ADRB3|CHRM2
adenylate cyclase-activating adrenergic receptor signaling pathway,GO:0071880,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CHRM2
adenylate cyclase-activating adrenergic receptor signaling pathway,GO:0071880,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MTNR1B
adenylate cyclase-activating dopamine receptor signaling pathway,GO:0007191,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADCY5
adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,6,ADRB3|AGT|IAPP|S1PR2|S1PR4|S1PR5
adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,5,ADCY5|GCG|GLP1R|IAPP|SCTR
adenylate cyclase-inhibiting adrenergic receptor signaling pathway,GO:0071881,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
adenylate cyclase-inhibiting dopamine receptor signaling pathway,GO:0007195,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADCY5
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,GO:0007197,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Parathion,0,
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,GO:0007197,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,1,CHRM2
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,GO:0007197,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CHRM2
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,GO:0007193,Diabetes Mellitus,MESH:D003920,1,Parathion,0,
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,GO:0007193,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,1,EDN1
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,GO:0007193,"Diabetes Mellitus, Type 2",MESH:D003924,2,alpha-Tocopherol|Glucose,3,ADCY5|EDN1|EDNRA
adenylate cyclase-modulating G protein-coupled receptor signaling pathway,GO:0007188,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ADRB3|CHRM2|S1PR4
adenylate cyclase-modulating G protein-coupled receptor signaling pathway,GO:0007188,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CHRM2
adenylate cyclase-modulating G protein-coupled receptor signaling pathway,GO:0007188,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCG|SCTR
adhesion of symbiont to host,GO:0044406,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ICAM1
adhesion of symbiont to host,GO:0044406,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ICAM1
adiponectin-activated signaling pathway,GO:0033211,Diabetes Mellitus,MESH:D003920,0,,1,ADIPOQ
adiponectin-activated signaling pathway,GO:0033211,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACSL1
adiponectin-activated signaling pathway,GO:0033211,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADIPOQ
adiponectin secretion,GO:0070162,Diabetes Mellitus,MESH:D003920,1,Plant Preparations,0,
adiponectin secretion,GO:0070162,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Preparations,0,
adiponectin secretion,GO:0070162,"Diabetes Mellitus, Type 2",MESH:D003924,3,perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid,0,
adipose tissue development,GO:0060612,Diabetes Mellitus,MESH:D003920,24,"Air Pollutants|Arsenic|Berberine|Bezafibrate|bisphenol A|Cadmium|Clozapine|Cyclosporine|DDT|Mercury|Metformin|Methylprednisolone|Niacin|Olanzapine|o,p'-DDT|Particulate Matter|Pesticides|Pioglitazone|Plant Extracts|Resveratrol|Risperidone|Rosiglitazone|Telmisartan|Troglitazone",0,
adipose tissue development,GO:0060612,"Diabetes Mellitus, Experimental",MESH:D003921,20,Berberine|Bezafibrate|bisphenol A|Capsaicin|Dietary Fats|fenugreek seed meal|Metformin|Nicotine|pimagedine|Pioglitazone|Plant Extracts|platycodin D|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Sodium Glutamate|Telmisartan|tributyltin|Troglitazone,2,LEP|PPARGC1A
adipose tissue development,GO:0060612,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
adipose tissue development,GO:0060612,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Calcitriol|Genistein|Mercury|Resveratrol|sodium arsenite,0,
adipose tissue development,GO:0060612,"Diabetes Mellitus, Type 2",MESH:D003924,26,Air Pollutants|Arsenic|Berberine|Bezafibrate|bisphenol A|Cadmium|Clozapine|Dietary Fats|efavirenz|Folic Acid|Genistein|Mercury|Metformin|Nelfinavir|Nicotine|Particulate Matter|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pesticides|Pioglitazone|Plant Extracts|Resveratrol|Rosiglitazone|Telmisartan|Troglitazone,4,ENPP1|FTO|LEP|PPARGC1A
ADP biosynthetic process,GO:0006172,Diabetes Mellitus,MESH:D003920,3,Metformin|Polychlorinated Biphenyls|Tobacco Smoke Pollution,0,
ADP biosynthetic process,GO:0006172,"Diabetes Mellitus, Experimental",MESH:D003921,2,Hydrogen Peroxide|Metformin,0,
ADP biosynthetic process,GO:0006172,"Diabetes Mellitus, Type 2",MESH:D003924,2,Metformin|Polychlorinated Biphenyls,0,
ADP metabolic process,GO:0046031,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
ADP metabolic process,GO:0046031,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
adrenal gland development,GO:0030325,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
adrenal gland development,GO:0030325,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,INSR
adrenal gland development,GO:0030325,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
adrenal gland development,GO:0030325,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
adrenal gland development,GO:0030325,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
adrenergic receptor signaling pathway,GO:0071875,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ADRA1A
adrenergic receptor signaling pathway,GO:0071875,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
adult behavior,GO:0030534,Diabetes Mellitus,MESH:D003920,2,Atrazine|bisphenol A,0,
adult behavior,GO:0030534,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Diethylhexyl Phthalate,0,
adult behavior,GO:0030534,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
adult behavior,GO:0030534,"Diabetes Mellitus, Type 2",MESH:D003924,4,Atrazine|bisphenol A|Diethylhexyl Phthalate|epigallocatechin gallate,1,SLC1A2
adult fat body development,GO:0007505,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP2
adult feeding behavior,GO:0008343,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Chlorpyrifos|Methylprednisolone,1,A
adult feeding behavior,GO:0008343,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dietary Fats|Fructose,1,LEP
adult feeding behavior,GO:0008343,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
adult feeding behavior,GO:0008343,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Dietary Fats|Ethanol|Fructose,2,A|LEP
adult heart development,GO:0007512,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ADRA1A
adult locomotory behavior,GO:0008344,Diabetes Mellitus,MESH:D003920,7,Air Pollutants|bisphenol A|Chlorpyrifos|Dichlorvos|Particulate Matter|Pesticides|Streptozocin,0,
adult locomotory behavior,GO:0008344,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
adult locomotory behavior,GO:0008344,"Diabetes Mellitus, Experimental",MESH:D003921,8,"bisphenol A|Diethylhexyl Phthalate|Dronabinol|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|sodium arsenite|Streptozocin|Taurine",0,
adult locomotory behavior,GO:0008344,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Dichlorvos|sodium arsenite|Streptozocin|Taurine,0,
adult locomotory behavior,GO:0008344,"Diabetes Mellitus, Type 2",MESH:D003924,9,Air Pollutants|bisphenol A|Diethylhexyl Phthalate|Ethanol|Nicotine|Particulate Matter|Pesticides|Streptozocin|Topiramate,3,CCND2|ENPP1|WFS1
adult walking behavior,GO:0007628,Diabetes Mellitus,MESH:D003920,2,Copper|Lead,0,
adult walking behavior,GO:0007628,"Diabetes Mellitus, Type 2",MESH:D003924,4,Copper|Ethanol|Lead|mono(2-ethyl-5-hydroxyhexyl) phthalate,1,ENPP1
aerobic electron transport chain,GO:0019646,Diabetes Mellitus,MESH:D003920,7,"2,2',4,4'-tetrabromodiphenyl ether|Cyclosporine|Dichlorodiphenyl Dichloroethylene|Docosahexaenoic Acids|Streptozocin|Tetrachlorodibenzodioxin|Troglitazone",0,
aerobic electron transport chain,GO:0019646,"Diabetes Mellitus, Experimental",MESH:D003921,2,Streptozocin|Troglitazone,1,PPARGC1A
aerobic electron transport chain,GO:0019646,"Diabetes Mellitus, Type 1",MESH:D003922,2,Streptozocin|Tetrachlorodibenzodioxin,0,
aerobic electron transport chain,GO:0019646,"Diabetes Mellitus, Type 2",MESH:D003924,5,Curcumin|Dichlorodiphenyl Dichloroethylene|Streptozocin|TAK-875|Troglitazone,1,PPARGC1A
aerobic respiration,GO:0009060,Diabetes Mellitus,MESH:D003920,15,Air Pollutants|Arsenic|arsenite|bisphenol A|Cadmium|Chlorpyrifos|Gallic Acid|Lead|methylarsonite|Particulate Matter|Pyruvaldehyde|Resveratrol|Rosiglitazone|Trifluoperazine|Zinc,1,CAT
aerobic respiration,GO:0009060,"Diabetes Mellitus, Experimental",MESH:D003921,13,Bile Acids and Salts|bisphenol A|Capsaicin|cinnamaldehyde|Dietary Fats|Dronabinol|Gallic Acid|Glucose|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|tributyltin,2,CAT|ND1
aerobic respiration,GO:0009060,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Calcitriol|Lipopolysaccharides|Norepinephrine|Resveratrol|sodium arsenite,1,CAT
aerobic respiration,GO:0009060,"Diabetes Mellitus, Type 2",MESH:D003924,19,Air Pollutants|Arsenic|Ascorbic Acid|bisphenol A|Cadmium|cinnamaldehyde|Curcumin|Dietary Fats|Glucose|Lead|Malathion|mono-(2-ethylhexyl)phthalate|Particulate Matter|perfluorooctane sulfonic acid|Resveratrol|Rosiglitazone|TAK-875|Vehicle Emissions|Zinc,1,CAT
aflatoxin metabolic process,GO:0046222,Diabetes Mellitus,MESH:D003920,0,,1,CPT1A
aflatoxin metabolic process,GO:0046222,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CPT1A
aflatoxin metabolic process,GO:0046222,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,CPT1A|CYP1A2|LIPC
aggressive behavior,GO:0002118,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Docosahexaenoic Acids|Lead,0,
aggressive behavior,GO:0002118,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
aggressive behavior,GO:0002118,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
aggressive behavior,GO:0002118,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Lead|perfluorooctane sulfonic acid,0,
aging,GO:0007568,Diabetes Mellitus,MESH:D003920,1,Nitrogen Oxides,0,
aging,GO:0007568,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
aging,GO:0007568,"Diabetes Mellitus, Type 2",MESH:D003924,2,Diethylhexyl Phthalate|mono-(2-ethylhexyl)phthalate,0,
agmatine biosynthetic process,GO:0097055,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
agmatine biosynthetic process,GO:0097055,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
agmatine biosynthetic process,GO:0097055,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
agmatine biosynthetic process,GO:0097055,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
alanine biosynthetic process,GO:0006523,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
alanine biosynthetic process,GO:0006523,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|tributyltin,0,
alanine biosynthetic process,GO:0006523,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
alanine biosynthetic process,GO:0006523,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
alanine metabolic process,GO:0006522,Diabetes Mellitus,MESH:D003920,3,Cadmium|Dichlorodiphenyl Dichloroethylene|Tobacco Smoke Pollution,0,
alanine metabolic process,GO:0006522,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Dichlorodiphenyl Dichloroethylene|Pantothenic Acid,0,
alcohol metabolic process,GO:0006066,"Diabetes Mellitus, Experimental",MESH:D003921,1,Inositol,0,
aldaric acid metabolic process,GO:0019577,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
aldaric acid metabolic process,GO:0019577,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,0,
aldosterone biosynthetic process,GO:0032342,"Diabetes Mellitus, Experimental",MESH:D003921,2,Nicotine|Quercetin,0,
aldosterone biosynthetic process,GO:0032342,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
aldosterone metabolic process,GO:0032341,"Diabetes Mellitus, Experimental",MESH:D003921,2,Aldosterone|Dietary Fats,0,
aldosterone metabolic process,GO:0032341,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,1,EDNRB
aldosterone secretion,GO:0035932,Diabetes Mellitus,MESH:D003920,1,triphenyltin,0,
aldosterone secretion,GO:0035932,"Diabetes Mellitus, Experimental",MESH:D003921,2,Aldosterone|tributyltin,1,AGT
alkaloid catabolic process,GO:0009822,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP3A11
alkaloid catabolic process,GO:0009822,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP3A2
alkaloid metabolic process,GO:0009820,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
alkaloid metabolic process,GO:0009820,"Diabetes Mellitus, Type 2",MESH:D003924,1,Atrazine,1,CYP1A2
allantois development,GO:1905069,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
allantois development,GO:1905069,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
allantois development,GO:1905069,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
allantois development,GO:1905069,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
alpha-amino acid metabolic process,GO:1901605,Diabetes Mellitus,MESH:D003920,2,Arsenic|arsenite,0,
alpha-amino acid metabolic process,GO:1901605,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Malathion,0,
alpha-beta T cell activation,GO:0046631,Diabetes Mellitus,MESH:D003920,0,,2,INS|INS2
alpha-beta T cell activation,GO:0046631,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INS1
alpha-beta T cell activation,GO:0046631,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
alpha-beta T cell activation,GO:0046631,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,INS|INS2
alpha-beta T cell activation,GO:0046631,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,INS|INS1
alpha-beta T cell differentiation,GO:0046632,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BRAF
alpha-linolenic acid metabolic process,GO:0036109,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,1,ACOX1
alpha-linolenic acid metabolic process,GO:0036109,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
alpha-linolenic acid metabolic process,GO:0036109,"Diabetes Mellitus, Type 2",MESH:D003924,4,perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctanoic acid|perfluoroundecanoic acid,0,
alpha-tubulin acetylation,GO:0071929,Diabetes Mellitus,MESH:D003920,2,Niacin|Resveratrol,0,
alpha-tubulin acetylation,GO:0071929,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
alpha-tubulin acetylation,GO:0071929,"Diabetes Mellitus, Experimental",MESH:D003921,3,"Niacinamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Resveratrol",0,
alpha-tubulin acetylation,GO:0071929,"Diabetes Mellitus, Type 1",MESH:D003922,3,Lipopolysaccharides|Niacinamide|Resveratrol,0,
alpha-tubulin acetylation,GO:0071929,"Diabetes Mellitus, Type 2",MESH:D003924,2,Niacinamide|Resveratrol,0,
amacrine cell differentiation,GO:0035881,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NEUROD1
amacrine cell differentiation,GO:0035881,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
amacrine cell differentiation,GO:0035881,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NEUROD1
amide metabolic process,GO:0043603,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Tolbutamide,0,
amine metabolic process,GO:0009308,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Lead|Selenium|Uranium,1,AOC3
amine metabolic process,GO:0009308,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,2,AOC3|CYP1A1
amine metabolic process,GO:0009308,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
amine metabolic process,GO:0009308,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Lead,0,
amino-acid betaine biosynthetic process,GO:0006578,Diabetes Mellitus,MESH:D003920,1,Polychlorinated Biphenyls,0,
amino-acid betaine biosynthetic process,GO:0006578,"Diabetes Mellitus, Type 2",MESH:D003924,2,perfluorooctanoic acid|Polychlorinated Biphenyls,0,
amino-acid betaine catabolic process,GO:0006579,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BHMT
amino-acid betaine metabolic process,GO:0006577,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
amino-acid betaine metabolic process,GO:0006577,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
amino-acid betaine metabolic process,GO:0006577,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
amino-acid betaine metabolic process,GO:0006577,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|bisphenol S|Ethanol,1,BHMT
amino acid biosynthetic process,GO:0008652,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Cadmium|Chlorpyrifos|Ozone|Uranium,0,
amino acid biosynthetic process,GO:0008652,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dietary Fats|Hydrogen Peroxide,0,
amino acid biosynthetic process,GO:0008652,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
amino acid biosynthetic process,GO:0008652,"Diabetes Mellitus, Type 2",MESH:D003924,12,Amino Acids|bisphenol A|bisphenol S|Cadmium|Cysteine|Dietary Fats|Ethanol|Folic Acid|Pantothenic Acid|perfluorodecanoic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid,0,
amino acid export across plasma membrane,GO:0032973,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
amino acid import,GO:0043090,"Diabetes Mellitus, Type 2",MESH:D003924,2,Curcumin|Vehicle Emissions,0,
amino acid metabolic process,GO:0006520,Diabetes Mellitus,MESH:D003920,13,Air Pollutants|arsenite|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Particulate Matter|Polychlorinated Biphenyls|Resveratrol|Selenium|Sodium Selenite|Streptozocin|Tetrachlorodibenzodioxin|Zinc,0,
amino acid metabolic process,GO:0006520,"Diabetes Mellitus, Experimental",MESH:D003921,7,bisphenol A|Diethylhexyl Phthalate|Resveratrol|sodium arsenite|Sodium Selenite|Streptozocin|Taurine,0,
amino acid metabolic process,GO:0006520,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Resveratrol|sodium arsenite|Streptozocin|Taurine|Tetrachlorodibenzodioxin,0,
amino acid metabolic process,GO:0006520,"Diabetes Mellitus, Type 2",MESH:D003924,16,Air Pollutants|bisphenol A|bisphenol S|Cadmium|Cysteine|Diethylhexyl Phthalate|Ethanol|Glutathione|Pantothenic Acid|Particulate Matter|Polychlorinated Biphenyls|Resveratrol|S-Adenosylmethionine|Streptozocin|Vehicle Emissions|Zinc,1,PEPD
amino acid transport,GO:0006865,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
amino acid transport,GO:0006865,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
amino acid transport,GO:0006865,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
amino acid transport,GO:0006865,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
amino sugar metabolic process,GO:0006040,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
amino sugar metabolic process,GO:0006040,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dichlorodiphenyl Dichloroethylene,0,
ammonium excretion,GO:0140734,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
ammonium excretion,GO:0140734,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
ammonium excretion,GO:0140734,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
ammonium excretion,GO:0140734,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
ammonium homeostasis,GO:0097272,Diabetes Mellitus,MESH:D003920,3,arsenite|bisphenol A|Tetrachlorodibenzodioxin,0,
ammonium homeostasis,GO:0097272,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
ammonium homeostasis,GO:0097272,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Tetrachlorodibenzodioxin,0,
ammonium homeostasis,GO:0097272,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
AMPA selective glutamate receptor signaling pathway,GO:0098990,Diabetes Mellitus,MESH:D003920,1,Chlordan,0,
AMPA selective glutamate receptor signaling pathway,GO:0098990,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,0,
AMP biosynthetic process,GO:0006167,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,0,
AMP metabolic process,GO:0046033,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|honokiol,0,
AMP metabolic process,GO:0046033,"Diabetes Mellitus, Type 2",MESH:D003924,4,Dietary Fats|Ethanol|Folic Acid|perfluorooctanoic acid,0,
amylin receptor 1 signaling pathway,GO:0150059,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IAPP
amylin receptor 1 signaling pathway,GO:0150059,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IAPP
amylin receptor 2 signaling pathway,GO:0150060,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IAPP
amylin receptor 2 signaling pathway,GO:0150060,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IAPP
amylin receptor 3 signaling pathway,GO:0150061,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IAPP
amylin receptor 3 signaling pathway,GO:0150061,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IAPP
amylin receptor signaling pathway,GO:0097647,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IAPP
amylin receptor signaling pathway,GO:0097647,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IAPP
amyloid-beta clearance,GO:0097242,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
amyloid-beta clearance,GO:0097242,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
amyloid-beta clearance,GO:0097242,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,C3
amyloid-beta clearance by cellular catabolic process,GO:0150094,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
amyloid-beta metabolic process,GO:0050435,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
amyloid-beta metabolic process,GO:0050435,"Diabetes Mellitus, Experimental",MESH:D003921,1,Coconut Oil,2,ACE|REN
amyloid-beta metabolic process,GO:0050435,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Vehicle Emissions,0,
amyloid fibril formation,GO:1990000,Diabetes Mellitus,MESH:D003920,3,Docosahexaenoic Acids|Particulate Matter|Raloxifene Hydrochloride,0,
amyloid fibril formation,GO:1990000,"Diabetes Mellitus, Experimental",MESH:D003921,1,thymoquinone,1,IAPP
amyloid fibril formation,GO:1990000,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Vehicle Emissions,2,CD36|IAPP
amylopectin biosynthetic process,GO:0010021,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC2A4
amylopectin biosynthetic process,GO:0010021,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A4
anagen,GO:0042640,Diabetes Mellitus,MESH:D003920,0,,1,PTGS2
anagen,GO:0042640,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
anagen,GO:0042640,"Diabetes Mellitus, Experimental",MESH:D003921,1,Cyclophosphamide,1,PTGS2
anagen,GO:0042640,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
anagen,GO:0042640,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
anatomical structure arrangement,GO:0048532,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,1,RAC1
anatomical structure development,GO:0048856,Diabetes Mellitus,MESH:D003920,0,,1,NR1I3
anatomical structure development,GO:0048856,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
anatomical structure development,GO:0048856,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PAX4
anatomical structure development,GO:0048856,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctane sulfonic acid,3,HNF4A|PAX4|PAX6
anatomical structure morphogenesis,GO:0009653,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
anatomical structure morphogenesis,GO:0009653,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PCSK2|RELA|TP53
anatomical structure morphogenesis,GO:0009653,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,IGF2BP2|NFKB1|PCSK2|SMAD5
anatomical structure regression,GO:0060033,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Particulate Matter,0,
anatomical structure regression,GO:0060033,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
anatomical structure regression,GO:0060033,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
anatomical structure regression,GO:0060033,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Curcumin|Particulate Matter,0,
androgen biosynthetic process,GO:0006702,Diabetes Mellitus,MESH:D003920,2,Atrazine|bisphenol A,0,
androgen biosynthetic process,GO:0006702,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Cholesterol|Nicotine,0,
androgen biosynthetic process,GO:0006702,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
androgen biosynthetic process,GO:0006702,"Diabetes Mellitus, Type 2",MESH:D003924,5,Ascorbic Acid|Atrazine|bisphenol A|Nicotine|perfluorooctanoic acid,0,
androgen catabolic process,GO:0006710,"Diabetes Mellitus, Experimental",MESH:D003921,1,Tocotrienols,0,
androgen catabolic process,GO:0006710,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tocotrienols,0,
androgen metabolic process,GO:0008209,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Cyclosporine|Trichlorfon,0,
androgen metabolic process,GO:0008209,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Quercetin|sodium arsenite,1,PPARGC1A
androgen metabolic process,GO:0008209,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Dehydroepiandrosterone|sodium arsenite,0,
androgen metabolic process,GO:0008209,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,2,PLEKHA1|PPARGC1A
androgen receptor signaling pathway,GO:0030521,Diabetes Mellitus,MESH:D003920,2,Atrazine|Resveratrol,0,
androgen receptor signaling pathway,GO:0030521,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,1,IGF1
androgen receptor signaling pathway,GO:0030521,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,1,IGF1
androgen receptor signaling pathway,GO:0030521,"Diabetes Mellitus, Type 2",MESH:D003924,2,Atrazine|Resveratrol,0,
androgen secretion,GO:0035935,Diabetes Mellitus,MESH:D003920,1,"2,2',4,4'-tetrabromodiphenyl ether",0,
"androst-4-ene-3,17-dione biosynthetic process",GO:1903449,Diabetes Mellitus,MESH:D003920,3,Chlorpromazine|Clozapine|Risperidone,0,
"androst-4-ene-3,17-dione biosynthetic process",GO:1903449,"Diabetes Mellitus, Type 2",MESH:D003924,1,Clozapine,0,
androstenedione secretion,GO:0035941,"Diabetes Mellitus, Experimental",MESH:D003921,3,Dibutyl Phthalate|Diethylhexyl Phthalate|Sodium Glutamate,0,
androstenedione secretion,GO:0035941,"Diabetes Mellitus, Type 2",MESH:D003924,4,Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate|mono-(2-ethylhexyl)phthalate,0,
angioblast cell migration,GO:0035476,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
angiogenesis,GO:0001525,Diabetes Mellitus,MESH:D003920,8,bisphenol A|Cadmium|Chlorpyrifos|Copper|Metformin|morroniside|Particulate Matter|Streptozocin,4,FN1|LEPR|PTGS2|SIRT1
angiogenesis,GO:0001525,"Diabetes Mellitus, Experimental",MESH:D003921,10,bisphenol A|Glucose|honokiol|Metformin|Nicotine|platycodin D|Quercetin|Streptozocin|Ursolic Acid|Vitamin E,13,CAV1|HMOX1|ID1|LEP|LEPR|MFGE8|MMP2|NOS3|PRKCA|PTGS2|SERPINE1|SIRT1|VEGFA
angiogenesis,GO:0001525,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,1,NOS3
angiogenesis,GO:0001525,"Diabetes Mellitus, Type 2",MESH:D003924,14,Ascorbic Acid|bisphenol A|Cadmium|Copper|Curcumin|Diethylnitrosamine|Ethanol|Folic Acid|Glucose|Metformin|Nicotine|Particulate Matter|Silver|Streptozocin,11,CASP8|EDNRA|HMOX1|ID1|LEP|LEPR|NOS3|NUS1|PIK3CG|SIRT1|SMAD5
angiogenesis involved in coronary vascular morphogenesis,GO:0060978,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ACE|VEGFA
angiogenesis involved in wound healing,GO:0060055,Diabetes Mellitus,MESH:D003920,1,morroniside,0,
angiogenesis involved in wound healing,GO:0060055,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CX3CL1|GPX1
angiogenesis involved in wound healing,GO:0060055,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,ETS1|GPX1|MIR222
angiotensin-activated signaling pathway,GO:0038166,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,3,ACE|AGT|CAV1
angiotensin-activated signaling pathway,GO:0038166,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
angiotensin-activated signaling pathway involved in heart process,GO:0086098,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
angiotensin maturation,GO:0002003,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ACE|REN
angiotensin-mediated drinking behavior,GO:0003051,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AGT
angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,GO:0001998,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AGT
angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure,GO:0002033,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AGT
animal organ development,GO:0048513,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
animal organ development,GO:0048513,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CASP12
animal organ development,GO:0048513,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctane sulfonic acid,2,HNF1B|PAX6
animal organ morphogenesis,GO:0009887,"Diabetes Mellitus, Experimental",MESH:D003921,0,,9,BCL2|FGF21|INSR|NKX6-1|PAX6|PDX1|RELA|TGFB1|TNF
animal organ morphogenesis,GO:0009887,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
animal organ morphogenesis,GO:0009887,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
animal organ morphogenesis,GO:0009887,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,FGF21|PAX4|TNF
animal organ morphogenesis,GO:0009887,"Diabetes Mellitus, Type 2",MESH:D003924,0,,10,BCL2|BRAF|FGF21|HHEX|NKX6-1|NOTCH2|PAX4|PAX6|PDX1|TNF
animal organ regeneration,GO:0031100,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
animal organ regeneration,GO:0031100,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,ACE|CAV1|PDX1|PPARG|TGFB1
animal organ regeneration,GO:0031100,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HP
animal organ regeneration,GO:0031100,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,HP|PDX1|PPARG
anisotropic cell growth,GO:0051211,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
anisotropic cell growth,GO:0051211,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
anoikis,GO:0043276,"Diabetes Mellitus, Experimental",MESH:D003921,4,Hydrogen Peroxide|Nicotine|Nitric Oxide|pimagedine,0,
anoikis,GO:0043276,"Diabetes Mellitus, Type 1",MESH:D003922,1,Nitric Oxide,0,
anoikis,GO:0043276,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,1,AKT1
antennal morphogenesis,GO:0048800,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Coumaphos,0,
anterior lateral line development,GO:0048899,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
anterior lateral line development,GO:0048899,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDN1
anterior lateral line neuromast development,GO:0048901,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,EDN1|S1PR2
anterior lateral line neuromast development,GO:0048901,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDN1
anterior lateral line neuromast hair cell development,GO:0035676,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR2
anterior neural tube closure,GO:0061713,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CASP3
anterior neural tube closure,GO:0061713,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP3
anterior neuropore closure,GO:0021506,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
anterior/posterior axis specification,GO:0009948,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,RELA
anterior/posterior axis specification,GO:0009948,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
anterior/posterior pattern specification,GO:0009952,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,NEUROD1|PAX6|PDX1
anterior/posterior pattern specification,GO:0009952,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,HHEX|HNF1B|NEUROD1|PAX6|PDX1|RETN
anterograde axonal protein transport,GO:0099641,Diabetes Mellitus,MESH:D003920,0,,1,KIF5B
anterograde axonal transport,GO:0008089,Diabetes Mellitus,MESH:D003920,0,,2,KIF1A|SOD1
anterograde axonal transport,GO:0008089,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SOD1
anterograde axonal transport,GO:0008089,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AP3S2|SOD1
anterograde dendritic transport,GO:0098937,Diabetes Mellitus,MESH:D003920,0,,1,KIF1A
anterograde neuronal dense core vesicle transport,GO:1990048,Diabetes Mellitus,MESH:D003920,0,,2,KIF1A|KIF5B
anterograde synaptic vesicle transport,GO:0048490,Diabetes Mellitus,MESH:D003920,0,,1,KIF1A
anterograde synaptic vesicle transport,GO:0048490,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AP3S2
anthranilate metabolic process,GO:0043420,Diabetes Mellitus,MESH:D003920,1,Uranium,0,
antibacterial innate immune response,GO:0140367,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NFKB1
antigen processing and presentation,GO:0019882,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IFNG
antigen processing and presentation,GO:0019882,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,CTSH|IFNG
antigen processing and presentation of endogenous peptide antigen via MHC class II,GO:0002491,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HLA-DRB1
antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0019886,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,HLA-DQB1|HLA-DRB1
antigen processing and presentation of peptide antigen,GO:0048002,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
antigen processing and presentation of peptide antigen via MHC class I,GO:0002474,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
antigen transcytosis by M cells in mucosal-associated lymphoid tissue,GO:0002412,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GP2
antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061844,Diabetes Mellitus,MESH:D003920,0,,1,POMC
antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061844,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CCL20
antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061844,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CCL20
antimicrobial humoral response,GO:0019730,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
antimicrobial humoral response,GO:0019730,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
antimicrobial humoral response,GO:0019730,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,SLC11A1
antimicrobial humoral response,GO:0019730,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
antiviral innate immune response,GO:0140374,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,RELA|TNF
antiviral innate immune response,GO:0140374,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
antiviral innate immune response,GO:0140374,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNF
antral ovarian follicle growth,GO:0001547,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Dichlorodiphenyl Dichloroethylene|Resveratrol,0,
antral ovarian follicle growth,GO:0001547,"Diabetes Mellitus, Experimental",MESH:D003921,7,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate|Resveratrol|sodium arsenite|Taurine|tributyltin,1,FOXO3
antral ovarian follicle growth,GO:0001547,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Genistein|Resveratrol|sodium arsenite|Taurine,0,
antral ovarian follicle growth,GO:0001547,"Diabetes Mellitus, Type 2",MESH:D003924,11,bisphenol A|bisphenol S|Curcumin|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|diethyl phthalate|Genistein|mono-(2-ethylhexyl)phthalate|perfluorooctanoic acid|Resveratrol,0,
aorta development,GO:0035904,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEP
aorta development,GO:0035904,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,EDNRA|ENPP1|LEP
aorta morphogenesis,GO:0035909,Diabetes Mellitus,MESH:D003920,1,Zinc,0,
aorta morphogenesis,GO:0035909,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
aorta morphogenesis,GO:0035909,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Zinc,1,ADAMTS9
aorta smooth muscle tissue morphogenesis,GO:0060414,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
aortic valve development,GO:0003176,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TNFRSF1A
aortic valve development,GO:0003176,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,TNFRSF1A|TNFRSF1B
aortic valve morphogenesis,GO:0003180,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NOS3|TGFB1
aortic valve morphogenesis,GO:0003180,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
aortic valve morphogenesis,GO:0003180,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOS3
apical dendrite arborization,GO:0150023,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
apical dendrite arborization,GO:0150023,"Diabetes Mellitus, Experimental",MESH:D003921,1,Cyclophosphamide,0,
apical dendrite arborization,GO:0150023,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
apical dendrite morphogenesis,GO:0150021,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
apical dendrite morphogenesis,GO:0150021,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
apoptosome assembly,GO:0097314,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
apoptosome assembly,GO:0097314,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
apoptotic cell clearance,GO:0043277,Diabetes Mellitus,MESH:D003920,1,Aspirin,0,
apoptotic cell clearance,GO:0043277,"Diabetes Mellitus, Experimental",MESH:D003921,1,Cromolyn Sodium,1,MFGE8
apoptotic cell clearance,GO:0043277,"Diabetes Mellitus, Type 1",MESH:D003922,1,Norepinephrine,0,
apoptotic cell clearance,GO:0043277,"Diabetes Mellitus, Type 2",MESH:D003924,2,daidzein|Malathion,1,CD36
apoptotic chromosome condensation,GO:0030263,Diabetes Mellitus,MESH:D003920,21,Air Pollutants|Arsenic|Atrazine|Berberine|bisphenol A|Blood Glucose|Cadmium|Chlorpyrifos|Cyclosporine|Diazinon|Flavonoids|Lead|Metformin|Nitrogen Dioxide|Particulate Matter|Plant Extracts|Resveratrol|Streptozocin|Sulfur Dioxide|Tacrolimus|Zinc,0,
apoptotic chromosome condensation,GO:0030263,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
apoptotic chromosome condensation,GO:0030263,"Diabetes Mellitus, Experimental",MESH:D003921,22,"astaxanthine|Berberine|bisphenol A|Blood Glucose|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Hydrogen Peroxide|Metformin|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|Quercetin|Resveratrol|sarpogrelate|sodium arsenite|Sodium Glutamate|Streptozocin|Tacrolimus|Taurine|thymoquinone|tributyltin",0,
apoptotic chromosome condensation,GO:0030263,"Diabetes Mellitus, Type 1",MESH:D003922,10,bisphenol A|Cyclophosphamide|Genistein|Lipopolysaccharides|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|Taurine|Thioctic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Diabetes Mellitus, Type 2",MESH:D003924,28,"Air Pollutants|Arsenic|Ascorbic Acid|astaxanthine|Atrazine|Berberine|bisphenol A|bisphenol S|Blood Glucose|Cadmium|Curcumin|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Drugs, Chinese Herbal|epigallocatechin gallate|Ethanol|Genistein|Glutathione|Lead|Metformin|Nickel|Particulate Matter|Plant Extracts|Resveratrol|Streptozocin|Topiramate|Zinc",0,
apoptotic DNA fragmentation,GO:0006309,Diabetes Mellitus,MESH:D003920,29,aroclor 1260|Aspirin|Cadmium|Cyclosporine|Diazoxide|Docosahexaenoic Acids|Flavonoids|Gallic Acid|Glucocorticoids|Glyburide|Magnesium|Methylprednisolone|Particulate Matter|Perindopril|Plant Extracts|Prednisolone|Pyruvaldehyde|Raloxifene Hydrochloride|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Tacrolimus|Telmisartan|Tetrachlorodibenzodioxin|Troglitazone|Zinc,0,
apoptotic DNA fragmentation,GO:0006309,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
apoptotic DNA fragmentation,GO:0006309,"Diabetes Mellitus, Experimental",MESH:D003921,29,Capsaicin|Cyclophosphamide|Dietary Fats|Enalapril|Fenretinide|Gallic Acid|Glucose|Glyburide|Hydrogen Peroxide|Losartan|mangiferin|Nicotine|Nitric Oxide|Plant Extracts|pycnogenols|Quercetin|resiniferatoxin|Resveratrol|Rosiglitazone|sodium arsenite|Sodium Selenite|Streptozocin|Tacrolimus|tangeretin|Taurine|Telmisartan|tributyltin|Troglitazone|Vitamin E,0,
apoptotic DNA fragmentation,GO:0006309,"Diabetes Mellitus, Type 1",MESH:D003922,14,Calcitriol|Cyclophosphamide|Genistein|Lipopolysaccharides|Nitric Oxide|Norepinephrine|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|Taurine|Tetrachlorodibenzodioxin|Vitamin A,0,
apoptotic DNA fragmentation,GO:0006309,"Diabetes Mellitus, Type 2",MESH:D003924,34,alpha-Tocopherol|Ascorbic Acid|Cadmium|Calcium|Curcumin|daidzein|Dietary Fats|Enalapril|Ethanol|Genistein|Glucose|Glyburide|Magnesium|Malathion|mangiferin|Nickel|Nicotine|Particulate Matter|Pentoxifylline|perfluorodecanoic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts|Reactive Oxygen Species|Resveratrol|Rosiglitazone|S-Adenosylmethionine|Silver|Streptozocin|Telmisartan|Tolbutamide|Troglitazone|Vehicle Emissions|Zinc,0,
apoptotic mitochondrial changes,GO:0008637,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
apoptotic mitochondrial changes,GO:0008637,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,AIFM1|BAX|BCL2|BCL2L1|SOD2
apoptotic mitochondrial changes,GO:0008637,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,AIFM1
apoptotic mitochondrial changes,GO:0008637,"Diabetes Mellitus, Type 2",MESH:D003924,2,Curcumin|Dichlorodiphenyl Dichloroethylene,6,AKT1|BAX|BCL2|BCL2L1|GCLM|SOD2
apoptotic nuclear changes,GO:0030262,Diabetes Mellitus,MESH:D003920,7,arsenite|bisphenol A|Chlorpyrifos|Cyclosporine|Plant Extracts|Selenium|Tobacco Smoke Pollution,0,
apoptotic nuclear changes,GO:0030262,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Hydrogen Peroxide|Plant Extracts|sodium arsenite,0,
apoptotic nuclear changes,GO:0030262,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
apoptotic nuclear changes,GO:0030262,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Thioctic Acid,1,HNF1A
apoptotic nuclear changes,GO:0030262,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Ethanol|Plant Extracts,1,HNF1A
apoptotic process,GO:0006915,Diabetes Mellitus,MESH:D003920,82,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Alloxan|Antimony|Arsenic|arsenite|Aspirin|Atrazine|Berberine|Bezafibrate|bisphenol A|Cadmium|Chlorpromazine|Chlorpyrifos|Chromium|Clozapine|Copper|Cyclosporine|DDT|Diazinon|Diazoxide|Dichlorodiphenyl Dichloroethylene|Dichlorvos|dimethylarsinous acid|Docosahexaenoic Acids|Flavonoids|Gallic Acid|Gliclazide|Glucocorticoids|Glyburide|Hexachlorobenzene|Indapamide|Iron|Lead|Liraglutide|Meglumine Antimoniate|Mercury|Metals, Heavy|Metformin|Methylprednisolone|Molybdenum|morroniside|Nateglinide|Niacin|Nitrogen Dioxide|Olanzapine|osthol|Ozone|Particulate Matter|Perindopril|Phenformin|Pioglitazone|Plant Extracts|Plant Preparations|Polychlorinated Biphenyls|Potassium|Pravastatin|Prednisolone|pregna-4,17-diene-3,16-dione|puerarin|Pyruvaldehyde|Quetiapine Fumarate|Raloxifene Hydrochloride|Ramipril|Reactive Oxygen Species|repaglinide|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Sulfur Dioxide|Tacrolimus|Telmisartan|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Trifluoperazine|triphenyltin|Troglitazone|Vanadium Compounds|Zinc",1,SOD1
apoptotic process,GO:0006915,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
apoptotic process,GO:0006915,"Diabetes Mellitus, Experimental",MESH:D003921,84,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid|7-hydroxycoumarin|Aldosterone|Alloxan|astaxanthine|Berberine|Bezafibrate|Biguanides|bisphenol A|Capsaicin|Cholesterol|Cholesterol, LDL|Chromium|cinnamaldehyde|Clioquinol|cobaltiprotoporphyrin|Cromolyn Sodium|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Diltiazem|Diosmin|Dronabinol|Enalapril|Exenatide|Fatty Acids, Nonesterified|FeCl tetrakis-2-(triethyleneglycolmonomethylether)pyridylporphyrin|Fenretinide|fenugreek seed meal|Fructose|Gallic Acid|ginsenoside Re|Gliclazide|Glucose|Glyburide|Hemin|honokiol|Hydrogen Peroxide|Imatinib Mesylate|Losartan|Malondialdehyde|Manganese|mangiferin|Metformin|Naproxen|Niacinamide|Nicotine|Nitric Oxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|pimagedine|Pioglitazone|Plant Extracts|Plant Preparations|Propolis|pterostilbene|puerarin|pycnogenols|Quercetin|Ramipril|resiniferatoxin|Resveratrol|Rosiglitazone|S-allylcysteine|sarpogrelate|Sertraline|sodium arsenite|Sodium Glutamate|Sodium Selenite|stannous chloride|Streptozocin|Superoxides|swietenine|Tacrolimus|tangeretin|Taurine|Telmisartan|thymoquinone|tributyltin|Troglitazone|Ursolic Acid|Valsartan|Vitamin E",22,ADRA1A|AIFM1|BAX|BCL2|BCL2L1|CASP3|FAS|GPX1|IAPP|ID1|IFNG|IL1B|KCNJ11|MMP9|PRKCA|PRKCD|PRKCE|SOD1|TNFRSF1A|TP53|TRP53|VEGFA
apoptotic process,GO:0006915,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
apoptotic process,GO:0006915,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
apoptotic process,GO:0006915,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
apoptotic process,GO:0006915,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
apoptotic process,GO:0006915,"Diabetes Mellitus, Type 1",MESH:D003922,27,Alloxan|bisphenol A|Calcitriol|Cyclophosphamide|decabromobiphenyl ether|Dichlorvos|FeCl tetrakis-2-(triethyleneglycolmonomethylether)pyridylporphyrin|Genistein|Imatinib Mesylate|Iron|Lipopolysaccharides|Mercury|Niacinamide|Nitric Oxide|Norepinephrine|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Superoxides|Tacrolimus|Taurine|Tetrachlorodibenzodioxin|Thioctic Acid|Uric Acid|Vitamin A|Warfarin,8,AIFM1|CASP12|CTSH|DDIT3|IFNG|IL19|IL2RA|KCNJ11
apoptotic process,GO:0006915,"Diabetes Mellitus, Type 2",MESH:D003924,88,"Air Pollutants|Alloxan|alpha-Tocopherol|Amoxicillin|Angiotensin-Converting Enzyme Inhibitors|Arsenic|Ascorbic Acid|astaxanthine|Atrazine|Berberine|Bezafibrate|bisphenol A|bisphenol S|Boron|Cadmium|Calcium|Cholesterol, LDL|Chromium|cinnamaldehyde|Clozapine|Copper|coumarin|Curcumin|Cysteine|daidzein|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Diosmin|Drugs, Chinese Herbal|Enalapril|epigallocatechin gallate|Ethanol|Exenatide|Fatty Acids, Nonesterified|Folic Acid|Fructose|Genistein|ginsenoside Re|Gliclazide|Glucose|Glutathione|Glyburide|Hemin|Irbesartan|Iron|Lead|Liraglutide|Malathion|Malondialdehyde|Manganese|mangiferin|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Nelfinavir|Niacinamide|Nickel|Nicotine|Nitrendipine|Orlistat|Particulate Matter|Pentoxifylline|perfluorodecanoic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Plant Extracts|Polychlorinated Biphenyls|procyanidin B1|procyanidin B2|Reactive Oxygen Species|Resveratrol|Rosiglitazone|S-Adenosylmethionine|Silver|Sitagliptin Phosphate|stannous chloride|Streptozocin|Superoxides|Telmisartan|titanium dioxide|Tolbutamide|Troglitazone|Vehicle Emissions|Zinc",19,BAX|BCL2|BCL2L1|BCL2L11|CASP3|CASP8|FAS|GPX1|HNF1B|IAPP|ID1|INPPL1|KCNJ11|NFKB1|NOTCH2|PRKCB|SOD1|TNFRSF1A|TNFRSF1B
apoptotic process in bone marrow cell,GO:0071839,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2L1
apoptotic process in bone marrow cell,GO:0071839,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2L1
apoptotic process involved in blood vessel morphogenesis,GO:1902262,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,BAX|TP53
apoptotic process involved in blood vessel morphogenesis,GO:1902262,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
apoptotic process involved in development,GO:1902742,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TP53
apoptotic process involved in development,GO:1902742,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
apoptotic process involved in embryonic digit morphogenesis,GO:1902263,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
apoptotic process involved in embryonic digit morphogenesis,GO:1902263,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BAX|BCL2L11
apoptotic process involved in mammary gland involution,GO:0060057,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
apoptotic process involved in mammary gland involution,GO:0060057,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
apoptotic signaling pathway,GO:0097190,Diabetes Mellitus,MESH:D003920,0,,1,MAP3K5
apoptotic signaling pathway,GO:0097190,"Diabetes Mellitus, Experimental",MESH:D003921,0,,9,BAX|CASP3|CAV1|FAS|MAP3K5|PRKCA|TNF|TP53|TRP53
apoptotic signaling pathway,GO:0097190,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
apoptotic signaling pathway,GO:0097190,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,BAX|CASP3|CASP8|FAS|TNF
arabinose biosynthetic process,GO:0019567,Diabetes Mellitus,MESH:D003920,1,"2,2',4,4'-tetrabromodiphenyl ether",0,
arabinose biosynthetic process,GO:0019567,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
arabinose biosynthetic process,GO:0019567,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
arachidonic acid metabolic process,GO:0019369,Diabetes Mellitus,MESH:D003920,9,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A|Chlorpyrifos|Docosahexaenoic Acids|docosapentaenoic acid|Resveratrol|Rosiglitazone|Tetrachlorodibenzodioxin|Uranium",0,
arachidonic acid metabolic process,GO:0019369,"Diabetes Mellitus, Experimental",MESH:D003921,8,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid|bisphenol A|Diethylhexyl Phthalate|Dronabinol|Resveratrol|Rosiglitazone|sodium arsenite|Thromboxane B2",3,CYP4A10|GPX1|REN
arachidonic acid metabolic process,GO:0019369,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Resveratrol|sodium arsenite|Tetrachlorodibenzodioxin,0,
arachidonic acid metabolic process,GO:0019369,"Diabetes Mellitus, Type 2",MESH:D003924,11,bisphenol A|bisphenol S|Diethylhexyl Phthalate|Malathion|mono-(2-ethylhexyl)phthalate|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctanoic acid|perfluoroundecanoic acid|Resveratrol|Rosiglitazone,2,CYP1A2|GPX1
arachidonic acid secretion,GO:0050482,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
arginine biosynthetic process,GO:0006526,Diabetes Mellitus,MESH:D003920,1,DDT,0,
arginine catabolic process,GO:0006527,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NOS2|NOS3
arginine catabolic process,GO:0006527,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,2,NOS1|NOS3
arginine catabolic process,GO:0006527,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NOS2|NOS3
arginine metabolic process,GO:0006525,Diabetes Mellitus,MESH:D003920,4,Air Pollutants|Nitrogen Dioxide|Particulate Matter|Resveratrol,0,
arginine metabolic process,GO:0006525,"Diabetes Mellitus, Experimental",MESH:D003921,2,Hydrogen Peroxide|Resveratrol,0,
arginine metabolic process,GO:0006525,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
arginine metabolic process,GO:0006525,"Diabetes Mellitus, Type 2",MESH:D003924,3,Air Pollutants|Particulate Matter|Resveratrol,0,
arsenate ion transmembrane transport,GO:1901684,Diabetes Mellitus,MESH:D003920,1,arsenite,0,
arsenite transport,GO:0015700,Diabetes Mellitus,MESH:D003920,3,Arsenic|arsenite|Selenium,0,
arsenite transport,GO:0015700,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
arsenite transport,GO:0015700,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
arsenite transport,GO:0015700,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Ethanol,0,
artery development,GO:0060840,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
artery development,GO:0060840,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
artery development,GO:0060840,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,1,ENPP1
artery morphogenesis,GO:0048844,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
artery smooth muscle contraction,GO:0014824,Diabetes Mellitus,MESH:D003920,5,Particulate Matter|Plant Preparations|Resveratrol|Serotonin|Tobacco Smoke Pollution,0,
artery smooth muscle contraction,GO:0014824,"Diabetes Mellitus, Experimental",MESH:D003921,4,pimagedine|Plant Preparations|Resveratrol|sodium arsenite,2,AGT|EDN1
artery smooth muscle contraction,GO:0014824,"Diabetes Mellitus, Type 1",MESH:D003922,3,Norepinephrine|Resveratrol|sodium arsenite,0,
artery smooth muscle contraction,GO:0014824,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Resveratrol,2,EDN1|EDNRA
artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure,GO:0001984,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure,GO:0001984,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,0,
articular cartilage development,GO:0061975,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,1,ENPP1
asparagine biosynthetic process,GO:0006529,Diabetes Mellitus,MESH:D003920,2,DDT|Polychlorinated Biphenyls,0,
asparagine biosynthetic process,GO:0006529,"Diabetes Mellitus, Type 2",MESH:D003924,1,Polychlorinated Biphenyls,0,
asparagine metabolic process,GO:0006528,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
asparagine metabolic process,GO:0006528,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
aspartate biosynthetic process,GO:0006532,Diabetes Mellitus,MESH:D003920,2,DDT|Methylprednisolone,0,
aspartate catabolic process,GO:0006533,Diabetes Mellitus,MESH:D003920,3,Flavonoids|Plant Extracts|puerarin,0,
aspartate catabolic process,GO:0006533,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
aspartate catabolic process,GO:0006533,"Diabetes Mellitus, Experimental",MESH:D003921,3,Cyclophosphamide|Plant Extracts|puerarin,0,
aspartate catabolic process,GO:0006533,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
aspartate catabolic process,GO:0006533,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
aspartate metabolic process,GO:0006531,Diabetes Mellitus,MESH:D003920,5,Air Pollutants|Dichlorodiphenyl Dichloroethylene|Nitrogen Dioxide|Ozone|Particulate Matter,0,
aspartate metabolic process,GO:0006531,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|Dichlorodiphenyl Dichloroethylene|Particulate Matter|perfluorooctanoic acid,0,
associative learning,GO:0008306,Diabetes Mellitus,MESH:D003920,2,Aspirin|bisphenol A,0,
associative learning,GO:0008306,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Dronabinol,2,AGT|SNAP25
associative learning,GO:0008306,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
associative learning,GO:0008306,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,2,GLP1R|SNAP25
astral microtubule nucleation,GO:0030954,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
astral microtubule nucleation,GO:0030954,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
astral microtubule nucleation,GO:0030954,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
astral microtubule nucleation,GO:0030954,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
astrocyte activation,GO:0048143,Diabetes Mellitus,MESH:D003920,11,Air Pollutants|bisphenol A|Blood Glucose|Diazoxide|Lead|Metformin|Particulate Matter|Reactive Oxygen Species|repaglinide|Resveratrol|Streptozocin,0,
astrocyte activation,GO:0048143,"Diabetes Mellitus, Experimental",MESH:D003921,12,bisphenol A|Blood Glucose|Dietary Fats|Dronabinol|Metformin|Phycocyanin|Quercetin|Resveratrol|sodium arsenite|Sodium Glutamate|Streptozocin|tributyltin,4,AGT|IFNG|IL1B|TNF
astrocyte activation,GO:0048143,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Lipopolysaccharides|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin,2,IFNG|TNF
astrocyte activation,GO:0048143,"Diabetes Mellitus, Type 2",MESH:D003924,10,Air Pollutants|bisphenol A|Blood Glucose|Dietary Fats|Lead|Metformin|Particulate Matter|Reactive Oxygen Species|Resveratrol|Streptozocin,2,EGFR|TNF
astrocyte activation involved in immune response,GO:0002265,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
astrocyte activation involved in immune response,GO:0002265,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
astrocyte activation involved in immune response,GO:0002265,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
astrocyte activation involved in immune response,GO:0002265,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
astrocyte cell migration,GO:0043615,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
astrocyte cell migration,GO:0043615,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
astrocyte cell migration,GO:0043615,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,0,
astrocyte development,GO:0014002,Diabetes Mellitus,MESH:D003920,6,Arsenic|bisphenol A|Cadmium|Chlorpyrifos|Lead|Plant Extracts,0,
astrocyte development,GO:0014002,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Plant Extracts|Quercetin|sodium arsenite,0,
astrocyte development,GO:0014002,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
astrocyte development,GO:0014002,"Diabetes Mellitus, Type 2",MESH:D003924,6,Arsenic|bisphenol A|Cadmium|Ethanol|Lead|Plant Extracts,0,
astrocyte differentiation,GO:0048708,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
astrocyte differentiation,GO:0048708,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
astrocyte differentiation,GO:0048708,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
astrocyte differentiation,GO:0048708,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,1,PAX6
astrocyte fate commitment,GO:0060018,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
ATF6-mediated unfolded protein response,GO:0036500,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
ATP biosynthetic process,GO:0006754,Diabetes Mellitus,MESH:D003920,29,Air Pollutants|arsenite|Berberine|bisphenol A|Cadmium|Chlorpromazine|Clozapine|Copper|Cyclosporine|Dichlorvos|Gallic Acid|Glyburide|Lead|Metformin|Particulate Matter|Plant Extracts|Polychlorinated Biphenyls|puerarin|Pyruvaldehyde|Resveratrol|Risperidone|Rosiglitazone|Streptozocin|Thioridazine|Tobacco Smoke Pollution|Trifluoperazine|triphenyltin|Troglitazone|Zinc,1,ATP6
ATP biosynthetic process,GO:0006754,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
ATP biosynthetic process,GO:0006754,"Diabetes Mellitus, Experimental",MESH:D003921,26,"Berberine|Bile Acids and Salts|bisphenol A|Dibutyl Phthalate|Dietary Fats|Gallic Acid|Glucose|Glyburide|honokiol|Hydrogen Peroxide|Imatinib Mesylate|Metformin|Monocrotophos|Niacinamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|pimagedine|Plant Extracts|puerarin|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Streptozocin|tributyltin|Troglitazone|Vitamin E",1,TGFB1
ATP biosynthetic process,GO:0006754,"Diabetes Mellitus, Type 1",MESH:D003922,9,bisphenol A|Dichlorvos|Imatinib Mesylate|Lipopolysaccharides|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Thioctic Acid,0,
ATP biosynthetic process,GO:0006754,"Diabetes Mellitus, Type 2",MESH:D003924,29,Air Pollutants|Ascorbic Acid|Berberine|bisphenol A|Cadmium|Clozapine|Copper|Curcumin|Dibutyl Phthalate|Dietary Fats|epigallocatechin gallate|Ethanol|Glucose|Glyburide|Lead|Metformin|mono-(2-ethylhexyl)phthalate|Niacinamide|Particulate Matter|perfluorooctane sulfonic acid|Plant Extracts|Polychlorinated Biphenyls|Resveratrol|Rosiglitazone|Streptozocin|titanium dioxide|Troglitazone|Vehicle Emissions|Zinc,0,
ATP generation from ADP,GO:0006757,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
ATP generation from ADP,GO:0006757,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
ATP generation from ADP,GO:0006757,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Lipopolysaccharides,0,
ATP generation from ADP,GO:0006757,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
ATP metabolic process,GO:0046034,Diabetes Mellitus,MESH:D003920,35,"2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Arsenic|bisphenol A|Blood Glucose|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpromazine|Chlorpyrifos|Cyclosporine|DDT|Dichlorodiphenyl Dichloroethylene|Dieldrin|Heptachlor|Hexachlorobenzene|Lead|Liraglutide|Mercury|Metals, Heavy|Metformin|Molybdenum|Niacin|Nitrogen Dioxide|Ozone|Particulate Matter|Plant Extracts|puerarin|Raloxifene Hydrochloride|Resveratrol|Rosiglitazone|Selenium|Streptozocin|Sulfur Dioxide|Troglitazone|Zinc",0,
ATP metabolic process,GO:0046034,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
ATP metabolic process,GO:0046034,"Diabetes Mellitus, Experimental",MESH:D003921,27,"bisphenol A|Blood Glucose|Capsaicin|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Dronabinol|Glucose|honokiol|Hydrogen Peroxide|Imatinib Mesylate|Manganese|Metformin|Niacinamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|puerarin|Quercetin|Resveratrol|Rosiglitazone|sarpogrelate|Sertraline|sodium arsenite|Streptozocin|Taurine|tianhuang|Troglitazone",0,
ATP metabolic process,GO:0046034,"Diabetes Mellitus, Type 1",MESH:D003922,10,bisphenol A|Imatinib Mesylate|Lipopolysaccharides|Mercury|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Taurine|Uric Acid,0,
ATP metabolic process,GO:0046034,"Diabetes Mellitus, Type 2",MESH:D003924,34,Air Pollutants|Arsenic|Ascorbic Acid|bisphenol A|bisphenol S|Blood Glucose|Cadmium|Curcumin|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|diethyl phthalate|Ethanol|Glucose|Glutathione|Lead|Liraglutide|Manganese|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Niacinamide|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts|Resveratrol|Rosiglitazone|Streptozocin|titanium dioxide|Troglitazone|Vehicle Emissions|Zinc,1,ENPP1
atrial cardiac muscle cell action potential,GO:0086014,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
atrial cardiac muscle tissue development,GO:0003228,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDNRA
atrial cardiac muscle tissue morphogenesis,GO:0055009,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
atrial septum morphogenesis,GO:0060413,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOTCH2
atrioventricular node development,GO:0003162,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOTCH2
attachment of mitotic spindle microtubules to kinetochore,GO:0051315,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
attachment of mitotic spindle microtubules to kinetochore,GO:0051315,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
attachment of mitotic spindle microtubules to kinetochore,GO:0051315,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
attachment of mitotic spindle microtubules to kinetochore,GO:0051315,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
attachment of spindle microtubules to kinetochore,GO:0008608,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
attachment of spindle microtubules to kinetochore,GO:0008608,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
attachment of spindle microtubules to kinetochore,GO:0008608,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
attachment of spindle microtubules to kinetochore,GO:0008608,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
auditory behavior,GO:0031223,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
auditory behavior,GO:0031223,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Dronabinol,0,
auditory behavior,GO:0031223,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Calcium|Dietary Fats,0,
auditory receptor cell development,GO:0060117,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
auditory receptor cell morphogenesis,GO:0002093,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
auditory receptor cell stereocilium organization,GO:0060088,Diabetes Mellitus,MESH:D003920,0,,1,SOD1
auditory receptor cell stereocilium organization,GO:0060088,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SOD1
auditory receptor cell stereocilium organization,GO:0060088,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SOD1
autocrine signaling,GO:0035425,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CD68|CX3CL1
autophagic cell death,GO:0048102,Diabetes Mellitus,MESH:D003920,2,Cadmium|Resveratrol,0,
autophagic cell death,GO:0048102,"Diabetes Mellitus, Experimental",MESH:D003921,2,ginsenoside Re|Resveratrol,0,
autophagic cell death,GO:0048102,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Resveratrol,0,
autophagic cell death,GO:0048102,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|ginsenoside Re|Resveratrol,0,
autophagosome assembly,GO:0000045,Diabetes Mellitus,MESH:D003920,11,Arsenic|arsenite|Atrazine|bisphenol A|Cadmium|Cyclosporine|Dichlorodiphenyl Dichloroethylene|Docosahexaenoic Acids|Metformin|Raloxifene Hydrochloride|Resveratrol,0,
autophagosome assembly,GO:0000045,"Diabetes Mellitus, Experimental",MESH:D003921,10,bisphenol A|Diethylhexyl Phthalate|Glucose|Hydrogen Peroxide|Imatinib Mesylate|Metformin|Quercetin|Resveratrol|sodium arsenite|Ursolic Acid,1,ATP2A2
autophagosome assembly,GO:0000045,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|Calcitriol|Imatinib Mesylate|Lipopolysaccharides|Resveratrol|sodium arsenite|Uric Acid,0,
autophagosome assembly,GO:0000045,"Diabetes Mellitus, Type 2",MESH:D003924,12,Arsenic|Atrazine|bisphenol A|Cadmium|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|Ethanol|Glucose|Metformin|Nickel|Resveratrol|titanium dioxide,1,ATP2A2
autophagosome-lysosome fusion,GO:0061909,Diabetes Mellitus,MESH:D003920,2,arsenite|Cadmium,0,
autophagosome-lysosome fusion,GO:0061909,"Diabetes Mellitus, Experimental",MESH:D003921,3,Cholesterol|Imatinib Mesylate|sodium arsenite,0,
autophagosome-lysosome fusion,GO:0061909,"Diabetes Mellitus, Type 1",MESH:D003922,2,Imatinib Mesylate|sodium arsenite,0,
autophagosome-lysosome fusion,GO:0061909,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Curcumin|perfluorooctane sulfonic acid,0,
autophagosome maturation,GO:0097352,"Diabetes Mellitus, Experimental",MESH:D003921,3,Glucose|Hydrogen Peroxide|sodium arsenite,0,
autophagosome maturation,GO:0097352,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
autophagosome maturation,GO:0097352,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,0,
autophagosome membrane docking,GO:0016240,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ATP2A2
autophagosome membrane docking,GO:0016240,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ATP2A2
autophagosome organization,GO:1905037,Diabetes Mellitus,MESH:D003920,4,Berberine|Cadmium|Lead|Resveratrol,0,
autophagosome organization,GO:1905037,"Diabetes Mellitus, Experimental",MESH:D003921,3,Berberine|Dibutyl Phthalate|Resveratrol,0,
autophagosome organization,GO:1905037,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
autophagosome organization,GO:1905037,"Diabetes Mellitus, Type 2",MESH:D003924,5,Berberine|Cadmium|Dibutyl Phthalate|Lead|Resveratrol,0,
autophagy,GO:0006914,Diabetes Mellitus,MESH:D003920,19,Arsenic|arsenite|Atrazine|bisphenol A|Cadmium|Copper|Cyclosporine|Iron|Metformin|morroniside|Ozone|Particulate Matter|Raloxifene Hydrochloride|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin,0,
autophagy,GO:0006914,"Diabetes Mellitus, Experimental",MESH:D003921,24,bisphenol A|Capsaicin|Cholesterol|Clioquinol|Dietary Fats|Exenatide|Fenretinide|Glucose|Hydrogen Peroxide|Imatinib Mesylate|Inositol|Manganese|Metformin|Quercetin|Resveratrol|Rosiglitazone|Sertraline|sodium arsenite|Sodium Selenite|Streptozocin|Taurine|thymoquinone|Ursolic Acid|Vitamin E,3,BCL2|TP53|TRP53
autophagy,GO:0006914,"Diabetes Mellitus, Type 1",MESH:D003922,11,bisphenol A|Calcitriol|Imatinib Mesylate|Iron|Lipopolysaccharides|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Taurine|Thioctic Acid,2,CLEC16A|PTPN22
autophagy,GO:0006914,"Diabetes Mellitus, Type 2",MESH:D003924,25,alpha-Tocopherol|Arsenic|Atrazine|bisphenol A|Cadmium|Copper|Curcumin|Dietary Fats|Ethanol|Exenatide|Glucose|Iron|Manganese|Metformin|Nelfinavir|Orlistat|Particulate Matter|Pentoxifylline|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Sitagliptin Phosphate|Streptozocin|titanium dioxide|Vehicle Emissions,3,BCL2|CISD2|HMGA1
autophagy of mitochondrion,GO:0000422,Diabetes Mellitus,MESH:D003920,3,Atrazine|Cadmium|Cyclosporine,0,
autophagy of mitochondrion,GO:0000422,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hemin,1,PPARGC1A
autophagy of mitochondrion,GO:0000422,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
autophagy of mitochondrion,GO:0000422,"Diabetes Mellitus, Type 2",MESH:D003924,4,Atrazine|Cadmium|Hemin|perfluorooctane sulfonic acid,3,CAPN10|CISD2|PPARGC1A
axis elongation,GO:0003401,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|YWHAH
axis elongation,GO:0003401,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
axo-dendritic transport,GO:0008088,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Streptozocin,0,
axo-dendritic transport,GO:0008088,"Diabetes Mellitus, Experimental",MESH:D003921,2,Inositol|Streptozocin,0,
axo-dendritic transport,GO:0008088,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
axo-dendritic transport,GO:0008088,"Diabetes Mellitus, Type 2",MESH:D003924,1,Streptozocin,0,
axonal fasciculation,GO:0007413,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
axonal fasciculation,GO:0007413,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CASP3
axonal fasciculation,GO:0007413,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP3
axon arborization,GO:0140060,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
axon arborization,GO:0140060,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
axon arborization,GO:0140060,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
axon development,GO:0061564,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Glyburide,0,
axon development,GO:0061564,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dronabinol|Glyburide|sodium arsenite|Ursolic Acid,1,NEUROD1
axon development,GO:0061564,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
axon development,GO:0061564,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glyburide,1,NEUROD1
axon extension,GO:0048675,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Chlorpyrifos,1,RAC1
axon extension,GO:0048675,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,EDN1
axon extension,GO:0048675,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Thioctic Acid,0,
axon extension,GO:0048675,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,4,AUTS2|EDN1|EDNRA|RNF6
axon guidance,GO:0007411,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Copper,1,RAC1
axon guidance,GO:0007411,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Nicotine,2,EDN1|PAX6
axon guidance,GO:0007411,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,PRKCQ
axon guidance,GO:0007411,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Copper|Nicotine,6,ECE1|EDN1|EDNRA|NOTCH2|PAX6|RETN
axon midline choice point recognition,GO:0016199,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
axonogenesis,GO:0007409,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Lead|Particulate Matter,0,
axonogenesis,GO:0007409,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Hemin|Sodium Glutamate,4,BCL2|PAX6|S100A6|SNAP25
axonogenesis,GO:0007409,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
axonogenesis,GO:0007409,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Hemin|Lead|Particulate Matter|Vehicle Emissions,5,BCL2|GCLC|PAX6|S100A6|SNAP25
axonogenesis involved in innervation,GO:0060385,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
axonogenesis involved in innervation,GO:0060385,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,ECE1|EDN1|EDNRA
axon regeneration,GO:0031103,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
axon regeneration,GO:0031103,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2|ENPP1
B-1 B cell homeostasis,GO:0001922,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
baculum development,GO:1990375,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
baculum development,GO:1990375,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
baculum development,GO:1990375,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
baculum development,GO:1990375,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
basal dendrite arborization,GO:0150020,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
basal dendrite arborization,GO:0150020,"Diabetes Mellitus, Experimental",MESH:D003921,1,Cyclophosphamide,0,
basal dendrite arborization,GO:0150020,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
base-excision repair,GO:0006284,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
base-excision repair,GO:0006284,"Diabetes Mellitus, Experimental",MESH:D003921,3,"Hydrogen Peroxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|sodium arsenite",0,
base-excision repair,GO:0006284,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
base-excision repair,GO:0006284,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,HMGA1|OGG1|UBE2E2
"base-excision repair, AP site formation",GO:0006285,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
basement membrane disassembly,GO:0034769,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP2
basement membrane organization,GO:0071711,Diabetes Mellitus,MESH:D003920,2,Chlorodiphenyl (54% Chlorine)|Streptozocin,0,
basement membrane organization,GO:0071711,"Diabetes Mellitus, Experimental",MESH:D003921,2,sodium arsenite|Streptozocin,2,CAV1|MMP2
basement membrane organization,GO:0071711,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Streptozocin,0,
basement membrane organization,GO:0071711,"Diabetes Mellitus, Type 2",MESH:D003924,1,Streptozocin,0,
basophil chemotaxis,GO:0002575,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
B cell activation,GO:0042113,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,C3|CASP8|PRKCB|TNFRSF1B
B cell apoptotic process,GO:0001783,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,BAX|BCL2
B cell apoptotic process,GO:0001783,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BAX|BCL2
B cell differentiation,GO:0030183,Diabetes Mellitus,MESH:D003920,2,Tetrachlorodibenzodioxin|Tungsten,0,
B cell differentiation,GO:0030183,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,1,BCL2
B cell differentiation,GO:0030183,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,1,IL10
B cell differentiation,GO:0030183,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,BCL2|HHEX|HMGA1
B cell homeostasis,GO:0001782,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|Nitrogen Dioxide|Particulate Matter,0,
B cell homeostasis,GO:0001782,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,3,BAX|BCL2|CASP3
B cell homeostasis,GO:0001782,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,5,BAX|BCL2|BCL2L11|CASP3|MIR17HG
B cell homeostatic proliferation,GO:0002358,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
B cell homeostatic proliferation,GO:0002358,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
B cell lineage commitment,GO:0002326,Diabetes Mellitus,MESH:D003920,2,Cadmium|Tetrachlorodibenzodioxin,0,
B cell lineage commitment,GO:0002326,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,BCL2|TP53|TRP53
B cell lineage commitment,GO:0002326,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
B cell lineage commitment,GO:0002326,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,1,BCL2
B cell mediated immunity,GO:0019724,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FAS
B cell mediated immunity,GO:0019724,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FAS
B cell negative selection,GO:0002352,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
B cell negative selection,GO:0002352,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
B cell proliferation,GO:0042100,Diabetes Mellitus,MESH:D003920,4,Chlorpyrifos|Plant Extracts|Resveratrol|Tungsten,0,
B cell proliferation,GO:0042100,"Diabetes Mellitus, Experimental",MESH:D003921,2,Plant Extracts|Resveratrol,2,BCL2|PRKCD
B cell proliferation,GO:0042100,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Resveratrol,1,IL10
B cell proliferation,GO:0042100,"Diabetes Mellitus, Type 2",MESH:D003924,3,perfluorooctanoic acid|Plant Extracts|Resveratrol,1,BCL2
B cell receptor apoptotic signaling pathway,GO:1990117,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
B cell receptor apoptotic signaling pathway,GO:1990117,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
B cell receptor signaling pathway,GO:0050853,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
B cell receptor signaling pathway,GO:0050853,"Diabetes Mellitus, Insulin-Dependent, 12",MESH:C563326,0,,1,CTLA4
B cell receptor signaling pathway,GO:0050853,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,BCL2|NFATC2|NFKB1|PLEKHA1|PRKCB
behavior,GO:0007610,Diabetes Mellitus,MESH:D003920,9,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|Arsenic|bisphenol A|Cadmium|Chlorpyrifos|Lead|Particulate Matter|Tobacco Smoke Pollution",0,
behavior,GO:0007610,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Dietary Fats|Dronabinol|Manganese,0,
behavior,GO:0007610,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Lipopolysaccharides,0,
behavior,GO:0007610,"Diabetes Mellitus, Type 2",MESH:D003924,12,Air Pollutants|Arsenic|bisphenol A|Cadmium|Dietary Fats|Lead|Manganese|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Phthalic Acids|Topiramate,0,
behavioral defense response,GO:0002209,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
behavioral defense response,GO:0002209,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Diethylhexyl Phthalate|Nicotine,0,
behavioral defense response,GO:0002209,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
behavioral defense response,GO:0002209,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Diethylhexyl Phthalate|Ethanol|Nicotine,0,
behavioral fear response,GO:0001662,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Cadmium,0,
behavioral fear response,GO:0001662,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
behavioral fear response,GO:0001662,"Diabetes Mellitus, Experimental",MESH:D003921,4,"bisphenol A|Dronabinol|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Taurine",1,BCL2
behavioral fear response,GO:0001662,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Calcitriol|Taurine,0,
behavioral fear response,GO:0001662,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Cadmium|Ethanol|Folic Acid,1,BCL2
behavioral response to acetic acid induced pain,GO:0061367,Diabetes Mellitus,MESH:D003920,2,Glyburide|Plant Extracts,0,
behavioral response to acetic acid induced pain,GO:0061367,"Diabetes Mellitus, Experimental",MESH:D003921,4,Capsaicin|Dronabinol|Glyburide|Plant Extracts,0,
behavioral response to acetic acid induced pain,GO:0061367,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glyburide|Plant Extracts,0,
behavioral response to chemical pain,GO:0061366,Diabetes Mellitus,MESH:D003920,3,Plant Extracts|Resveratrol|Zinc,0,
behavioral response to chemical pain,GO:0061366,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
behavioral response to chemical pain,GO:0061366,"Diabetes Mellitus, Experimental",MESH:D003921,6,Capsaicin|cinnamaldehyde|Cyclophosphamide|Dronabinol|Plant Extracts|Resveratrol,0,
behavioral response to chemical pain,GO:0061366,"Diabetes Mellitus, Type 1",MESH:D003922,2,Cyclophosphamide|Resveratrol,0,
behavioral response to chemical pain,GO:0061366,"Diabetes Mellitus, Type 2",MESH:D003924,4,cinnamaldehyde|Plant Extracts|Resveratrol|Zinc,0,
behavioral response to cocaine,GO:0048148,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dronabinol|Nicotine,0,
behavioral response to cocaine,GO:0048148,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS1
behavioral response to cocaine,GO:0048148,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
behavioral response to ethanol,GO:0048149,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,1,SIRT1
behavioral response to ethanol,GO:0048149,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
behavioral response to ethanol,GO:0048149,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,3,EGFR|GCLM|SIRT1
behavioral response to formalin induced pain,GO:0061368,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
behavioral response to formalin induced pain,GO:0061368,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dronabinol|Plant Extracts|platycodin D|sodium arsenite,0,
behavioral response to formalin induced pain,GO:0061368,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
behavioral response to formalin induced pain,GO:0061368,"Diabetes Mellitus, Type 2",MESH:D003924,2,Curcumin|Plant Extracts,0,
behavioral response to nicotine,GO:0035095,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dronabinol|Nicotine,1,PPARA
behavioral response to nicotine,GO:0035095,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,1,PPARA
behavioral response to pain,GO:0048266,Diabetes Mellitus,MESH:D003920,4,Arsenic|Chlorpyrifos|Plant Extracts|Streptozocin,0,
behavioral response to pain,GO:0048266,"Diabetes Mellitus, Experimental",MESH:D003921,8,cobaltiprotoporphyrin|Dronabinol|Glucose|Nicotine|Plant Extracts|platycodin D|sodium arsenite|Streptozocin,0,
behavioral response to pain,GO:0048266,"Diabetes Mellitus, Type 1",MESH:D003922,3,Dehydroepiandrosterone|sodium arsenite|Streptozocin,0,
behavioral response to pain,GO:0048266,"Diabetes Mellitus, Type 2",MESH:D003924,6,Arsenic|Glucose|Nicotine|Pentoxifylline|Plant Extracts|Streptozocin,1,AKT1
behavioral response to starvation,GO:0042595,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
behavioral response to starvation,GO:0042595,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
behavioral response to starvation,GO:0042595,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
behavioral response to water deprivation,GO:0042630,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
behavioral response to water deprivation,GO:0042630,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
behavioral response to water deprivation,GO:0042630,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
behavioral response to water deprivation,GO:0042630,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
benzoate transport,GO:0042919,Diabetes Mellitus,MESH:D003920,2,Niacin|Pravastatin,0,
benzoate transport,GO:0042919,"Diabetes Mellitus, Type 2",MESH:D003924,1,Benzoic Acid,0,
beta-alanine metabolic process,GO:0019482,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|Nitrogen Dioxide|Particulate Matter,0,
beta-alanine metabolic process,GO:0019482,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,0,
bicarbonate transport,GO:0015701,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
bicarbonate transport,GO:0015701,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
bicarbonate transport,GO:0015701,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
bicarbonate transport,GO:0015701,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
bile acid and bile salt transport,GO:0015721,Diabetes Mellitus,MESH:D003920,3,Chlorpromazine|Cyclosporine|Glyburide,0,
bile acid and bile salt transport,GO:0015721,"Diabetes Mellitus, Experimental",MESH:D003921,3,Bile Acids and Salts|Dietary Fats|Glyburide,0,
bile acid and bile salt transport,GO:0015721,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
bile acid and bile salt transport,GO:0015721,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HNF1A
bile acid and bile salt transport,GO:0015721,"Diabetes Mellitus, Type 2",MESH:D003924,4,Dietary Fats|Glyburide|perfluorodecanoic acid|TAK-875,1,HNF1A
bile acid biosynthetic process,GO:0006699,Diabetes Mellitus,MESH:D003920,2,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A",0,
bile acid biosynthetic process,GO:0006699,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Dietary Fats,0,
bile acid biosynthetic process,GO:0006699,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
bile acid biosynthetic process,GO:0006699,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,HNF1A
bile acid biosynthetic process,GO:0006699,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|Dietary Fats|Ethanol|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid,1,HNF1A
bile acid catabolic process,GO:0030573,Diabetes Mellitus,MESH:D003920,1,Phorate,0,
bile acid catabolic process,GO:0030573,"Diabetes Mellitus, Experimental",MESH:D003921,2,Lithocholic Acid|Tocotrienols,0,
bile acid catabolic process,GO:0030573,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tocotrienols,0,
bile acid catabolic process,GO:0030573,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lithocholic Acid,0,
bile acid conjugation,GO:0002152,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
bile acid conjugation,GO:0002152,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Streptozocin,0,
bile acid conjugation,GO:0002152,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
bile acid conjugation,GO:0002152,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Streptozocin,0,
bile acid metabolic process,GO:0008206,Diabetes Mellitus,MESH:D003920,15,"2,2',4,4'-tetrabromodiphenyl ether|Arsenic|bisphenol A|Cadmium|Chromium|Copper|Cyclosporine|Dichlorodiphenyl Dichloroethylene|Lead|Mercury|Metformin|Selenium|Sodium Selenite|Tetrachlorodibenzodioxin|Zinc",0,
bile acid metabolic process,GO:0008206,"Diabetes Mellitus, Experimental",MESH:D003921,9,Bile Acids and Salts|bisphenol A|Chromium|Dietary Fats|Lithocholic Acid|Manganese|Metformin|Sodium Selenite|Taurine,1,LEP
bile acid metabolic process,GO:0008206,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Lipopolysaccharides|Mercury|Taurine|Tetrachlorodibenzodioxin,0,
bile acid metabolic process,GO:0008206,"Diabetes Mellitus, Type 2",MESH:D003924,17,Arsenic|bisphenol A|bisphenol S|Cadmium|Chromium|Copper|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Ethanol|Lead|Lithocholic Acid|Manganese|Mercury|Metformin|Nickel|perfluorooctanoic acid|Zinc,1,LEP
bile acid secretion,GO:0032782,Diabetes Mellitus,MESH:D003920,5,Chlorpromazine|Metformin|Resveratrol|Tetrachlorodibenzodioxin|Troglitazone,0,
bile acid secretion,GO:0032782,"Diabetes Mellitus, Experimental",MESH:D003921,4,Lithocholic Acid|Metformin|Resveratrol|Troglitazone,0,
bile acid secretion,GO:0032782,"Diabetes Mellitus, Type 1",MESH:D003922,2,Resveratrol|Tetrachlorodibenzodioxin,0,
bile acid secretion,GO:0032782,"Diabetes Mellitus, Type 2",MESH:D003924,4,Lithocholic Acid|Metformin|Resveratrol|Troglitazone,0,
bilirubin conjugation,GO:0006789,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorodecanoic acid,0,
bilirubin transport,GO:0015723,Diabetes Mellitus,MESH:D003920,8,Arsenic|Plant Extracts|Pravastatin|Prednisolone|puerarin|Resveratrol|Rosiglitazone|Zinc,0,
bilirubin transport,GO:0015723,"Diabetes Mellitus, Experimental",MESH:D003921,6,Dietary Fats|Plant Extracts|puerarin|Resveratrol|Rosiglitazone|Taurine,0,
bilirubin transport,GO:0015723,"Diabetes Mellitus, Type 1",MESH:D003922,2,Resveratrol|Taurine,0,
bilirubin transport,GO:0015723,"Diabetes Mellitus, Type 2",MESH:D003924,7,Arsenic|Dietary Fats|Folic Acid|Plant Extracts|Resveratrol|Rosiglitazone|Zinc,0,
binding of sperm to zona pellucida,GO:0007339,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
binding of sperm to zona pellucida,GO:0007339,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
binding of sperm to zona pellucida,GO:0007339,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
binding of sperm to zona pellucida,GO:0007339,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
biogenic amine metabolic process,GO:0006576,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
biogenic amine metabolic process,GO:0006576,"Diabetes Mellitus, Type 2",MESH:D003924,1,Manganese,0,
biological_process,GO:0008150,Diabetes Mellitus,MESH:D003920,0,,2,INS2|ZFP57
biological_process,GO:0008150,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,YWHAH
biological_process,GO:0008150,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
biological_process,GO:0008150,"Diabetes Mellitus, Type 1",MESH:D003922,0,,5,CLEC16A|IL19|IL20|INS2|SLC11A1
biological_process,GO:0008150,"Diabetes Mellitus, Type 2",MESH:D003924,0,,14,CCDC92|CDKAL1|CISD2|EPC2|FAM234A|GNB3|NFATC2|PLEKHA1|PPP1R3A|RNF6|SMIM43|VPS26A|ZC3HC1|ZFAND3
biological process involved in interaction with host,GO:0051701,"Diabetes Mellitus, Experimental",MESH:D003921,2,cobaltiprotoporphyrin|Nicotine,0,
biological process involved in interaction with host,GO:0051701,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
biological process involved in interaction with symbiont,GO:0051702,Diabetes Mellitus,MESH:D003920,0,,1,FN1
biological process involved in interaction with symbiont,GO:0051702,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GPX1
biological process involved in interaction with symbiont,GO:0051702,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GPX1
biological process involved in symbiotic interaction,GO:0044403,Diabetes Mellitus,MESH:D003920,3,Arsenic|Chlorpyrifos|Streptozocin,0,
biological process involved in symbiotic interaction,GO:0044403,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dietary Fats|Dietary Sugars|Nicotine|Streptozocin,0,
biological process involved in symbiotic interaction,GO:0044403,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Streptozocin,0,
biological process involved in symbiotic interaction,GO:0044403,"Diabetes Mellitus, Type 2",MESH:D003924,5,Arsenic|Dietary Fats|Dietary Sugars|Nicotine|Streptozocin,0,
biomineral tissue development,GO:0031214,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
biomineral tissue development,GO:0031214,"Diabetes Mellitus, Type 2",MESH:D003924,2,Canagliflozin|Glucose,1,ENPP1
biosynthetic process of antibacterial peptides active against Gram-positive bacteria,GO:0002815,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
biosynthetic process of antibacterial peptides active against Gram-positive bacteria,GO:0002815,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,0,
blastocyst development,GO:0001824,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
blastocyst development,GO:0001824,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
blastocyst development,GO:0001824,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
blastocyst development,GO:0001824,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Genistein,1,HNF1A
blastocyst development,GO:0001824,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|bisphenol S|Genistein|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid,1,HNF1A
blastocyst formation,GO:0001825,Diabetes Mellitus,MESH:D003920,5,Arsenic|bisphenol A|Chlorpyrifos|Resveratrol|Tetrachlorodibenzodioxin,0,
blastocyst formation,GO:0001825,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
blastocyst formation,GO:0001825,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Cyclophosphamide|Diethylhexyl Phthalate|Dronabinol|Resveratrol,0,
blastocyst formation,GO:0001825,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Cyclophosphamide|Resveratrol|Tetrachlorodibenzodioxin,0,
blastocyst formation,GO:0001825,"Diabetes Mellitus, Type 2",MESH:D003924,7,Arsenic|bisphenol A|bisphenol S|Diethylhexyl Phthalate|Malathion|mono-(2-ethylhexyl)phthalate|Resveratrol,0,
blastocyst growth,GO:0001832,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Malathion,0,
blastocyst hatching,GO:0001835,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
blastocyst hatching,GO:0001835,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
blastocyst hatching,GO:0001835,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
blastocyst hatching,GO:0001835,"Diabetes Mellitus, Type 2",MESH:D003924,2,mono-(2-ethylhexyl)phthalate|Resveratrol,0,
bleb assembly,GO:0032060,Diabetes Mellitus,MESH:D003920,3,"2,2',4,4'-tetrabromodiphenyl ether|Arsenic|Cadmium",0,
bleb assembly,GO:0032060,"Diabetes Mellitus, Experimental",MESH:D003921,2,astaxanthine|sodium arsenite,0,
bleb assembly,GO:0032060,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
bleb assembly,GO:0032060,"Diabetes Mellitus, Type 2",MESH:D003924,3,Arsenic|astaxanthine|Cadmium,0,
blood circulation,GO:0008015,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|bisphenol A|Particulate Matter,1,PON1
blood circulation,GO:0008015,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Capsaicin|resiniferatoxin,0,
blood circulation,GO:0008015,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Genistein,0,
blood circulation,GO:0008015,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|bisphenol A|Genistein|Particulate Matter,2,EDNRA|EDNRB
blood coagulation,GO:0007596,Diabetes Mellitus,MESH:D003920,4,Air Pollutants|bisphenol A|Particulate Matter|Plant Extracts,0,
blood coagulation,GO:0007596,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Plant Extracts,0,
blood coagulation,GO:0007596,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Genistein|Warfarin,0,
blood coagulation,GO:0007596,"Diabetes Mellitus, Type 2",MESH:D003924,6,Air Pollutants|bisphenol A|Genistein|Malathion|Particulate Matter|Plant Extracts,2,CD36|HNF4A
"blood coagulation, fibrin clot formation",GO:0072378,Diabetes Mellitus,MESH:D003920,4,Air Pollutants|Copper|Mercury|Particulate Matter,0,
"blood coagulation, fibrin clot formation",GO:0072378,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
"blood coagulation, fibrin clot formation",GO:0072378,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Mercury,0,
"blood coagulation, fibrin clot formation",GO:0072378,"Diabetes Mellitus, Type 2",MESH:D003924,7,Air Pollutants|Calcium|Copper|Manganese|Mercury|Particulate Matter|Vehicle Emissions,0,
blood vessel development,GO:0001568,Diabetes Mellitus,MESH:D003920,4,Air Pollutants|Arsenic|Particulate Matter|Resveratrol,0,
blood vessel development,GO:0001568,"Diabetes Mellitus, Experimental",MESH:D003921,6,Dibutyl Phthalate|Diethylhexyl Phthalate|Glucose|platycodin D|Quercetin|Resveratrol,3,AGT|PAX6|VEGFA
blood vessel development,GO:0001568,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
blood vessel development,GO:0001568,"Diabetes Mellitus, Type 2",MESH:D003924,8,Air Pollutants|Arsenic|Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate|Glucose|Particulate Matter|Resveratrol,2,PAX6|TCF7L2
blood vessel diameter maintenance,GO:0097746,Diabetes Mellitus,MESH:D003920,6,bisphenol A|Cadmium|Particulate Matter|Resveratrol|Tobacco Smoke Pollution|Tungsten,0,
blood vessel diameter maintenance,GO:0097746,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Nitric Oxide|Resveratrol,4,ACE|AGT|EDN1|NOS3
blood vessel diameter maintenance,GO:0097746,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Nitric Oxide|Resveratrol,1,NOS3
blood vessel diameter maintenance,GO:0097746,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Cadmium|Particulate Matter|Resveratrol,6,CBS|ECE1|EDN1|GCLC|GCLM|NOS3
blood vessel endothelial cell differentiation,GO:0060837,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ETS1|PROX1
blood vessel endothelial cell migration,GO:0043534,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,GPX1|ID1
blood vessel endothelial cell migration,GO:0043534,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GPX1|ID1
blood vessel endothelial cell proliferation involved in sprouting angiogenesis,GO:0002043,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR30A
blood vessel maturation,GO:0001955,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP2
blood vessel maturation,GO:0001955,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
blood vessel morphogenesis,GO:0048514,Diabetes Mellitus,MESH:D003920,1,Trientine,0,
blood vessel morphogenesis,GO:0048514,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,EDN1|ID1|VEGFA
blood vessel morphogenesis,GO:0048514,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,EDN1|ETS1|ID1|SMAD5
blood vessel remodeling,GO:0001974,Diabetes Mellitus,MESH:D003920,2,Tobacco Smoke Pollution|Zinc,0,
blood vessel remodeling,GO:0001974,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dibutyl Phthalate|Dietary Fats,7,ACE|AGT|BAX|IGF1|NOS2|NOS3|VEGFA
blood vessel remodeling,GO:0001974,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
blood vessel remodeling,GO:0001974,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,2,IGF1|NOS3
blood vessel remodeling,GO:0001974,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dibutyl Phthalate|Dietary Fats|Zinc,5,BAX|CBS|EDNRA|NOS2|NOS3
BMP signaling pathway,GO:0030509,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
BMP signaling pathway,GO:0030509,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ID1|PPARG|TGFB1
BMP signaling pathway,GO:0030509,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,ID1|MIRLET7D|NOTCH2|PPARG|SMAD5|TCF7L2
body fluid secretion,GO:0007589,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
body fluid secretion,GO:0007589,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDN1
body morphogenesis,GO:0010171,Diabetes Mellitus,MESH:D003920,3,"Dichlorodiphenyl Dichloroethylene|o,p'-DDT|Zinc",0,
body morphogenesis,GO:0010171,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
body morphogenesis,GO:0010171,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
body morphogenesis,GO:0010171,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dichlorodiphenyl Dichloroethylene|Nickel|Zinc,0,
bone cell development,GO:0098751,Diabetes Mellitus,MESH:D003920,1,Parathion,0,
bone development,GO:0060348,Diabetes Mellitus,MESH:D003920,9,"2,2',4,4'-tetrabromodiphenyl ether|Arsenic|bisphenol A|Cadmium|Lead|morroniside|Nitrogen Dioxide|Particulate Matter|Prednisolone",0,
bone development,GO:0060348,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,2,IGF1|NOS3
bone development,GO:0060348,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,2,IGF1|NOS3
bone development,GO:0060348,"Diabetes Mellitus, Type 2",MESH:D003924,7,Arsenic|bisphenol A|Cadmium|Curcumin|Ethanol|Lead|Particulate Matter,4,AKT2|ENPP1|NOS3|SMAD5
bone growth,GO:0098868,Diabetes Mellitus,MESH:D003920,6,Air Pollutants|aroclor 1260|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Particulate Matter,1,LEPR
bone growth,GO:0098868,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Monocrotophos,2,LEP|LEPR
bone growth,GO:0098868,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
bone growth,GO:0098868,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|bisphenol A|Cadmium|Particulate Matter,3,ENPP1|LEP|LEPR
bone marrow development,GO:0048539,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
bone marrow development,GO:0048539,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
bone marrow development,GO:0048539,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
bone mineralization,GO:0030282,Diabetes Mellitus,MESH:D003920,12,bisphenol A|Cadmium|Cyclosporine|Lead|Metformin|morroniside|Niacin|Prednisolone|Prednisone|Raloxifene Hydrochloride|Streptozocin|Tetrachlorodibenzodioxin,1,PTGS2
bone mineralization,GO:0030282,"Diabetes Mellitus, Experimental",MESH:D003921,8,bisphenol A|Dietary Fats|Enalapril|Glucose|Hydrogen Peroxide|Metformin|Quercetin|Streptozocin,1,PTGS2
bone mineralization,GO:0030282,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Calcitriol|Lipopolysaccharides|Streptozocin|Tetrachlorodibenzodioxin|Warfarin,0,
bone mineralization,GO:0030282,"Diabetes Mellitus, Type 2",MESH:D003924,14,Ascorbic Acid|bisphenol A|Cadmium|Dietary Fats|Enalapril|Ethanol|Glucose|Lead|Metformin|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Streptozocin,2,ENPP1|TCF7L2
bone mineralization involved in bone maturation,GO:0035630,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IGF1|LEP
bone mineralization involved in bone maturation,GO:0035630,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
bone mineralization involved in bone maturation,GO:0035630,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ENPP1|LEP
bone morphogenesis,GO:0060349,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
bone morphogenesis,GO:0060349,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EDN1|SFRP4
bone remodeling,GO:0046849,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
bone remodeling,GO:0046849,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,1,IL6
bone remodeling,GO:0046849,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL6
bone remodeling,GO:0046849,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Ethanol|Nicotine,3,ENPP1|IL6|NOTCH2
bone resorption,GO:0045453,Diabetes Mellitus,MESH:D003920,5,Cadmium|Iron|Methylprednisolone|Pyruvaldehyde|Raloxifene Hydrochloride,1,RAC1
bone resorption,GO:0045453,"Diabetes Mellitus, Experimental",MESH:D003921,2,corilagin|sodium arsenite,1,IAPP
bone resorption,GO:0045453,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
bone resorption,GO:0045453,"Diabetes Mellitus, Type 1",MESH:D003922,3,Iron|Lipopolysaccharides|sodium arsenite,1,HNF1A
bone resorption,GO:0045453,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|Iron,3,ENPP1|HNF1A|IAPP
bone trabecula formation,GO:0060346,Diabetes Mellitus,MESH:D003920,2,Pyruvaldehyde|Streptozocin,0,
bone trabecula formation,GO:0060346,"Diabetes Mellitus, Experimental",MESH:D003921,3,Dietary Fats|Monocrotophos|Streptozocin,2,MMP2|VEGFA
bone trabecula formation,GO:0060346,"Diabetes Mellitus, Type 1",MESH:D003922,2,Calcitriol|Streptozocin,0,
bone trabecula formation,GO:0060346,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Streptozocin,1,ENPP1
bone trabecula morphogenesis,GO:0061430,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
border follicle cell migration,GO:0007298,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
border follicle cell migration,GO:0007298,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
bradykinin catabolic process,GO:0010815,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
bradykinin catabolic process,GO:0010815,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CTSH
bradykinin catabolic process,GO:0010815,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ECE1
brain-derived neurotrophic factor receptor signaling pathway,GO:0031547,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Chlorodiphenyl (54% Chlorine)|Plant Extracts,0,
brain-derived neurotrophic factor receptor signaling pathway,GO:0031547,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Plant Extracts,1,INSR
brain-derived neurotrophic factor receptor signaling pathway,GO:0031547,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
brain-derived neurotrophic factor receptor signaling pathway,GO:0031547,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
brain-derived neurotrophic factor receptor signaling pathway,GO:0031547,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Plant Extracts,1,EGFR
brain development,GO:0007420,Diabetes Mellitus,MESH:D003920,7,Air Pollutants|Arsenic|bisphenol A|Cadmium|Lead|Particulate Matter|Tobacco Smoke Pollution,0,
brain development,GO:0007420,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Nicotine|Quercetin,3,IRS2|PAX6|SLC2A2
brain development,GO:0007420,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
brain development,GO:0007420,"Diabetes Mellitus, Type 2",MESH:D003924,10,Air Pollutants|Arsenic|bisphenol A|Cadmium|Curcumin|Ethanol|Folic Acid|Lead|Nicotine|Particulate Matter,7,IRS2|NOTCH2|OGG1|PAX6|PROX1|SCTR|SLC2A2
brain morphogenesis,GO:0048854,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Chlorpyrifos|Pesticides,0,
brain morphogenesis,GO:0048854,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,FOXO3
brain morphogenesis,GO:0048854,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
brain morphogenesis,GO:0048854,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Ethanol|Pesticides,0,
brain renin-angiotensin system,GO:0002035,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AGT
branched-chain amino acid metabolic process,GO:0009081,Diabetes Mellitus,MESH:D003920,2,Niacin|Ozone,0,
branch elongation involved in mammary gland duct branching,GO:0060751,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
branching involved in blood vessel morphogenesis,GO:0001569,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,EDN1|VEGFA
branching involved in blood vessel morphogenesis,GO:0001569,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,EDN1|EDNRA|MIR30A
branching involved in labyrinthine layer morphogenesis,GO:0060670,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL10
branching involved in mammary gland duct morphogenesis,GO:0060444,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Cadmium|Tetrachlorodibenzodioxin,0,
branching involved in mammary gland duct morphogenesis,GO:0060444,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
branching involved in mammary gland duct morphogenesis,GO:0060444,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Genistein|Tetrachlorodibenzodioxin,0,
branching involved in mammary gland duct morphogenesis,GO:0060444,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Cadmium|Genistein,0,
branching involved in pancreas morphogenesis,GO:0061114,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
branching involved in salivary gland morphogenesis,GO:0060445,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IL6
branching involved in salivary gland morphogenesis,GO:0060445,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL6
branching involved in salivary gland morphogenesis,GO:0060445,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IL6
branching involved in ureteric bud morphogenesis,GO:0001658,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,AGT|BCL2
branching involved in ureteric bud morphogenesis,GO:0001658,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2
branching morphogenesis of an epithelial tube,GO:0048754,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IGF1
branching morphogenesis of an epithelial tube,GO:0048754,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
branching morphogenesis of an epithelial tube,GO:0048754,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF1B
bronchiole development,GO:0060435,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
brown fat cell differentiation,GO:0050873,Diabetes Mellitus,MESH:D003920,2,Resveratrol|Rosiglitazone,4,ADIPOQ|ADRB1|PPARG|PTGS2
brown fat cell differentiation,GO:0050873,"Diabetes Mellitus, Experimental",MESH:D003921,3,Resveratrol|Rosiglitazone|tributyltin,5,ADRB3|PPARG|PPARGC1A|PTGS2|SLC2A4
brown fat cell differentiation,GO:0050873,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
brown fat cell differentiation,GO:0050873,"Diabetes Mellitus, Type 2",MESH:D003924,2,Resveratrol|Rosiglitazone,4,ADIPOQ|PPARG|PPARGC1A|SLC2A4
brown fat cell proliferation,GO:0070342,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
brown fat cell proliferation,GO:0070342,"Diabetes Mellitus, Experimental",MESH:D003921,5,Diethylhexyl Phthalate|diphtheria toxin fragment A|Sodium Glutamate|Taurine|tributyltin,0,
brown fat cell proliferation,GO:0070342,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
brown fat cell proliferation,GO:0070342,"Diabetes Mellitus, Type 2",MESH:D003924,3,Air Pollutants|Diethylhexyl Phthalate|Particulate Matter,0,
butyrate metabolic process,GO:0019605,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
butyrate metabolic process,GO:0019605,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
C21-steroid hormone biosynthetic process,GO:0006700,"Diabetes Mellitus, Experimental",MESH:D003921,2,Aldosterone|Nicotine,0,
C21-steroid hormone biosynthetic process,GO:0006700,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Nicotine,0,
C21-steroid hormone metabolic process,GO:0008207,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cholesterol|Diethylhexyl Phthalate,0,
C21-steroid hormone metabolic process,GO:0008207,"Diabetes Mellitus, Type 1",MESH:D003922,1,Dehydroepiandrosterone,0,
C21-steroid hormone metabolic process,GO:0008207,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,0,
C4-dicarboxylate transport,GO:0015740,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
C4-dicarboxylate transport,GO:0015740,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UCP2
C-5 methylation of cytosine,GO:0090116,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Particulate Matter|Pesticides|Resveratrol|Tobacco Smoke Pollution,0,
C-5 methylation of cytosine,GO:0090116,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Diethylhexyl Phthalate|Hydrogen Peroxide|pterostilbene|Resveratrol|sodium arsenite,0,
C-5 methylation of cytosine,GO:0090116,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|sodium arsenite,0,
C-5 methylation of cytosine,GO:0090116,"Diabetes Mellitus, Type 2",MESH:D003924,10,Ascorbic Acid|bisphenol A|bisphenol S|Diethylhexyl Phthalate|Glutathione|Particulate Matter|perfluorooctanoic acid|Pesticides|Resveratrol|S-Adenosylmethionine,0,
cadmium ion homeostasis,GO:0055073,Diabetes Mellitus,MESH:D003920,2,Cadmium|Zinc,0,
cadmium ion homeostasis,GO:0055073,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|Zinc,0,
cadmium ion transmembrane transport,GO:0070574,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
cadmium ion transport,GO:0015691,Diabetes Mellitus,MESH:D003920,2,Cadmium|Zinc,0,
cadmium ion transport,GO:0015691,"Diabetes Mellitus, Experimental",MESH:D003921,1,Taurine,0,
cadmium ion transport,GO:0015691,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
cadmium ion transport,GO:0015691,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|Zinc,0,
calcineurin-NFAT signaling cascade,GO:0033173,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NFATC2
calcitonin catabolic process,GO:0010816,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ECE1
calcitriol biosynthetic process from calciol,GO:0036378,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
calcitriol biosynthetic process from calciol,GO:0036378,"Diabetes Mellitus, Type 1",MESH:D003922,2,Calcitriol|Tetrachlorodibenzodioxin,0,
calcitriol biosynthetic process from calciol,GO:0036378,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP3A2
calcium export from the mitochondrion,GO:0099093,Diabetes Mellitus,MESH:D003920,2,Cyclosporine|Troglitazone,0,
calcium export from the mitochondrion,GO:0099093,"Diabetes Mellitus, Experimental",MESH:D003921,1,Troglitazone,0,
calcium export from the mitochondrion,GO:0099093,"Diabetes Mellitus, Type 2",MESH:D003924,1,Troglitazone,0,
calcium import into the mitochondrion,GO:0036444,Diabetes Mellitus,MESH:D003920,1,Lead,0,
calcium import into the mitochondrion,GO:0036444,"Diabetes Mellitus, Experimental",MESH:D003921,1,ginsenoside Re,0,
calcium import into the mitochondrion,GO:0036444,"Diabetes Mellitus, Type 2",MESH:D003924,2,ginsenoside Re|Lead,0,
calcium-independent cell-matrix adhesion,GO:0007161,Diabetes Mellitus,MESH:D003920,0,,1,FN1
calcium ion export,GO:1901660,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
calcium ion export,GO:1901660,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
calcium ion export,GO:1901660,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
calcium ion export,GO:1901660,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Calcium,0,
calcium ion homeostasis,GO:0055074,Diabetes Mellitus,MESH:D003920,16,"2,2',4,4'-tetrabromodiphenyl ether|Atrazine|bisphenol A|Cadmium|Chlorpromazine|Chlorpyrifos|Docosahexaenoic Acids|Gallic Acid|Lead|Metformin|Methylprednisolone|Resveratrol|Selenium|Streptozocin|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution",0,
calcium ion homeostasis,GO:0055074,"Diabetes Mellitus, Experimental",MESH:D003921,14,bisphenol A|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Fructose|Gallic Acid|Glucose|Hydrogen Peroxide|Metformin|Quercetin|Resveratrol|sodium arsenite|Streptozocin,1,CAV1
calcium ion homeostasis,GO:0055074,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin|Warfarin,1,ITPR3
calcium ion homeostasis,GO:0055074,"Diabetes Mellitus, Type 2",MESH:D003924,23,Ascorbic Acid|Atrazine|bisphenol A|bisphenol S|Cadmium|Calcium|Canagliflozin|Curcumin|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|epigallocatechin gallate|Ethanol|Fructose|Glucose|Glutathione|Lead|Metformin|perfluorooctane sulfonic acid|perfluorooctanoic acid|Resveratrol|Streptozocin,3,ENPP1|KL|WFS1
calcium ion import,GO:0070509,Diabetes Mellitus,MESH:D003920,6,arsenite|bisphenol A|Diazinon|Diazoxide|dimethylarsinous acid|methylarsonite,0,
calcium ion import,GO:0070509,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
calcium ion import,GO:0070509,"Diabetes Mellitus, Experimental",MESH:D003921,9,"bisphenol A|Capsaicin|Cholesterol|Glucose|Hydrogen Peroxide|Manganese|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Quercetin",1,GCK
calcium ion import,GO:0070509,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
calcium ion import,GO:0070509,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,DDIT3
calcium ion import,GO:0070509,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|Calcium|Glucose|Manganese|Nicotine|Vehicle Emissions,1,GCK
calcium ion import across plasma membrane,GO:0098703,Diabetes Mellitus,MESH:D003920,3,"2,2',4,4'-tetrabromodiphenyl ether|Copper|Pesticides",0,
calcium ion import across plasma membrane,GO:0098703,"Diabetes Mellitus, Experimental",MESH:D003921,1,mangiferin,0,
calcium ion import across plasma membrane,GO:0098703,"Diabetes Mellitus, Type 2",MESH:D003924,5,Ascorbic Acid|Copper|mangiferin|Pesticides|Silver,0,
calcium ion import into cytosol,GO:1902656,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctane sulfonic acid,0,
calcium ion import into sarcoplasmic reticulum,GO:1990036,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ATP2A2
calcium ion import into sarcoplasmic reticulum,GO:1990036,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ATP2A2
calcium ion-regulated exocytosis of neurotransmitter,GO:0048791,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SNAP25
calcium ion-regulated exocytosis of neurotransmitter,GO:0048791,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SNAP25
calcium ion transmembrane transport,GO:0070588,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ATP2A2|ATP2A3|EDN1
calcium ion transmembrane transport,GO:0070588,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ITPR3
calcium ion transmembrane transport,GO:0070588,"Diabetes Mellitus, Type 2",MESH:D003924,1,Calcium,5,ATP2A2|ATP2A3|EDN1|EDNRA|EDNRB
calcium ion transmembrane transport via high voltage-gated calcium channel,GO:0061577,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
calcium ion transmembrane transport via high voltage-gated calcium channel,GO:0061577,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Resveratrol,0,
calcium ion transmembrane transport via high voltage-gated calcium channel,GO:0061577,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
calcium ion transmembrane transport via high voltage-gated calcium channel,GO:0061577,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glucose|Resveratrol,0,
calcium ion transport,GO:0006816,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
calcium ion transport,GO:0006816,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Glucose|Nicotine|Quercetin,5,ATP2A2|ATP2A3|CAV1|CAV3|NOS3
calcium ion transport,GO:0006816,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
calcium ion transport,GO:0006816,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,3,ITPR3|NOS1|NOS3
calcium ion transport,GO:0006816,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Calcium|Glucose|Nicotine,4,ATP2A2|ATP2A3|NOS3|PRKCB
calcium ion transport from cytosol to endoplasmic reticulum,GO:1903515,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
calcium ion transport from cytosol to endoplasmic reticulum,GO:1903515,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,2,ATP2A2|ATP2A3
calcium ion transport from cytosol to endoplasmic reticulum,GO:1903515,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
calcium ion transport from cytosol to endoplasmic reticulum,GO:1903515,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,2,ATP2A2|ATP2A3
calcium ion transport into cytosol,GO:0060402,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,3,ADRA1A|BAX|BCL2
calcium ion transport into cytosol,GO:0060402,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BAX|BCL2
calcium-mediated signaling,GO:0019722,Diabetes Mellitus,MESH:D003920,13,arsenite|Cadmium|Cyclosporine|Diazoxide|Glyburide|Indapamide|Metformin|Methylprednisolone|Niacin|Particulate Matter|Resveratrol|Risperidone|Tetrachlorodibenzodioxin,1,POMC
calcium-mediated signaling,GO:0019722,"Diabetes Mellitus, Experimental",MESH:D003921,8,Capsaicin|Fenretinide|Glucose|Glyburide|Hydrogen Peroxide|Metformin|Nicotine|Resveratrol,4,BDKRB1|CCL20|EDN1|TNF
calcium-mediated signaling,GO:0019722,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
calcium-mediated signaling,GO:0019722,"Diabetes Mellitus, Type 1",MESH:D003922,4,Calcitriol|Norepinephrine|Resveratrol|Tetrachlorodibenzodioxin,3,CCL20|ITPR3|TNF
calcium-mediated signaling,GO:0019722,"Diabetes Mellitus, Type 2",MESH:D003924,12,alpha-Tocopherol|Cadmium|Calcium|Curcumin|Glucose|Glyburide|Metformin|Nicotine|Particulate Matter|Resveratrol|Tolbutamide|Topiramate,4,EDN1|EDNRB|KSR2|TNF
calcium-mediated signaling using intracellular calcium source,GO:0035584,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|tributyltin,0,
calcium-mediated signaling using intracellular calcium source,GO:0035584,"Diabetes Mellitus, Type 2",MESH:D003924,2,Calcium|Glucose,0,
camera-type eye development,GO:0043010,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
camera-type eye development,GO:0043010,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,CYP1A1|GPD2|LEPR|NEUROD1|PAX6
camera-type eye development,GO:0043010,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,GPD2|LEPR|MTNR1B|NEUROD1|PAX6
camera-type eye morphogenesis,GO:0048593,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
camera-type eye morphogenesis,GO:0048593,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADAMTS9
camera-type eye photoreceptor cell development,GO:0062139,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NEUROD1
camera-type eye photoreceptor cell development,GO:0062139,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NEUROD1
CAMKK-AMPK signaling cascade,GO:0061762,Diabetes Mellitus,MESH:D003920,0,,1,CP
CAMKK-AMPK signaling cascade,GO:0061762,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,KCNJ11
CAMKK-AMPK signaling cascade,GO:0061762,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
CAMKK-AMPK signaling cascade,GO:0061762,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,CP|KCNJ11
CAMKK-AMPK signaling cascade,GO:0061762,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNJ11
cAMP biosynthetic process,GO:0006171,Diabetes Mellitus,MESH:D003920,5,Atrazine|bisphenol A|Particulate Matter|Resveratrol|triphenyltin,0,
cAMP biosynthetic process,GO:0006171,"Diabetes Mellitus, Experimental",MESH:D003921,10,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate|Dronabinol|Manganese|Nicotine|Quercetin|Resveratrol|tributyltin|Vitamin E,0,
cAMP biosynthetic process,GO:0006171,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Lipopolysaccharides|Norepinephrine|Resveratrol,0,
cAMP biosynthetic process,GO:0006171,"Diabetes Mellitus, Type 2",MESH:D003924,14,Atrazine|bisphenol A|bisphenol S|Curcumin|Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate|Ethanol|Manganese|Nicotine|Particulate Matter|perfluorooctanoic acid|Resveratrol|Vehicle Emissions,1,ADCY5
cAMP-mediated signaling,GO:0019933,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEP
cAMP-mediated signaling,GO:0019933,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GLP1R|LEP
cAMP metabolic process,GO:0046058,Diabetes Mellitus,MESH:D003920,5,Atrazine|Blood Glucose|Particulate Matter|Resveratrol|Streptozocin,0,
cAMP metabolic process,GO:0046058,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
cAMP metabolic process,GO:0046058,"Diabetes Mellitus, Experimental",MESH:D003921,10,Blood Glucose|Cyclophosphamide|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Dronabinol|Resveratrol|sodium arsenite|Streptozocin|Taurine,0,
cAMP metabolic process,GO:0046058,"Diabetes Mellitus, Type 1",MESH:D003922,5,Cyclophosphamide|Resveratrol|sodium arsenite|Streptozocin|Taurine,0,
cAMP metabolic process,GO:0046058,"Diabetes Mellitus, Type 2",MESH:D003924,14,Atrazine|Blood Glucose|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Ethanol|Malathion|Particulate Matter|Pentoxifylline|Resveratrol|saxagliptin|Sitagliptin Phosphate|Streptozocin|Vehicle Emissions,0,
canalicular bile acid transport,GO:0015722,"Diabetes Mellitus, Experimental",MESH:D003921,2,Bile Acids and Salts|Lithocholic Acid,0,
canalicular bile acid transport,GO:0015722,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lithocholic Acid,0,
cannabinoid biosynthetic process,GO:1901696,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
cannabinoid biosynthetic process,GO:1901696,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Orlistat,0,
canonical glycolysis,GO:0061621,Diabetes Mellitus,MESH:D003920,2,Metformin|Ozone,0,
canonical glycolysis,GO:0061621,"Diabetes Mellitus, Experimental",MESH:D003921,3,cinnamaldehyde|Metformin|sodium arsenite,3,GCK|HK1|PFKM
canonical glycolysis,GO:0061621,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
canonical glycolysis,GO:0061621,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
canonical glycolysis,GO:0061621,"Diabetes Mellitus, Type 2",MESH:D003924,3,cinnamaldehyde|Diethylnitrosamine|Metformin,2,GCK|HK1
canonical Wnt signaling pathway,GO:0060070,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CAV1|EDN1|FOXO3|TGFB1
canonical Wnt signaling pathway,GO:0060070,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,EDN1|EDNRA|EDNRB|SFRP4|TCF7L2
canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,GO:0044334,"Diabetes Mellitus, Experimental",MESH:D003921,1,thymoquinone,0,
canonical Wnt signaling pathway involved in stem cell proliferation,GO:1905474,"Diabetes Mellitus, Experimental",MESH:D003921,1,Benzamides,0,
carbohydrate derivative metabolic process,GO:1901135,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GCKR
carbohydrate export,GO:0033231,"Diabetes Mellitus, Type 2",MESH:D003924,1,Curcumin,0,
carbohydrate metabolic process,GO:0005975,Diabetes Mellitus,MESH:D003920,4,aroclor 1260|Atrazine|bisphenol A|Selenium,0,
carbohydrate metabolic process,GO:0005975,"Diabetes Mellitus, Experimental",MESH:D003921,8,bisphenol A|Fructose|Glucose|Hydrogen Peroxide|Inositol|Palm Oil|sodium arsenite|Vitamin E,5,ADRB3|GCK|HK1|SLC2A2|SLC2A4
carbohydrate metabolic process,GO:0005975,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
carbohydrate metabolic process,GO:0005975,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Genistein|Palm Oil|sodium arsenite,0,
carbohydrate metabolic process,GO:0005975,"Diabetes Mellitus, Type 2",MESH:D003924,9,"1,5-anhydroglucitol|Ascorbic Acid|Atrazine|bisphenol A|bisphenol S|Fructose|Genistein|Glucose|Lactic Acid",6,GCK|HK1|KL|OGG1|SLC2A2|SLC2A4
carbohydrate phosphorylation,GO:0046835,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,GCK|HK1|PFKM
carbohydrate phosphorylation,GO:0046835,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
carbohydrate phosphorylation,GO:0046835,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCK|HK1
carbohydrate transport,GO:0008643,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,1,SLC2A2
carbohydrate transport,GO:0008643,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,1,SLC2A2
carbohydrate utilization,GO:0009758,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC2A2
carbohydrate utilization,GO:0009758,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A2
carbon dioxide transport,GO:0015670,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HBA1
carboxylic acid catabolic process,GO:0046395,Diabetes Mellitus,MESH:D003920,0,,1,PON1
carboxylic acid metabolic process,GO:0019752,Diabetes Mellitus,MESH:D003920,7,bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Polychlorinated Biphenyls|Selenium|Uranium|Zinc,0,
carboxylic acid metabolic process,GO:0019752,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dibutyl Phthalate|Hydrogen Peroxide,0,
carboxylic acid metabolic process,GO:0019752,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
carboxylic acid metabolic process,GO:0019752,"Diabetes Mellitus, Type 2",MESH:D003924,8,Aconitic Acid|bisphenol A|Cadmium|Dibutyl Phthalate|Lactic Acid|perfluorooctanoic acid|Polychlorinated Biphenyls|Zinc,0,
cardiac atrium development,GO:0003230,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IGF1
cardiac atrium development,GO:0003230,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
cardiac atrium morphogenesis,GO:0003209,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
cardiac atrium morphogenesis,GO:0003209,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
cardiac chamber ballooning,GO:0003242,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cardiac chamber ballooning,GO:0003242,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
cardiac chamber ballooning,GO:0003242,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cardiac chamber ballooning,GO:0003242,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
cardiac chamber formation,GO:0003207,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDNRA
cardiac conduction,GO:0061337,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
cardiac conduction system development,GO:0003161,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SMAD5
cardiac epithelial to mesenchymal transition,GO:0060317,Diabetes Mellitus,MESH:D003920,2,arsenite|Zinc,0,
cardiac epithelial to mesenchymal transition,GO:0060317,"Diabetes Mellitus, Type 2",MESH:D003924,1,Zinc,0,
cardiac fibroblast cell differentiation,GO:0060935,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cardiac fibroblast cell differentiation,GO:0060935,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
cardiac fibroblast cell differentiation,GO:0060935,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cardiac fibroblast cell differentiation,GO:0060935,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
cardiac muscle cell action potential,GO:0086001,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
cardiac muscle cell action potential,GO:0086001,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dronabinol|Streptozocin,0,
cardiac muscle cell action potential,GO:0086001,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
cardiac muscle cell action potential,GO:0086001,"Diabetes Mellitus, Type 2",MESH:D003924,1,Streptozocin,0,
cardiac muscle cell apoptotic process,GO:0010659,Diabetes Mellitus,MESH:D003920,3,Cadmium|Metformin|morroniside,1,SIRT1
cardiac muscle cell apoptotic process,GO:0010659,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Metformin,3,SIRT1|TP53|TRP53
cardiac muscle cell apoptotic process,GO:0010659,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Glucose|Metformin,1,SIRT1
cardiac muscle cell contraction,GO:0086003,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Glyburide|Raloxifene Hydrochloride,0,
cardiac muscle cell contraction,GO:0086003,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Diltiazem|Glyburide,1,SLC9A1
cardiac muscle cell contraction,GO:0086003,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cardiac muscle cell contraction,GO:0086003,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|bisphenol S|Calcium|Ethanol|Glyburide|perfluorooctane sulfonic acid,1,KCNQ1
cardiac muscle cell development,GO:0055013,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
cardiac muscle cell development,GO:0055013,"Diabetes Mellitus, Experimental",MESH:D003921,2,bellidifolin|Nicotine,2,CAV3|VEGFA
cardiac muscle cell development,GO:0055013,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
cardiac muscle cell development,GO:0055013,"Diabetes Mellitus, Type 2",MESH:D003924,2,epigallocatechin gallate|Nicotine,1,OGG1
cardiac muscle cell differentiation,GO:0055007,"Diabetes Mellitus, Experimental",MESH:D003921,2,ginsenoside Re|Nicotine,1,SLC9A1
cardiac muscle cell differentiation,GO:0055007,"Diabetes Mellitus, Type 2",MESH:D003924,3,ginsenoside Re|Nicotine|perfluorooctane sulfonic acid,0,
cardiac muscle cell myoblast differentiation,GO:0060379,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ATF3
cardiac muscle cell myoblast differentiation,GO:0060379,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ATF3
cardiac muscle cell proliferation,GO:0060038,Diabetes Mellitus,MESH:D003920,2,Metformin|morroniside,0,
cardiac muscle cell proliferation,GO:0060038,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Metformin,1,CAV1
cardiac muscle cell proliferation,GO:0060038,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glucose|Metformin,0,
cardiac muscle contraction,GO:0060048,Diabetes Mellitus,MESH:D003920,6,Alloxan|bisphenol A|Iron|Particulate Matter|Rosiglitazone|Streptozocin,0,
cardiac muscle contraction,GO:0060048,"Diabetes Mellitus, Experimental",MESH:D003921,6,Alloxan|bisphenol A|Diltiazem|Nicotine|Rosiglitazone|Streptozocin,0,
cardiac muscle contraction,GO:0060048,"Diabetes Mellitus, Type 1",MESH:D003922,5,Alloxan|bisphenol A|Iron|Norepinephrine|Streptozocin,0,
cardiac muscle contraction,GO:0060048,"Diabetes Mellitus, Type 2",MESH:D003924,10,Alloxan|bisphenol A|Calcium|Iron|Nicotine|Particulate Matter|Rosiglitazone|Streptozocin|Tolbutamide|Vehicle Emissions,2,KCNQ1|SMAD5
cardiac muscle hypertrophy,GO:0003300,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Plant Preparations|Resveratrol,0,
cardiac muscle hypertrophy,GO:0003300,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Plant Preparations|Resveratrol|swietenine,2,CAV3|LEP
cardiac muscle hypertrophy,GO:0003300,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Lipopolysaccharides|Resveratrol,0,
cardiac muscle hypertrophy,GO:0003300,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|bisphenol S|Ethanol|Resveratrol|Vehicle Emissions,2,LEP|MIR195
cardiac muscle hypertrophy in response to stress,GO:0014898,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ATP2A2
cardiac muscle hypertrophy in response to stress,GO:0014898,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ATP2A2
cardiac muscle tissue development,GO:0048738,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP8
cardiac muscle tissue growth involved in heart morphogenesis,GO:0003245,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,1,MIR195
cardiac muscle tissue morphogenesis,GO:0055008,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Selenium|Tetrachlorodibenzodioxin,0,
cardiac muscle tissue morphogenesis,GO:0055008,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Diethylhexyl Phthalate,0,
cardiac muscle tissue morphogenesis,GO:0055008,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Tetrachlorodibenzodioxin,0,
cardiac muscle tissue morphogenesis,GO:0055008,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Diethylhexyl Phthalate,0,
cardiac muscle tissue regeneration,GO:0061026,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
cardiac muscle tissue regeneration,GO:0061026,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
cardiac neural crest cell migration involved in outflow tract morphogenesis,GO:0003253,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
cardiac neural crest cell migration involved in outflow tract morphogenesis,GO:0003253,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EDN1|EDNRA
cardiac right ventricle morphogenesis,GO:0003215,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR17HG
cardiac septum morphogenesis,GO:0060411,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
cardiac vascular smooth muscle cell development,GO:0060948,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dibutyl Phthalate,1,VEGFA
cardiac vascular smooth muscle cell development,GO:0060948,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dibutyl Phthalate,0,
cardiac ventricle morphogenesis,GO:0003208,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
cardiac ventricle morphogenesis,GO:0003208,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
cardioblast migration to the midline involved in heart rudiment formation,GO:0003319,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,MMP2|S1PR2
cardiolipin biosynthetic process,GO:0032049,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
cardiolipin biosynthetic process,GO:0032049,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
cardiolipin biosynthetic process,GO:0032049,"Diabetes Mellitus, Type 2",MESH:D003924,1,Atrazine,0,
cardiolipin metabolic process,GO:0032048,Diabetes Mellitus,MESH:D003920,2,Pyruvaldehyde|Troglitazone,0,
cardiolipin metabolic process,GO:0032048,"Diabetes Mellitus, Experimental",MESH:D003921,1,Troglitazone,0,
cardiolipin metabolic process,GO:0032048,"Diabetes Mellitus, Type 2",MESH:D003924,1,Troglitazone,0,
carnitine biosynthetic process,GO:0045329,Diabetes Mellitus,MESH:D003920,1,Olanzapine,0,
carnitine biosynthetic process,GO:0045329,"Diabetes Mellitus, Experimental",MESH:D003921,4,Diethylhexyl Phthalate|Fructose|Quercetin|sodium arsenite,0,
carnitine biosynthetic process,GO:0045329,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
carnitine biosynthetic process,GO:0045329,"Diabetes Mellitus, Type 2",MESH:D003924,3,Diethylhexyl Phthalate|Fructose|perfluorooctanoic acid,0,
carnitine metabolic process,GO:0009437,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Dichlorodiphenyl Dichloroethylene|Selenium,1,CPT1A
carnitine metabolic process,GO:0009437,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dronabinol|sodium arsenite,2,CPT1A|CPT1B
carnitine metabolic process,GO:0009437,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
carnitine metabolic process,GO:0009437,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Dichlorodiphenyl Dichloroethylene|perfluorooctanoic acid,1,CPT1A
"carnitine metabolic process, CoA-linked",GO:0019254,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
"carnitine metabolic process, CoA-linked",GO:0019254,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
"carnitine metabolic process, CoA-linked",GO:0019254,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dichlorodiphenyl Dichloroethylene|Dietary Fats,0,
carnitine shuttle,GO:0006853,Diabetes Mellitus,MESH:D003920,1,Sodium Selenite,1,CPT1A
carnitine shuttle,GO:0006853,"Diabetes Mellitus, Experimental",MESH:D003921,1,Sodium Selenite,2,CPT1A|CPT1B
carnitine shuttle,GO:0006853,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,1,CPT1A
carnitine transmembrane transport,GO:1902603,Diabetes Mellitus,MESH:D003920,2,Berberine|Clozapine,0,
carnitine transmembrane transport,GO:1902603,"Diabetes Mellitus, Experimental",MESH:D003921,1,Berberine,0,
carnitine transmembrane transport,GO:1902603,"Diabetes Mellitus, Type 2",MESH:D003924,2,Berberine|Clozapine,0,
carnitine transport,GO:0015879,Diabetes Mellitus,MESH:D003920,1,Olanzapine,0,
cartilage development,GO:0051216,Diabetes Mellitus,MESH:D003920,2,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A",0,
cartilage development,GO:0051216,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Nicotine,3,EDN1|ESRRA|TIMP1
cartilage development,GO:0051216,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cartilage development,GO:0051216,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|diethyl phthalate|Ethanol|Nicotine,6,EDN1|ENPP1|MIR140|NFATC2|SMAD5|TIMP1
cartilage development involved in endochondral bone morphogenesis,GO:0060351,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
cartilage development involved in endochondral bone morphogenesis,GO:0060351,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,CBS|EDN1|NOTCH2
cartilage homeostasis,GO:1990079,Diabetes Mellitus,MESH:D003920,1,Lead,0,
cartilage homeostasis,GO:1990079,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
cartilage homeostasis,GO:1990079,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lead,0,
cartilage morphogenesis,GO:0060536,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cartilage morphogenesis,GO:0060536,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,EDN1
cartilage morphogenesis,GO:0060536,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cartilage morphogenesis,GO:0060536,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,EDN1
catecholamine secretion,GO:0050432,Diabetes Mellitus,MESH:D003920,1,Potassium,0,
catecholamine secretion,GO:0050432,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
catecholamine secretion,GO:0050432,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
catechol-containing compound metabolic process,GO:0009712,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
catechol-containing compound metabolic process,GO:0009712,"Diabetes Mellitus, Type 2",MESH:D003924,1,Atrazine,0,
caveola assembly,GO:0070836,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CAV1|CAV3
caveolin-mediated endocytosis,GO:0072584,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
CD40 signaling pathway,GO:0023035,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNFRSF1B
"CD4-positive, alpha-beta intraepithelial T cell differentiation",GO:0002301,Diabetes Mellitus,MESH:D003920,1,Lead,0,
"CD4-positive, alpha-beta intraepithelial T cell differentiation",GO:0002301,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lead,0,
"CD4-positive, alpha-beta T cell activation",GO:0035710,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
"CD4-positive, alpha-beta T cell activation",GO:0035710,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
"CD4-positive, alpha-beta T cell differentiation",GO:0043367,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BRAF
"CD4-positive, alpha-beta T cell differentiation involved in immune response",GO:0002294,Diabetes Mellitus,MESH:D003920,1,Pesticides,0,
"CD4-positive, alpha-beta T cell differentiation involved in immune response",GO:0002294,"Diabetes Mellitus, Type 2",MESH:D003924,1,Pesticides,0,
"CD4-positive, alpha-beta T cell lineage commitment",GO:0043373,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
"CD4-positive, alpha-beta T cell lineage commitment",GO:0043373,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
"CD4-positive, alpha-beta T cell proliferation",GO:0035739,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PRKCQ
"CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment",GO:0002362,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",GO:0043369,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BRAF
CD80 biosynthetic process,GO:0035780,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
CD80 biosynthetic process,GO:0035780,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,0,
CD80 biosynthetic process,GO:0035780,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
CD86 biosynthetic process,GO:0035781,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
CD86 biosynthetic process,GO:0035781,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,0,
CD86 biosynthetic process,GO:0035781,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
"CD8-positive, alpha-beta cytotoxic T cell differentiation",GO:0002308,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
"CD8-positive, alpha-beta cytotoxic T cell differentiation",GO:0002308,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
"CD8-positive, alpha-beta cytotoxic T cell differentiation",GO:0002308,"Diabetes Mellitus, Type 2",MESH:D003924,1,epigallocatechin gallate,0,
"CD8-positive, alpha-beta T cell activation",GO:0036037,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
"CD8-positive, alpha-beta T cell activation",GO:0036037,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
"CD8-positive, alpha-beta T cell activation",GO:0036037,"Diabetes Mellitus, Type 2",MESH:D003924,1,S-Adenosylmethionine,0,
"CD8-positive, alpha-beta T cell differentiation",GO:0043374,Diabetes Mellitus,MESH:D003920,2,Arsenic|Lead,0,
"CD8-positive, alpha-beta T cell differentiation",GO:0043374,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,0,,1,TNFSF8
"CD8-positive, alpha-beta T cell differentiation",GO:0043374,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Lead,0,
"CD8-positive, alpha-beta T cell differentiation involved in immune response",GO:0002302,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IFNG
"CD8-positive, alpha-beta T cell differentiation involved in immune response",GO:0002302,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IFNG
"CD8-positive, alpha-beta T cell lineage commitment",GO:0043375,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
"CD8-positive, alpha-beta T cell lineage commitment",GO:0043375,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
"CD8-positive, alpha-beta T cell lineage commitment",GO:0043375,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,1,BCL2
CDP-choline pathway,GO:0006657,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CPT1B
CDP-diacylglycerol biosynthetic process,GO:0016024,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GPAM
CDP metabolic process,GO:0046704,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
cell-abiotic substrate adhesion,GO:0036164,Diabetes Mellitus,MESH:D003920,2,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A",0,
cell-abiotic substrate adhesion,GO:0036164,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Hydrogen Peroxide|sodium arsenite,1,ID1
cell-abiotic substrate adhesion,GO:0036164,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
cell-abiotic substrate adhesion,GO:0036164,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,ID1
cell activation,GO:0001775,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
cell activation,GO:0001775,"Diabetes Mellitus, Experimental",MESH:D003921,2,Resveratrol|sodium arsenite,2,IGF1|TGFB1
cell activation,GO:0001775,"Diabetes Mellitus, Type 1",MESH:D003922,2,Resveratrol|sodium arsenite,1,IGF1
cell activation,GO:0001775,"Diabetes Mellitus, Type 2",MESH:D003924,2,Nickel|Resveratrol,0,
cell adhesion,GO:0007155,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Plant Extracts|Resveratrol,4,AOC3|FN1|RAC1|THBS2
cell adhesion,GO:0007155,"Diabetes Mellitus, Experimental",MESH:D003921,7,bisphenol A|Glucose|Hydrogen Peroxide|Plant Extracts|Resveratrol|sodium arsenite|Vitamin E,7,AOC3|ATP2A2|CX3CL1|ICAM1|MFGE8|PRKCA|PRKCE
cell adhesion,GO:0007155,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|sodium arsenite,0,
cell adhesion,GO:0007155,"Diabetes Mellitus, Type 2",MESH:D003924,7,bisphenol A|Folic Acid|Glucose|mono-(2-ethylhexyl)phthalate|perfluorooctane sulfonic acid|Plant Extracts|Resveratrol,6,ATP2A2|CD36|ICAM1|INPPL1|ITGA1|MAEA
cell adhesion mediated by integrin,GO:0033627,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ICAM1
cell adhesion mediated by integrin,GO:0033627,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ICAM1|ITGA1
cell aggregation,GO:0098743,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Chlorpromazine|Plant Extracts,0,
cell aggregation,GO:0098743,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate|Nicotine|Plant Extracts|thymoquinone,0,
cell aggregation,GO:0098743,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Lipopolysaccharides,0,
cell aggregation,GO:0098743,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate|Nicotine|Plant Extracts,0,
cell-cell adhesion,GO:0098609,Diabetes Mellitus,MESH:D003920,5,Arsenic|arsenite|bisphenol A|DDT|Plant Extracts,0,
cell-cell adhesion,GO:0098609,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cell-cell adhesion,GO:0098609,"Diabetes Mellitus, Experimental",MESH:D003921,5,"bisphenol A|Glucose|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|sodium arsenite",4,BCL2|CX3CL1|ICAM1|VEGFA
cell-cell adhesion,GO:0098609,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Lipopolysaccharides|sodium arsenite|Uric Acid,0,
cell-cell adhesion,GO:0098609,"Diabetes Mellitus, Type 2",MESH:D003924,6,Arsenic|bisphenol A|Glucose|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts,4,BCL2|EGFR|ICAM1|ITGA1
cell-cell adhesion in response to extracellular stimulus,GO:0140039,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Resveratrol,0,
cell-cell adhesion in response to extracellular stimulus,GO:0140039,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Resveratrol,0,
cell-cell adhesion in response to extracellular stimulus,GO:0140039,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Resveratrol,0,
cell-cell adhesion in response to extracellular stimulus,GO:0140039,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Resveratrol,0,
cell-cell adhesion via plasma-membrane adhesion molecules,GO:0098742,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
cell-cell adhesion via plasma-membrane adhesion molecules,GO:0098742,"Diabetes Mellitus, Type 2",MESH:D003924,3,Curcumin|Particulate Matter|titanium dioxide,1,CD36
cell-cell fusion,GO:0140253,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cell-cell fusion,GO:0140253,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
cell-cell fusion,GO:0140253,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cell-cell fusion,GO:0140253,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
cell-cell junction assembly,GO:0007043,"Diabetes Mellitus, Type 1",MESH:D003922,1,Thioctic Acid,0,
cell-cell junction assembly,GO:0007043,"Diabetes Mellitus, Type 2",MESH:D003924,1,Calcium,0,
cell-cell junction maintenance,GO:0045217,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
cell-cell junction organization,GO:0045216,Diabetes Mellitus,MESH:D003920,2,Lead|Resveratrol,1,RAC1
cell-cell junction organization,GO:0045216,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,2,MMP2|TGFB1
cell-cell junction organization,GO:0045216,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
cell-cell junction organization,GO:0045216,"Diabetes Mellitus, Type 2",MESH:D003924,2,Lead|Resveratrol,1,HNF4A
cell-cell signaling,GO:0007267,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Cadmium|Resveratrol,2,INS|POMC
cell-cell signaling,GO:0007267,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,0,,1,TNFSF8
cell-cell signaling,GO:0007267,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|ginsenoside Re|Resveratrol,8,ADRA1A|AGT|CCL20|CX3CL1|EDN1|FGF21|IAPP|IL1B
cell-cell signaling,GO:0007267,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
cell-cell signaling,GO:0007267,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
cell-cell signaling,GO:0007267,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Genistein|Resveratrol,3,CCL20|FGF21|INS
cell-cell signaling,GO:0007267,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Cadmium|Genistein|ginsenoside Re|Resveratrol,4,EDN1|FGF21|IAPP|INS
cell-cell signaling via exosome,GO:0099156,Diabetes Mellitus,MESH:D003920,2,Arsenic|arsenite,0,
cell-cell signaling via exosome,GO:0099156,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
cell-cell signaling via exosome,GO:0099156,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|sodium arsenite,0,
cell-cell signaling via exosome,GO:0099156,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
cell chemotaxis,GO:0060326,Diabetes Mellitus,MESH:D003920,20,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|Arsenic|arsenite|Aspirin|Atrazine|Berberine|bisphenol A|Cadmium|Dichlorodiphenyl Dichloroethylene|Gallic Acid|Hexachlorobenzene|Magnesium|Metformin|o,p'-DDT|Particulate Matter|Plant Extracts|Raloxifene Hydrochloride|Resveratrol|Rosiglitazone",0,
cell chemotaxis,GO:0060326,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
cell chemotaxis,GO:0060326,"Diabetes Mellitus, Experimental",MESH:D003921,17,Berberine|bisphenol A|Cyclophosphamide|Dibutyl Phthalate|Dronabinol|Gallic Acid|Hydrogen Peroxide|mangiferin|Metformin|Naproxen|Nicotine|Plant Extracts|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Ursolic Acid,5,BDKRB1|CCL20|CX3CL1|PRKCD|VEGFA
cell chemotaxis,GO:0060326,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
cell chemotaxis,GO:0060326,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|Calcitriol|Cyclophosphamide|Lipopolysaccharides|Norepinephrine|Resveratrol|sodium arsenite,2,CCL20|PRKCQ
cell chemotaxis,GO:0060326,"Diabetes Mellitus, Type 2",MESH:D003924,27,alpha-Tocopherol|Arsenic|Ascorbic Acid|Atrazine|Berberine|bisphenol A|bisphenol S|Cadmium|Calcium|Curcumin|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|epigallocatechin gallate|Folic Acid|Magnesium|mangiferin|Metformin|mono-(2-ethylhexyl)phthalate|Nicotine|Particulate Matter|Pentoxifylline|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts|Resveratrol|Rosiglitazone|Vehicle Emissions,1,ITGA1
cell communication,GO:0007154,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cholesterol|Triglycerides,0,
cell communication,GO:0007154,"Diabetes Mellitus, Type 2",MESH:D003924,1,Triglycerides,0,
cell communication by electrical coupling involved in cardiac conduction,GO:0086064,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
cell communication by electrical coupling involved in cardiac conduction,GO:0086064,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,0,
cell competition in a multicellular organism,GO:0035212,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
cell cycle,GO:0007049,Diabetes Mellitus,MESH:D003920,22,Aspirin|Berberine|bisphenol A|Cadmium|Cyclosporine|Docosahexaenoic Acids|Indapamide|Niacin|Pesticides|Phenformin|Plant Extracts|Prednisolone|Raloxifene Hydrochloride|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Sodium Selenite|Streptozocin|Tacrolimus|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Troglitazone,0,
cell cycle,GO:0007049,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
cell cycle,GO:0007049,"Diabetes Mellitus, Experimental",MESH:D003921,20,Berberine|bisphenol A|Capsaicin|Cholesterol|Cyclophosphamide|Glucose|Hydrogen Peroxide|Imatinib Mesylate|Naproxen|Nicotine|Nitric Oxide|Plant Extracts|Resveratrol|Rosiglitazone|sodium arsenite|Sodium Selenite|Streptozocin|Tacrolimus|Troglitazone|Vitamin E,0,
cell cycle,GO:0007049,"Diabetes Mellitus, Type 1",MESH:D003922,14,bisphenol A|Calcitriol|Cyclophosphamide|Genistein|Imatinib Mesylate|Nitric Oxide|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|Tetrachlorodibenzodioxin|Thioctic Acid|Vitamin A,0,
cell cycle,GO:0007049,"Diabetes Mellitus, Type 2",MESH:D003924,21,alpha-Tocopherol|Ascorbic Acid|Berberine|bisphenol A|Cadmium|Curcumin|efavirenz|Genistein|Glucose|Glutathione|Nelfinavir|Nicotine|Orlistat|Pentoxifylline|Pesticides|Plant Extracts|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Streptozocin|Troglitazone,1,BCL2L11
cell cycle checkpoint signaling,GO:0000075,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
cell cycle phase transition,GO:0044770,"Diabetes Mellitus, Experimental",MESH:D003921,1,Ursolic Acid,0,
cell cycle process,GO:0022402,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
cell death,GO:0008219,Diabetes Mellitus,MESH:D003920,60,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Alloxan|Arsenic|arsenite|Aspirin|Bezafibrate|bisphenol A|Blood Glucose|Cadmium|Chlordan|Chlorpromazine|Chlorpyrifos|Clozapine|Copper|Cyclosporine|DDT|Diazoxide|Dichlorodiphenyl Dichloroethylene|Dichlorvos|Dieldrin|dimethylarsinous acid|Docosahexaenoic Acids|Gallic Acid|Gliclazide|Glucocorticoids|Glyburide|Hexachlorobenzene|Indapamide|Iron|Lead|Magnesium|Mercury|Metformin|Methylprednisolone|Molybdenum|Nitrogen Dioxide|Ozone|Particulate Matter|Pentamidine|Perindopril|Plant Extracts|Pyruvaldehyde|Raloxifene Hydrochloride|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Selenium|Serotonin|Sodium Selenite|Streptozocin|Tacrolimus|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Trifluoperazine|Troglitazone|Uranium|Vanadium Compounds|Zinc",0,
cell death,GO:0008219,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cell death,GO:0008219,"Diabetes Mellitus, Experimental",MESH:D003921,62,"2',3'-dialdehyde ATP|7-hydroxycoumarin|Aldosterone|Alloxan|Bezafibrate|Biguanides|bisphenol A|Blood Glucose|Capsaicin|Cholesterol|cinnamaldehyde|Clioquinol|cobaltiprotoporphyrin|Coconut Oil|costunolide|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Diltiazem|Dronabinol|Enalapril|Eucalyptol|Exenatide|Fatty Acids, Nonesterified|Fenretinide|Gallic Acid|ginsenoside Re|Gliclazide|Glucose|Glyburide|Hemin|honokiol|Hydrogen Peroxide|Imatinib Mesylate|Losartan|Manganese|Metformin|Nicotine|Nitric Oxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Phlorhizin|pimagedine|Plant Extracts|platycodin D|pterostilbene|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|Superoxides|Tacrolimus|tangeretin|Taurine|thymoquinone|tributyltin|Troglitazone|Ursolic Acid|Vitamin E",0,
cell death,GO:0008219,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
cell death,GO:0008219,"Diabetes Mellitus, Type 1",MESH:D003922,24,Alloxan|bisphenol A|Calcitriol|decabromobiphenyl ether|Dichlorvos|Genistein|Imatinib Mesylate|Iron|Lipopolysaccharides|Mercury|Nitric Oxide|Norepinephrine|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Superoxides|Tacrolimus|Taurine|Tetrachlorodibenzodioxin|Thioctic Acid|Uric Acid|Vitamin A|Warfarin,0,
cell death,GO:0008219,"Diabetes Mellitus, Type 2",MESH:D003924,70,"Air Pollutants|Alloxan|alpha-Tocopherol|Amino Acids|Arsenic|Ascorbic Acid|Bezafibrate|bisphenol A|bisphenol S|Blood Glucose|Cadmium|Calcium|cinnamaldehyde|Clozapine|Copper|coumarin|Curcumin|Cysteine|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|diethyl phthalate|Drugs, Chinese Herbal|Enalapril|epigallocatechin gallate|Ethanol|Exenatide|Fatty Acids, Nonesterified|Folic Acid|Genistein|ginsenoside Re|Gliclazide|Glucose|Glutathione|Glyburide|Hemin|Iron|Lead|Magnesium|Malathion|Manganese|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Nelfinavir|Nickel|Nicotine|Orlistat|Particulate Matter|Pentoxifylline|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|perfluoroundecanoic acid|Plant Extracts|procyanidin B1|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Silver|Streptozocin|Superoxides|titanium dioxide|Tolbutamide|Topiramate|Troglitazone|Vehicle Emissions|Zinc",0,
cell death in response to hydrogen peroxide,GO:0036474,Diabetes Mellitus,MESH:D003920,2,morroniside|Resveratrol,0,
cell death in response to hydrogen peroxide,GO:0036474,"Diabetes Mellitus, Experimental",MESH:D003921,2,Hydrogen Peroxide|Resveratrol,0,
cell death in response to hydrogen peroxide,GO:0036474,"Diabetes Mellitus, Type 1",MESH:D003922,2,Genistein|Resveratrol,0,
cell death in response to hydrogen peroxide,GO:0036474,"Diabetes Mellitus, Type 2",MESH:D003924,3,daidzein|Genistein|Resveratrol,0,
cell death in response to oxidative stress,GO:0036473,"Diabetes Mellitus, Type 2",MESH:D003924,1,epigallocatechin gallate,0,
cell development,GO:0048468,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IGF1
cell development,GO:0048468,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
cell development,GO:0048468,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,1,PROX1
cell differentiation,GO:0030154,Diabetes Mellitus,MESH:D003920,16,"Aspirin|bisphenol A|Clozapine|dimethylarsinous acid|Glucocorticoids|Lead|Metformin|o,p'-DDT|Plant Extracts|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Sodium Selenite|Tacrolimus|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution",3,NR1I2|NR1I3|PPARG
cell differentiation,GO:0030154,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
cell differentiation,GO:0030154,"Diabetes Mellitus, Experimental",MESH:D003921,16,bisphenol A|Capsaicin|Cyclophosphamide|Fenretinide|Glucose|Metformin|Nicotine|pimagedine|Plant Extracts|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Sodium Selenite|Tacrolimus|Vitamin E,13,CAV1|CAV3|FGF21|ID1|IL6|NEUROD1|NKX6-1|PAX6|PDX1|PPARA|PPARG|SLC9A1|VEGFA
cell differentiation,GO:0030154,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
cell differentiation,GO:0030154,"Diabetes Mellitus, Type 1",MESH:D003922,14,bisphenol A|Calcitriol|Cyclophosphamide|decabromobiphenyl ether|Dehydroepiandrosterone|Genistein|Lipopolysaccharides|Norepinephrine|Reactive Oxygen Species|Resveratrol|sodium arsenite|Tacrolimus|Tetrachlorodibenzodioxin|Vitamin A,4,FGF21|IL6|STAT3|TYK2
cell differentiation,GO:0030154,"Diabetes Mellitus, Type 2",MESH:D003924,17,bisphenol A|Calcium|Clozapine|Curcumin|efavirenz|Ethanol|Genistein|Glucose|Lead|Metformin|mono-(2-ethylhexyl)phthalate|Nicotine|Pentoxifylline|Plant Extracts|Reactive Oxygen Species|Resveratrol|Rosiglitazone,19,AKT1|BRAF|EGFR|ETS1|FGF21|HHEX|HNF4A|ID1|IL6|NEUROD1|NKX6-1|NOTCH2|NUS1|PAX6|PDX1|PPARA|PPARG|SFRP4|SMAD5
cell differentiation involved in embryonic placenta development,GO:0060706,"Diabetes Mellitus, Type 2",MESH:D003924,1,mono-(2-ethylhexyl)phthalate,0,
cell division,GO:0051301,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Chlorpyrifos,0,
cell division,GO:0051301,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
cell division,GO:0051301,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Cyclophosphamide,1,PRKCE
cell division,GO:0051301,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Cyclophosphamide,0,
cell division,GO:0051301,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,3,CCND2|MAEA|ZC3HC1
cell fate commitment,GO:0045165,Diabetes Mellitus,MESH:D003920,1,Cadmium,1,PPARG
cell fate commitment,GO:0045165,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CASP3|NEUROD1|PAX6|PPARG
cell fate commitment,GO:0045165,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
cell fate commitment,GO:0045165,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,4,CASP3|NEUROD1|PAX6|PPARG
cell fate determination,GO:0001709,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ATF3|PAX6
cell fate determination,GO:0001709,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,ATF3|NOTCH2|PAX6
cell growth,GO:0016049,Diabetes Mellitus,MESH:D003920,22,"2,4,5,2',4',5'-hexachlorobiphenyl|Arsenic|arsenite|bisphenol A|Cadmium|Chlorpromazine|Chlorpyrifos|Cyclosporine|Docosahexaenoic Acids|Lead|Meglumine Antimoniate|Metformin|Particulate Matter|Plant Extracts|Plant Preparations|Pyruvaldehyde|Raloxifene Hydrochloride|Resveratrol|Selenium|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Troglitazone",0,
cell growth,GO:0016049,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cell growth,GO:0016049,"Diabetes Mellitus, Experimental",MESH:D003921,25,"7-hydroxycoumarin|bisphenol A|Capsaicin|cinnamaldehyde|Cyclophosphamide|Dietary Fats|Diethylhexyl Phthalate|Exenatide|Glucose|Hemin|Hydrogen Peroxide|Imatinib Mesylate|Metformin|Monocrotophos|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|Plant Preparations|Quercetin|Resveratrol|sodium arsenite|thymoquinone|tributyltin|Troglitazone|Ursolic Acid|Vitamin E",1,BCL2
cell growth,GO:0016049,"Diabetes Mellitus, Type 1",MESH:D003922,9,bisphenol A|Cyclophosphamide|decabromobiphenyl ether|Imatinib Mesylate|Lipopolysaccharides|Resveratrol|sodium arsenite|Tetrachlorodibenzodioxin|Thioctic Acid,0,
cell growth,GO:0016049,"Diabetes Mellitus, Type 2",MESH:D003924,36,"alpha-Tocopherol|Amoxicillin|Arsenic|Ascorbic Acid|bisphenol A|bisphenol S|Cadmium|cinnamaldehyde|Curcumin|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Drugs, Chinese Herbal|epigallocatechin gallate|Ethanol|Exenatide|Folic Acid|Glucose|Glutathione|Hemin|Lead|Malathion|Metformin|mono-(2-ethylhexyl)phthalate|Particulate Matter|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|perfluoroundecanoic acid|Plant Extracts|Resveratrol|Silver|TAK-875|titanium dioxide|Troglitazone",1,BCL2
cell growth involved in cardiac muscle cell development,GO:0061049,Diabetes Mellitus,MESH:D003920,1,Rosiglitazone,0,
cell growth involved in cardiac muscle cell development,GO:0061049,"Diabetes Mellitus, Experimental",MESH:D003921,1,Rosiglitazone,2,ADRA1A|AGT
cell growth involved in cardiac muscle cell development,GO:0061049,"Diabetes Mellitus, Type 2",MESH:D003924,1,Rosiglitazone,1,MIR195
cell killing,GO:0001906,"Diabetes Mellitus, Experimental",MESH:D003921,1,mangiferin,0,
cell killing,GO:0001906,"Diabetes Mellitus, Type 2",MESH:D003924,1,mangiferin,0,
cell-matrix adhesion,GO:0007160,Diabetes Mellitus,MESH:D003920,1,DDT,3,ALPK1|FN1|RAC1
cell-matrix adhesion,GO:0007160,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AGT
cell-matrix adhesion,GO:0007160,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2L11|ITGA1
cell maturation,GO:0048469,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
cell maturation,GO:0048469,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cell maturation,GO:0048469,"Diabetes Mellitus, Experimental",MESH:D003921,2,"Dronabinol|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",3,PPARG|REN|VEGFA
cell maturation,GO:0048469,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
cell maturation,GO:0048469,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,1,PPARG
cell migration,GO:0016477,Diabetes Mellitus,MESH:D003920,22,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|Arsenic|arsenite|bisphenol A|Cadmium|Clozapine|Copper|Dichlorodiphenyl Dichloroethylene|Docosahexaenoic Acids|Gallic Acid|Hexachlorobenzene|Metformin|o,p'-DDT|Particulate Matter|Perindopril|Plant Extracts|Raloxifene Hydrochloride|Resveratrol|Streptozocin|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution",2,IRS1|RAC1
cell migration,GO:0016477,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cell migration,GO:0016477,"Diabetes Mellitus, Experimental",MESH:D003921,21,"bisphenol A|cinnamaldehyde|Clioquinol|Cyclophosphamide|Dietary Fats|Diethylhexyl Phthalate|Dronabinol|Gallic Acid|Glucose|honokiol|Hydrogen Peroxide|Imatinib Mesylate|Metformin|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Streptozocin|thymoquinone|Ursolic Acid",8,BCL2|BDKRB1|IRS1|IRS2|MMP2|MMP9|SLC9A1|VEGFA
cell migration,GO:0016477,"Diabetes Mellitus, Type 1",MESH:D003922,9,bisphenol A|Cyclophosphamide|Genistein|Imatinib Mesylate|Lipopolysaccharides|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin,0,
cell migration,GO:0016477,"Diabetes Mellitus, Type 2",MESH:D003924,28,"Arsenic|bisphenol A|bisphenol S|Cadmium|cinnamaldehyde|Clozapine|Copper|Curcumin|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|Drugs, Chinese Herbal|epigallocatechin gallate|Ethanol|Folic Acid|Genistein|Glucose|Lactic Acid|Linagliptin|Metformin|mono-(2-ethylhexyl)phthalate|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts|procyanidin B1|Resveratrol|Streptozocin",6,BCL2|IRS1|IRS2|NFATC2|PIK3CG|TMEM18
cell migration involved in gastrulation,GO:0042074,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ESRRA|S1PR2
cell migration involved in gastrulation,GO:0042074,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
cell migration involved in heart development,GO:0060973,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR2
cell migration involved in sprouting angiogenesis,GO:0002042,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
cell migration involved in sprouting angiogenesis,GO:0002042,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,SIRT1|VEGFA
cell migration involved in sprouting angiogenesis,GO:0002042,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|SIRT1
cell migration involved in vasculogenesis,GO:0035441,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
cell migration to the midline involved in heart development,GO:0003318,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR2
cell morphogenesis,GO:0000902,Diabetes Mellitus,MESH:D003920,2,Lead|Plant Extracts,0,
cell morphogenesis,GO:0000902,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
cell morphogenesis,GO:0000902,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cyclophosphamide|Plant Extracts,2,BCL2|TGFB1
cell morphogenesis,GO:0000902,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
cell morphogenesis,GO:0000902,"Diabetes Mellitus, Type 2",MESH:D003924,3,Lead|Nickel|Plant Extracts,3,BCL2|EGFR|ENPP1
cell motility,GO:0048870,Diabetes Mellitus,MESH:D003920,1,bisphenol A,1,RAC1
cell motility,GO:0048870,"Diabetes Mellitus, Experimental",MESH:D003921,3,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid|bisphenol A|mangiferin",0,
cell motility,GO:0048870,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cell motility,GO:0048870,"Diabetes Mellitus, Type 2",MESH:D003924,3,"bisphenol A|Drugs, Chinese Herbal|mangiferin",1,ETS1
cell population proliferation,GO:0008283,Diabetes Mellitus,MESH:D003920,67,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|Adrenal Cortex Hormones|Air Pollutants|Allergens|Arsenic|arsenite|Aspirin|Atrazine|Berberine|bisphenol A|Cadmium|Chlordan|Chlorodiphenyl (54% Chlorine)|Chlorpromazine|Chlorpyrifos|Clozapine|Copper|Cyclosporine|DDT|Diazinon|Diazoxide|Dichlorodiphenyl Dichloroethylene|Dichlorvos|Dieldrin|Docosahexaenoic Acids|Flavonoids|Gallic Acid|Glucocorticoids|Glyburide|Hexachlorobenzene|Indapamide|Iron|Lead|Mercury|Metformin|Molybdenum|morroniside|Olanzapine|o,p'-DDT|osthol|Ozone|Parathion|Particulate Matter|Phenformin|Pioglitazone|Plant Extracts|Plant Preparations|Polychlorinated Biphenyls|Prednisolone|Pyruvaldehyde|Raloxifene Hydrochloride|Ramipril|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Serotonin|Sodium Selenite|Streptozocin|Tacrolimus|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Trifluoperazine|triphenyltin|Troglitazone|Vanadium Compounds|Zinc",1,PPARG
cell population proliferation,GO:0008283,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cell population proliferation,GO:0008283,"Diabetes Mellitus, Experimental",MESH:D003921,66,"7-hydroxycoumarin|astaxanthine|bellidifolin|Berberine|Bile Acids and Salts|bisphenol A|Capsaicin|Cholesterol|cinnamaldehyde|Clioquinol|cobaltiprotoporphyrin|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Diltiazem|Diosmin|Dronabinol|Enalapril|Eucalyptol|Fenretinide|Fructose|Gallic Acid|ginsenoside Re|Glucose|Glyburide|Hemin|honokiol|Hydrogen Peroxide|Imatinib Mesylate|Losartan|Manganese|mangiferin|Metformin|Monocrotophos|Niacinamide|Nicotine|Nitric Oxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|pimagedine|Pioglitazone|Plant Extracts|Plant Preparations|platycodin D|Propolis|pterostilbene|Quercetin|Ramipril|Resveratrol|Rosiglitazone|Sertraline|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|Tacrolimus|tangeretin|Taurine|thymoquinone|tributyltin|triphenyltin chloride|Troglitazone|Ursolic Acid|Vitamin E|Zinc Compounds",14,AGT|BAX|BCL2|CAV1|IGF1|IRS2|PAX6|PDX1|PPARG|PRKCA|TGFB1|TP53|TRP53|VEGFA
cell population proliferation,GO:0008283,"Diabetes Mellitus, Type 1",MESH:D003922,24,bisphenol A|Calcitriol|Cyclophosphamide|decabromobiphenyl ether|Dehydroepiandrosterone|Dichlorvos|Genistein|Imatinib Mesylate|Iron|Lipopolysaccharides|Mercury|Niacinamide|Nitric Oxide|Norepinephrine|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|Taurine|Tetrachlorodibenzodioxin|Thioctic Acid|Vitamin A|Warfarin,3,IGF1|STAT3|TYK2
cell population proliferation,GO:0008283,"Diabetes Mellitus, Type 2",MESH:D003924,79,"Air Pollutants|alpha-Tocopherol|Arsenic|Ascorbic Acid|astaxanthine|Atrazine|Benzoic Acid|Berberine|bisphenol A|bisphenol S|Cadmium|Calcium|Canagliflozin|cinnamaldehyde|Clozapine|Copper|coumarin|Curcumin|Cysteine|daidzein|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|diethyl phthalate|Diosmin|Drugs, Chinese Herbal|efavirenz|Enalapril|epigallocatechin gallate|Ethanol|Folic Acid|Fructose|Genistein|ginsenoside Re|Glucose|Glutathione|Glyburide|Hemin|Iron|Lead|Malathion|Manganese|mangiferin|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Nelfinavir|Niacinamide|Nickel|Nicotine|Nitrendipine|Orlistat|Pantothenic Acid|Particulate Matter|Pentoxifylline|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|perfluoroundecanoic acid|Pioglitazone|Plant Extracts|Polychlorinated Biphenyls|procyanidin B1|procyanidin B2|Reactive Oxygen Species|Resveratrol|Rosiglitazone|S-Adenosylmethionine|Silver|Streptozocin|titanium dioxide|Tolbutamide|Topiramate|Troglitazone|Vehicle Emissions|Zinc",13,AKT1|BAX|BCL2|EDNRA|EGFR|ENPP1|HMGA1|IRS2|NOTCH2|PAX6|PDX1|PPARG|PROX1
cell projection assembly,GO:0030031,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
cell projection assembly,GO:0030031,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,0,
cell projection assembly,GO:0030031,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,1,EGFR
cell projection morphogenesis,GO:0048858,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cell projection morphogenesis,GO:0048858,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
cell projection morphogenesis,GO:0048858,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
cell projection morphogenesis,GO:0048858,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
cell projection organization,GO:0030030,Diabetes Mellitus,MESH:D003920,1,bisphenol A,1,RAC1
cell projection organization,GO:0030030,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
cell projection organization,GO:0030030,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cell projection organization,GO:0030030,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,AKT1
cell proliferation in bone marrow,GO:0071838,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cell proliferation in bone marrow,GO:0071838,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
cell proliferation in bone marrow,GO:0071838,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Cyclophosphamide,1,ACE
cell proliferation in bone marrow,GO:0071838,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Cyclophosphamide,0,
cell proliferation in bone marrow,GO:0071838,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
cell proliferation in midbrain,GO:0033278,Diabetes Mellitus,MESH:D003920,1,Trifluoperazine,0,
cell quiescence,GO:0044838,Diabetes Mellitus,MESH:D003920,1,Lead,0,
cell quiescence,GO:0044838,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lead,0,
cell redox homeostasis,GO:0045454,Diabetes Mellitus,MESH:D003920,28,Air Pollutants|Arsenic|Aspirin|Atrazine|Berberine|bisphenol A|Cadmium|Chlorpyrifos|Copper|Dichlorvos|Hexachlorobenzene|Metformin|Ozone|Particulate Matter|Pioglitazone|Plant Extracts|Plant Preparations|Polychlorinated Biphenyls|Prednisolone|puerarin|Reactive Oxygen Species|Resveratrol|Selenium|Sodium Selenite|Streptozocin|Tobacco Smoke Pollution|Trichlorfon|Zinc,0,
cell redox homeostasis,GO:0045454,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cell redox homeostasis,GO:0045454,"Diabetes Mellitus, Experimental",MESH:D003921,28,"Berberine|bisphenol A|Cholesterol|Coconut Oil|Dietary Fats|Diethylhexyl Phthalate|Fatty Acids, Nonesterified|Fructose|Glucose|Hydrogen Peroxide|Lithocholic Acid|Malondialdehyde|Metformin|Niacinamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Pioglitazone|Plant Extracts|Plant Preparations|pterostilbene|puerarin|Quercetin|Resveratrol|S-allylcysteine|sodium arsenite|Sodium Selenite|Streptozocin|tributyltin|Vitamin E",6,GPX1|GSR|IL6|NOS2|NOS3|NQO1
cell redox homeostasis,GO:0045454,"Diabetes Mellitus, Type 1",MESH:D003922,9,bisphenol A|Calcitriol|Dichlorvos|Niacinamide|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Vitamin A,5,DDIT3|IL6|NOS1|NOS3|SLC11A1
cell redox homeostasis,GO:0045454,"Diabetes Mellitus, Type 2",MESH:D003924,38,"Air Pollutants|alpha-Tocopherol|Arsenic|Ascorbic Acid|Atrazine|Berberine|bisphenol A|bisphenol S|Cadmium|Calcium|Copper|Curcumin|Dietary Fats|Diethylhexyl Phthalate|Ethanol|Fatty Acids, Nonesterified|Folic Acid|Fructose|Glucose|Glutathione|Lithocholic Acid|Malathion|Malondialdehyde|Metformin|mono-(2-ethylhexyl)phthalate|Niacinamide|Orlistat|Particulate Matter|perfluorooctane sulfonic acid|Pioglitazone|Plant Extracts|Polychlorinated Biphenyls|Reactive Oxygen Species|Resveratrol|S-Adenosylmethionine|Streptozocin|Vildagliptin|Zinc",6,GCLC|GCLM|GPX1|IL6|NOS2|NOS3
cell-substrate adhesion,GO:0031589,Diabetes Mellitus,MESH:D003920,5,arsenite|bisphenol A|Cadmium|Gallic Acid|Raloxifene Hydrochloride,0,
cell-substrate adhesion,GO:0031589,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Dibutyl Phthalate|Gallic Acid|Hydrogen Peroxide|Vitamin E,1,PRKCE
cell-substrate adhesion,GO:0031589,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cell-substrate adhesion,GO:0031589,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Cadmium|Dibutyl Phthalate|titanium dioxide,0,
cell-substrate junction assembly,GO:0007044,Diabetes Mellitus,MESH:D003920,0,,1,FN1
cell surface receptor signaling pathway,GO:0007166,Diabetes Mellitus,MESH:D003920,1,bisphenol A,1,LEPR
cell surface receptor signaling pathway,GO:0007166,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,5,AGT|EDN1|IFNG|LEPR|TNFRSF1A
cell surface receptor signaling pathway,GO:0007166,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
cell surface receptor signaling pathway,GO:0007166,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
cell surface receptor signaling pathway,GO:0007166,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,2,IFNG|IL2RA
cell surface receptor signaling pathway,GO:0007166,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,10,CD36|EDN1|EDNRB|EGFR|GLP1R|IL13RA1|LEPR|SCTR|TNFRSF1A|TNFRSF1B
cellular aldehyde metabolic process,GO:0006081,Diabetes Mellitus,MESH:D003920,1,Chlorpromazine,0,
cellular aldehyde metabolic process,GO:0006081,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glutathione,0,
cellular amino acid homeostasis,GO:0080144,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cellular amino acid homeostasis,GO:0080144,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Taurine,0,
cellular amino acid homeostasis,GO:0080144,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Taurine,0,
cellular amino acid homeostasis,GO:0080144,"Diabetes Mellitus, Type 2",MESH:D003924,2,Amino Acids|bisphenol A,0,
cellular aromatic compound metabolic process,GO:0006725,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
cellular aromatic compound metabolic process,GO:0006725,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
cellular cadmium ion homeostasis,GO:0006876,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
cellular cadmium ion homeostasis,GO:0006876,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
cellular calcium ion homeostasis,GO:0006874,Diabetes Mellitus,MESH:D003920,23,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|arsenite|bisphenol A|Cadmium|Chlorpromazine|Chlorpyrifos|Cyclosporine|Diazoxide|Docosahexaenoic Acids|Glyburide|Insecticides|Lead|Magnesium|Metformin|Particulate Matter|Plant Extracts|Pyruvaldehyde|Resveratrol|Streptozocin|Tetrachlorodibenzodioxin|Troglitazone|Zinc",0,
cellular calcium ion homeostasis,GO:0006874,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cellular calcium ion homeostasis,GO:0006874,"Diabetes Mellitus, Experimental",MESH:D003921,25,"bisphenol A|Capsaicin|Clioquinol|Dietary Fats|Diethylhexyl Phthalate|Diltiazem|Fructose|ginsenoside Re|Glucose|Glyburide|Hydrogen Peroxide|mangiferin|Metformin|Monocrotophos|Naproxen|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|pimagedine|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Streptozocin|tianhuang|Troglitazone",7,ATP2A2|ATP2A3|BCL2|CAV1|EDN1|PRKCA|TGFB1
cellular calcium ion homeostasis,GO:0006874,"Diabetes Mellitus, Type 1",MESH:D003922,10,bisphenol A|decabromobiphenyl ether|Genistein|Lipopolysaccharides|Norepinephrine|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin|Thioctic Acid,0,
cellular calcium ion homeostasis,GO:0006874,"Diabetes Mellitus, Type 2",MESH:D003924,29,Ascorbic Acid|bisphenol A|bisphenol S|Cadmium|Calcium|Dietary Fats|Diethylhexyl Phthalate|Ethanol|Folic Acid|Fructose|Genistein|ginsenoside Re|Glucose|Glutathione|Glyburide|Lead|Magnesium|mangiferin|Metformin|Nickel|Nicotine|Particulate Matter|perfluorooctanoic acid|Plant Extracts|Resveratrol|Streptozocin|Troglitazone|Vehicle Emissions|Zinc,6,ATP2A2|ATP2A3|BCL2|EDN1|EDNRA|PRKCB
cellular carbohydrate metabolic process,GO:0044262,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
cellular carbohydrate metabolic process,GO:0044262,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
cellular carbohydrate metabolic process,GO:0044262,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dichlorodiphenyl Dichloroethylene|Glucose,0,
cellular chemical homeostasis,GO:0055082,"Diabetes Mellitus, Type 2",MESH:D003924,1,Curcumin,0,
cellular chloride ion homeostasis,GO:0030644,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
cellular component disassembly involved in execution phase of apoptosis,GO:0006921,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
cellular component disassembly involved in execution phase of apoptosis,GO:0006921,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CAPN10
cellular component organization,GO:0016043,Diabetes Mellitus,MESH:D003920,3,Berberine|Docosahexaenoic Acids|Plant Preparations,0,
cellular component organization,GO:0016043,"Diabetes Mellitus, Experimental",MESH:D003921,2,Berberine|Plant Preparations,0,
cellular component organization,GO:0016043,"Diabetes Mellitus, Type 2",MESH:D003924,2,Berberine|Quinolines,0,
cellular copper ion homeostasis,GO:0006878,Diabetes Mellitus,MESH:D003920,3,Copper|Streptozocin|Trientine,2,CP|MT2A
cellular copper ion homeostasis,GO:0006878,"Diabetes Mellitus, Experimental",MESH:D003921,2,Manganese|Streptozocin,0,
cellular copper ion homeostasis,GO:0006878,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,1,CP
cellular copper ion homeostasis,GO:0006878,"Diabetes Mellitus, Type 2",MESH:D003924,3,Copper|Manganese|Streptozocin,0,
cellular defense response,GO:0006968,Diabetes Mellitus,MESH:D003920,0,,1,NCF1
cellular defense response,GO:0006968,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NCF1|RELA
cellular defense response,GO:0006968,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
cellular detoxification,GO:1990748,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cellular detoxification,GO:1990748,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
cellular detoxification,GO:1990748,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cellular detoxification,GO:1990748,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,SLC22A3
cellular detoxification of cadmium ion,GO:0098849,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
cellular detoxification of hydrogen peroxide,GO:0061692,Diabetes Mellitus,MESH:D003920,0,,1,CAT
cellular detoxification of hydrogen peroxide,GO:0061692,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,1,CAT
cellular detoxification of hydrogen peroxide,GO:0061692,"Diabetes Mellitus, Type 1",MESH:D003922,1,Thioctic Acid,1,CAT
cellular detoxification of hydrogen peroxide,GO:0061692,"Diabetes Mellitus, Type 2",MESH:D003924,1,Curcumin,1,CAT
cellular detoxification of nitrogen compound,GO:0070458,"Diabetes Mellitus, Experimental",MESH:D003921,2,mangiferin|Nitric Oxide,0,
cellular detoxification of nitrogen compound,GO:0070458,"Diabetes Mellitus, Type 1",MESH:D003922,1,Nitric Oxide,0,
cellular detoxification of nitrogen compound,GO:0070458,"Diabetes Mellitus, Type 2",MESH:D003924,1,mangiferin,1,GSTM1
cellular extravasation,GO:0045123,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
cellular extravasation,GO:0045123,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
cellular extravasation,GO:0045123,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cyclophosphamide|fenugreek seed meal,1,TNF
cellular extravasation,GO:0045123,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,1,TNF
cellular extravasation,GO:0045123,"Diabetes Mellitus, Type 2",MESH:D003924,1,alpha-Tocopherol,2,ITGA1|TNF
cellular glucose homeostasis,GO:0001678,Diabetes Mellitus,MESH:D003920,1,Bezafibrate,1,SIRT1
cellular glucose homeostasis,GO:0001678,"Diabetes Mellitus, Experimental",MESH:D003921,4,Bezafibrate|Glucose|sodium arsenite|Sodium Glutamate,5,GCK|HK1|PFKM|PPARGC1A|SIRT1
cellular glucose homeostasis,GO:0001678,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
cellular glucose homeostasis,GO:0001678,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
cellular glucose homeostasis,GO:0001678,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
cellular glucose homeostasis,GO:0001678,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,1,ABCC8
cellular glucose homeostasis,GO:0001678,"Diabetes Mellitus, Type 2",MESH:D003924,3,Bezafibrate|Glucose|mono-(2-ethylhexyl)phthalate,7,ABCC8|GCK|GCKR|HK1|PPARGC1A|SIRT1|TCF7L2
cellular glutamate homeostasis,GO:0090461,Diabetes Mellitus,MESH:D003920,1,Blood Glucose,0,
cellular glutamate homeostasis,GO:0090461,"Diabetes Mellitus, Experimental",MESH:D003921,2,Blood Glucose|Dronabinol,0,
cellular glutamate homeostasis,GO:0090461,"Diabetes Mellitus, Type 2",MESH:D003924,1,Blood Glucose,0,
cellular heat acclimation,GO:0070370,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
cellular heat acclimation,GO:0070370,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cellular homeostasis,GO:0019725,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
cellular hyperosmotic response,GO:0071474,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCK1
cellular hyperosmotic response,GO:0071474,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A1
cellular hyperosmotic salinity response,GO:0071475,Diabetes Mellitus,MESH:D003920,1,Chlorodiphenyl (54% Chlorine),0,
cellular hyperosmotic salinity response,GO:0071475,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,1,PCK1
cellular hyperosmotic salinity response,GO:0071475,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cellular hyperosmotic salinity response,GO:0071475,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|MIR204
cellular hypotonic response,GO:0071476,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCK1
cellular hypotonic salinity response,GO:0071477,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCK1
cellular iron ion homeostasis,GO:0006879,Diabetes Mellitus,MESH:D003920,11,"2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|bisphenol A|Cadmium|Copper|Iron|Lead|Particulate Matter|Resveratrol|Selenium|Streptozocin",2,CP|SOD1
cellular iron ion homeostasis,GO:0006879,"Diabetes Mellitus, Experimental",MESH:D003921,7,astaxanthine|bis(maltolato)oxovanadium(IV)|bisphenol A|Dietary Fats|Glucose|Resveratrol|Streptozocin,2,HMOX1|SOD1
cellular iron ion homeostasis,GO:0006879,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
cellular iron ion homeostasis,GO:0006879,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Iron|Resveratrol|Streptozocin,2,CP|SLC11A1
cellular iron ion homeostasis,GO:0006879,"Diabetes Mellitus, Type 2",MESH:D003924,14,Air Pollutants|astaxanthine|bisphenol A|Cadmium|Copper|Dietary Fats|Ethanol|Glucose|Iron|Lactic Acid|Lead|Particulate Matter|Resveratrol|Streptozocin,7,CAPN10|CISD2|HMOX1|HPX|SMAD5|SOD1|ZFAND3
cellular ketone metabolic process,GO:0042180,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP2B10|CYP2B9
cellular lipid biosynthetic process,GO:0097384,"Diabetes Mellitus, Experimental",MESH:D003921,1,platycodin D,0,
cellular lipid catabolic process,GO:0044242,Diabetes Mellitus,MESH:D003920,12,Alloxan|Arsenic|Cadmium|Metformin|Plant Extracts|Plant Preparations|Reactive Oxygen Species|Resveratrol|Sodium Selenite|Streptozocin|Sulfur Dioxide|Telmisartan,0,
cellular lipid catabolic process,GO:0044242,"Diabetes Mellitus, Experimental",MESH:D003921,13,Alloxan|Hydrogen Peroxide|Metformin|Monocrotophos|Nicotine|Plant Extracts|Plant Preparations|Resveratrol|sodium arsenite|Sodium Selenite|Streptozocin|tangeretin|Telmisartan,0,
cellular lipid catabolic process,GO:0044242,"Diabetes Mellitus, Type 1",MESH:D003922,6,Alloxan|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Vitamin A,0,
cellular lipid catabolic process,GO:0044242,"Diabetes Mellitus, Type 2",MESH:D003924,11,Alloxan|Arsenic|Cadmium|Ethanol|Metformin|Nicotine|Plant Extracts|Reactive Oxygen Species|Resveratrol|Streptozocin|Telmisartan,0,
cellular lipid metabolic process,GO:0044255,Diabetes Mellitus,MESH:D003920,10,"2,4,5,2',4',5'-hexachlorobiphenyl|arsenite|bisphenol A|Fatty Acids, Omega-3|netoglitazone|Ozone|Pioglitazone|Rosiglitazone|Telmisartan|Troglitazone",0,
cellular lipid metabolic process,GO:0044255,"Diabetes Mellitus, Experimental",MESH:D003921,15,"bisphenol A|Cholesterol|Dietary Fats|Fatty Acids, Nonesterified|Fatty Acids, Omega-3|honokiol|Pioglitazone|Rosiglitazone|sodium arsenite|Telmisartan|tesaglitazar|tributyltin|Triglycerides|triphenyltin chloride|Troglitazone",0,
cellular lipid metabolic process,GO:0044255,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
cellular lipid metabolic process,GO:0044255,"Diabetes Mellitus, Type 2",MESH:D003924,13,"bisphenol A|Dietary Fats|Fatty Acids, Nonesterified|mono-(2-ethylhexyl)phthalate|Pantothenic Acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Rosiglitazone|Telmisartan|Triglycerides|Troglitazone",0,
cellular metabolic process,GO:0044237,Diabetes Mellitus,MESH:D003920,59,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Antimony|aroclor 1260|Arsenic|arsenite|Aspirin|Atrazine|Berberine|bisphenol A|Blood Glucose|Cadmium|Chlordan|Chlorodiphenyl (54% Chlorine)|Chlorpromazine|Chlorpyrifos|Chromium|Copper|Cyclosporine|Dichlorodiphenyl Dichloroethylene|Dieldrin|Docosahexaenoic Acids|Fatty Acids, Omega-3|Flavonoids|Gallic Acid|Glyburide|Hexachlorobenzene|Iron|Lead|Liraglutide|Mercury|Metals, Heavy|Metformin|morroniside|Niacin|osthol|Ozone|Particulate Matter|Pioglitazone|Plant Extracts|pregna-4,17-diene-3,16-dione|Pyruvaldehyde|Quetiapine Fumarate|Raloxifene Hydrochloride|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Tacrolimus|terbufos|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Troglitazone|Tungsten|Uranium|voglibose|Zinc",0,
cellular metabolic process,GO:0044237,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cellular metabolic process,GO:0044237,"Diabetes Mellitus, Experimental",MESH:D003921,66,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid|7-hydroxycoumarin|Aldosterone|astaxanthine|Berberine|Biguanides|Bile Acids and Salts|bisphenol A|Blood Glucose|Capsaicin|Chromium|Clioquinol|corilagin|costunolide|Cromolyn Sodium|Cyclophosphamide|Dibutyl Phthalate|Diethylhexyl Phthalate|Diltiazem|Dronabinol|Exenatide|Fatty Acids, Nonesterified|Fatty Acids, Omega-3|FeCl tetrakis-2-(triethyleneglycolmonomethylether)pyridylporphyrin|Fructose|Gallic Acid|Glucose|Glyburide|Heme|honokiol|Hydrogen Peroxide|Imatinib Mesylate|Losartan|Manganese|mangiferin|Metformin|Monocrotophos|Naproxen|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Phlorhizin|pimagedine|Pioglitazone|Plant Extracts|Propolis|pterostilbene|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sarpogrelate|sodium arsenite|Sodium Glutamate|Sodium Selenite|stannous chloride|Streptozocin|swietenine|Tacrolimus|tangeretin|Taurine|thymoquinone|tributyltin|Troglitazone|Ursolic Acid|Valsartan|Vitamin E",0,
cellular metabolic process,GO:0044237,"Diabetes Mellitus, Type 1",MESH:D003922,19,bisphenol A|Calcitriol|Cyclophosphamide|decabromobiphenyl ether|FeCl tetrakis-2-(triethyleneglycolmonomethylether)pyridylporphyrin|Genistein|Imatinib Mesylate|Iron|Lipopolysaccharides|Mercury|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|Taurine|Tetrachlorodibenzodioxin|Thioctic Acid|Uric Acid|Warfarin,0,
cellular metabolic process,GO:0044237,"Diabetes Mellitus, Type 2",MESH:D003924,72,"2-palmitoylglycerol|Air Pollutants|alpha-Tocopherol|Amoxicillin|Arsenic|Ascorbic Acid|astaxanthine|Atrazine|Berberine|bisphenol A|bisphenol S|Blood Glucose|Cadmium|Calcium|Chromium|Copper|coumarin|Curcumin|Cysteine|daidzein|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|Drugs, Chinese Herbal|epigallocatechin gallate|Ethanol|Exenatide|Fatty Acids, Nonesterified|Folic Acid|Fructose|Genistein|Glucose|Glutathione|Glyburide|Heme|Irbesartan|Iron|Lactic Acid|Lead|Liraglutide|Malathion|Manganese|mangiferin|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Nickel|Nicotine|Orlistat|Pantothenic Acid|Particulate Matter|Pentoxifylline|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|perfluoroundecanoic acid|Pioglitazone|Plant Extracts|Resveratrol|Rosiglitazone|S-Adenosylmethionine|saxagliptin|Silver|stannous chloride|Streptozocin|TAK-875|titanium dioxide|Troglitazone|Vehicle Emissions|Vildagliptin|Zinc",0,
cellular metal ion homeostasis,GO:0006875,Diabetes Mellitus,MESH:D003920,3,Cadmium|Iron|Zinc,0,
cellular metal ion homeostasis,GO:0006875,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
cellular metal ion homeostasis,GO:0006875,"Diabetes Mellitus, Type 1",MESH:D003922,1,Iron,0,
cellular metal ion homeostasis,GO:0006875,"Diabetes Mellitus, Type 2",MESH:D003924,4,Cadmium|Iron|Manganese|Zinc,0,
cellular nitric oxide homeostasis,GO:0033484,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|Atrazine|Particulate Matter,0,
cellular nitric oxide homeostasis,GO:0033484,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nitric Oxide,1,CAV1
cellular nitric oxide homeostasis,GO:0033484,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Nitric Oxide,0,
cellular nitric oxide homeostasis,GO:0033484,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|Atrazine|Curcumin|Particulate Matter,0,
cellular nitrogen compound metabolic process,GO:0034641,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cellular nitrogen compound metabolic process,GO:0034641,"Diabetes Mellitus, Experimental",MESH:D003921,2,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|pimagedine",0,
cellular nitrogen compound metabolic process,GO:0034641,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
cellular oxidant detoxification,GO:0098869,Diabetes Mellitus,MESH:D003920,2,Metformin|Reactive Oxygen Species,3,CAT|CP|PTGS2
cellular oxidant detoxification,GO:0098869,"Diabetes Mellitus, Experimental",MESH:D003921,3,Hydrogen Peroxide|Metformin|Superoxides,4,CAT|GPX1|GSR|PTGS2
cellular oxidant detoxification,GO:0098869,"Diabetes Mellitus, Type 1",MESH:D003922,2,Reactive Oxygen Species|Superoxides,3,CAT|CP|HP
cellular oxidant detoxification,GO:0098869,"Diabetes Mellitus, Type 2",MESH:D003924,5,"Ascorbic Acid|Drugs, Chinese Herbal|Metformin|Reactive Oxygen Species|Superoxides",4,CAT|GPX1|HBA1|HP
cellular oxygen homeostasis,GO:0032364,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SOD2
cellular oxygen homeostasis,GO:0032364,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
cellular oxygen homeostasis,GO:0032364,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SOD2
cellular phosphate ion homeostasis,GO:0030643,Diabetes Mellitus,MESH:D003920,1,Chlorides,0,
cellular phosphate ion homeostasis,GO:0030643,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
cellular pigmentation,GO:0033059,Diabetes Mellitus,MESH:D003920,0,,1,POMC
cellular respiration,GO:0045333,Diabetes Mellitus,MESH:D003920,15,Air Pollutants|bisphenol A|Cadmium|Chlorpyrifos|Clozapine|Cyclosporine|Lead|Liraglutide|Mercury|Particulate Matter|Pyruvaldehyde|Resveratrol|Rosiglitazone|Streptozocin|Tetrachlorodibenzodioxin,0,
cellular respiration,GO:0045333,"Diabetes Mellitus, Experimental",MESH:D003921,14,bisphenol A|Dietary Fats|Dronabinol|Fructose|Glucose|Hydrogen Peroxide|Imatinib Mesylate|Lithocholic Acid|Manganese|Nicotine|Quercetin|Resveratrol|Rosiglitazone|Streptozocin,3,BAX|COX2|PPARGC1A
cellular respiration,GO:0045333,"Diabetes Mellitus, Type 1",MESH:D003922,8,bisphenol A|Imatinib Mesylate|Lipopolysaccharides|Mercury|Resveratrol|Streptozocin|Tetrachlorodibenzodioxin|Thioctic Acid,0,
cellular respiration,GO:0045333,"Diabetes Mellitus, Type 2",MESH:D003924,27,Air Pollutants|Ascorbic Acid|bisphenol A|bisphenol S|Cadmium|Clozapine|Curcumin|Dietary Fats|epigallocatechin gallate|Folic Acid|Fructose|Glucose|Lactic Acid|Lead|Liraglutide|Lithocholic Acid|Malathion|Manganese|Mercury|mono-(2-ethylhexyl)phthalate|Nicotine|Particulate Matter|Pentoxifylline|Resveratrol|Rosiglitazone|Streptozocin|Vehicle Emissions,3,BAX|CYP1A2|PPARGC1A
"cellular response to 2,3,7,8-tetrachlorodibenzodioxine",GO:1904613,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
"cellular response to 2,3,7,8-tetrachlorodibenzodioxine",GO:1904613,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
cellular response to acadesine,GO:1904102,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PDX1
cellular response to acadesine,GO:1904102,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PDX1
cellular response to acetaldehyde,GO:1905641,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
cellular response to acetate,GO:0071311,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
cellular response to acetate,GO:0071311,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEPR
cellular response to acetate,GO:0071311,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LEPR
cellular response to acidic pH,GO:0071468,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC9A1
cellular response to acidic pH,GO:0071468,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
cellular response to actinomycin D,GO:0072717,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
cellular response to aldehyde,GO:0110096,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
cellular response to aldehyde,GO:0110096,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,0,
cellular response to aldehyde,GO:0110096,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
cellular response to aldosterone,GO:1904045,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ACE|AIFM1|SERPINE1
cellular response to aldosterone,GO:1904045,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,AIFM1
cellular response to alkaloid,GO:0071312,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,BCL2L1|ICAM1
cellular response to alkaloid,GO:0071312,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2L1|ICAM1
cellular response to amino acid starvation,GO:0034198,Diabetes Mellitus,MESH:D003920,0,,1,MAP3K5
cellular response to amino acid starvation,GO:0034198,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,ATF3|FAS|MAP3K5|UCP2
cellular response to amino acid starvation,GO:0034198,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,ATF3|FAS|UCP2
cellular response to amino acid stimulus,GO:0071230,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,BCL2L1|MMP2|TNF
cellular response to amino acid stimulus,GO:0071230,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
cellular response to amino acid stimulus,GO:0071230,"Diabetes Mellitus, Type 2",MESH:D003924,0,,10,BCL2L1|EGFR|MIR192|MIR214|MIR221|MIR222|MIR30A|MIR92B|MIRLET7D|TNF
cellular response to ammonium ion,GO:0071242,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
cellular response to ammonium ion,GO:0071242,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
cellular response to ammonium ion,GO:0071242,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
cellular response to ammonium ion,GO:0071242,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
cellular response to amyloid-beta,GO:1904646,Diabetes Mellitus,MESH:D003920,0,,2,FN1|SIRT1
cellular response to amyloid-beta,GO:1904646,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,5,FOXO3|ICAM1|IGF1|SIRT1|TNF
cellular response to amyloid-beta,GO:1904646,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IGF1|TNF
cellular response to amyloid-beta,GO:1904646,"Diabetes Mellitus, Type 2",MESH:D003924,0,,8,BCL2L11|CD36|ICAM1|MIR140|MIR200A|MIR98|SIRT1|TNF
cellular response to angiotensin,GO:1904385,Diabetes Mellitus,MESH:D003920,0,,2,FN1|IRS1
cellular response to angiotensin,GO:1904385,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,AGT|CYBA|IRS1|PRKCD|RELA|SERPINE1
cellular response to angiotensin,GO:1904385,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,CYBA|IRS1|NFKB1|PTPN1
cellular response to antibiotic,GO:0071236,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
cellular response to antibiotic,GO:0071236,"Diabetes Mellitus, Experimental",MESH:D003921,1,Bile Acids and Salts,3,IL1B|SIRT1|SLC9A1
cellular response to antibiotic,GO:0071236,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL10
cellular response to antibiotic,GO:0071236,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
cellular response to Aroclor 1254,GO:1904011,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
cellular response to arsenic-containing substance,GO:0071243,Diabetes Mellitus,MESH:D003920,5,Arsenic|arsenite|Resveratrol|Selenium|Sodium Selenite,0,
cellular response to arsenic-containing substance,GO:0071243,"Diabetes Mellitus, Experimental",MESH:D003921,3,Resveratrol|sodium arsenite|Sodium Selenite,1,HMOX1
cellular response to arsenic-containing substance,GO:0071243,"Diabetes Mellitus, Type 1",MESH:D003922,2,Resveratrol|sodium arsenite,0,
cellular response to arsenic-containing substance,GO:0071243,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Resveratrol,1,HMOX1
cellular response to arsenite(3-),GO:1903841,Diabetes Mellitus,MESH:D003920,2,Arsenic|Arsenicals,0,
cellular response to arsenite(3-),GO:1903841,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
cellular response to astaxanthin,GO:1905218,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2L1
cellular response to astaxanthin,GO:1905218,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2L1
cellular response to ATP,GO:0071318,Diabetes Mellitus,MESH:D003920,0,,2,PTGS2|SOD1
cellular response to ATP,GO:0071318,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PTGS2|SERPINE1|SOD1
cellular response to ATP,GO:0071318,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SOD1
cellular response to bacterial lipopeptide,GO:0071221,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
cellular response to biotic stimulus,GO:0071216,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,RELA
cellular response to bisphenol A,GO:1903926,"Diabetes Mellitus, Type 1",MESH:D003922,1,Calcitriol,0,
cellular response to blue light,GO:0071483,Diabetes Mellitus,MESH:D003920,2,Plant Extracts|Resveratrol,0,
cellular response to blue light,GO:0071483,"Diabetes Mellitus, Experimental",MESH:D003921,2,Plant Extracts|Resveratrol,0,
cellular response to blue light,GO:0071483,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
cellular response to blue light,GO:0071483,"Diabetes Mellitus, Type 2",MESH:D003924,3,Plant Extracts|procyanidin B2|Resveratrol,0,
cellular response to BMP stimulus,GO:0071773,Diabetes Mellitus,MESH:D003920,0,,1,FN1
cellular response to brain-derived neurotrophic factor stimulus,GO:1990416,Diabetes Mellitus,MESH:D003920,0,,1,IRS1
cellular response to brain-derived neurotrophic factor stimulus,GO:1990416,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IRS1
cellular response to brain-derived neurotrophic factor stimulus,GO:1990416,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,IRS1|NFKB1
cellular response to butyrate,GO:1903545,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
cellular response to butyrate,GO:1903545,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEPR
cellular response to butyrate,GO:1903545,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LEPR
cellular response to cadmium ion,GO:0071276,Diabetes Mellitus,MESH:D003920,1,Cadmium,3,CYBB|MT2A|SOD1
cellular response to cadmium ion,GO:0071276,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CYBB|HMOX1|MMP9|SOD1
cellular response to cadmium ion,GO:0071276,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,6,AKT1|CYP1A2|EGFR|HMOX1|OGG1|SOD1
cellular response to caffeine,GO:0071313,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARGC1A
cellular response to caffeine,GO:0071313,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARGC1A
cellular response to calcium ion,GO:0071277,Diabetes Mellitus,MESH:D003920,1,Lead,0,
cellular response to calcium ion,GO:0071277,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
cellular response to calcium ion,GO:0071277,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
cellular response to calcium ion,GO:0071277,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lead,3,BRAF|EDN1|NFATC2
cellular response to cAMP,GO:0071320,Diabetes Mellitus,MESH:D003920,0,,1,ADIPOQ
cellular response to cAMP,GO:0071320,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,BCL2L1|NOS3|PCK1|SERPINE1
cellular response to cAMP,GO:0071320,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,ITPR3|NOS3
cellular response to cAMP,GO:0071320,"Diabetes Mellitus, Type 2",MESH:D003924,0,,7,ADIPOQ|BCL2L1|ENPP1|KCNQ1|LIPC|NOS3|PIK3CG
cellular response to camptothecin,GO:0072757,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
cellular response to camptothecin,GO:0072757,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,0,
cellular response to carbohydrate stimulus,GO:0071322,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCA
cellular response to carbohydrate stimulus,GO:0071322,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NFKB1|PRKCB
cellular response to cell-matrix adhesion,GO:0071460,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP9
cellular response to cGMP,GO:0071321,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SERPINE1
cellular response to chemical stimulus,GO:0070887,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
cellular response to chemical stimulus,GO:0070887,"Diabetes Mellitus, Type 2",MESH:D003924,3,Atrazine|Cysteine|Folic Acid,0,
cellular response to chemokine,GO:1990869,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SH2B3
cellular response to chromate,GO:0071247,Diabetes Mellitus,MESH:D003920,1,Chromium,0,
cellular response to chromate,GO:0071247,"Diabetes Mellitus, Experimental",MESH:D003921,2,Chromium|sodium arsenite,0,
cellular response to chromate,GO:0071247,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cellular response to chromate,GO:0071247,"Diabetes Mellitus, Type 2",MESH:D003924,1,Chromium,0,
cellular response to cisplatin,GO:0072719,Diabetes Mellitus,MESH:D003920,1,Aspirin,0,
cellular response to cisplatin,GO:0072719,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cellular response to cisplatin,GO:0072719,"Diabetes Mellitus, Experimental",MESH:D003921,2,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|sodium arsenite",1,HMOX1
cellular response to cisplatin,GO:0072719,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cellular response to cisplatin,GO:0072719,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HMOX1
cellular response to cobalt ion,GO:0071279,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FAS
cellular response to cobalt ion,GO:0071279,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FAS
cellular response to cocaine,GO:0071314,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
cellular response to cold,GO:0070417,"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS",OMIM:616192,0,,1,DNAJC3
cellular response to cold,GO:0070417,"Diabetes Mellitus, Experimental",MESH:D003921,2,Superoxides|tributyltin,1,SLC9A1
cellular response to cold,GO:0070417,"Diabetes Mellitus, Type 1",MESH:D003922,1,Superoxides,0,
cellular response to cold,GO:0070417,"Diabetes Mellitus, Type 2",MESH:D003924,1,Superoxides,0,
cellular response to copper ion,GO:0071280,Diabetes Mellitus,MESH:D003920,1,Copper,1,MT2A
cellular response to copper ion,GO:0071280,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
cellular response to copper ion,GO:0071280,"Diabetes Mellitus, Type 2",MESH:D003924,1,Copper,1,CYP1A2
cellular response to corticosterone stimulus,GO:0071386,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FOXO3
cellular response to curcumin,GO:1904644,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
cellular response to curcumin,GO:1904644,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
cellular response to curcumin,GO:1904644,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
cellular response to cycloheximide,GO:0071409,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SERPINE1
cellular response to cytokine stimulus,GO:0071345,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,FAS|IL6|MMP2|MMP9|NKX6-1|NOS2
cellular response to cytokine stimulus,GO:0071345,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IL6|STAT3
cellular response to cytokine stimulus,GO:0071345,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,FAS|IL6|NFKB1|NKX6-1|NOS2
cellular response to decreased oxygen levels,GO:0036294,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|MIR142|MIR204|MIR221|MIR222
cellular response to dexamethasone stimulus,GO:0071549,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,BCL2L1|ICAM1|IGF1|IL6|PCK1|SERPINE1|TGFB1|VEGFA
cellular response to dexamethasone stimulus,GO:0071549,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IGF1|IL6
cellular response to dexamethasone stimulus,GO:0071549,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,BCL2L1|CCND2|EGFR|ICAM1|IL6
cellular response to diacyl bacterial lipopeptide,GO:0071726,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
cellular response to diterpene,GO:1904630,"Diabetes Mellitus, Type 2",MESH:D003924,1,Calcium,1,NFKB1
cellular response to DNA damage stimulus,GO:0006974,Diabetes Mellitus,MESH:D003920,33,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|alachlor|Alloxan|Arsenic|arsenite|Atrazine|Berberine|bisphenol A|Cadmium|Chlorpyrifos|Copper|Cyclosporine|Diazinon|Dichlorvos|dimethylarsinous acid|Iron|Lead|Metformin|Niacin|Ozone|Particulate Matter|Pesticides|Plant Extracts|Plant Preparations|Polychlorinated Biphenyls|Pyruvaldehyde|Resveratrol|Selenium|Streptozocin|terbufos|Tobacco Smoke Pollution|Zinc",1,SIRT1
cellular response to DNA damage stimulus,GO:0006974,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cellular response to DNA damage stimulus,GO:0006974,"Diabetes Mellitus, Experimental",MESH:D003921,35,"Aldosterone|Alloxan|Berberine|bisphenol A|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Diosmin|Dronabinol|Eucalyptol|Glucose|Heme|Hemin|Hydrogen Peroxide|Lithocholic Acid|Losartan|Manganese|Metformin|Monocrotophos|Niacinamide|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|pimagedine|Plant Extracts|Plant Preparations|Propolis|Quercetin|Resveratrol|S-allylcysteine|sodium arsenite|Streptozocin|Taurine|Vitamin E",7,BAX|BCL2|CASP3|PRKCD|SIRT1|TP53|TRP53
cellular response to DNA damage stimulus,GO:0006974,"Diabetes Mellitus, Insulin-Dependent, 12",MESH:C563326,0,,1,CTLA4
cellular response to DNA damage stimulus,GO:0006974,"Diabetes Mellitus, Type 1",MESH:D003922,13,Alloxan|bisphenol A|Cyclophosphamide|decabromobiphenyl ether|Dichlorvos|Genistein|Iron|Lipopolysaccharides|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Taurine,1,DDIT3
cellular response to DNA damage stimulus,GO:0006974,"Diabetes Mellitus, Type 2",MESH:D003924,48,Air Pollutants|Alloxan|alpha-Tocopherol|Arsenic|Ascorbic Acid|Atrazine|Berberine|bisphenol A|bisphenol S|Cadmium|Copper|coumarin|Curcumin|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Diosmin|epigallocatechin gallate|Ethanol|Folic Acid|Genistein|Glucose|Glutathione|Heme|Hemin|Iron|Lead|Lithocholic Acid|Malathion|Manganese|Metformin|mono-(2-ethylhexyl)phthalate|Niacinamide|Nickel|Nicotine|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pesticides|Plant Extracts|Polychlorinated Biphenyls|Resveratrol|Silver|Streptozocin|titanium dioxide|Vehicle Emissions|Zinc,8,AKT1|BAX|BCL2|CASP3|NFATC2|OGG1|SIRT1|UBE2E2
cellular response to dopamine,GO:1903351,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ID1
cellular response to dopamine,GO:1903351,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ID1
cellular response to dsRNA,GO:0071359,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NFKB1
cellular response to electrical stimulus,GO:0071257,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nitric Oxide,2,IGF1|SLC9A1
cellular response to electrical stimulus,GO:0071257,"Diabetes Mellitus, Type 1",MESH:D003922,1,Nitric Oxide,1,IGF1
cellular response to endothelin,GO:1990859,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IRS2
cellular response to endothelin,GO:1990859,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IRS2
cellular response to epidermal growth factor stimulus,GO:0071364,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ID1
cellular response to epidermal growth factor stimulus,GO:0071364,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
cellular response to epidermal growth factor stimulus,GO:0071364,"Diabetes Mellitus, Type 2",MESH:D003924,1,Genistein,3,AKT1|EGFR|ID1
cellular response to epinephrine stimulus,GO:0071872,Diabetes Mellitus,MESH:D003920,0,,1,ADIPOQ
cellular response to epinephrine stimulus,GO:0071872,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PKLR|SLC9A1
cellular response to epinephrine stimulus,GO:0071872,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS1
cellular response to epinephrine stimulus,GO:0071872,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ADIPOQ|KCNQ1
cellular response to erythropoietin,GO:0036018,Diabetes Mellitus,MESH:D003920,0,,1,MT2A
cellular response to erythropoietin,GO:0036018,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2L1
cellular response to erythropoietin,GO:0036018,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2L1
cellular response to estradiol stimulus,GO:0071392,"Diabetes Mellitus, Experimental",MESH:D003921,0,,7,AIFM1|HSD11B1|IGF1|IL6|MMP2|PPARGC1A|TNFRSF1A
cellular response to estradiol stimulus,GO:0071392,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,AIFM1|IGF1|IL10|IL6
cellular response to estradiol stimulus,GO:0071392,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,BCL2L11|EGFR|IL6|PPARGC1A|TNFRSF1A
cellular response to estrogen stimulus,GO:0071391,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cellular response to estrogen stimulus,GO:0071391,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,2,FAS|VEGFA
cellular response to estrogen stimulus,GO:0071391,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Genistein,0,
cellular response to estrogen stimulus,GO:0071391,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Genistein,4,FAS|MIR125B1|MIR142|MIR195
cellular response to ethanol,GO:0071361,Diabetes Mellitus,MESH:D003920,0,,1,CYBB
cellular response to ethanol,GO:0071361,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CYBB|PRKCE|SOD2
cellular response to ethanol,GO:0071361,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,MIR10B|MIR200A|MIR30A|MIR339|SOD2
cellular response to exogenous dsRNA,GO:0071360,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
cellular response to external biotic stimulus,GO:0071217,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
cellular response to fatty acid,GO:0071398,Diabetes Mellitus,MESH:D003920,1,Reactive Oxygen Species,2,CPT1A|IRS1
cellular response to fatty acid,GO:0071398,"Diabetes Mellitus, Experimental",MESH:D003921,0,,9,CPT1A|EDN1|IL1B|IRS1|PDK4|PPARGC1A|PRKCD|SLC2A2|SREBF1
cellular response to fatty acid,GO:0071398,"Diabetes Mellitus, Type 1",MESH:D003922,1,Reactive Oxygen Species,0,
cellular response to fatty acid,GO:0071398,"Diabetes Mellitus, Type 2",MESH:D003924,1,Reactive Oxygen Species,5,CPT1A|EDN1|IRS1|PPARGC1A|SLC2A2
cellular response to fibroblast growth factor stimulus,GO:0044344,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PAX6|SERPINE1|VEGFA
cellular response to fibroblast growth factor stimulus,GO:0044344,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,GCLC|GCLM|MIR339|PAX6|PTPN1
cellular response to fluid shear stress,GO:0071498,Diabetes Mellitus,MESH:D003920,0,,1,PTGS2
cellular response to fluid shear stress,GO:0071498,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,MMP2|PTGS2
cellular response to fluoride,GO:1902618,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cellular response to fluoride,GO:1902618,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,BCL2
cellular response to fluoride,GO:1902618,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cellular response to fluoride,GO:1902618,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,BCL2
cellular response to follicle-stimulating hormone stimulus,GO:0071372,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,EDN1|PPARGC1A|SERPINE1
cellular response to follicle-stimulating hormone stimulus,GO:0071372,"Diabetes Mellitus, Type 2",MESH:D003924,0,,6,CCND2|EDN1|EDNRA|GCLC|GCLM|PPARGC1A
cellular response to food,GO:0071240,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
cellular response to food,GO:0071240,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
cellular response to forskolin,GO:1904322,"Diabetes Mellitus, Type 2",MESH:D003924,0,,8,ADCY5|MIR10B|MIR125B1|MIR214|MIR221|MIR222|MIR30A|MIR92B
cellular response to fructose stimulus,GO:0071332,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PCK1|PPARA|PPARGC1A
cellular response to fructose stimulus,GO:0071332,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PPARA|PPARGC1A
cellular response to gamma radiation,GO:0071480,Diabetes Mellitus,MESH:D003920,4,Arsenic|Cadmium|Lead|Reactive Oxygen Species,0,
cellular response to gamma radiation,GO:0071480,"Diabetes Mellitus, Experimental",MESH:D003921,1,Superoxides,4,BCL2L1|CYBA|TP53|TRP53
cellular response to gamma radiation,GO:0071480,"Diabetes Mellitus, Type 1",MESH:D003922,3,Lipopolysaccharides|Reactive Oxygen Species|Superoxides,0,
cellular response to gamma radiation,GO:0071480,"Diabetes Mellitus, Type 2",MESH:D003924,7,Arsenic|Cadmium|Calcium|Glutathione|Lead|Reactive Oxygen Species|Superoxides,2,BCL2L1|CYBA
cellular response to glucagon stimulus,GO:0071377,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,FGF21|PCK1|SERPINE1
cellular response to glucagon stimulus,GO:0071377,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,FGF21
cellular response to glucagon stimulus,GO:0071377,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,FGF21|GCG|GLP1R
cellular response to glucocorticoid stimulus,GO:0071385,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
cellular response to glucocorticoid stimulus,GO:0071385,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2L11|EDN1
cellular response to glucose starvation,GO:0042149,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
cellular response to glucose starvation,GO:0042149,"Diabetes Mellitus, Experimental",MESH:D003921,0,,7,BCL2|FOXO3|GCK|PRKCD|SIRT1|TP53|TRP53
cellular response to glucose starvation,GO:0042149,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
cellular response to glucose starvation,GO:0042149,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,BCL2|GCK|SIRT1|SLC2A1
cellular response to glucose stimulus,GO:0071333,Diabetes Mellitus,MESH:D003920,0,,2,FN1|NCF1
cellular response to glucose stimulus,GO:0071333,"Diabetes Mellitus, Experimental",MESH:D003921,0,,20,ACE|BCL2|CYBA|FGF21|FOXO3|GPX1|ICAM1|IGF1|IL1B|INS1|IRS2|KCNJ11|NCF1|NEUROD1|PAX6|PCK1|PPARGC1A|SERPINE1|TGFB1|UCP2
cellular response to glucose stimulus,GO:0071333,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
cellular response to glucose stimulus,GO:0071333,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
cellular response to glucose stimulus,GO:0071333,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
cellular response to glucose stimulus,GO:0071333,"Diabetes Mellitus, Type 1",MESH:D003922,0,,5,ABCC8|FGF21|HNF1A|IGF1|KCNJ11
cellular response to glucose stimulus,GO:0071333,"Diabetes Mellitus, Type 2",MESH:D003924,0,,22,ABCC8|BCL2|CYBA|FGF21|GCLC|GCLM|GPX1|HNF1A|ICAM1|INS1|IRS2|KCNJ11|MIR192|MIR200A|MIR221|MIR222|MIR27A|MIR532|NEUROD1|PAX6|PPARGC1A|UCP2
cellular response to glucoside,GO:1904632,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NFKB1
cellular response to glyoxal,GO:0036471,"Diabetes Mellitus, Experimental",MESH:D003921,1,Capsaicin,0,
cellular response to granulocyte macrophage colony-stimulating factor stimulus,GO:0097011,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
cellular response to gravity,GO:0071258,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SERPINE1
cellular response to growth factor stimulus,GO:0071363,Diabetes Mellitus,MESH:D003920,0,,1,CAT
cellular response to growth factor stimulus,GO:0071363,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,CAT|INSR|NOS3|SERPINE1|TGFB1
cellular response to growth factor stimulus,GO:0071363,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
cellular response to growth factor stimulus,GO:0071363,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,CAT|NOS1|NOS3
cellular response to growth factor stimulus,GO:0071363,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|CAT|EGFR|NOS3|TNFRSF1B
cellular response to growth hormone stimulus,GO:0071378,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CCND2
cellular response to heat,GO:0034605,Diabetes Mellitus,MESH:D003920,2,arsenite|bisphenol A,1,PTGS2
cellular response to heat,GO:0034605,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,5,ATP2A2|HMOX1|NOS3|PTGS2|TP53
cellular response to heat,GO:0034605,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,1,NOS3
cellular response to heat,GO:0034605,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,4,AKT1|ATP2A2|HMOX1|NOS3
cellular response to hepatocyte growth factor stimulus,GO:0035729,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IL6|RELA
cellular response to hepatocyte growth factor stimulus,GO:0035729,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IL10|IL6
cellular response to hepatocyte growth factor stimulus,GO:0035729,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,GCLC|GCLM|IL6
cellular response to high density lipoprotein particle stimulus,GO:0071403,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NOS3
cellular response to high density lipoprotein particle stimulus,GO:0071403,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
cellular response to high density lipoprotein particle stimulus,GO:0071403,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOS3
cellular response to high light intensity,GO:0071486,Diabetes Mellitus,MESH:D003920,2,Diazoxide|Indapamide,0,
cellular response to high light intensity,GO:0071486,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT2
cellular response to homocysteine,GO:1905375,Diabetes Mellitus,MESH:D003920,0,,1,PTGS2
cellular response to homocysteine,GO:1905375,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PTGS2
cellular response to hormone stimulus,GO:0032870,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
cellular response to hormone stimulus,GO:0032870,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
cellular response to hormone stimulus,GO:0032870,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,AKT2|LIPC|UCP2
cellular response to human chorionic gonadotropin stimulus,GO:0044751,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
cellular response to human chorionic gonadotropin stimulus,GO:0044751,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EDN1|EDNRA
cellular response to hydrogen peroxide,GO:0070301,Diabetes Mellitus,MESH:D003920,1,Alloxan,2,MAP3K5|SIRT1
cellular response to hydrogen peroxide,GO:0070301,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cellular response to hydrogen peroxide,GO:0070301,"Diabetes Mellitus, Experimental",MESH:D003921,4,"Alloxan|Glucose|Hydrogen Peroxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",12,AIFM1|BAX|BCL2|EDN1|FAS|IL6|MAP3K5|NQO1|PRKCD|RELA|SERPINE1|SIRT1
cellular response to hydrogen peroxide,GO:0070301,"Diabetes Mellitus, Type 1",MESH:D003922,1,Alloxan,3,AIFM1|CASP12|IL6
cellular response to hydrogen peroxide,GO:0070301,"Diabetes Mellitus, Type 2",MESH:D003924,3,Alloxan|Glucose|Pentoxifylline,9,BAX|BCL2|EDN1|EDNRA|ETS1|FAS|IL6|PLEKHA1|SIRT1
cellular response to hydroperoxide,GO:0071447,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCD
cellular response to hydroperoxide,GO:0071447,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
cellular response to hydrostatic pressure,GO:0071464,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FAS
cellular response to hydrostatic pressure,GO:0071464,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FAS
cellular response to hyperoxia,GO:0071455,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
cellular response to hyperoxia,GO:0071455,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CAV1|FAS|PPARG
cellular response to hyperoxia,GO:0071455,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,FAS|PPARG
cellular response to hypoxia,GO:0071456,Diabetes Mellitus,MESH:D003920,2,Plant Extracts|Resveratrol,5,CYBB|IRS1|PPARG|PTGS2|SIRT1
cellular response to hypoxia,GO:0071456,"Diabetes Mellitus, Experimental",MESH:D003921,3,Plant Extracts|Quercetin|Resveratrol,22,AIFM1|BCL2|BCL2L1|CAV1|CYBB|EDN1|FAS|FOXO3|ICAM1|IRS1|PCK1|PPARG|PPARGC1A|PRKCE|PTGS2|SERPINE1|SIRT1|SLC2A4|SLC9A1|TGFB1|TP53|VEGFA
cellular response to hypoxia,GO:0071456,"Diabetes Mellitus, Type 1",MESH:D003922,2,Genistein|Resveratrol,1,AIFM1
cellular response to hypoxia,GO:0071456,"Diabetes Mellitus, Type 2",MESH:D003924,4,Curcumin|Genistein|Plant Extracts|Resveratrol,17,AKT1|BCL2|BCL2L1|CBS|EDN1|FAS|HNF4A|ICAM1|IRS1|MIR140|MIR214|MIR222|PPARG|PPARGC1A|PTPN1|SIRT1|SLC2A4
cellular response to inorganic substance,GO:0071241,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
cellular response to inorganic substance,GO:0071241,"Diabetes Mellitus, Type 1",MESH:D003922,1,Warfarin,0,
cellular response to inorganic substance,GO:0071241,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
cellular response to insulin-like growth factor stimulus,GO:1990314,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IGF1|TGFB1
cellular response to insulin-like growth factor stimulus,GO:1990314,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
cellular response to insulin stimulus,GO:0032869,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Plant Extracts|Resveratrol|Streptozocin,4,ADIPOQ|IRS1|PPARG|SIRT1
cellular response to insulin stimulus,GO:0032869,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Plant Extracts|Resveratrol|Streptozocin,19,GCK|GPAM|IGF1|INSR|IRS1|IRS2|LEP|NOS3|PAX6|PCK1|PKLR|PPARG|PRKCD|SERPINE1|SIRT1|SLC2A4|SLC9A1|SREBF1|UCP2
cellular response to insulin stimulus,GO:0032869,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
cellular response to insulin stimulus,GO:0032869,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
cellular response to insulin stimulus,GO:0032869,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
cellular response to insulin stimulus,GO:0032869,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|Streptozocin,2,IGF1|NOS3
cellular response to insulin stimulus,GO:0032869,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|bisphenol S|Plant Extracts|Resveratrol|Streptozocin,20,ADIPOQ|AKT1|AKT2|CAPN10|CCND2|CD36|ENPP1|GCK|GCLC|GRB14|IRS1|IRS2|LEP|NOS3|PAX6|PPARG|PTPN1|SIRT1|SLC2A4|UCP2
cellular response to interleukin-1,GO:0071347,Diabetes Mellitus,MESH:D003920,0,,1,FN1
cellular response to interleukin-1,GO:0071347,"Diabetes Mellitus, Experimental",MESH:D003921,0,,13,BCL2L1|CCL20|CX3CL1|EDN1|FAS|ICAM1|IL6|MMP2|MMP9|NOS2|PCK1|RELA|SERPINE1
cellular response to interleukin-1,GO:0071347,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,CCL20|IL6
cellular response to interleukin-1,GO:0071347,"Diabetes Mellitus, Type 2",MESH:D003924,0,,8,BCL2L1|EDN1|FAS|ICAM1|IL6|NFKB1|NOS2|TNFRSF1B
cellular response to interleukin-17,GO:0097398,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IL1B|IL6
cellular response to interleukin-17,GO:0097398,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IL6|STAT3
cellular response to interleukin-17,GO:0097398,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,IL6|MIR409|NFKB1
cellular response to interleukin-18,GO:0071351,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IFNG
cellular response to interleukin-18,GO:0071351,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IFNG
cellular response to interleukin-3,GO:0036016,Diabetes Mellitus,MESH:D003920,0,,1,MT2A
cellular response to interleukin-3,GO:0036016,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SH2B3
cellular response to interleukin-6,GO:0071354,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ICAM1|PPARGC1A|RELA
cellular response to interleukin-6,GO:0071354,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
cellular response to interleukin-6,GO:0071354,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,ICAM1|MIR125B1|NFKB1|PPARGC1A
cellular response to ionizing radiation,GO:0071479,Diabetes Mellitus,MESH:D003920,3,Plant Extracts|Reactive Oxygen Species|Resveratrol,1,SIRT1
cellular response to ionizing radiation,GO:0071479,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cellular response to ionizing radiation,GO:0071479,"Diabetes Mellitus, Experimental",MESH:D003921,4,"Malondialdehyde|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|Resveratrol",5,SIRT1|TGFB1|TNF|TP53|TRP53
cellular response to ionizing radiation,GO:0071479,"Diabetes Mellitus, Type 1",MESH:D003922,3,Genistein|Reactive Oxygen Species|Resveratrol,1,TNF
cellular response to ionizing radiation,GO:0071479,"Diabetes Mellitus, Type 2",MESH:D003924,7,Curcumin|Genistein|Glutathione|Malondialdehyde|Plant Extracts|Reactive Oxygen Species|Resveratrol,2,SIRT1|TNF
cellular response to ionomycin,GO:1904637,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CAV3|PPARGC1A|SERPINE1
cellular response to ionomycin,GO:1904637,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARGC1A
cellular response to iron(III) ion,GO:0071283,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP9
cellular response to laminar fluid shear stress,GO:0071499,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR126
cellular response to L-ascorbic acid,GO:0071298,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEP
cellular response to L-ascorbic acid,GO:0071298,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LEP
cellular response to lead ion,GO:0071284,Diabetes Mellitus,MESH:D003920,2,Lead|Magnesium,1,PTGS2
cellular response to lead ion,GO:0071284,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PTGS2|UCP2
cellular response to lead ion,GO:0071284,"Diabetes Mellitus, Type 2",MESH:D003924,4,Calcium|Glutathione|Lead|Magnesium,1,UCP2
cellular response to lectin,GO:1990858,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
cellular response to lectin,GO:1990858,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cellular response to leptin stimulus,GO:0044320,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,GCK|LEP
cellular response to leptin stimulus,GO:0044320,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
cellular response to leptin stimulus,GO:0044320,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
cellular response to leptin stimulus,GO:0044320,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCK|LEP
cellular response to leucine,GO:0071233,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
cellular response to leucine,GO:0071233,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HNF1A
cellular response to leucine,GO:0071233,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF1A
cellular response to leukemia inhibitory factor,GO:1990830,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
cellular response to leukemia inhibitory factor,GO:1990830,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,ICAM1|PAX6|SERPINE1|SIRT1
cellular response to leukemia inhibitory factor,GO:1990830,"Diabetes Mellitus, Type 2",MESH:D003924,0,,20,GCLM|ICAM1|MIR125B1|MIR127|MIR130B|MIR142|MIR181C|MIR200A|MIR204|MIR205|MIR27A|MIR335|MIR339|MIR409|MIR485|MIR532|MIR744|MRAS|PAX6|SIRT1
cellular response to L-glutamate,GO:1905232,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
cellular response to L-glutamate,GO:1905232,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2
cellular response to L-glutamine,GO:1904845,Diabetes Mellitus,MESH:D003920,0,,1,CYBB
cellular response to L-glutamine,GO:1904845,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYBA|CYBB
cellular response to L-glutamine,GO:1904845,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYBA
cellular response to light stimulus,GO:0071482,Diabetes Mellitus,MESH:D003920,2,Blood Glucose|Chlorpromazine,0,
cellular response to light stimulus,GO:0071482,"Diabetes Mellitus, Experimental",MESH:D003921,1,Blood Glucose,0,
cellular response to light stimulus,GO:0071482,"Diabetes Mellitus, Type 2",MESH:D003924,1,Blood Glucose,0,
cellular response to lipid,GO:0071396,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IL1B
cellular response to lipopolysaccharide,GO:0071222,Diabetes Mellitus,MESH:D003920,2,Ozone|Plant Extracts,2,FN1|PTGS2
cellular response to lipopolysaccharide,GO:0071222,"Diabetes Mellitus, Experimental",MESH:D003921,3,Plant Extracts|Quercetin|sodium arsenite,13,CCL20|CD68|ICAM1|IFNG|IL1B|IL6|MMP9|NOS2|PPARGC1A|PTGS2|RELA|SERPINE1|TNF
cellular response to lipopolysaccharide,GO:0071222,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
cellular response to lipopolysaccharide,GO:0071222,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|sodium arsenite,5,CCL20|IFNG|IL10|IL6|TNF
cellular response to lipopolysaccharide,GO:0071222,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,16,CD36|EDNRB|ICAM1|IL6|MIR140|MIR142|MIR181C|MIR205|MIR27A|MIR409|MIR98|NFKB1|NOS2|PPARGC1A|TNF|TNFRSF1B
cellular response to lipoteichoic acid,GO:0071223,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CCL20|RELA
cellular response to lipoteichoic acid,GO:0071223,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CCL20
cellular response to lipoteichoic acid,GO:0071223,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
cellular response to lithium ion,GO:0071285,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
cellular response to lithium ion,GO:0071285,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,FAS|NOS2|PPARG
cellular response to lithium ion,GO:0071285,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,FAS|NOS2|PPARG
cellular response to low-density lipoprotein particle stimulus,GO:0071404,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
cellular response to low-density lipoprotein particle stimulus,GO:0071404,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,FGF21|MMP9|NOS3|PPARG|SERPINE1|TGFB1
cellular response to low-density lipoprotein particle stimulus,GO:0071404,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,FGF21|NOS3
cellular response to low-density lipoprotein particle stimulus,GO:0071404,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,CD36|FGF21|NOS3|PPARG
cellular response to luteinizing hormone stimulus,GO:0071373,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
cellular response to luteinizing hormone stimulus,GO:0071373,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EDN1|EDNRA
cellular response to magnesium ion,GO:0071286,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NOS3
cellular response to magnesium ion,GO:0071286,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
cellular response to magnesium ion,GO:0071286,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOS3
cellular response to magnetism,GO:0071259,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nitric Oxide,0,
cellular response to magnetism,GO:0071259,"Diabetes Mellitus, Type 1",MESH:D003922,1,Nitric Oxide,0,
cellular response to manganese ion,GO:0071287,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,CASP12|DDIT3
cellular response to mechanical stimulus,GO:0071260,Diabetes Mellitus,MESH:D003920,0,,2,PTGS2|RAC1
cellular response to mechanical stimulus,GO:0071260,"Diabetes Mellitus, Experimental",MESH:D003921,0,,12,AGT|CAV1|CYBA|FAS|IL1B|NOS3|PTGS2|SERPINE1|SLC9A1|TGFB1|TNFRSF1A|VEGFA
cellular response to mechanical stimulus,GO:0071260,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,NOS1|NOS3
cellular response to mechanical stimulus,GO:0071260,"Diabetes Mellitus, Type 2",MESH:D003924,0,,14,AKT1|CASP8|CYBA|EDNRA|EGFR|ENPP1|FAS|GCLC|MIR125B1|MIR214|NFKB1|NOS3|SLC2A1|TNFRSF1A
cellular response to mercury ion,GO:0071288,Diabetes Mellitus,MESH:D003920,1,Mercury,1,FN1
cellular response to mercury ion,GO:0071288,"Diabetes Mellitus, Type 1",MESH:D003922,1,Mercury,0,
cellular response to mercury ion,GO:0071288,"Diabetes Mellitus, Type 2",MESH:D003924,1,Mercury,0,
cellular response to metal ion,GO:0071248,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NQO1|SERPINE1
cellular response to mineralocorticoid stimulus,GO:0071389,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
cellular response to mineralocorticoid stimulus,GO:0071389,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDN1
cellular response to misfolded protein,GO:0071218,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
cellular response to molecule of bacterial origin,GO:0071219,Diabetes Mellitus,MESH:D003920,0,,1,NR1I2
cellular response to molecule of bacterial origin,GO:0071219,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IL1B|TNF
cellular response to molecule of bacterial origin,GO:0071219,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
cellular response to molecule of bacterial origin,GO:0071219,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNF
cellular response to muramyl dipeptide,GO:0071225,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PTPN22
cellular response to mycotoxin,GO:0036146,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ascorbic Acid,0,
cellular response to nerve growth factor stimulus,GO:1990090,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,FOXO3|ID1|SERPINE1
cellular response to nerve growth factor stimulus,GO:1990090,"Diabetes Mellitus, Type 2",MESH:D003924,0,,7,AKT1|BCL2L11|BRAF|ID1|MIR221|MIR222|PTPN1
cellular response to nickel ion,GO:0071289,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nickel,0,
cellular response to nicotine,GO:0071316,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,5,IGF1|KCNJ11|RELA|SERPINE1|TNF
cellular response to nicotine,GO:0071316,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
cellular response to nicotine,GO:0071316,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,IGF1|KCNJ11|TNF
cellular response to nicotine,GO:0071316,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,3,KCNJ11|NFKB1|TNF
cellular response to nitric oxide,GO:0071732,"Diabetes Mellitus, Experimental",MESH:D003921,1,mangiferin,2,AIFM1|BCL2L1
cellular response to nitric oxide,GO:0071732,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,AIFM1|CRP
cellular response to nitric oxide,GO:0071732,"Diabetes Mellitus, Type 2",MESH:D003924,1,mangiferin,2,BCL2L1|PTPN1
cellular response to nitrite,GO:0071250,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARGC1A
cellular response to nitrite,GO:0071250,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARGC1A
cellular response to nitrosative stress,GO:0071500,Diabetes Mellitus,MESH:D003920,2,Ozone|Particulate Matter,0,
cellular response to nitrosative stress,GO:0071500,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Particulate Matter,0,
cellular response to non-ionic osmotic stress,GO:0071471,Diabetes Mellitus,MESH:D003920,0,,1,PTGS2
cellular response to non-ionic osmotic stress,GO:0071471,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PTGS2
cellular response to norepinephrine stimulus,GO:0071874,"Diabetes Mellitus, Type 1",MESH:D003922,1,Norepinephrine,0,
cellular response to nutrient,GO:0031670,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HMOX1
cellular response to nutrient,GO:0031670,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HMOX1
cellular response to nutrient levels,GO:0031669,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cellular response to nutrient levels,GO:0031669,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,4,CD68|ICAM1|IL6|KCNJ11
cellular response to nutrient levels,GO:0031669,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
cellular response to nutrient levels,GO:0031669,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
cellular response to nutrient levels,GO:0031669,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,3,ABCC8|IL6|KCNJ11
cellular response to nutrient levels,GO:0031669,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,4,ABCC8|ICAM1|IL6|KCNJ11
cellular response to organic cyclic compound,GO:0071407,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
cellular response to osmotic stress,GO:0071470,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC2A4
cellular response to osmotic stress,GO:0071470,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A4
cellular response to oxidative stress,GO:0034599,Diabetes Mellitus,MESH:D003920,10,Air Pollutants|Arsenic|Cadmium|Lead|Nitrogen Dioxide|Ozone|Particulate Matter|Plant Extracts|Reactive Oxygen Species|Resveratrol,1,SOD1
cellular response to oxidative stress,GO:0034599,"Diabetes Mellitus, Experimental",MESH:D003921,10,8-epi-prostaglandin F2alpha|Diethylhexyl Phthalate|Hydrogen Peroxide|inotodiol|Malondialdehyde|mangiferin|Nitric Oxide|Plant Extracts|Resveratrol|sodium arsenite,9,ATP2A2|FOXO3|GPX1|GSR|NQO1|PPARGC1A|PRKCD|SOD1|SOD2
cellular response to oxidative stress,GO:0034599,"Diabetes Mellitus, Insulin-Dependent, 5",MESH:C563958,0,,1,SUMO4
cellular response to oxidative stress,GO:0034599,"Diabetes Mellitus, Type 1",MESH:D003922,5,Lipopolysaccharides|Nitric Oxide|Reactive Oxygen Species|Resveratrol|sodium arsenite,0,
cellular response to oxidative stress,GO:0034599,"Diabetes Mellitus, Type 2",MESH:D003924,19,8-epi-prostaglandin F2alpha|Air Pollutants|Arsenic|Cadmium|Curcumin|Diethylhexyl Phthalate|Ethanol|Glutathione|Lead|Malondialdehyde|mangiferin|mono(2-ethyl-5-hydroxyhexyl) phthalate|mono-(2-ethylhexyl)phthalate|Particulate Matter|Phthalic Acids|Plant Extracts|Reactive Oxygen Species|Resveratrol|Vehicle Emissions,8,ATP2A2|CD36|EDNRA|GPX1|OGG1|PPARGC1A|SOD1|SOD2
cellular response to oxidised low-density lipoprotein particle stimulus,GO:0140052,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CD68
cellular response to oxidised low-density lipoprotein particle stimulus,GO:0140052,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|CD36
cellular response to oxygen-containing compound,GO:1901701,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INS1
cellular response to oxygen-containing compound,GO:1901701,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,INS1
cellular response to ozone,GO:0071457,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
cellular response to peptide,GO:1901653,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ID1|IRS2|TIMP1
cellular response to peptide,GO:1901653,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,AKT1|ID1|IRS2|NFKB1|TIMP1
cellular response to peptide hormone stimulus,GO:0071375,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CAV1|EDN1|NKX6-1
cellular response to peptide hormone stimulus,GO:0071375,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EDN1|NKX6-1
cellular response to peptidoglycan,GO:0071224,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,RELA
cellular response to phenylalanine,GO:0071234,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FAS
cellular response to phenylalanine,GO:0071234,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,FAS|MIR27A|MIR377|MIR409|MIR487B
cellular response to phorbol 13-acetate 12-myristate,GO:1904628,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYBA|PCK1
cellular response to phorbol 13-acetate 12-myristate,GO:1904628,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYBA
cellular response to platelet-derived growth factor stimulus,GO:0036120,Diabetes Mellitus,MESH:D003920,1,Resveratrol,2,FN1|PPARG
cellular response to platelet-derived growth factor stimulus,GO:0036120,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,3,PPARG|PRKCE|SERPINE1
cellular response to platelet-derived growth factor stimulus,GO:0036120,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
cellular response to platelet-derived growth factor stimulus,GO:0036120,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,3,AKT1|PPARG|PTPN1
cellular response to polyamine macromolecule,GO:1904584,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TP53
cellular response to polyamine macromolecule,GO:1904584,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR222
cellular response to potassium ion,GO:0035865,Diabetes Mellitus,MESH:D003920,0,,1,SOD1
cellular response to potassium ion,GO:0035865,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PPARGC1A|SERPINE1|SOD1
cellular response to potassium ion,GO:0035865,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PPARGC1A|SOD1
cellular response to potassium ion starvation,GO:0051365,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCK1
cellular response to progesterone stimulus,GO:0071393,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IGF1
cellular response to progesterone stimulus,GO:0071393,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
cellular response to prolactin,GO:1990646,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,BCL2L1|IL6
cellular response to prolactin,GO:1990646,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL6
cellular response to prolactin,GO:1990646,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2L1|IL6
cellular response to prostaglandin E stimulus,GO:0071380,Diabetes Mellitus,MESH:D003920,0,,2,FN1|PPARG
cellular response to prostaglandin E stimulus,GO:0071380,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PAX6|PPARG|PRKCE
cellular response to prostaglandin E stimulus,GO:0071380,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,AKT1|PAX6|PPARG
cellular response to prostaglandin stimulus,GO:0071379,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
cellular response to prostaglandin stimulus,GO:0071379,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARG
cellular response to prostaglandin stimulus,GO:0071379,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARG
cellular response to pyrimidine ribonucleotide,GO:1905835,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SERPINE1
cellular response to radiation,GO:0071478,Diabetes Mellitus,MESH:D003920,1,arsenite,1,IRS1
cellular response to radiation,GO:0071478,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IRS1
cellular response to radiation,GO:0071478,"Diabetes Mellitus, Type 2",MESH:D003924,1,Folic Acid,1,IRS1
cellular response to raffinose,GO:0097403,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCK1
cellular response to rapamycin,GO:0072752,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
cellular response to rapamycin,GO:0072752,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HNF1A
cellular response to rapamycin,GO:0072752,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|HNF1A
cellular response to reactive nitrogen species,GO:1902170,Diabetes Mellitus,MESH:D003920,0,,1,MAP3K5
cellular response to reactive nitrogen species,GO:1902170,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MAP3K5
cellular response to reactive oxygen species,GO:0034614,Diabetes Mellitus,MESH:D003920,1,Reactive Oxygen Species,0,
cellular response to reactive oxygen species,GO:0034614,"Diabetes Mellitus, Experimental",MESH:D003921,3,ginsenoside Re|Hydrogen Peroxide|Quercetin,4,MMP2|MMP9|TP53|TRP53
cellular response to reactive oxygen species,GO:0034614,"Diabetes Mellitus, Type 1",MESH:D003922,2,Genistein|Reactive Oxygen Species,0,
cellular response to reactive oxygen species,GO:0034614,"Diabetes Mellitus, Type 2",MESH:D003924,5,daidzein|Genistein|ginsenoside Re|Kangen-karyu|Reactive Oxygen Species,3,AKT1|EGFR|OGG1
cellular response to redox state,GO:0071461,Diabetes Mellitus,MESH:D003920,3,Cadmium|Lead|Reactive Oxygen Species,0,
cellular response to redox state,GO:0071461,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,1,NOS2
cellular response to redox state,GO:0071461,"Diabetes Mellitus, Type 1",MESH:D003922,2,Reactive Oxygen Species|sodium arsenite,0,
cellular response to redox state,GO:0071461,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Lead|Reactive Oxygen Species,1,NOS2
cellular response to resveratrol,GO:1904639,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
cellular response to resveratrol,GO:1904639,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PPARGC1A|SERPINE1|SIRT1
cellular response to resveratrol,GO:1904639,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PPARGC1A|SIRT1
cellular response to retinoic acid,GO:0071300,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
cellular response to retinoic acid,GO:0071300,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,LEP|PCK1|PPARG|TNF
cellular response to retinoic acid,GO:0071300,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
cellular response to retinoic acid,GO:0071300,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,LEP|PPARG|TNF
cellular response to rotenone,GO:1904648,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
cellular response to rotenone,GO:1904648,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NOS3|SIRT1
cellular response to rotenone,GO:1904648,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
cellular response to rotenone,GO:1904648,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NOS3|SIRT1
cellular response to silver ion,GO:0071292,"Diabetes Mellitus, Type 2",MESH:D003924,1,Silver,0,
cellular response to singlet oxygen,GO:0071452,"Diabetes Mellitus, Type 2",MESH:D003924,1,Kangen-karyu,0,
cellular response to sodium arsenite,GO:1903936,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
cellular response to sodium arsenite,GO:1903936,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
cellular response to sodium arsenite,GO:1903936,"Diabetes Mellitus, Type 1",MESH:D003922,2,Calcitriol|sodium arsenite,0,
cellular response to sodium arsenite,GO:1903936,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
cellular response to sodium phosphate,GO:1904384,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
cellular response to sorbitol,GO:0072709,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
cellular response to starvation,GO:0009267,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
cellular response to starvation,GO:0009267,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,5,CAV1|PDK4|PPARA|SIRT1|SREBF1
cellular response to starvation,GO:0009267,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CLEC16A
cellular response to starvation,GO:0009267,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,3,PPARA|SIRT1|TCF7L2
cellular response to staurosporine,GO:0072734,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CASP3
cellular response to staurosporine,GO:0072734,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP3
cellular response to stimulus,GO:0051716,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
cellular response to stress,GO:0033554,Diabetes Mellitus,MESH:D003920,4,Aspirin|Cadmium|Copper|Zinc,1,MAP3K5
cellular response to stress,GO:0033554,"Diabetes Mellitus, Experimental",MESH:D003921,2,Hydrogen Peroxide|sodium arsenite,4,MAP3K5|RELA|TP53|TRP53
cellular response to stress,GO:0033554,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cellular response to stress,GO:0033554,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Copper|Zinc,2,AKT1|NFKB1
cellular response to testosterone stimulus,GO:0071394,Diabetes Mellitus,MESH:D003920,0,,1,NCF1
cellular response to testosterone stimulus,GO:0071394,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NCF1
cellular response to testosterone stimulus,GO:0071394,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CCND2
cellular response to Thyroglobulin triiodothyronine,GO:1904017,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IGF1
cellular response to Thyroglobulin triiodothyronine,GO:1904017,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
cellular response to thyroid hormone stimulus,GO:0097067,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARGC1A
cellular response to thyroid hormone stimulus,GO:0097067,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CTSH
cellular response to thyroid hormone stimulus,GO:0097067,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARGC1A
cellular response to thyroxine stimulus,GO:0097069,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCLC|GCLM
cellular response to toxic substance,GO:0097237,Diabetes Mellitus,MESH:D003920,5,"Chlorpyrifos|o,p'-DDT|Reactive Oxygen Species|Resveratrol|Tetrachlorodibenzodioxin",0,
cellular response to toxic substance,GO:0097237,"Diabetes Mellitus, Experimental",MESH:D003921,8,Diethylhexyl Phthalate|Dronabinol|Manganese|Nicotine|Quercetin|Resveratrol|sodium arsenite|Ursolic Acid,2,EDN1|TNF
cellular response to toxic substance,GO:0097237,"Diabetes Mellitus, Type 1",MESH:D003922,4,Reactive Oxygen Species|Resveratrol|sodium arsenite|Tetrachlorodibenzodioxin,1,TNF
cellular response to toxic substance,GO:0097237,"Diabetes Mellitus, Type 2",MESH:D003924,5,Diethylhexyl Phthalate|Manganese|Nicotine|Reactive Oxygen Species|Resveratrol,3,EDN1|EDNRA|TNF
cellular response to transforming growth factor beta stimulus,GO:0071560,Diabetes Mellitus,MESH:D003920,0,,1,FN1
cellular response to transforming growth factor beta stimulus,GO:0071560,"Diabetes Mellitus, Experimental",MESH:D003921,0,,7,CAV1|EDN1|ID1|NOS3|PPARGC1A|SERPINE1|TGFB1
cellular response to transforming growth factor beta stimulus,GO:0071560,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
cellular response to transforming growth factor beta stimulus,GO:0071560,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
cellular response to transforming growth factor beta stimulus,GO:0071560,"Diabetes Mellitus, Type 2",MESH:D003924,0,,8,EDN1|ENPP1|ID1|MIR142|MIR192|MIR27A|NOS3|PPARGC1A
cellular response to triglyceride,GO:0071401,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TP53
cellular response to triterpenoid,GO:1905837,"Diabetes Mellitus, Experimental",MESH:D003921,1,Ursolic Acid,0,
cellular response to tumor cell,GO:0071228,"Diabetes Mellitus, Experimental",MESH:D003921,1,mangiferin,0,
cellular response to tumor cell,GO:0071228,"Diabetes Mellitus, Type 2",MESH:D003924,1,mangiferin,1,NOTCH2
cellular response to tumor necrosis factor,GO:0071356,Diabetes Mellitus,MESH:D003920,0,,2,MAP3K5|SIRT1
cellular response to tumor necrosis factor,GO:0071356,"Diabetes Mellitus, Experimental",MESH:D003921,0,,18,BCL2L1|CCL20|CX3CL1|CYBA|EDN1|FAS|ICAM1|IL6|KCNJ11|MAP3K5|MMP9|NOS2|NOS3|PCK1|PPARGC1A|RELA|SIRT1|SLC2A4
cellular response to tumor necrosis factor,GO:0071356,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
cellular response to tumor necrosis factor,GO:0071356,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
cellular response to tumor necrosis factor,GO:0071356,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,CCL20|IL6|KCNJ11|NOS3
cellular response to tumor necrosis factor,GO:0071356,"Diabetes Mellitus, Type 2",MESH:D003924,0,,19,AKT1|BCL2L1|CYBA|EDN1|FAS|ICAM1|IL6|KCNJ11|MIR125B1|MIR221|MIR222|MIR27A|NFKB1|NOS2|NOS3|PPARGC1A|SIRT1|SLC2A4|TNFRSF1B
cellular response to type II interferon,GO:0071346,Diabetes Mellitus,MESH:D003920,0,,1,KIF5B
cellular response to type II interferon,GO:0071346,"Diabetes Mellitus, Experimental",MESH:D003921,0,,7,CCL20|CX3CL1|EDN1|FAS|ICAM1|NOS2|TNF
cellular response to type II interferon,GO:0071346,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,CCL20|TNF
cellular response to type II interferon,GO:0071346,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,EDN1|FAS|ICAM1|NOS2|TNF
cellular response to type I interferon,GO:0071357,Diabetes Mellitus,MESH:D003920,0,,1,NR1I2
cellular response to unfolded protein,GO:0034620,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
cellular response to unfolded protein,GO:0034620,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
cellular response to unfolded protein,GO:0034620,"Diabetes Mellitus, Type 1",MESH:D003922,1,Norepinephrine,0,
cellular response to unfolded protein,GO:0034620,"Diabetes Mellitus, Type 2",MESH:D003924,2,Nelfinavir|Particulate Matter,2,BAX|PTPN1
cellular response to UV,GO:0034644,Diabetes Mellitus,MESH:D003920,1,Chlorpromazine,0,
cellular response to UV,GO:0034644,"Diabetes Mellitus, Experimental",MESH:D003921,2,Quercetin|sodium arsenite,4,BAX|PRKCD|TP53|TRP53
cellular response to UV,GO:0034644,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Uric Acid,0,
cellular response to UV,GO:0034644,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
cellular response to UV-A,GO:0071492,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
cellular response to UV-A,GO:0071492,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,3,MMP2|MMP9|TIMP1
cellular response to UV-A,GO:0071492,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,1,TIMP1
cellular response to UV-B,GO:0071493,Diabetes Mellitus,MESH:D003920,6,arsenite|Chlorpyrifos|Gallic Acid|Reactive Oxygen Species|Resveratrol|Rosiglitazone,0,
cellular response to UV-B,GO:0071493,"Diabetes Mellitus, Experimental",MESH:D003921,8,Gallic Acid|Hydrogen Peroxide|Malondialdehyde|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Superoxides,0,
cellular response to UV-B,GO:0071493,"Diabetes Mellitus, Type 1",MESH:D003922,5,Calcitriol|Reactive Oxygen Species|Resveratrol|sodium arsenite|Superoxides,0,
cellular response to UV-B,GO:0071493,"Diabetes Mellitus, Type 2",MESH:D003924,7,Ascorbic Acid|Glutathione|Malondialdehyde|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Superoxides,0,
cellular response to UV-C,GO:0071494,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cellular response to UV-C,GO:0071494,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,2,TP53|TRP53
cellular response to UV-C,GO:0071494,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cellular response to UV-C,GO:0071494,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
cellular response to vascular endothelial growth factor stimulus,GO:0035924,Diabetes Mellitus,MESH:D003920,0,,1,FN1
cellular response to vascular endothelial growth factor stimulus,GO:0035924,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
cellular response to vascular endothelial growth factor stimulus,GO:0035924,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|MIR27A
cellular response to virus,GO:0098586,Diabetes Mellitus,MESH:D003920,2,Resveratrol|Tetrachlorodibenzodioxin,0,
cellular response to virus,GO:0098586,"Diabetes Mellitus, Experimental",MESH:D003921,2,Resveratrol|sodium arsenite,5,BAX|IFNG|IL6|S100A6|TGFB1
cellular response to virus,GO:0098586,"Diabetes Mellitus, Type 1",MESH:D003922,3,Resveratrol|sodium arsenite|Tetrachlorodibenzodioxin,4,IFNG|IL10|IL6|TYK2
cellular response to virus,GO:0098586,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,4,BAX|IL6|NFKB1|S100A6
cellular response to vitamin B3,GO:0071303,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
cellular response to vitamin B3,GO:0071303,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
cellular response to vitamin B3,GO:0071303,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
cellular response to vitamin D,GO:0071305,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NOS2
cellular response to vitamin D,GO:0071305,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,MIR125B1|NOS2
cellular response to vitamin E,GO:0071306,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
cellular response to vitamin E,GO:0071306,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,1,PPARG
cellular response to vitamin E,GO:0071306,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,1,PPARG
cellular response to wortmannin,GO:1904568,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
cellular response to xenobiotic stimulus,GO:0071466,Diabetes Mellitus,MESH:D003920,4,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A|Particulate Matter|Rosiglitazone",1,ADIPOQ
cellular response to xenobiotic stimulus,GO:0071466,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|cinnamaldehyde|Glucose|Rosiglitazone,12,BCL2L1|EDN1|FGF21|IL1B|NOS2|NQO1|PAX6|REN|SERPINE1|TP53|TRP53|VEGFA
cellular response to xenobiotic stimulus,GO:0071466,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Calcitriol,2,CD69|FGF21
cellular response to xenobiotic stimulus,GO:0071466,"Diabetes Mellitus, Type 2",MESH:D003924,10,bisphenol A|bisphenol S|cinnamaldehyde|Glucose|Nickel|Particulate Matter|perfluorooctane sulfonic acid|Rosiglitazone|Silver|Vehicle Emissions,10,ADIPOQ|BCL2L1|BRAF|EDN1|EGFR|FGF21|GSTM1|KCNQ1|NOS2|PAX6
cellular response to X-ray,GO:0071481,Diabetes Mellitus,MESH:D003920,2,Gallic Acid|Reactive Oxygen Species,0,
cellular response to X-ray,GO:0071481,"Diabetes Mellitus, Experimental",MESH:D003921,1,Gallic Acid,0,
cellular response to X-ray,GO:0071481,"Diabetes Mellitus, Type 1",MESH:D003922,1,Reactive Oxygen Species,0,
cellular response to X-ray,GO:0071481,"Diabetes Mellitus, Type 2",MESH:D003924,1,Reactive Oxygen Species,1,CCND2
cellular response to zinc ion,GO:0071294,Diabetes Mellitus,MESH:D003920,1,Zinc,1,MT2A
cellular response to zinc ion,GO:0071294,"Diabetes Mellitus, Type 2",MESH:D003924,1,Zinc,0,
cellular response to zinc ion starvation,GO:0034224,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IGF1|INSR
cellular response to zinc ion starvation,GO:0034224,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
cellular response to zinc ion starvation,GO:0034224,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
cellular senescence,GO:0090398,Diabetes Mellitus,MESH:D003920,11,Air Pollutants|Aspirin|bisphenol A|Chlorpyrifos|Diazinon|Particulate Matter|Plant Extracts|Resveratrol|Sodium Selenite|Streptozocin|Tetrachlorodibenzodioxin,1,MAP3K5
cellular senescence,GO:0090398,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cellular senescence,GO:0090398,"Diabetes Mellitus, Experimental",MESH:D003921,17,"bisphenol A|Dietary Fats|Dietary Sucrose|Fructose|Glucose|Hydrogen Peroxide|Niacinamide|Nicotine|Nitric Oxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|pterostilbene|Resveratrol|sodium arsenite|Sodium Selenite|Streptozocin|Vitamin E",6,CAV1|ICAM1|MAP3K5|PRKCD|TP53|TRP53
cellular senescence,GO:0090398,"Diabetes Mellitus, Type 1",MESH:D003922,8,bisphenol A|Genistein|Niacinamide|Nitric Oxide|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin,0,
cellular senescence,GO:0090398,"Diabetes Mellitus, Type 2",MESH:D003924,16,Air Pollutants|bisphenol A|Dietary Fats|Diethylnitrosamine|Folic Acid|Fructose|Genistein|Glucose|Glutathione|Niacinamide|Nicotine|Particulate Matter|Plant Extracts|Resveratrol|Streptozocin|Vehicle Emissions,2,ICAM1|MIRLET7D
cellular sodium ion homeostasis,GO:0006883,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,AGT|SLC9A1
cellular stress response to acid chemical,GO:0097533,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
cellular triglyceride homeostasis,GO:0035356,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
cellular triglyceride homeostasis,GO:0035356,"Diabetes Mellitus, Experimental",MESH:D003921,2,platycodin D|Triglycerides,1,SIRT1
cellular triglyceride homeostasis,GO:0035356,"Diabetes Mellitus, Type 2",MESH:D003924,1,Triglycerides,1,SIRT1
cellular water homeostasis,GO:0009992,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SCTR
cellular zinc ion homeostasis,GO:0006882,Diabetes Mellitus,MESH:D003920,2,Copper|Zinc,1,MT2A
cellular zinc ion homeostasis,GO:0006882,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cellular zinc ion homeostasis,GO:0006882,"Diabetes Mellitus, Experimental",MESH:D003921,3,"Clioquinol|Hydrogen Peroxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cellular zinc ion homeostasis,GO:0006882,"Diabetes Mellitus, Type 2",MESH:D003924,5,Calcium|Copper|Glutathione|mono-(2-ethylhexyl)phthalate|Zinc,1,SLC30A8
cell volume homeostasis,GO:0006884,Diabetes Mellitus,MESH:D003920,3,Chlorides|Iron|Ozone,0,
cell volume homeostasis,GO:0006884,"Diabetes Mellitus, Experimental",MESH:D003921,4,astaxanthine|Enalapril|Quercetin|sodium arsenite,0,
cell volume homeostasis,GO:0006884,"Diabetes Mellitus, Type 1",MESH:D003922,3,Iron|Lipopolysaccharides|sodium arsenite,0,
cell volume homeostasis,GO:0006884,"Diabetes Mellitus, Type 2",MESH:D003924,4,astaxanthine|Enalapril|Iron|titanium dioxide,1,GNB3
cementum mineralization,GO:0071529,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
central nervous system control of baroreceptor feedback,GO:0003019,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
central nervous system development,GO:0007417,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PAX6|TP53|TRP53
central nervous system development,GO:0007417,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,HHEX|PAX6|SLC2A1
central nervous system myelination,GO:0022010,Diabetes Mellitus,MESH:D003920,2,Lead|Particulate Matter,0,
central nervous system myelination,GO:0022010,"Diabetes Mellitus, Type 2",MESH:D003924,3,Ethanol|Lead|Particulate Matter,1,ENPP1
central nervous system myelin maintenance,GO:0032286,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
central nervous system myelin maintenance,GO:0032286,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
central nervous system myelin maintenance,GO:0032286,"Diabetes Mellitus, Type 2",MESH:D003924,1,Linagliptin,0,
central nervous system neuron axonogenesis,GO:0021955,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCA
central nervous system neuron development,GO:0021954,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEP
central nervous system neuron development,GO:0021954,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LEP
central nervous system neuron differentiation,GO:0021953,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
central nervous system neuron differentiation,GO:0021953,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NKX6-1
central nervous system neuron differentiation,GO:0021953,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
central nervous system neuron differentiation,GO:0021953,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,1,NKX6-1
centriole replication,GO:0007099,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
centriole replication,GO:0007099,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
centriole replication,GO:0007099,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
centriole replication,GO:0007099,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
centrosome duplication,GO:0051298,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
centrosome duplication,GO:0051298,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
centrosome duplication,GO:0051298,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
centrosome duplication,GO:0051298,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
centrosome localization,GO:0051642,Diabetes Mellitus,MESH:D003920,0,,1,KIF5B
ceramide biosynthetic process,GO:0046513,Diabetes Mellitus,MESH:D003920,3,"2,4,5,2',4',5'-hexachlorobiphenyl|Particulate Matter|Tetrachlorodibenzodioxin",0,
ceramide biosynthetic process,GO:0046513,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
ceramide biosynthetic process,GO:0046513,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
ceramide biosynthetic process,GO:0046513,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dietary Fats|Particulate Matter|Vehicle Emissions,0,
ceramide metabolic process,GO:0006672,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Dichlorodiphenyl Dichloroethylene|Streptozocin,0,
ceramide metabolic process,GO:0006672,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|sodium arsenite|Streptozocin,0,
ceramide metabolic process,GO:0006672,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Streptozocin,0,
ceramide metabolic process,GO:0006672,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Dichlorodiphenyl Dichloroethylene|perfluorooctane sulfonic acid|perfluorooctanoic acid|Streptozocin,0,
cerebellar granule cell differentiation,GO:0021707,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
cerebellar granule cell precursor proliferation,GO:0021930,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IGF1
cerebellar granule cell precursor proliferation,GO:0021930,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
cerebellum development,GO:0021549,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,INSR|NEUROD1|PAX6|PPARGC1A|TP53|TRP53
cerebellum development,GO:0021549,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
cerebellum development,GO:0021549,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
cerebellum development,GO:0021549,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,ENPP1|NEUROD1|PAX6|PPARGC1A
cerebellum morphogenesis,GO:0021587,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
cerebral blood circulation,GO:0120275,Diabetes Mellitus,MESH:D003920,1,morroniside,0,
cerebral cortex cell migration,GO:0021795,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
cerebral cortex development,GO:0021987,Diabetes Mellitus,MESH:D003920,1,Reactive Oxygen Species,0,
cerebral cortex development,GO:0021987,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,BAX|BCL2|BCL2L1|PAX6
cerebral cortex development,GO:0021987,"Diabetes Mellitus, Type 1",MESH:D003922,1,Reactive Oxygen Species,0,
cerebral cortex development,GO:0021987,"Diabetes Mellitus, Type 2",MESH:D003924,1,Reactive Oxygen Species,6,BAX|BCL2|BCL2L1|ENPP1|PAX6|SLC2A1
cerebral cortex GABAergic interneuron development,GO:0021894,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
cerebral cortex neuron differentiation,GO:0021895,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
cerebral cortex radially oriented cell migration,GO:0021799,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
cerebral cortex regionalization,GO:0021796,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
cerebral cortex regionalization,GO:0021796,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAX6
cGMP biosynthetic process,GO:0006182,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Cadmium|Cyclosporine|Resveratrol|Streptozocin,0,
cGMP biosynthetic process,GO:0006182,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
cGMP biosynthetic process,GO:0006182,"Diabetes Mellitus, Experimental",MESH:D003921,7,bisphenol A|Cyclophosphamide|Nitric Oxide|Quercetin|Resveratrol|sodium arsenite|Streptozocin,0,
cGMP biosynthetic process,GO:0006182,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|Cyclophosphamide|decabromobiphenyl ether|Nitric Oxide|Resveratrol|sodium arsenite|Streptozocin,0,
cGMP biosynthetic process,GO:0006182,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Cadmium|Resveratrol|Streptozocin,0,
cGMP-mediated signaling,GO:0019934,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
cGMP-mediated signaling,GO:0019934,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nitric Oxide,1,NOS2
cGMP-mediated signaling,GO:0019934,"Diabetes Mellitus, Type 1",MESH:D003922,1,Nitric Oxide,0,
cGMP-mediated signaling,GO:0019934,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,3,CD36|EDNRB|NOS2
cGMP metabolic process,GO:0046068,Diabetes Mellitus,MESH:D003920,3,Raloxifene Hydrochloride|Streptozocin|Sulfur Dioxide,0,
cGMP metabolic process,GO:0046068,"Diabetes Mellitus, Experimental",MESH:D003921,2,pimagedine|Streptozocin,0,
cGMP metabolic process,GO:0046068,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
cGMP metabolic process,GO:0046068,"Diabetes Mellitus, Type 2",MESH:D003924,1,Streptozocin,0,
changes to DNA methylation involved in embryo development,GO:1901538,Diabetes Mellitus,MESH:D003920,2,DDT|Pesticides,0,
changes to DNA methylation involved in embryo development,GO:1901538,"Diabetes Mellitus, Type 2",MESH:D003924,1,Pesticides,0,
chemical homeostasis,GO:0048878,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
chemical synaptic transmission,GO:0007268,Diabetes Mellitus,MESH:D003920,6,Clozapine|Lead|Magnesium|Olanzapine|Quetiapine Fumarate|Risperidone,0,
chemical synaptic transmission,GO:0007268,"Diabetes Mellitus, Experimental",MESH:D003921,4,Capsaicin|Dronabinol|Nicotine|Nitric Oxide,3,ACE|CHRM2|SNAP25
chemical synaptic transmission,GO:0007268,"Diabetes Mellitus, Type 1",MESH:D003922,1,Nitric Oxide,1,CHRM2
chemical synaptic transmission,GO:0007268,"Diabetes Mellitus, Type 2",MESH:D003924,6,Calcium|Clozapine|Ethanol|Lead|Magnesium|Nicotine,3,MTNR1B|SLC1A2|SNAP25
"chemical synaptic transmission, postsynaptic",GO:0099565,"Diabetes Mellitus, Type 2",MESH:D003924,1,Orlistat,0,
chemokine (C-C motif) ligand 17 production,GO:0044809,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
chemokine (C-C motif) ligand 17 production,GO:0044809,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,0,
chemokine (C-C motif) ligand 17 production,GO:0044809,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
chemokine (C-C motif) ligand 4 production,GO:0071606,"Diabetes Mellitus, Type 2",MESH:D003924,1,Vehicle Emissions,0,
chemokine-mediated signaling pathway,GO:0070098,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CCL20|CX3CL1
chemokine-mediated signaling pathway,GO:0070098,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
chemokine-mediated signaling pathway,GO:0070098,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
chemokine-mediated signaling pathway,GO:0070098,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CCL20
chemokine-mediated signaling pathway,GO:0070098,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CAPN10
chemokine production,GO:0032602,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NFKB1
chemosensory behavior,GO:0007635,Diabetes Mellitus,MESH:D003920,3,2-naphthol|Chlorpyrifos|Resveratrol,0,
chemosensory behavior,GO:0007635,"Diabetes Mellitus, Experimental",MESH:D003921,6,Dronabinol|Eucalyptol|Inositol|Nicotine|Quercetin|Resveratrol,1,PRKCE
chemosensory behavior,GO:0007635,"Diabetes Mellitus, Type 1",MESH:D003922,2,Genistein|Resveratrol,0,
chemosensory behavior,GO:0007635,"Diabetes Mellitus, Type 2",MESH:D003924,4,Genistein|Nicotine|Resveratrol|Topiramate,0,
chemotaxis,GO:0006935,Diabetes Mellitus,MESH:D003920,3,"2,2',4,4'-tetrabromodiphenyl ether|Cadmium|Particulate Matter",1,RAC1
chemotaxis,GO:0006935,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Monocrotophos,2,CCL20|CX3CL1
chemotaxis,GO:0006935,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
chemotaxis,GO:0006935,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CCL20
chemotaxis,GO:0006935,"Diabetes Mellitus, Type 2",MESH:D003924,6,Cadmium|Curcumin|Glucose|Nickel|Particulate Matter|perfluorooctane sulfonic acid,2,C3|PIK3CG
chloride ion homeostasis,GO:0055064,Diabetes Mellitus,MESH:D003920,4,Atrazine|Chlorides|Dichlorodiphenyl Dichloroethylene|Resveratrol,0,
chloride ion homeostasis,GO:0055064,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Resveratrol,0,
chloride ion homeostasis,GO:0055064,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
chloride ion homeostasis,GO:0055064,"Diabetes Mellitus, Type 2",MESH:D003924,4,Atrazine|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Resveratrol,1,KCNQ1
chloride transmembrane transport,GO:1902476,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
chloride transmembrane transport,GO:1902476,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
chloride transmembrane transport,GO:1902476,"Diabetes Mellitus, Type 2",MESH:D003924,1,alpha-Tocopherol,1,UCP2
chloride transport,GO:0006821,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
chloride transport,GO:0006821,"Diabetes Mellitus, Experimental",MESH:D003921,3,Nicotine|Quercetin|Resveratrol,0,
chloride transport,GO:0006821,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
chloride transport,GO:0006821,"Diabetes Mellitus, Type 2",MESH:D003924,2,Nicotine|Resveratrol,0,
cholangiocyte proliferation,GO:1990705,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOTCH2
cholecystokinin signaling pathway,GO:0038188,Diabetes Mellitus,MESH:D003920,2,Gallic Acid|Plant Extracts,0,
cholecystokinin signaling pathway,GO:0038188,"Diabetes Mellitus, Experimental",MESH:D003921,2,Gallic Acid|Plant Extracts,0,
cholecystokinin signaling pathway,GO:0038188,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
cholesterol biosynthetic process,GO:0006695,Diabetes Mellitus,MESH:D003920,25,"Bezafibrate|bisphenol A|Cadmium|Clozapine|Docosahexaenoic Acids|docosapentaenoic acid|Fatty Acids, Omega-3|Glyburide|Magnesium|Metformin|Niacin|Particulate Matter|Pioglitazone|Plant Extracts|Plant Preparations|Polychlorinated Biphenyls|Pravastatin|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Telmisartan|Tetrachlorodibenzodioxin|Zinc",0,
cholesterol biosynthetic process,GO:0006695,"Diabetes Mellitus, Experimental",MESH:D003921,39,"7-hydroxycoumarin|Bezafibrate|bisphenol A|Capsaicin|Cholesterol|Coconut Oil|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Dietary Sugars|Diethylhexyl Phthalate|Eucalyptol|Fatty Acids, Nonesterified|Fatty Acids, Omega-3|Fructose|Glyburide|Hydrogen Peroxide|Inositol|mangiferin|Metformin|Nicotine|Pioglitazone|Plant Extracts|Plant Preparations|Propolis|pterostilbene|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|Taurine|Telmisartan|thymoquinone|tributyltin|Ursolic Acid",1,SREBF1
cholesterol biosynthetic process,GO:0006695,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
cholesterol biosynthetic process,GO:0006695,"Diabetes Mellitus, Type 1",MESH:D003922,9,bisphenol A|decabromobiphenyl ether|Genistein|Lipopolysaccharides|Resveratrol|sodium arsenite|Streptozocin|Taurine|Tetrachlorodibenzodioxin,0,
cholesterol biosynthetic process,GO:0006695,"Diabetes Mellitus, Type 2",MESH:D003924,39,"alpha-Tocopherol|Bezafibrate|bisphenol A|bisphenol S|Boron|Cadmium|Clozapine|Curcumin|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Diethylnitrosamine|Drugs, Chinese Herbal|Ethanol|Fatty Acids, Nonesterified|Fructose|Genistein|Glyburide|Linagliptin|Magnesium|mangiferin|Metformin|Nicotine|Particulate Matter|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Plant Extracts|Polychlorinated Biphenyls|Resveratrol|Rosiglitazone|Silver|Streptozocin|Telmisartan|Vehicle Emissions|Vildagliptin|Zinc",0,
cholesterol efflux,GO:0033344,Diabetes Mellitus,MESH:D003920,2,Cyclosporine|Plant Preparations,0,
cholesterol efflux,GO:0033344,"Diabetes Mellitus, Experimental",MESH:D003921,5,Cholesterol|Dibutyl Phthalate|Hydrogen Peroxide|Plant Preparations|sodium arsenite,1,CAV1
cholesterol efflux,GO:0033344,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cholesterol efflux,GO:0033344,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dibutyl Phthalate|Ethanol|perfluorooctane sulfonic acid,0,
cholesterol homeostasis,GO:0042632,Diabetes Mellitus,MESH:D003920,28,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|Alloxan|Berberine|bisphenol A|Chlorpyrifos|Chromium|Copper|Dichlorodiphenyl Dichloroethylene|Fatty Acids, Omega-3|Glyburide|Magnesium|Mercury|Metformin|Olanzapine|Ozone|Particulate Matter|Pioglitazone|Plant Extracts|Plant Preparations|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Tobacco Smoke Pollution|Tungsten|Zinc",1,SIRT1
cholesterol homeostasis,GO:0042632,"Diabetes Mellitus, Experimental",MESH:D003921,38,"Alloxan|Berberine|Bile Acids and Salts|bisphenol A|Cholesterol|Cholesterol, HDL|Cholesterol, LDL|Chromium|Coconut Oil|corilagin|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Enalapril|Fatty Acids, Omega-3|fenugreek seed meal|Fructose|Glyburide|Manganese|Metformin|Nicotine|Pioglitazone|Plant Extracts|Plant Preparations|platycodin D|Propolis|pterostilbene|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|Taurine|thymoquinone|Vitamin E",4,ACOX1|CAV1|CAV3|SIRT1
cholesterol homeostasis,GO:0042632,"Diabetes Mellitus, Type 1",MESH:D003922,10,Alloxan|bisphenol A|Genistein|Lipopolysaccharides|Mercury|Resveratrol|sodium arsenite|Streptozocin|Taurine|Thioctic Acid,0,
cholesterol homeostasis,GO:0042632,"Diabetes Mellitus, Type 2",MESH:D003924,43,"Air Pollutants|Alloxan|alpha-Tocopherol|Amino Acids|Ascorbic Acid|Berberine|bisphenol A|Calcium|Cholesterol, HDL|Cholesterol, LDL|Chromium|Copper|Curcumin|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|diethyl phthalate|Drugs, Chinese Herbal|efavirenz|Enalapril|Ethanol|Folic Acid|Fructose|Genistein|Glyburide|Magnesium|Manganese|Mercury|Metformin|Nicotine|Orlistat|Particulate Matter|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Plant Extracts|Resveratrol|Rosiglitazone|Streptozocin|Vildagliptin|Zinc",6,HNF4A|LIPC|MIR144|MIR33B|NUS1|SIRT1
cholesterol import,GO:0070508,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
cholesterol metabolic process,GO:0008203,Diabetes Mellitus,MESH:D003920,35,"2,4,5,2',4',5'-hexachlorobiphenyl|2-hydroxyfluorene|Air Pollutants|Alloxan|aroclor 1260|Arsenic|Aspirin|Atrazine|Bezafibrate|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpyrifos|Chromium|Cyclosporine|Fatty Acids, Omega-3|Gallic Acid|Glyburide|Iron|Lead|Mercury|Metformin|morroniside|Ozone|Particulate Matter|Pesticides|Pioglitazone|Plant Extracts|Polychlorinated Biphenyls|Resveratrol|Selenium|Sodium Selenite|Streptozocin|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution",3,CAT|LEPR|PON1
cholesterol metabolic process,GO:0008203,"Diabetes Mellitus, Experimental",MESH:D003921,43,"7-hydroxycoumarin|Alloxan|astaxanthine|Bezafibrate|bisphenol A|Cholesterol|Cholesterol, HDL|Cholesterol, LDL|Chromium|Coconut Oil|corilagin|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Dietary Sugars|Diethylhexyl Phthalate|eupafolin|Fatty Acids, Nonesterified|Fatty Acids, Omega-3|Fructose|Gallic Acid|Glucose|Glyburide|Hydrogen Peroxide|mangiferin|Metformin|Monocrotophos|Niacinamide|Nicotine|Palm Oil|Pioglitazone|Plant Extracts|pterostilbene|Quercetin|Resveratrol|sodium arsenite|Sodium Selenite|Streptozocin|swietenine|thymoquinone|tianhuang|triphenyltin chloride|Vitamin E",4,CAT|LEP|LEPR|SREBF1
cholesterol metabolic process,GO:0008203,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
cholesterol metabolic process,GO:0008203,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
cholesterol metabolic process,GO:0008203,"Diabetes Mellitus, Type 1",MESH:D003922,13,Alloxan|bisphenol A|Iron|Lipopolysaccharides|Mercury|Niacinamide|Palm Oil|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin|Thioctic Acid|Vitamin A,2,CAT|HNF1A
cholesterol metabolic process,GO:0008203,"Diabetes Mellitus, Type 2",MESH:D003924,47,"2-((6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexyl)oxy)-1,1,2,2-tetrafluoroethanesulfonic acid|Air Pollutants|Alloxan|alpha-Tocopherol|Arsenic|Ascorbic Acid|astaxanthine|Atrazine|Bezafibrate|bisphenol A|bisphenol S|Cadmium|Cholesterol, HDL|Cholesterol, LDL|Chromium|Curcumin|Cysteine|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|epigallocatechin gallate|Ethanol|Fatty Acids, Nonesterified|Folic Acid|Fructose|Glucose|Glyburide|Iron|Lead|Malathion|mangiferin|Mercury|Metformin|Niacinamide|Nicotine|Particulate Matter|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|perfluoroundecanoic acid|Pesticides|Pioglitazone|Plant Extracts|Polychlorinated Biphenyls|Resveratrol|Streptozocin",6,CAT|CYP1A2|HNF1A|LEP|LEPR|LIPC
cholesterol transport,GO:0030301,"Diabetes Mellitus, Experimental",MESH:D003921,3,"Cholesterol, HDL|Cholesterol, LDL|Dietary Fats",1,CAV1
cholesterol transport,GO:0030301,"Diabetes Mellitus, Type 2",MESH:D003924,3,"Cholesterol, HDL|Cholesterol, LDL|Dietary Fats",2,CD36|LIPC
cholesterol transport involved in cholesterol storage,GO:0010879,"Diabetes Mellitus, Experimental",MESH:D003921,2,"2-Hydroxypropyl-beta-cyclodextrin|Cholesterol, LDL",0,
cholesterol transport involved in cholesterol storage,GO:0010879,"Diabetes Mellitus, Type 2",MESH:D003924,1,"Cholesterol, LDL",0,
choline biosynthetic process,GO:0042425,Diabetes Mellitus,MESH:D003920,1,"2,2',4,4'-tetrabromodiphenyl ether",0,
choline biosynthetic process,GO:0042425,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
choline biosynthetic process,GO:0042425,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|perfluorooctanoic acid,0,
choline catabolic process,GO:0042426,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
choline metabolic process,GO:0019695,Diabetes Mellitus,MESH:D003920,4,Atrazine|bisphenol A|Lead|Mercury,0,
choline metabolic process,GO:0019695,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Diethylhexyl Phthalate|sodium arsenite,1,ACE
choline metabolic process,GO:0019695,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Mercury|sodium arsenite,0,
choline metabolic process,GO:0019695,"Diabetes Mellitus, Type 2",MESH:D003924,7,Atrazine|bisphenol A|bisphenol S|Diethylhexyl Phthalate|Lead|Mercury|perfluorooctane sulfonic acid,0,
chondroblast differentiation,GO:0060591,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ascorbic Acid,0,
chondrocyte development,GO:0002063,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
chondrocyte development,GO:0002063,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
chondrocyte differentiation,GO:0002062,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Sodium Selenite,0,
chondrocyte differentiation,GO:0002062,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Nicotine|Sodium Selenite,2,PRKCA|TGFB1
chondrocyte differentiation,GO:0002062,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
chondrocyte differentiation,GO:0002062,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|bisphenol S|Nicotine,0,
chondroitin sulfate biosynthetic process,GO:0030206,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
chondroitin sulfate biosynthetic process,GO:0030206,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
chondroitin sulfate proteoglycan biosynthetic process,GO:0050650,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IGF1
chondroitin sulfate proteoglycan biosynthetic process,GO:0050650,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
chordate embryonic development,GO:0043009,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
chordate embryonic development,GO:0043009,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FAS
chordate embryonic development,GO:0043009,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,2,FAS|FTO
chorion-containing eggshell pattern formation,GO:0030381,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
chorionic trophoblast cell development,GO:0060719,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
chorionic trophoblast cell differentiation,GO:0060718,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
chorionic trophoblast cell differentiation,GO:0060718,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
chromatin organization,GO:0006325,Diabetes Mellitus,MESH:D003920,4,"2,4,5,2',4',5'-hexachlorobiphenyl|Dichlorodiphenyl Dichloroethylene|Lead|Resveratrol",1,SIRT1
chromatin organization,GO:0006325,"Diabetes Mellitus, Experimental",MESH:D003921,4,Diethylhexyl Phthalate|Resveratrol|sodium arsenite|Sodium Glutamate,3,ACOX1|RELA|SIRT1
chromatin organization,GO:0006325,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,HYMAI
chromatin organization,GO:0006325,"Diabetes Mellitus, Type 1",MESH:D003922,2,Resveratrol|sodium arsenite,0,
chromatin organization,GO:0006325,"Diabetes Mellitus, Type 2",MESH:D003924,5,alpha-Tocopherol|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|Lead|Resveratrol,5,EPC2|HMG20A|HMGA1|PRKCB|SIRT1
chromatin remodeling,GO:0006338,Diabetes Mellitus,MESH:D003920,4,arsenite|bisphenol A|Pyruvaldehyde|Rosiglitazone,1,ALPK1
chromatin remodeling,GO:0006338,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Glucose|Hydrogen Peroxide|pterostilbene|Rosiglitazone|sodium arsenite,2,PAX6|PRKCA
chromatin remodeling,GO:0006338,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
chromatin remodeling,GO:0006338,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,3,HNF1A|PTPN22|TYK2
chromatin remodeling,GO:0006338,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|bisphenol S|Glucose|Rosiglitazone,10,AKT1|AKT2|BRAF|HNF1A|JADE2|KSR2|PAX6|PIK3CG|PRKCB|PTPN1
chromatin reprogramming in the zygote,GO:0044725,Diabetes Mellitus,MESH:D003920,0,,2,A|ZFP57
chromatin reprogramming in the zygote,GO:0044725,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
chromatin reprogramming in the zygote,GO:0044725,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,A
chromosome condensation,GO:0030261,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
chromosome condensation,GO:0030261,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
chromosome condensation,GO:0030261,"Diabetes Mellitus, Experimental",MESH:D003921,4,"Hydrogen Peroxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|sodium arsenite",0,
chromosome condensation,GO:0030261,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
chromosome condensation,GO:0030261,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
chromosome localization,GO:0050000,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
chromosome localization,GO:0050000,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
chromosome localization,GO:0050000,"Diabetes Mellitus, Experimental",MESH:D003921,2,"bisphenol A|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
chromosome localization,GO:0050000,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
chromosome localization,GO:0050000,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|perfluorodecanoic acid,0,
chromosome organization,GO:0051276,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,2,TP53|TRP53
chromosome organization,GO:0051276,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
chromosome organization,GO:0051276,"Diabetes Mellitus, Type 2",MESH:D003924,1,Indium,0,
chromosome organization involved in meiotic cell cycle,GO:0070192,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,0,
chronic inflammatory response to antigenic stimulus,GO:0002439,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IL1B|TNF
chronic inflammatory response to antigenic stimulus,GO:0002439,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IL10|TNF
chronic inflammatory response to antigenic stimulus,GO:0002439,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNF
chylomicron remnant clearance,GO:0034382,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
chylomicron remodeling,GO:0034371,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
ciliary basal body-plasma membrane docking,GO:0097711,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAM
ciliary body morphogenesis,GO:0061073,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOTCH2
ciliary neurotrophic factor-mediated signaling pathway,GO:0070120,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL27
cilium assembly,GO:0060271,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,1,ALPK1
cilium assembly,GO:0060271,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,FTO|PAM
cilium disassembly,GO:0061523,"Diabetes Mellitus, Experimental",MESH:D003921,1,Malondialdehyde,0,
cilium disassembly,GO:0061523,"Diabetes Mellitus, Type 2",MESH:D003924,1,Malondialdehyde,0,
cilium movement,GO:0003341,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,0,
cilium movement,GO:0003341,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ascorbic Acid|Glutathione,0,
cilium organization,GO:0044782,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,0,
circadian behavior,GO:0048512,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
circadian regulation of gene expression,GO:0032922,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Resveratrol,1,SIRT1
circadian regulation of gene expression,GO:0032922,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dietary Fats|Resveratrol,4,ID1|PPARA|PPARGC1A|SIRT1
circadian regulation of gene expression,GO:0032922,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Resveratrol,0,
circadian regulation of gene expression,GO:0032922,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Dietary Fats|Resveratrol,5,HNF1B|ID1|PPARA|PPARGC1A|SIRT1
circadian rhythm,GO:0007623,Diabetes Mellitus,MESH:D003920,1,bisphenol A,2,ADIPOQ|SIRT1
circadian rhythm,GO:0007623,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,11,FAS|ID1|IGF1|LEP|NOS2|SIRT1|SLC9A3|SREBF1|TNF|TP53|TRP53
circadian rhythm,GO:0007623,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,3,IGF1|PAX4|TNF
circadian rhythm,GO:0007623,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Ethanol|perfluorooctane sulfonic acid,12,ADIPOQ|EGFR|FAS|ID1|LEP|LIPC|MTNR1B|NOS2|PAX4|PROX1|SIRT1|TNF
circadian temperature homeostasis,GO:0060086,"Diabetes Mellitus, Type 2",MESH:D003924,1,Kangen-karyu,0,
circulatory system development,GO:0072359,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
circulatory system development,GO:0072359,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,0,
circulatory system process,GO:0003013,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,0,
citrate metabolic process,GO:0006101,Diabetes Mellitus,MESH:D003920,2,Resveratrol|Streptozocin,0,
citrate metabolic process,GO:0006101,"Diabetes Mellitus, Experimental",MESH:D003921,2,Resveratrol|Streptozocin,0,
citrate metabolic process,GO:0006101,"Diabetes Mellitus, Type 1",MESH:D003922,2,Resveratrol|Streptozocin,0,
citrate metabolic process,GO:0006101,"Diabetes Mellitus, Type 2",MESH:D003924,3,perfluorooctanoic acid|Resveratrol|Streptozocin,0,
citrulline biosynthetic process,GO:0019240,Diabetes Mellitus,MESH:D003920,1,Polychlorinated Biphenyls,0,
citrulline biosynthetic process,GO:0019240,"Diabetes Mellitus, Type 2",MESH:D003924,1,Polychlorinated Biphenyls,0,
citrulline metabolic process,GO:0000052,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
citrulline metabolic process,GO:0000052,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
"clathrin-coated vesicle cargo loading, AP-3-mediated",GO:0035654,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AP3S2
cleavage furrow ingression,GO:0036090,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
CMP metabolic process,GO:0046035,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
CMP metabolic process,GO:0046035,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cobalamin metabolic process,GO:0009235,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
cobalamin metabolic process,GO:0009235,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
cobalamin metabolic process,GO:0009235,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cobalamin metabolic process,GO:0009235,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Curcumin,0,
cochlea development,GO:0090102,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
cochlea morphogenesis,GO:0090103,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
cochlear nucleus development,GO:0021747,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
cochlear nucleus development,GO:0021747,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2
coenzyme A biosynthetic process,GO:0015937,"Diabetes Mellitus, Type 2",MESH:D003924,2,Malathion|Pantothenic Acid,0,
coenzyme A catabolic process,GO:0015938,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
coenzyme A metabolic process,GO:0015936,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|Dichlorodiphenyl Dichloroethylene|Particulate Matter,0,
coenzyme A metabolic process,GO:0015936,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
coenzyme A metabolic process,GO:0015936,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Particulate Matter,0,
cognition,GO:0050890,Diabetes Mellitus,MESH:D003920,20,"2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Antimony|Arsenic|bisphenol A|Cadmium|Chlorpyrifos|DDT|Diazinon|Dichlorodiphenyl Dichloroethylene|Lead|Mercury|Nitrogen Dioxide|o,p'-DDT|Particulate Matter|Pesticides|Pioglitazone|Polychlorinated Biphenyls|Sulfur Dioxide|Tobacco Smoke Pollution",1,INS
cognition,GO:0050890,"Diabetes Mellitus, Experimental",MESH:D003921,10,bisphenol A|Coconut Oil|Dietary Fats|Diethylhexyl Phthalate|Dronabinol|Manganese|Nicotine|Pioglitazone|Quercetin|thymoquinone,1,TNF
cognition,GO:0050890,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
cognition,GO:0050890,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|decabromobiphenyl ether|Lipopolysaccharides|Mercury,2,INS|TNF
cognition,GO:0050890,"Diabetes Mellitus, Type 2",MESH:D003924,22,Air Pollutants|Arsenic|bisphenol A|Cadmium|Curcumin|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|Ethanol|Lead|Manganese|Mercury|Nicotine|Particulate Matter|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pesticides|Phthalic Acids|Pioglitazone|Polychlorinated Biphenyls|Vehicle Emissions,2,INS|TNF
cold-induced thermogenesis,GO:0106106,Diabetes Mellitus,MESH:D003920,1,Arsenic,1,PPARG
cold-induced thermogenesis,GO:0106106,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,1,PPARG
cold-induced thermogenesis,GO:0106106,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cold-induced thermogenesis,GO:0106106,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,2,IGF2BP2|PPARG
collagen-activated signaling pathway,GO:0038065,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
collagen-activated tyrosine kinase receptor signaling pathway,GO:0038063,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
collagen-activated tyrosine kinase receptor signaling pathway,GO:0038063,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
collagen-activated tyrosine kinase receptor signaling pathway,GO:0038063,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
collagen biosynthetic process,GO:0032964,Diabetes Mellitus,MESH:D003920,9,Arsenic|bisphenol A|Cadmium|Gallic Acid|Particulate Matter|Prednisolone|Resveratrol|Streptozocin|Zinc,0,
collagen biosynthetic process,GO:0032964,"Diabetes Mellitus, Experimental",MESH:D003921,10,bisphenol A|Dietary Fats|Gallic Acid|Hydrogen Peroxide|Quercetin|Resveratrol|sodium arsenite|Streptozocin|thymoquinone|tributyltin,0,
collagen biosynthetic process,GO:0032964,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Resveratrol|sodium arsenite|Streptozocin,0,
collagen biosynthetic process,GO:0032964,"Diabetes Mellitus, Type 2",MESH:D003924,12,Arsenic|Ascorbic Acid|bisphenol A|Cadmium|Dietary Fats|epigallocatechin gallate|Ethanol|Particulate Matter|Resveratrol|Streptozocin|Vehicle Emissions|Zinc,0,
collagen catabolic process,GO:0030574,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
collagen catabolic process,GO:0030574,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,MMP2|MMP9
collagen catabolic process,GO:0030574,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,1,PEPD
collagen fibril organization,GO:0030199,Diabetes Mellitus,MESH:D003920,25,Air Pollutants|Arsenic|arsenite|Atrazine|Berberine|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Cyclosporine|Glyburide|Lead|lipoxin A4|Metformin|Methylprednisolone|morroniside|Particulate Matter|Pioglitazone|Prednisolone|Prednisone|Raloxifene Hydrochloride|Ramipril|Resveratrol|Selenium|Streptozocin|Tobacco Smoke Pollution,0,
collagen fibril organization,GO:0030199,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
collagen fibril organization,GO:0030199,"Diabetes Mellitus, Experimental",MESH:D003921,28,7-hydroxycoumarin|Berberine|bisphenol A|chebulagic acid|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Dietary Sugars|Fructose|Glyburide|Imatinib Mesylate|Losartan|Metformin|Nicotine|Palm Oil|pimagedine|Pioglitazone|Quercetin|Ramipril|Resveratrol|sodium arsenite|Streptozocin|swietenine|tianhuang|tributyltin|Valsartan|Vitamin E,1,MMP9
collagen fibril organization,GO:0030199,"Diabetes Mellitus, Type 1",MESH:D003922,11,bisphenol A|Cyclophosphamide|Imatinib Mesylate|Lipopolysaccharides|Palm Oil|Resveratrol|sodium arsenite|Streptozocin|Thioctic Acid|Uric Acid|Vitamin A,0,
collagen fibril organization,GO:0030199,"Diabetes Mellitus, Type 2",MESH:D003924,26,"2-((6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexyl)oxy)-1,1,2,2-tetrafluoroethanesulfonic acid|Air Pollutants|Arsenic|Ascorbic Acid|Atrazine|Berberine|bisphenol A|Cadmium|Curcumin|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylnitrosamine|Ethanol|Folic Acid|Fructose|Glyburide|Lead|Metformin|Nelfinavir|Nicotine|Particulate Matter|Pioglitazone|Resveratrol|Streptozocin|Vehicle Emissions",0,
collagen metabolic process,GO:0032963,Diabetes Mellitus,MESH:D003920,3,arsenite|Particulate Matter|puerarin,0,
collagen metabolic process,GO:0032963,"Diabetes Mellitus, Experimental",MESH:D003921,1,puerarin,2,ID1|PRKCD
collagen metabolic process,GO:0032963,"Diabetes Mellitus, Type 2",MESH:D003924,3,Glutathione|Particulate Matter|Vildagliptin,1,ID1
collateral sprouting,GO:0048668,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS1
columnar/cuboidal epithelial cell maturation,GO:0002069,"Diabetes Mellitus, Experimental",MESH:D003921,1,Eucalyptol,1,TGFB1
columnar/cuboidal epithelial cell maturation,GO:0002069,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
commissural neuron axon guidance,GO:0071679,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
commitment of neuronal cell to specific neuron type in forebrain,GO:0021902,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
commitment of neuronal cell to specific neuron type in forebrain,GO:0021902,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAX6
common bile duct development,GO:0061009,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HHEX|MIR30A
common myeloid progenitor cell proliferation,GO:0035726,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
common myeloid progenitor cell proliferation,GO:0035726,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,1,MIR125B1
complement activation,GO:0006956,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,C3
"complement activation, alternative pathway",GO:0006957,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,C3
"complement activation, classical pathway",GO:0006958,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
"complement activation, classical pathway",GO:0006958,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,C3
"complement activation, lectin pathway",GO:0001867,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CD69
complement-dependent cytotoxicity,GO:0097278,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,C3
complement-mediated synapse pruning,GO:0150062,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,C3
complement receptor mediated signaling pathway,GO:0002430,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,C3
compound eye cone cell differentiation,GO:0042675,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
compound eye development,GO:0048749,Diabetes Mellitus,MESH:D003920,0,,1,A
compound eye development,GO:0048749,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,A|EGFR
compound eye photoreceptor cell differentiation,GO:0001751,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
conditioned place preference,GO:1990708,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
conditioned place preference,GO:1990708,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
conditioned taste aversion,GO:0001661,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
connective tissue development,GO:0061448,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
connective tissue replacement involved in inflammatory response wound healing,GO:0002248,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
connective tissue replacement involved in inflammatory response wound healing,GO:0002248,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TGFB1|TIMP1
connective tissue replacement involved in inflammatory response wound healing,GO:0002248,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
connective tissue replacement involved in inflammatory response wound healing,GO:0002248,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TIMP1
contact inhibition,GO:0060242,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
contact inhibition,GO:0060242,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
contact inhibition,GO:0060242,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Tetrachlorodibenzodioxin,0,
convergent extension,GO:0060026,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR2
convergent extension involved in gastrulation,GO:0060027,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR2
copper ion homeostasis,GO:0055070,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Cadmium|Copper,0,
copper ion homeostasis,GO:0055070,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Clioquinol|Fructose|Manganese|sodium arsenite,0,
copper ion homeostasis,GO:0055070,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
copper ion homeostasis,GO:0055070,"Diabetes Mellitus, Type 2",MESH:D003924,7,bisphenol A|Cadmium|Copper|epigallocatechin gallate|Ethanol|Fructose|Manganese,0,
copper ion import across plasma membrane,GO:0098705,Diabetes Mellitus,MESH:D003920,1,Trientine,0,
copper ion transport,GO:0006825,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
copper ion transport,GO:0006825,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
copper ion transport,GO:0006825,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|Manganese,0,
copulation,GO:0007620,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
copulation,GO:0007620,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
copulation,GO:0007620,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
copulation,GO:0007620,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
cornea development in camera-type eye,GO:0061303,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
cornea development in camera-type eye,GO:0061303,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ADAMTS9|PAX6
coronary artery morphogenesis,GO:0060982,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
coronary vein morphogenesis,GO:0003169,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
corpus callosum development,GO:0022038,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
corpus callosum development,GO:0022038,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
cortical actin cytoskeleton organization,GO:0030866,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
cortical actin cytoskeleton organization,GO:0030866,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TNF
cortical actin cytoskeleton organization,GO:0030866,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
cortical actin cytoskeleton organization,GO:0030866,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNF
cortical cytoskeleton organization,GO:0030865,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
corticosteroid hormone secretion,GO:0035930,"Diabetes Mellitus, Experimental",MESH:D003921,1,Sodium Glutamate,0,
corticosterone secretion,GO:0035934,Diabetes Mellitus,MESH:D003920,6,Arsenic|bisphenol A|Cadmium|Selenium|Sodium Selenite|triphenyltin,0,
corticosterone secretion,GO:0035934,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Diethylhexyl Phthalate|Monocrotophos|Sodium Glutamate|Sodium Selenite,0,
corticosterone secretion,GO:0035934,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
corticosterone secretion,GO:0035934,"Diabetes Mellitus, Type 2",MESH:D003924,5,Arsenic|bisphenol A|Cadmium|Diethylhexyl Phthalate|perfluorooctanoic acid,1,KCNQ1
corticotropin-releasing hormone secretion,GO:0043396,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol S|mono(2-ethyl-5-hydroxyhexyl) phthalate|perfluorooctanoic acid|Phthalic Acids,0,
cortisol biosynthetic process,GO:0034651,Diabetes Mellitus,MESH:D003920,1,Polychlorinated Biphenyls,0,
cortisol biosynthetic process,GO:0034651,"Diabetes Mellitus, Type 2",MESH:D003924,1,Polychlorinated Biphenyls,0,
cortisol metabolic process,GO:0034650,Diabetes Mellitus,MESH:D003920,3,Arsenicals|Cadmium|Lead,0,
cortisol metabolic process,GO:0034650,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HSD11B2
cortisol metabolic process,GO:0034650,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Ethanol|Lead,0,
cortisol secretion,GO:0043400,Diabetes Mellitus,MESH:D003920,1,triphenyltin,1,POMC
cortisol secretion,GO:0043400,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
cortisol secretion,GO:0043400,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctane sulfonic acid,0,
coumarin metabolic process,GO:0009804,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
courtship behavior,GO:0007619,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
courtship behavior,GO:0007619,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
courtship behavior,GO:0007619,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
courtship behavior,GO:0007619,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
cranial skeletal system development,GO:1904888,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cranial skeletal system development,GO:1904888,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,EDN1
cranial skeletal system development,GO:1904888,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cranial skeletal system development,GO:1904888,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Ethanol|Folic Acid|Silver,3,EDN1|EDNRA|USP48
cranial suture morphogenesis,GO:0060363,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IGF1
cranial suture morphogenesis,GO:0060363,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
CRD-mediated mRNA stabilization,GO:0070934,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IGF2BP2
creatine biosynthetic process,GO:0006601,Diabetes Mellitus,MESH:D003920,2,Plant Extracts|Streptozocin,0,
creatine biosynthetic process,GO:0006601,"Diabetes Mellitus, Experimental",MESH:D003921,5,Dietary Fats|Diethylhexyl Phthalate|Plant Extracts|sodium arsenite|Streptozocin,0,
creatine biosynthetic process,GO:0006601,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Streptozocin,0,
creatine biosynthetic process,GO:0006601,"Diabetes Mellitus, Type 2",MESH:D003924,8,Curcumin|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts|Streptozocin,0,
creatine metabolic process,GO:0006600,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Dichlorodiphenyl Dichloroethylene|Lead|Plant Extracts,0,
creatine metabolic process,GO:0006600,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dietary Fats|Plant Extracts,0,
creatine metabolic process,GO:0006600,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
creatine metabolic process,GO:0006600,"Diabetes Mellitus, Type 2",MESH:D003924,7,bisphenol A|Curcumin|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Lead|perfluorooctanoic acid|Plant Extracts,0,
creatinine catabolic process,GO:0006602,Diabetes Mellitus,MESH:D003920,1,Blood Glucose,0,
creatinine catabolic process,GO:0006602,"Diabetes Mellitus, Experimental",MESH:D003921,2,Blood Glucose|terutroban,0,
creatinine catabolic process,GO:0006602,"Diabetes Mellitus, Type 2",MESH:D003924,1,Blood Glucose,0,
creatinine metabolic process,GO:0046449,Diabetes Mellitus,MESH:D003920,30,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|Alloxan|Arsenic|Atrazine|Berberine|bisphenol A|Blood Glucose|Cadmium|Chlorpyrifos|Cyclosporine|Fatty Acids, Omega-3|Gallic Acid|Glyburide|Lead|Mercury|Metformin|morroniside|Ozone|Particulate Matter|Phorate|Pioglitazone|Plant Extracts|Plant Preparations|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Tacrolimus",0,
creatinine metabolic process,GO:0046449,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
creatinine metabolic process,GO:0046449,"Diabetes Mellitus, Experimental",MESH:D003921,40,"7-hydroxycoumarin|Alloxan|Anthocyanins|Berberine|bisphenol A|Blood Glucose|cobaltiprotoporphyrin|Cromolyn Sodium|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Dietary Sugars|Fatty Acids, Omega-3|Fructose|Gallic Acid|Glucose|Glyburide|mangiferin|Metformin|Monocrotophos|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|pimagedine|pinitol|Pioglitazone|Plant Extracts|Plant Preparations|pterostilbene|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sarpogrelate|sodium arsenite|Sodium Selenite|Streptozocin|Tacrolimus|thymoquinone|Valsartan|Vitamin E",0,
creatinine metabolic process,GO:0046449,"Diabetes Mellitus, Type 1",MESH:D003922,10,Alloxan|bisphenol A|Cyclophosphamide|Lipopolysaccharides|Mercury|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|Uric Acid,0,
creatinine metabolic process,GO:0046449,"Diabetes Mellitus, Type 2",MESH:D003924,37,"2-((6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexyl)oxy)-1,1,2,2-tetrafluoroethanesulfonic acid|Air Pollutants|Alloxan|Arsenic|Ascorbic Acid|Atrazine|Berberine|bisphenol A|Blood Glucose|Boron|Cadmium|Curcumin|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylnitrosamine|Folic Acid|Fructose|Glucose|Glyburide|Kangen-karyu|Lead|Linagliptin|mangiferin|Mercury|Metformin|Nickel|Particulate Matter|Pentoxifylline|Pioglitazone|Plant Extracts|Resveratrol|Rosiglitazone|Sitagliptin Phosphate|Streptozocin|Vehicle Emissions|Vildagliptin",0,
cristae formation,GO:0042407,Diabetes Mellitus,MESH:D003920,1,Sulfur Dioxide,0,
CTP metabolic process,GO:0046036,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
cumulus cell differentiation,GO:0001549,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cumulus cell differentiation,GO:0001549,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
cumulus cell differentiation,GO:0001549,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cumulus cell differentiation,GO:0001549,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
cyclic nucleotide biosynthetic process,GO:0009190,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADCY5
cyclooxygenase pathway,GO:0019371,Diabetes Mellitus,MESH:D003920,2,Resveratrol|Tobacco Smoke Pollution,1,PTGS2
cyclooxygenase pathway,GO:0019371,"Diabetes Mellitus, Experimental",MESH:D003921,2,Quercetin|Resveratrol,2,BDKRB1|PTGS2
cyclooxygenase pathway,GO:0019371,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Resveratrol,0,
cyclooxygenase pathway,GO:0019371,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
cysteine biosynthetic process,GO:0019344,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|DDT,0,
cysteine biosynthetic process,GO:0019344,"Diabetes Mellitus, Experimental",MESH:D003921,1,Taurine,0,
cysteine biosynthetic process,GO:0019344,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
cysteine biosynthetic process,GO:0019344,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cysteine|hypotaurine|perfluorooctane sulfonic acid,1,CBS
cysteine biosynthetic process from serine,GO:0006535,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
cysteine biosynthetic process via cystathionine,GO:0019343,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
cysteine metabolic process,GO:0006534,Diabetes Mellitus,MESH:D003920,4,Atrazine|Cadmium|Dichlorodiphenyl Dichloroethylene|Sodium Selenite,0,
cysteine metabolic process,GO:0006534,"Diabetes Mellitus, Experimental",MESH:D003921,2,sodium arsenite|Sodium Selenite,0,
cysteine metabolic process,GO:0006534,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Thioctic Acid,0,
cysteine metabolic process,GO:0006534,"Diabetes Mellitus, Type 2",MESH:D003924,4,Atrazine|Cadmium|Cysteine|Dichlorodiphenyl Dichloroethylene,4,CBS|CDO1|GCLC|GCLM
cysteine transmembrane transport,GO:1903712,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
cytidine biosynthetic process,GO:0046088,Diabetes Mellitus,MESH:D003920,1,Polychlorinated Biphenyls,0,
cytidine biosynthetic process,GO:0046088,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
cytidine biosynthetic process,GO:0046088,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
cytidine biosynthetic process,GO:0046088,"Diabetes Mellitus, Type 2",MESH:D003924,1,Polychlorinated Biphenyls,0,
cytidine metabolic process,GO:0046087,Diabetes Mellitus,MESH:D003920,1,Selenium,0,
cytidine transport,GO:0015861,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
cytochrome c biosynthetic process,GO:1903607,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
cytochrome complex assembly,GO:0017004,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYBA
cytochrome complex assembly,GO:0017004,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYBA
cytokine-mediated signaling pathway,GO:0019221,Diabetes Mellitus,MESH:D003920,2,Nitrogen Dioxide|Particulate Matter,2,IRS1|LEPR
cytokine-mediated signaling pathway,GO:0019221,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,CAV1|CX3CL1|IL1B|IL6|IRS1|LEPR|RELA|TNFRSF1A
cytokine-mediated signaling pathway,GO:0019221,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,IL6|STAT3|TYK2
cytokine-mediated signaling pathway,GO:0019221,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,6,AKT1|IL13RA1|IL6|IRS1|LEPR|TNFRSF1A
cytokine production,GO:0001816,Diabetes Mellitus,MESH:D003920,2,Insecticides|Polychlorinated Biphenyls,0,
cytokine production,GO:0001816,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NQO1
cytokine production,GO:0001816,"Diabetes Mellitus, Type 2",MESH:D003924,1,Polychlorinated Biphenyls,3,MIR409|NFATC2|NFKB1
cytokine production involved in immune response,GO:0002367,Diabetes Mellitus,MESH:D003920,6,Atrazine|Nitrogen Dioxide|Ozone|Particulate Matter|Sulfur Dioxide|Tobacco Smoke Pollution,0,
cytokine production involved in immune response,GO:0002367,"Diabetes Mellitus, Type 2",MESH:D003924,2,Atrazine|Particulate Matter,0,
cytokine production involved in inflammatory response,GO:0002534,Diabetes Mellitus,MESH:D003920,13,Air Pollutants|Arsenic|bisphenol A|Iron|Lead|morroniside|Ozone|Particulate Matter|Pravastatin|Rosiglitazone|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Zinc,0,
cytokine production involved in inflammatory response,GO:0002534,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|ginsenoside Re|Manganese|platycodin D|Rosiglitazone|sarpogrelate,0,
cytokine production involved in inflammatory response,GO:0002534,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Iron|Lipopolysaccharides|Tetrachlorodibenzodioxin,0,
cytokine production involved in inflammatory response,GO:0002534,"Diabetes Mellitus, Type 2",MESH:D003924,15,Air Pollutants|Arsenic|bisphenol A|Curcumin|ginsenoside Re|Iron|Lead|Manganese|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Phthalic Acids|Rosiglitazone|Vehicle Emissions|Zinc,0,
cytokinesis,GO:0000910,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cytokinesis,GO:0000910,"Diabetes Mellitus, Experimental",MESH:D003921,2,"Hydrogen Peroxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
cytokinesis,GO:0000910,"Diabetes Mellitus, Type 2",MESH:D003924,1,Indium,0,
cytokinetic process,GO:0032506,Diabetes Mellitus,MESH:D003920,1,Insecticides,0,
cytolysis,GO:0019835,Diabetes Mellitus,MESH:D003920,2,Chlordan|Ozone,0,
cytolysis,GO:0019835,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
cytoplasmic microtubule organization,GO:0031122,Diabetes Mellitus,MESH:D003920,2,"2,4,5-Trichlorophenoxyacetic Acid|Agent Orange",0,
cytoplasmic microtubule organization,GO:0031122,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV3
cytoplasmic microtubule organization,GO:0031122,"Diabetes Mellitus, Type 2",MESH:D003924,1,Agent Orange,0,
cytoplasmic sequestering of NF-kappaB,GO:0007253,Diabetes Mellitus,MESH:D003920,3,Berberine|Blood Glucose|Resveratrol,0,
cytoplasmic sequestering of NF-kappaB,GO:0007253,"Diabetes Mellitus, Experimental",MESH:D003921,4,Berberine|Blood Glucose|Eucalyptol|Resveratrol,0,
cytoplasmic sequestering of NF-kappaB,GO:0007253,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Resveratrol,0,
cytoplasmic sequestering of NF-kappaB,GO:0007253,"Diabetes Mellitus, Type 2",MESH:D003924,3,Berberine|Blood Glucose|Resveratrol,0,
cytoplasmic sequestering of transcription factor,GO:0042994,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
cytoplasmic sequestering of transcription factor,GO:0042994,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
cytoplasmic sequestering of transcription factor,GO:0042994,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Cyclophosphamide|Valsartan,0,
cytoplasmic sequestering of transcription factor,GO:0042994,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Cyclophosphamide,0,
cytoplasmic sequestering of transcription factor,GO:0042994,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
cytoplasm organization,GO:0007028,Diabetes Mellitus,MESH:D003920,1,bisphenol A,1,KIF5B
cytoplasm organization,GO:0007028,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
cytoplasm organization,GO:0007028,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cytoplasm organization,GO:0007028,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
cytoplasm protein quality control by the ubiquitin-proteasome system,GO:0071629,Diabetes Mellitus,MESH:D003920,2,cyanazine|Dieldrin,0,
cytosine metabolic process,GO:0019858,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Chlorodiphenyl (54% Chlorine)|Polychlorinated Biphenyls|Selenium,0,
cytosine metabolic process,GO:0019858,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
cytosine metabolic process,GO:0019858,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
cytosine metabolic process,GO:0019858,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|perfluorooctanoic acid|Polychlorinated Biphenyls,0,
"cytoskeletal rearrangement involved in phagocytosis, engulfment",GO:0060097,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
"cytoskeletal rearrangement involved in phagocytosis, engulfment",GO:0060097,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Vehicle Emissions,0,
cytoskeleton-dependent intracellular transport,GO:0030705,Diabetes Mellitus,MESH:D003920,0,,1,KIF1A
cytoskeleton organization,GO:0007010,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
cytoskeleton organization,GO:0007010,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,YWHAH
cytoskeleton organization,GO:0007010,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HLA-DRB1
cytoskeleton organization,GO:0007010,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|MAEA
cytosolic lipolysis,GO:0061725,"Diabetes Mellitus, Experimental",MESH:D003921,1,"Fatty Acids, Nonesterified",0,
cytosolic lipolysis,GO:0061725,"Diabetes Mellitus, Type 2",MESH:D003924,1,"Fatty Acids, Nonesterified",0,
cytosolic pattern recognition receptor signaling pathway,GO:0002753,Diabetes Mellitus,MESH:D003920,0,,1,ALPK1
D-aspartate import across plasma membrane,GO:0070779,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCD
D-aspartate import across plasma membrane,GO:0070779,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
decidualization,GO:0046697,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Copper|Lead,1,PTGS2
decidualization,GO:0046697,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Dronabinol,2,PTGS2|SERPINE1
decidualization,GO:0046697,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Genistein,0,
decidualization,GO:0046697,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Copper|Genistein|Lead|perfluorooctane sulfonic acid,1,SFRP4
defecation,GO:0030421,Diabetes Mellitus,MESH:D003920,1,Coumaphos,0,
defecation rhythm,GO:0035882,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
defecation rhythm,GO:0035882,"Diabetes Mellitus, Experimental",MESH:D003921,2,Capsaicin|mangiferin,0,
defecation rhythm,GO:0035882,"Diabetes Mellitus, Type 2",MESH:D003924,1,mangiferin,0,
defense response,GO:0006952,Diabetes Mellitus,MESH:D003920,0,,1,CYBB
defense response,GO:0006952,"Diabetes Mellitus, Experimental",MESH:D003921,0,,7,CX3CL1|CYBB|MPO|RELA|TGFB1|TNF|TNFRSF1A
defense response,GO:0006952,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
defense response,GO:0006952,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,HP|STAT3|TNF
defense response,GO:0006952,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,HP|TNF|TNFRSF1A
defense response to bacterium,GO:0042742,Diabetes Mellitus,MESH:D003920,2,Arsenic|bisphenol A,2,MAP3K5|NCF1
defense response to bacterium,GO:0042742,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,10,CCL20|IFNG|IL1B|MAP3K5|MPO|NCF1|NOS2|PRKCD|TNF|TNFRSF1A
defense response to bacterium,GO:0042742,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
defense response to bacterium,GO:0042742,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,6,CCL20|HP|IFNG|IL10|SLC11A1|TNF
defense response to bacterium,GO:0042742,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|bisphenol A,7,CD36|HP|MIR140|NOS2|NOTCH2|TNF|TNFRSF1A
defense response to fungus,GO:0050832,Diabetes Mellitus,MESH:D003920,0,,1,NCF1
defense response to fungus,GO:0050832,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,MPO|NCF1|TGFB1
defense response to Gram-negative bacterium,GO:0050829,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
defense response to Gram-negative bacterium,GO:0050829,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,3,IL6|NOS2|SERPINE1
defense response to Gram-negative bacterium,GO:0050829,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,2,IL6|SLC11A1
defense response to Gram-negative bacterium,GO:0050829,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol S|Resveratrol,3,IL6|NOS2|TNFRSF1B
defense response to Gram-positive bacterium,GO:0050830,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|Particulate Matter|Resveratrol,1,NCF1
defense response to Gram-positive bacterium,GO:0050830,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,0,,1,TNFSF8
defense response to Gram-positive bacterium,GO:0050830,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,5,IFNG|IL1B|IL6|NCF1|TNF
defense response to Gram-positive bacterium,GO:0050830,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,4,CRP|IFNG|IL6|TNF
defense response to Gram-positive bacterium,GO:0050830,"Diabetes Mellitus, Type 2",MESH:D003924,3,Air Pollutants|Particulate Matter|Resveratrol,4,CD36|IL6|TNF|TNFRSF1B
defense response to protozoan,GO:0042832,"Diabetes Mellitus, Experimental",MESH:D003921,1,ginsenoside Re,2,IFNG|IL6
defense response to protozoan,GO:0042832,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,IFNG|IL10|IL6|SLC11A1
defense response to protozoan,GO:0042832,"Diabetes Mellitus, Type 2",MESH:D003924,1,ginsenoside Re,3,ENPP1|IL6|TNFRSF1B
defense response to tumor cell,GO:0002357,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,RELA
defense response to virus,GO:0051607,"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS",OMIM:616192,0,,1,DNAJC3
defense response to virus,GO:0051607,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Particulate Matter|Tetrachlorodibenzodioxin,0,
defense response to virus,GO:0051607,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,6,BCL2|BCL2L1|GPAM|IFNG|IL6|RELA
defense response to virus,GO:0051607,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Tetrachlorodibenzodioxin,2,IFNG|IL6
defense response to virus,GO:0051607,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|epigallocatechin gallate|Particulate Matter|S-Adenosylmethionine,4,BCL2|BCL2L1|IL6|TNFRSF1B
definitive hemopoiesis,GO:0060216,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TP53
definitive hemopoiesis,GO:0060216,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR144
dehydroascorbic acid transport,GO:0070837,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC2A2
dehydroascorbic acid transport,GO:0070837,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,SLC2A1|SLC2A2
dehydroepiandrosterone secretion,GO:0035942,Diabetes Mellitus,MESH:D003920,1,Docosahexaenoic Acids,0,
dehydroepiandrosterone secretion,GO:0035942,"Diabetes Mellitus, Type 1",MESH:D003922,1,Dehydroepiandrosterone,0,
dehydroepiandrosterone secretion,GO:0035942,"Diabetes Mellitus, Type 2",MESH:D003924,4,mono-(2-ethylhexyl)phthalate|perfluorooctane sulfonic acid|perfluorooctanoic acid|Phthalic Acids,0,
delamination,GO:0060232,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,0,
dendrite arborization,GO:0140059,Diabetes Mellitus,MESH:D003920,5,Arsenic|bisphenol A|Particulate Matter|Tacrolimus|Tetrachlorodibenzodioxin,0,
dendrite arborization,GO:0140059,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Dronabinol|Nicotine|sodium arsenite|Tacrolimus,0,
dendrite arborization,GO:0140059,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|decabromobiphenyl ether|sodium arsenite|Tacrolimus|Tetrachlorodibenzodioxin|Vitamin A,0,
dendrite arborization,GO:0140059,"Diabetes Mellitus, Type 2",MESH:D003924,4,Arsenic|bisphenol A|Nicotine|Particulate Matter,0,
dendrite development,GO:0016358,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Chlorpyrifos|Lead,1,RAC1
dendrite development,GO:0016358,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
dendrite development,GO:0016358,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
dendrite development,GO:0016358,"Diabetes Mellitus, Type 2",MESH:D003924,3,Ascorbic Acid|bisphenol A|Lead,0,
dendrite extension,GO:0097484,Diabetes Mellitus,MESH:D003920,2,Particulate Matter|Resveratrol,0,
dendrite extension,GO:0097484,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
dendrite extension,GO:0097484,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
dendrite extension,GO:0097484,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Resveratrol,1,AUTS2
dendrite morphogenesis,GO:0048813,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
dendrite morphogenesis,GO:0048813,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,RETN
dendrite regeneration,GO:0031104,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FAS
dendrite regeneration,GO:0031104,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FAS
dendritic cell apoptotic process,GO:0097048,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,BCL2|BCL2L1
dendritic cell apoptotic process,GO:0097048,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2|BCL2L1
dendritic cell chemotaxis,GO:0002407,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
dendritic cell chemotaxis,GO:0002407,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PIK3CG
dendritic cell differentiation,GO:0097028,Diabetes Mellitus,MESH:D003920,1,Plant Preparations,0,
dendritic cell differentiation,GO:0097028,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Preparations,0,
dendritic cell differentiation,GO:0097028,"Diabetes Mellitus, Type 1",MESH:D003922,2,decabromobiphenyl ether|Lipopolysaccharides,0,
dendritic cell homeostasis,GO:0036145,Diabetes Mellitus,MESH:D003920,3,Arsenic|Chlorpyrifos|Tetrachlorodibenzodioxin,0,
dendritic cell homeostasis,GO:0036145,"Diabetes Mellitus, Experimental",MESH:D003921,2,Diethylhexyl Phthalate|sodium arsenite,0,
dendritic cell homeostasis,GO:0036145,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Tetrachlorodibenzodioxin,0,
dendritic cell homeostasis,GO:0036145,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Diethylhexyl Phthalate,0,
dendritic cell migration,GO:0036336,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
dendritic cell migration,GO:0036336,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dibutyl Phthalate,0,
dendritic cell migration,GO:0036336,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dibutyl Phthalate|Particulate Matter|Vehicle Emissions,0,
dendritic cell proliferation,GO:0044565,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
dendritic cell proliferation,GO:0044565,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,BCL2L1
dendritic cell proliferation,GO:0044565,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
dendritic cell proliferation,GO:0044565,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|perfluorooctanoic acid,1,BCL2L1
dendritic spine development,GO:0060996,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Lead,0,
dendritic spine development,GO:0060996,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
dendritic spine development,GO:0060996,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
dendritic spine development,GO:0060996,"Diabetes Mellitus, Type 2",MESH:D003924,3,Ascorbic Acid|bisphenol A|Lead,0,
dendritic spine maintenance,GO:0097062,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Lead,0,
dendritic spine maintenance,GO:0097062,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,INSR
dendritic spine maintenance,GO:0097062,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
dendritic spine maintenance,GO:0097062,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
dendritic spine maintenance,GO:0097062,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Lead,0,
dendritic spine morphogenesis,GO:0060997,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
dendritic spine morphogenesis,GO:0060997,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
dendritic spine morphogenesis,GO:0060997,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
'de novo' L-methionine biosynthetic process,GO:0071266,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BHMT
dense core granule cytoskeletal transport,GO:0099519,Diabetes Mellitus,MESH:D003920,0,,1,KIF1A
dentate gyrus development,GO:0021542,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NEUROD1
dentate gyrus development,GO:0021542,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,2,NEUROD1|PROX1
dentin mineralization,GO:0097188,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
dentinogenesis,GO:0097187,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SERPINE1
deoxyguanosine biosynthetic process,GO:0042452,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
deoxyguanosine biosynthetic process,GO:0042452,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Cholesterol|Dietary Fats,0,
deoxyguanosine biosynthetic process,GO:0042452,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
deoxyguanosine biosynthetic process,GO:0042452,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Dietary Fats,0,
deoxyguanosine metabolic process,GO:0042453,Diabetes Mellitus,MESH:D003920,2,Iron|Selenium,0,
deoxyguanosine metabolic process,GO:0042453,"Diabetes Mellitus, Type 1",MESH:D003922,1,Iron,0,
deoxyguanosine metabolic process,GO:0042453,"Diabetes Mellitus, Type 2",MESH:D003924,1,Iron,0,
dephosphorylation,GO:0016311,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PTPN22
dephosphorylation,GO:0016311,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PTPN1
depurination,GO:0045007,Diabetes Mellitus,MESH:D003920,1,Arsenicals,0,
depurination,GO:0045007,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
depyrimidination,GO:0045008,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
dermatan sulfate biosynthetic process,GO:0030208,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
dermatan sulfate biosynthetic process,GO:0030208,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
desensitization of G protein-coupled receptor signaling pathway by arrestin,GO:0002032,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
desmosome assembly,GO:0002159,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCA
detection of bacterium,GO:0016045,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HLA-DRB1
detection of calcium ion,GO:0005513,"Diabetes Mellitus, Type 2",MESH:D003924,1,Calcium,0,
detection of carbon dioxide,GO:0003031,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lactic Acid,0,
detection of chemical stimulus involved in sensory perception of pain,GO:0050968,Diabetes Mellitus,MESH:D003920,1,Glyburide,0,
detection of chemical stimulus involved in sensory perception of pain,GO:0050968,"Diabetes Mellitus, Experimental",MESH:D003921,3,Capsaicin|Glyburide|mangiferin,0,
detection of chemical stimulus involved in sensory perception of pain,GO:0050968,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glyburide|mangiferin,0,
detection of chemical stimulus involved in sensory perception of taste,GO:0050912,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
detection of chemical stimulus involved in sensory perception of taste,GO:0050912,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
detection of glucose,GO:0051594,"Diabetes Mellitus, Experimental",MESH:D003921,3,Dietary Fats|Dietary Sucrose|Glucose,0,
detection of glucose,GO:0051594,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Glucose,0,
detection of host,GO:0044405,"Diabetes Mellitus, Experimental",MESH:D003921,1,Eucalyptol,0,
detection of increased carbon dioxide by carotid body chemoreceptor signaling,GO:0003035,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
detection of increased carbon dioxide by carotid body chemoreceptor signaling,GO:0003035,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
detection of mechanical stimulus involved in sensory perception,GO:0050974,Diabetes Mellitus,MESH:D003920,1,Lead,0,
detection of mechanical stimulus involved in sensory perception,GO:0050974,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IGF1
detection of mechanical stimulus involved in sensory perception,GO:0050974,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
detection of mechanical stimulus involved in sensory perception,GO:0050974,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lead,0,
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,Diabetes Mellitus,MESH:D003920,3,Arsenic|Glyburide|Streptozocin,0,
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,"Diabetes Mellitus, Experimental",MESH:D003921,4,Glyburide|Nitric Oxide|sodium arsenite|Streptozocin,1,TNF
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,"Diabetes Mellitus, Type 1",MESH:D003922,4,Dehydroepiandrosterone|Nitric Oxide|sodium arsenite|Streptozocin,1,TNF
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,"Diabetes Mellitus, Type 2",MESH:D003924,3,Arsenic|Glyburide|Streptozocin,1,TNF
detection of mechanical stimulus involved in sensory perception of sound,GO:0050910,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
detection of muscle stretch,GO:0035995,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV3
detection of oxidative stress,GO:0070994,Diabetes Mellitus,MESH:D003920,49,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Arsenic|arsenite|Aspirin|Atrazine|Berberine|Bezafibrate|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpromazine|Chlorpyrifos|Clozapine|Copper|Diazinon|Dichlorvos|Docosahexaenoic Acids|Fatty Acids, Omega-3|Flavonoids|Gallic Acid|Glyburide|Hexachlorobenzene|Iron|Lead|Mercury|Metformin|morroniside|Niacin|Nitrogen Oxides|Ozone|Particulate Matter|Pioglitazone|Plant Extracts|Plant Preparations|puerarin|Pyruvaldehyde|Reactive Oxygen Species|repaglinide|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Telmisartan|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Zinc",1,ADIPOQ
detection of oxidative stress,GO:0070994,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
detection of oxidative stress,GO:0070994,"Diabetes Mellitus, Experimental",MESH:D003921,51,"7-hydroxycoumarin|astaxanthine|Berberine|Bezafibrate|bisphenol A|Capsaicin|corilagin|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Dronabinol|Enalapril|eupafolin|Fatty Acids, Omega-3|Fructose|Gallic Acid|ginsenoside Re|Glucose|Glyburide|Hydrogen Peroxide|Imatinib Mesylate|Losartan|Malondialdehyde|Manganese|Metformin|Monocrotophos|Niacinamide|Nicotine|Nitric Oxide|pimagedine|Pioglitazone|Plant Extracts|Plant Preparations|pterostilbene|puerarin|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|Superoxides|swietenine|Taurine|Telmisartan|tributyltin|Ursolic Acid|Vitamin E",0,
detection of oxidative stress,GO:0070994,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
detection of oxidative stress,GO:0070994,"Diabetes Mellitus, Type 1",MESH:D003922,20,bisphenol A|Calcitriol|Cyclophosphamide|decabromobiphenyl ether|Dichlorvos|Imatinib Mesylate|Iron|Lipopolysaccharides|Mercury|Niacinamide|Nitric Oxide|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Superoxides|Taurine|Tetrachlorodibenzodioxin|Thioctic Acid|Vitamin A,0,
detection of oxidative stress,GO:0070994,"Diabetes Mellitus, Type 2",MESH:D003924,57,"2-((6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexyl)oxy)-1,1,2,2-tetrafluoroethanesulfonic acid|Air Pollutants|Arsenic|Ascorbic Acid|astaxanthine|Atrazine|Berberine|Bezafibrate|bisphenol A|bisphenol S|Cadmium|Clozapine|Copper|coumarin|Curcumin|Cysteine|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Diethylnitrosamine|Drugs, Chinese Herbal|Enalapril|epigallocatechin gallate|Ethanol|Folic Acid|Fructose|ginsenoside Re|Glucose|Glutathione|Glyburide|Iron|Lead|Malathion|Malondialdehyde|Manganese|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Niacinamide|Nickel|Nicotine|Particulate Matter|Pioglitazone|Plant Extracts|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Silver|Streptozocin|Superoxides|Telmisartan|titanium dioxide|Tolbutamide|Topiramate|Vehicle Emissions|Zinc",1,ADIPOQ
detection of oxygen,GO:0003032,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SOD2
detection of oxygen,GO:0003032,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SOD2
detection of renal blood flow,GO:0002000,"Diabetes Mellitus, Type 1",MESH:D003922,1,Uric Acid,0,
detection of renal blood flow,GO:0002000,"Diabetes Mellitus, Type 2",MESH:D003924,1,Folic Acid,0,
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,"Diabetes Mellitus, Experimental",MESH:D003921,1,Streptozocin,0,
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,"Diabetes Mellitus, Type 1",MESH:D003922,2,Dehydroepiandrosterone|Streptozocin,0,
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,"Diabetes Mellitus, Type 2",MESH:D003924,1,Streptozocin,0,
determination of adult lifespan,GO:0008340,Diabetes Mellitus,MESH:D003920,6,arsenite|bisphenol A|Dichlorvos|Particulate Matter|Plant Extracts|Resveratrol,4,ATP6|CAT|SIRT1|SOD1
determination of adult lifespan,GO:0008340,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
determination of adult lifespan,GO:0008340,"Diabetes Mellitus, Experimental",MESH:D003921,8,"bisphenol A|Diethylhexyl Phthalate|Hydrogen Peroxide|Lithocholic Acid|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|Resveratrol|sodium arsenite",8,CAT|KCNJ11|LEP|SIRT1|SOD1|SOD2|TP53|TRP53
determination of adult lifespan,GO:0008340,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
determination of adult lifespan,GO:0008340,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Dichlorvos|Resveratrol|sodium arsenite,2,CAT|KCNJ11
determination of adult lifespan,GO:0008340,"Diabetes Mellitus, Type 2",MESH:D003924,7,bisphenol A|Diethylhexyl Phthalate|Lithocholic Acid|Particulate Matter|perfluorooctane sulfonic acid|Plant Extracts|Resveratrol,10,CAT|CBS|EGFR|ENPP1|KCNJ11|KL|LEP|SIRT1|SOD1|SOD2
determination of affect,GO:0050894,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
determination of digestive tract left/right asymmetry,GO:0071907,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
determination of digestive tract left/right asymmetry,GO:0071907,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PDX1
determination of digestive tract left/right asymmetry,GO:0071907,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PDX1
determination of dorsal/ventral asymmetry,GO:0048262,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SMAD5
determination of genital disc primordium,GO:0035225,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
determination of left/right asymmetry in diencephalon,GO:0035462,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TCF7L2
determination of left/right symmetry,GO:0007368,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,HHEX|NOTCH2|SMAD5
determination of liver left/right asymmetry,GO:0071910,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PDX1
determination of liver left/right asymmetry,GO:0071910,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PDX1
determination of pancreatic left/right asymmetry,GO:0035469,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PDX1
determination of pancreatic left/right asymmetry,GO:0035469,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PDX1
determination of ventral identity,GO:0048264,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SMAD5
detoxification,GO:0098754,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
detoxification,GO:0098754,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
detoxification,GO:0098754,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
detoxification,GO:0098754,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|bisphenol S|Calcium,0,
detoxification of arsenic-containing substance,GO:0071722,Diabetes Mellitus,MESH:D003920,2,Arsenic|Arsenicals,0,
detoxification of arsenic-containing substance,GO:0071722,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,0,
detoxification of arsenic-containing substance,GO:0071722,"Diabetes Mellitus, Type 2",MESH:D003924,3,Arsenic|Folic Acid|Glutathione,1,GCLM
detoxification of copper ion,GO:0010273,Diabetes Mellitus,MESH:D003920,0,,1,MT2A
detoxification of hydrogen peroxide,GO:0061691,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,0,
detoxification of nitrogen compound,GO:0051410,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nitric Oxide,0,
detoxification of nitrogen compound,GO:0051410,"Diabetes Mellitus, Type 1",MESH:D003922,1,Nitric Oxide,0,
developmental growth,GO:0048589,Diabetes Mellitus,MESH:D003920,10,"2,4,5,2',4',5'-hexachlorobiphenyl|Arsenic|bisphenol A|Cadmium|Chromium|Dichlorodiphenyl Dichloroethylene|Dieldrin|o,p'-DDT|Polychlorinated Biphenyls|Tobacco Smoke Pollution",0,
developmental growth,GO:0048589,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Chromium,1,BCL2
developmental growth,GO:0048589,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
developmental growth,GO:0048589,"Diabetes Mellitus, Type 2",MESH:D003924,11,Arsenic|bisphenol A|Boron|Cadmium|Chromium|Dichlorodiphenyl Dichloroethylene|Folic Acid|perfluorodecanoic acid|perfluorooctanoic acid|perfluoroundecanoic acid|Polychlorinated Biphenyls,2,BCL2|LIPC
developmental growth involved in morphogenesis,GO:0060560,Diabetes Mellitus,MESH:D003920,1,Copper,0,
developmental growth involved in morphogenesis,GO:0060560,"Diabetes Mellitus, Type 2",MESH:D003924,1,Copper,0,
developmental pigmentation,GO:0048066,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,1,BCL2
developmental pigmentation,GO:0048066,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
developmental pigmentation,GO:0048066,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,BCL2|BCL2L11|EDNRA|EDNRB
developmental process,GO:0032502,Diabetes Mellitus,MESH:D003920,8,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|aroclor 1260|arsenite|bisphenol A|Chlorodiphenyl (54% Chlorine)|Mercury|Particulate Matter",0,
developmental process,GO:0032502,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
developmental process,GO:0032502,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
developmental process,GO:0032502,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Mercury|sodium arsenite|Thioctic Acid,0,
developmental process,GO:0032502,"Diabetes Mellitus, Type 2",MESH:D003924,6,Air Pollutants|Amoxicillin|bisphenol A|Mercury|Particulate Matter|perfluorooctane sulfonic acid,0,
developmental process involved in reproduction,GO:0003006,Diabetes Mellitus,MESH:D003920,5,2-naphthol|Antimony|bisphenol A|Chromium|Lead,0,
developmental process involved in reproduction,GO:0003006,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Chromium|Dibutyl Phthalate|Diethylhexyl Phthalate|sodium arsenite,0,
developmental process involved in reproduction,GO:0003006,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|decabromobiphenyl ether|sodium arsenite,0,
developmental process involved in reproduction,GO:0003006,"Diabetes Mellitus, Type 2",MESH:D003924,9,bisphenol A|bisphenol S|Chromium|Dibutyl Phthalate|Diethylhexyl Phthalate|Lead|perfluorodecanoic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid,0,
development of secondary male sexual characteristics,GO:0046544,"Diabetes Mellitus, Type 2",MESH:D003924,2,mono(2-ethyl-5-hydroxyhexyl) phthalate|Phthalic Acids,0,
development of secondary sexual characteristics,GO:0045136,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
development of secondary sexual characteristics,GO:0045136,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
development of symbiont in host,GO:0044114,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
development of symbiont in host,GO:0044114,"Diabetes Mellitus, Type 2",MESH:D003924,1,Manganese,0,
D-gluconate metabolic process,GO:0019521,Diabetes Mellitus,MESH:D003920,1,Uranium,0,
dGMP biosynthetic process,GO:0006181,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
dGMP biosynthetic process,GO:0006181,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
diacylglycerol biosynthetic process,GO:0006651,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GPAM
diacylglycerol catabolic process,GO:0046340,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,DGKD
diacylglycerol metabolic process,GO:0046339,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
diacylglycerol metabolic process,GO:0046339,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
diacylglycerol metabolic process,GO:0046339,"Diabetes Mellitus, Type 2",MESH:D003924,4,Dichlorodiphenyl Dichloroethylene|mono(2-ethyl-5-hydroxyhexyl) phthalate|mono-(2-ethylhexyl)phthalate|perfluorooctane sulfonic acid,1,DGKD
diakinesis,GO:0000241,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
diakinesis,GO:0000241,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Dibutyl Phthalate,0,
diakinesis,GO:0000241,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
diakinesis,GO:0000241,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Dibutyl Phthalate,0,
diaphragm contraction,GO:0002086,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
dibenzo-p-dioxin catabolic process,GO:0019341,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
dibenzo-p-dioxin metabolic process,GO:0018894,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
dibenzo-p-dioxin metabolic process,GO:0018894,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CYP1A2|PRKCB
dicarboxylic acid metabolic process,GO:0043648,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,1,PCK1
dicarboxylic acid metabolic process,GO:0043648,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
dicarboxylic acid transport,GO:0006835,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
dichotomous subdivision of terminal units involved in lung branching,GO:0060448,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CTSH
diestrus,GO:0060207,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Dichlorodiphenyl Dichloroethylene,0,
diestrus,GO:0060207,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|tributyltin,0,
diestrus,GO:0060207,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Dehydroepiandrosterone,0,
diestrus,GO:0060207,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Dichlorodiphenyl Dichloroethylene|perfluorooctane sulfonic acid,0,
diet induced thermogenesis,GO:0002024,Diabetes Mellitus,MESH:D003920,1,DDT,2,ADRB1|PPARG
diet induced thermogenesis,GO:0002024,"Diabetes Mellitus, Experimental",MESH:D003921,1,Sodium Glutamate,2,ADRB3|PPARG
diet induced thermogenesis,GO:0002024,"Diabetes Mellitus, Type 2",MESH:D003924,2,perfluorooctane sulfonic acid|perfluorooctanoic acid,2,PPARG|SCTR
digestion,GO:0007586,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARGC1A
digestion,GO:0007586,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARGC1A
digestive system development,GO:0055123,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BHMT|TCF7L2
digestive system process,GO:0022600,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
digestive system process,GO:0022600,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
digestive system process,GO:0022600,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
digestive system process,GO:0022600,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Cysteine,1,KCNQ1
digestive tract development,GO:0048565,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
digestive tract development,GO:0048565,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CYP1A1|PDX1|TGFB1
digestive tract development,GO:0048565,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,CD36|HHEX|PDX1
digestive tract morphogenesis,GO:0048546,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
digestive tract morphogenesis,GO:0048546,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
digestive tract morphogenesis,GO:0048546,"Diabetes Mellitus, Type 2",MESH:D003924,1,Atrazine,2,BCL2|EGFR
diphosphate metabolic process,GO:0071344,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
disaccharide metabolic process,GO:0005984,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
disaccharide metabolic process,GO:0005984,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
disaccharide metabolic process,GO:0005984,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
disaccharide metabolic process,GO:0005984,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
diterpenoid metabolic process,GO:0016101,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
DNA amplification,GO:0006277,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
DNA amplification,GO:0006277,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
DNA biosynthetic process,GO:0071897,Diabetes Mellitus,MESH:D003920,11,"2,4,5-Trichlorophenoxyacetic Acid|Arsenic|Atrazine|Berberine|bisphenol A|Chlorpyrifos|Pioglitazone|Resveratrol|Rosiglitazone|Sodium Selenite|triphenyltin",0,
DNA biosynthetic process,GO:0071897,"Diabetes Mellitus, Experimental",MESH:D003921,8,Berberine|bisphenol A|Dietary Fats|Pioglitazone|Quercetin|Resveratrol|Rosiglitazone|Sodium Selenite,0,
DNA biosynthetic process,GO:0071897,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Lipopolysaccharides|Resveratrol,0,
DNA biosynthetic process,GO:0071897,"Diabetes Mellitus, Type 2",MESH:D003924,10,Arsenic|Atrazine|Berberine|bisphenol A|Dietary Fats|Folic Acid|Orlistat|Pioglitazone|Resveratrol|Rosiglitazone,0,
DNA catabolic process,GO:0006308,Diabetes Mellitus,MESH:D003920,12,Arsenic|Aspirin|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpromazine|Copper|Niacin|Particulate Matter|Plant Extracts|Resveratrol|Selenium|Tetrachlorodibenzodioxin,0,
DNA catabolic process,GO:0006308,"Diabetes Mellitus, Experimental",MESH:D003921,5,Hydrogen Peroxide|Plant Extracts|pterostilbene|Resveratrol|Vitamin E,0,
DNA catabolic process,GO:0006308,"Diabetes Mellitus, Type 1",MESH:D003922,3,Resveratrol|Tetrachlorodibenzodioxin|Vitamin A,0,
DNA catabolic process,GO:0006308,"Diabetes Mellitus, Type 2",MESH:D003924,10,Arsenic|Ascorbic Acid|Cadmium|Copper|Curcumin|Diethylnitrosamine|Glutathione|Particulate Matter|Plant Extracts|Resveratrol,0,
"DNA catabolic process, endonucleolytic",GO:0000737,Diabetes Mellitus,MESH:D003920,17,Arsenic|arsenite|Atrazine|bisphenol A|Blood Glucose|Cadmium|Chlorpyrifos|Copper|Cyclosporine|Diazinon|Iron|Particulate Matter|Reactive Oxygen Species|Resveratrol|Selenium|Streptozocin|Zinc,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Diabetes Mellitus, Experimental",MESH:D003921,13,"bisphenol A|Blood Glucose|Cyclophosphamide|Dietary Fats|Diethylhexyl Phthalate|fenugreek seed meal|Glucose|Hydrogen Peroxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Resveratrol|sodium arsenite|Streptozocin|thymoquinone",0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Diabetes Mellitus, Type 1",MESH:D003922,9,bisphenol A|Cyclophosphamide|Iron|Lipopolysaccharides|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Thioctic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Diabetes Mellitus, Type 2",MESH:D003924,21,Arsenic|Ascorbic Acid|Atrazine|bisphenol A|Blood Glucose|Cadmium|Copper|Curcumin|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Ethanol|Glucose|Iron|Malathion|Particulate Matter|Reactive Oxygen Species|Resveratrol|Streptozocin|Vehicle Emissions|Zinc,0,
DNA conformation change,GO:0071103,Diabetes Mellitus,MESH:D003920,1,Berberine,0,
DNA conformation change,GO:0071103,"Diabetes Mellitus, Experimental",MESH:D003921,2,Berberine|Hydrogen Peroxide,0,
DNA conformation change,GO:0071103,"Diabetes Mellitus, Type 2",MESH:D003924,1,Berberine,1,HHEX
DNA damage checkpoint signaling,GO:0000077,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
DNA damage checkpoint signaling,GO:0000077,"Diabetes Mellitus, Experimental",MESH:D003921,2,Plant Extracts|Quercetin,1,TP53
DNA damage checkpoint signaling,GO:0000077,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
"DNA damage response, signal transduction by p53 class mediator",GO:0030330,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,FOXO3|TP53|TRP53
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",GO:0006977,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",GO:0006977,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
DNA dealkylation involved in DNA repair,GO:0006307,Diabetes Mellitus,MESH:D003920,1,Gallic Acid,0,
DNA dealkylation involved in DNA repair,GO:0006307,"Diabetes Mellitus, Experimental",MESH:D003921,1,Gallic Acid,1,AGT
DNA dealkylation involved in DNA repair,GO:0006307,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FTO
DNA demethylation,GO:0080111,"Diabetes Mellitus, Experimental",MESH:D003921,2,Diosmin|Hydrogen Peroxide,0,
DNA demethylation,GO:0080111,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diosmin,0,
DNA duplex unwinding,GO:0032508,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
DNA endoreduplication,GO:0042023,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
DNA endoreduplication,GO:0042023,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
DNA endoreduplication,GO:0042023,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
DNA endoreduplication,GO:0042023,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
DNA hypermethylation,GO:0044026,Diabetes Mellitus,MESH:D003920,3,Allergens|Arsenic|Arsenicals,0,
DNA hypermethylation,GO:0044026,"Diabetes Mellitus, Experimental",MESH:D003921,2,sodium arsenite|tributyltin,0,
DNA hypermethylation,GO:0044026,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
DNA hypermethylation,GO:0044026,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Vehicle Emissions,0,
DNA hypomethylation,GO:0044028,Diabetes Mellitus,MESH:D003920,5,Allergens|Arsenic|Dichlorodiphenyl Dichloroethylene|Particulate Matter|Tetrachlorodibenzodioxin,0,
DNA hypomethylation,GO:0044028,"Diabetes Mellitus, Experimental",MESH:D003921,4,Hydrogen Peroxide|Quercetin|sodium arsenite|tributyltin,0,
DNA hypomethylation,GO:0044028,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Tetrachlorodibenzodioxin,0,
DNA hypomethylation,GO:0044028,"Diabetes Mellitus, Type 2",MESH:D003924,8,Arsenic|Curcumin|Dichlorodiphenyl Dichloroethylene|Glutathione|Particulate Matter|perfluorooctane sulfonic acid|S-Adenosylmethionine|Vehicle Emissions,0,
DNA integration,GO:0015074,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IL13RA1
DNA metabolic process,GO:0006259,Diabetes Mellitus,MESH:D003920,4,Plant Preparations|puerarin|Pyruvaldehyde|Tobacco Smoke Pollution,0,
DNA metabolic process,GO:0006259,"Diabetes Mellitus, Experimental",MESH:D003921,4,Glucose|Hydrogen Peroxide|Plant Preparations|puerarin,0,
DNA metabolic process,GO:0006259,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,0,
DNA methylation,GO:0006306,Diabetes Mellitus,MESH:D003920,27,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Arsenic|bisphenol A|Cadmium|Clozapine|Copper|DDT|Dichlorodiphenyl Dichloroethylene|Dieldrin|Hexachlorobenzene|Lead|Liraglutide|Mercury|Nitrogen Dioxide|o,p'-DDT|oxychlordane|Ozone|Particulate Matter|Pesticides|Selenium|Sodium Selenite|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Uranium|Zinc",0,
DNA methylation,GO:0006306,"Diabetes Mellitus, Experimental",MESH:D003921,9,bisphenol A|Diethylhexyl Phthalate|Dronabinol|Glucose|Hydrogen Peroxide|Quercetin|sodium arsenite|Sodium Selenite|Vitamin E,0,
DNA methylation,GO:0006306,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|decabromobiphenyl ether|Genistein|Lipopolysaccharides|Mercury|sodium arsenite|Tetrachlorodibenzodioxin,0,
DNA methylation,GO:0006306,"Diabetes Mellitus, Type 2",MESH:D003924,22,Air Pollutants|Arsenic|bisphenol A|bisphenol S|Cadmium|Clozapine|Copper|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|Folic Acid|Genistein|Glucose|Glutathione|Lead|Liraglutide|Mercury|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pesticides|Vehicle Emissions|Zinc,0,
DNA methylation-dependent heterochromatin formation,GO:0006346,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
DNA methylation-dependent heterochromatin formation,GO:0006346,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
DNA methylation-dependent heterochromatin formation,GO:0006346,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
DNA methylation involved in embryo development,GO:0043045,Diabetes Mellitus,MESH:D003920,3,"2,2',4,4'-tetrabromodiphenyl ether|Arsenic|Pesticides",0,
DNA methylation involved in embryo development,GO:0043045,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
DNA methylation involved in embryo development,GO:0043045,"Diabetes Mellitus, Type 2",MESH:D003924,7,Arsenic|Dietary Fats|Ethanol|perfluorodecanoic acid|perfluorooctane sulfonic acid|perfluoroundecanoic acid|Pesticides,0,
DNA methylation involved in gamete generation,GO:0043046,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Cadmium|Lead,0,
DNA methylation involved in gamete generation,GO:0043046,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
DNA methylation involved in gamete generation,GO:0043046,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
DNA methylation involved in gamete generation,GO:0043046,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Cadmium|Lead,0,
DNA methylation on cytosine,GO:0032776,Diabetes Mellitus,MESH:D003920,5,bisphenol A|DDT|Dieldrin|Lead|Streptozocin,0,
DNA methylation on cytosine,GO:0032776,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Dietary Fats|Diethylhexyl Phthalate|Hydrogen Peroxide|sodium arsenite|Streptozocin,0,
DNA methylation on cytosine,GO:0032776,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Streptozocin,0,
DNA methylation on cytosine,GO:0032776,"Diabetes Mellitus, Type 2",MESH:D003924,9,bisphenol A|bisphenol S|Dietary Fats|Diethylhexyl Phthalate|Folic Acid|Lead|mono-(2-ethylhexyl)phthalate|Streptozocin|Vehicle Emissions,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,Diabetes Mellitus,MESH:D003920,21,"2,2',4,4'-tetrabromodiphenyl ether|2-naphthol|Air Pollutants|Allergens|Arsenic|Arsenicals|Atrazine|bisphenol A|Cadmium|DDT|Dichlorodiphenyl Dichloroethylene|Dieldrin|Heptachlor|Insecticides|Lead|Nitrogen Dioxide|Nitrogen Oxides|Ozone|Particulate Matter|Pesticides|Tobacco Smoke Pollution",0,
DNA methylation on cytosine within a CG sequence,GO:0010424,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Diethylhexyl Phthalate|Dronabinol|Nicotine|sodium arsenite,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Warfarin,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,"Diabetes Mellitus, Type 2",MESH:D003924,24,Air Pollutants|Arsenic|Ascorbic Acid|Atrazine|bisphenol A|bisphenol S|Cadmium|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|Folic Acid|Lead|Malathion|mono(2-ethyl-5-hydroxyhexyl) phthalate|mono-(2-ethylhexyl)phthalate|Nickel|Nicotine|Particulate Matter|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pesticides|Phthalic Acids|Vehicle Emissions,0,
DNA methylation or demethylation,GO:0044728,Diabetes Mellitus,MESH:D003920,1,Lead,0,
DNA methylation or demethylation,GO:0044728,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lead,0,
DNA modification,GO:0006304,Diabetes Mellitus,MESH:D003920,26,"Air Pollutants|Arsenic|arsenite|Aspirin|bisphenol A|Cadmium|Chlordan|Chlorpyrifos|Copper|Cyclosporine|DDT|Dichlorodiphenyl Dichloroethylene|Docosahexaenoic Acids|Iron|o,p'-DDT|Particulate Matter|Pesticides|Plant Extracts|Polychlorinated Biphenyls|Reactive Oxygen Species|Resveratrol|Selenium|Streptozocin|Telmisartan|Tobacco Smoke Pollution|Zinc",0,
DNA modification,GO:0006304,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
DNA modification,GO:0006304,"Diabetes Mellitus, Experimental",MESH:D003921,15,"astaxanthine|bisphenol A|Dietary Fats|Fructose|Glucose|Hydrogen Peroxide|Monocrotophos|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Streptozocin|tangeretin|Telmisartan",0,
DNA modification,GO:0006304,"Diabetes Mellitus, Type 1",MESH:D003922,9,bisphenol A|Calcitriol|Genistein|Iron|Lipopolysaccharides|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin,0,
DNA modification,GO:0006304,"Diabetes Mellitus, Type 2",MESH:D003924,30,Air Pollutants|alpha-Tocopherol|Arsenic|Ascorbic Acid|astaxanthine|bisphenol A|Cadmium|Copper|Curcumin|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylnitrosamine|epigallocatechin gallate|Folic Acid|Fructose|Genistein|Glucose|Iron|Malathion|Particulate Matter|Pesticides|Plant Extracts|Polychlorinated Biphenyls|Reactive Oxygen Species|Resveratrol|S-Adenosylmethionine|Streptozocin|Telmisartan|Vehicle Emissions|Zinc,0,
DNA protection,GO:0042262,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
DNA repair,GO:0006281,Diabetes Mellitus,MESH:D003920,6,Arsenic|Cadmium|Lead|Particulate Matter|Pesticides|Resveratrol,0,
DNA repair,GO:0006281,"Diabetes Mellitus, Experimental",MESH:D003921,2,Resveratrol|sodium arsenite,1,AGT
DNA repair,GO:0006281,"Diabetes Mellitus, Type 1",MESH:D003922,2,Resveratrol|sodium arsenite,1,CLEC16A
DNA repair,GO:0006281,"Diabetes Mellitus, Type 2",MESH:D003924,7,Arsenic|Cadmium|Lead|Particulate Matter|Pesticides|Resveratrol|Vehicle Emissions,2,EPC2|OGG1
DNA repair-dependent chromatin remodeling,GO:0140861,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
DNA repair-dependent chromatin remodeling,GO:0140861,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
DNA repair-dependent chromatin remodeling,GO:0140861,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
DNA replication,GO:0006260,Diabetes Mellitus,MESH:D003920,5,Arsenic|bisphenol A|Cyclosporine|Dieldrin|Raloxifene Hydrochloride,0,
DNA replication,GO:0006260,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Diethylhexyl Phthalate|Hydrogen Peroxide|sodium arsenite,1,GCK
DNA replication,GO:0006260,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
DNA replication,GO:0006260,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Warfarin,0,
DNA replication,GO:0006260,"Diabetes Mellitus, Type 2",MESH:D003924,3,Arsenic|bisphenol A|Diethylhexyl Phthalate,1,GCK
DNA synthesis involved in DNA repair,GO:0000731,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
DNA synthesis involved in DNA repair,GO:0000731,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,1,SIRT1
DNA synthesis involved in DNA repair,GO:0000731,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
DNA synthesis involved in DNA repair,GO:0000731,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
DNA synthesis involved in DNA replication,GO:0090592,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dibutyl Phthalate|Dietary Fats,0,
DNA synthesis involved in DNA replication,GO:0090592,"Diabetes Mellitus, Type 2",MESH:D003924,4,Benzoic Acid|Dibutyl Phthalate|Dietary Fats|perfluorooctanoic acid,0,
DNA-templated transcription,GO:0006351,Diabetes Mellitus,MESH:D003920,0,,1,NR1I2
DNA-templated transcription,GO:0006351,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ESRRA|PDX1|RELA
DNA-templated transcription,GO:0006351,"Diabetes Mellitus, Type 2",MESH:D003924,1,mono-(2-ethylhexyl)phthalate,1,PDX1
DNA transport,GO:0051027,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
DNA transport,GO:0051027,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
DNA transport,GO:0051027,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
DNA transport,GO:0051027,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
dolichol biosynthetic process,GO:0019408,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NUS1
dolichyl diphosphate biosynthetic process,GO:0006489,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NUS1
dopamine biosynthetic process,GO:0042416,Diabetes Mellitus,MESH:D003920,9,"2,4,5,2',4',5'-hexachlorobiphenyl|Atrazine|bisphenol A|Copper|Metformin|Plant Extracts|Resveratrol|Streptozocin|Sulpiride",0,
dopamine biosynthetic process,GO:0042416,"Diabetes Mellitus, Experimental",MESH:D003921,12,bisphenol A|Dietary Fats|Glucose|Metformin|Monocrotophos|Nicotine|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Streptozocin|Vitamin E,0,
dopamine biosynthetic process,GO:0042416,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Calcitriol|Resveratrol|sodium arsenite|Streptozocin,0,
dopamine biosynthetic process,GO:0042416,"Diabetes Mellitus, Type 2",MESH:D003924,14,Atrazine|bisphenol A|Canagliflozin|Copper|Curcumin|Dietary Fats|Glucose|Lactic Acid|Metformin|Nicotine|Plant Extracts|Resveratrol|Streptozocin|Topiramate,0,
dopamine biosynthetic process from tyrosine,GO:0006585,"Diabetes Mellitus, Experimental",MESH:D003921,1,Taurine,0,
dopamine biosynthetic process from tyrosine,GO:0006585,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
dopamine catabolic process,GO:0042420,Diabetes Mellitus,MESH:D003920,2,"2,4,5,2',4',5'-hexachlorobiphenyl|Sulpiride",0,
dopamine catabolic process,GO:0042420,"Diabetes Mellitus, Type 2",MESH:D003924,1,Curcumin,0,
dopamine metabolic process,GO:0042417,Diabetes Mellitus,MESH:D003920,10,Air Pollutants|bisphenol A|Chlorpyrifos|Niacin|Parathion|Particulate Matter|Plant Extracts|Resveratrol|Streptozocin|Zinc,0,
dopamine metabolic process,GO:0042417,"Diabetes Mellitus, Experimental",MESH:D003921,9,bisphenol A|ginsenoside Re|Manganese|Nicotine|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Streptozocin,0,
dopamine metabolic process,GO:0042417,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Resveratrol|sodium arsenite|Streptozocin,0,
dopamine metabolic process,GO:0042417,"Diabetes Mellitus, Type 2",MESH:D003924,14,Air Pollutants|bisphenol A|bisphenol S|Curcumin|Ethanol|ginsenoside Re|Manganese|Nicotine|Particulate Matter|Plant Extracts|Resveratrol|Streptozocin|titanium dioxide|Zinc,0,
dopaminergic neuron differentiation,GO:0071542,Diabetes Mellitus,MESH:D003920,5,Air Pollutants|bisphenol A|Copper|Particulate Matter|Tobacco Smoke Pollution,1,RAC1
dopaminergic neuron differentiation,GO:0071542,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,1,VEGFA
dopaminergic neuron differentiation,GO:0071542,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
dopaminergic neuron differentiation,GO:0071542,"Diabetes Mellitus, Type 2",MESH:D003924,7,Air Pollutants|alpha-Tocopherol|Ascorbic Acid|bisphenol A|Copper|Particulate Matter|perfluorooctane sulfonic acid,0,
dopamine secretion,GO:0014046,Diabetes Mellitus,MESH:D003920,2,"2,4,5,2',4',5'-hexachlorobiphenyl|Iron",0,
dopamine secretion,GO:0014046,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
dopamine secretion,GO:0014046,"Diabetes Mellitus, Type 1",MESH:D003922,1,Iron,0,
dopamine secretion,GO:0014046,"Diabetes Mellitus, Type 2",MESH:D003924,3,Glucose|Iron|perfluorooctane sulfonic acid,0,
"dopamine secretion, neurotransmission",GO:0061527,Diabetes Mellitus,MESH:D003920,2,Dieldrin|Potassium,0,
"dopamine secretion, neurotransmission",GO:0061527,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dronabinol|Manganese,0,
"dopamine secretion, neurotransmission",GO:0061527,"Diabetes Mellitus, Type 2",MESH:D003924,1,Manganese,0,
dopamine transport,GO:0015872,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
dopamine transport,GO:0015872,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
dopamine uptake,GO:0090494,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
dopamine uptake,GO:0090494,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
dopamine uptake,GO:0090494,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Lipopolysaccharides,0,
dopamine uptake,GO:0090494,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,SLC22A3
dorsal appendage formation,GO:0046843,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
dorsal appendage formation,GO:0046843,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
dorsal closure,GO:0007391,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
dorsal closure,GO:0007391,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
"dorsal closure, amnioserosa morphology change",GO:0046664,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
"dorsal closure, elongation of leading edge cells",GO:0007394,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
"dorsal closure, spreading of leading edge cells",GO:0007395,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
"dorsal closure, spreading of leading edge cells",GO:0007395,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
dorsal convergence,GO:0060030,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SMAD5
dorsal spinal cord development,GO:0021516,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
dorsal/ventral axis specification,GO:0009950,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
dorsal/ventral axis specification,GO:0009950,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAX6
dorsal/ventral pattern formation,GO:0009953,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CAV1|EDN1|IGF1|PAX6
dorsal/ventral pattern formation,GO:0009953,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
dorsal/ventral pattern formation,GO:0009953,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,EDN1|HHEX|PAX6|SMAD5
double-strand break repair,GO:0006302,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
double-strand break repair involved in meiotic recombination,GO:1990918,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
double-strand break repair involved in meiotic recombination,GO:1990918,"Diabetes Mellitus, Type 2",MESH:D003924,1,Atrazine,0,
double-strand break repair via homologous recombination,GO:0000724,Diabetes Mellitus,MESH:D003920,1,terbufos,0,
D-ribose metabolic process,GO:0006014,"Diabetes Mellitus, Experimental",MESH:D003921,1,Vitamin E,0,
D-ribose metabolic process,GO:0006014,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,0,
drinking behavior,GO:0042756,Diabetes Mellitus,MESH:D003920,13,Arsenic|arsenite|bisphenol A|Cadmium|Gliclazide|Glyburide|Lead|Mercury|Plant Extracts|Selenium|Streptozocin|Sulfur Dioxide|Zinc,0,
drinking behavior,GO:0042756,"Diabetes Mellitus, Experimental",MESH:D003921,14,bisphenol A|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Dronabinol|Fructose|Gliclazide|Glyburide|Nicotine|Plant Extracts|sodium arsenite|Streptozocin|terutroban,2,AGT|REN
drinking behavior,GO:0042756,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Mercury|sodium arsenite|Streptozocin,0,
drinking behavior,GO:0042756,"Diabetes Mellitus, Type 2",MESH:D003924,20,Arsenic|bisphenol A|Cadmium|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Diethylnitrosamine|Ethanol|Fructose|Gliclazide|Glyburide|Lead|Mercury|Nickel|Nicotine|perfluorooctanoic acid|Plant Extracts|Streptozocin|Zinc,0,
D-serine biosynthetic process,GO:0070179,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
D-serine biosynthetic process,GO:0070179,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
D-serine transport,GO:0042942,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctane sulfonic acid,0,
D-xylose metabolic process,GO:0042732,"Diabetes Mellitus, Experimental",MESH:D003921,1,Vitamin E,0,
ear development,GO:0043583,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
ear development,GO:0043583,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Folic Acid,3,BCL2|BCL2L11|ECE1
eating behavior,GO:0042755,Diabetes Mellitus,MESH:D003920,7,Arsenic|Gliclazide|Metformin|Plant Extracts|repaglinide|Serotonin|Streptozocin,3,AOC3|CPT1A|LEPR
eating behavior,GO:0042755,"Diabetes Mellitus, Experimental",MESH:D003921,6,Dietary Fats|Gliclazide|Metformin|Nicotine|Plant Extracts|Streptozocin,7,ACE|ADRB3|AOC3|CPT1A|IAPP|LEP|LEPR
eating behavior,GO:0042755,"Diabetes Mellitus, Type 1",MESH:D003922,2,Dehydroepiandrosterone|Streptozocin,1,STAT3
eating behavior,GO:0042755,"Diabetes Mellitus, Type 2",MESH:D003924,11,Arsenic|bisphenol S|Dietary Fats|Diethylnitrosamine|Ethanol|Gliclazide|Metformin|Nickel|Nicotine|Plant Extracts|Streptozocin,6,CD36|CPT1A|IAPP|LEP|LEPR|TMEM18
ecdysone metabolic process,GO:0008205,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
ecdysone metabolic process,GO:0008205,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
ecdysone receptor-mediated signaling pathway,GO:0035076,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
eclosion,GO:0007562,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
eclosion,GO:0007562,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
ectodermal cell fate commitment,GO:0001712,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
ectodermal cell fate commitment,GO:0001712,"Diabetes Mellitus, Type 2",MESH:D003924,1,Atrazine,0,
ectopic germ cell programmed cell death,GO:0035234,Diabetes Mellitus,MESH:D003920,0,,1,SOD1
ectopic germ cell programmed cell death,GO:0035234,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,BAX|BCL2L1|IL1B|SOD1
ectopic germ cell programmed cell death,GO:0035234,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,BAX|BCL2L1|SOD1
eggshell formation,GO:0030703,Diabetes Mellitus,MESH:D003920,5,"Arsenic|Cadmium|o,p'-DDT|Selenium|Sodium Selenite",0,
eggshell formation,GO:0030703,"Diabetes Mellitus, Experimental",MESH:D003921,1,Sodium Selenite,0,
eggshell formation,GO:0030703,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Cadmium,0,
eiF2alpha phosphorylation in response to endoplasmic reticulum stress,GO:0036492,"Diabetes Mellitus, Experimental",MESH:D003921,1,platycodin D,0,
elastic fiber assembly,GO:0048251,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
elastin metabolic process,GO:0051541,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,LEP
elastin metabolic process,GO:0051541,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LEP
electron transport chain,GO:0022900,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Particulate Matter,0,
electron transport chain,GO:0022900,"Diabetes Mellitus, Experimental",MESH:D003921,5,Capsaicin|Dietary Fats|Nitric Oxide|resiniferatoxin|sodium arsenite,1,COX2
electron transport chain,GO:0022900,"Diabetes Mellitus, Type 1",MESH:D003922,3,Nitric Oxide|sodium arsenite|Thioctic Acid,0,
electron transport chain,GO:0022900,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Particulate Matter,0,
embryo development,GO:0009790,Diabetes Mellitus,MESH:D003920,11,"2,2',4,4'-tetrabromodiphenyl ether|2-naphthol|Air Pollutants|bisphenol A|Cadmium|Chlorpyrifos|Cyclosporine|Particulate Matter|Pyruvaldehyde|Resveratrol|Rosiglitazone",0,
embryo development,GO:0009790,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
embryo development,GO:0009790,"Diabetes Mellitus, Experimental",MESH:D003921,10,astaxanthine|bisphenol A|Cyclophosphamide|Dibutyl Phthalate|Diethylhexyl Phthalate|Dronabinol|Glucose|Resveratrol|Rosiglitazone|sodium arsenite,2,SLC9A1|TP53
embryo development,GO:0009790,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Cyclophosphamide|Resveratrol|sodium arsenite,0,
embryo development,GO:0009790,"Diabetes Mellitus, Type 2",MESH:D003924,17,Air Pollutants|alpha-Tocopherol|astaxanthine|bisphenol A|bisphenol S|Cadmium|Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate|Ethanol|Folic Acid|Glucose|Particulate Matter|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|Resveratrol|Rosiglitazone,0,
embryo development ending in birth or egg hatching,GO:0009792,Diabetes Mellitus,MESH:D003920,3,Atrazine|bisphenol A|Copper,0,
embryo development ending in birth or egg hatching,GO:0009792,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Cholesterol|sodium arsenite,3,ACE|TP53|TRP53
embryo development ending in birth or egg hatching,GO:0009792,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
embryo development ending in birth or egg hatching,GO:0009792,"Diabetes Mellitus, Type 2",MESH:D003924,6,Atrazine|bisphenol A|Copper|Folic Acid|perfluorooctanoic acid|Silver,1,EGFR
embryo implantation,GO:0007566,Diabetes Mellitus,MESH:D003920,6,bisphenol A|Hexachlorobenzene|Polychlorinated Biphenyls|Pyruvaldehyde|Resveratrol|Tetrachlorodibenzodioxin,2,PTGS2|SOD1
embryo implantation,GO:0007566,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Quercetin|Resveratrol|sodium arsenite,5,IL1B|MMP2|MMP9|PTGS2|SOD1
embryo implantation,GO:0007566,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Genistein|Resveratrol|sodium arsenite|Tetrachlorodibenzodioxin,0,
embryo implantation,GO:0007566,"Diabetes Mellitus, Type 2",MESH:D003924,6,alpha-Tocopherol|bisphenol A|bisphenol S|Genistein|Polychlorinated Biphenyls|Resveratrol,2,MIRLET7D|SOD1
embryonic anterior midgut (ectodermal) morphogenesis,GO:0048615,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
embryonic body morphogenesis,GO:0010172,Diabetes Mellitus,MESH:D003920,3,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A|o,p'-DDT",0,
embryonic body morphogenesis,GO:0010172,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Diethylhexyl Phthalate|sodium arsenite,0,
embryonic body morphogenesis,GO:0010172,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
embryonic body morphogenesis,GO:0010172,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|bisphenol S|Diethylhexyl Phthalate|Ethanol|perfluorooctane sulfonic acid|perfluorooctanoic acid,0,
embryonic brain development,GO:1990403,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
embryonic brain development,GO:1990403,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
embryonic brain development,GO:1990403,"Diabetes Mellitus, Type 2",MESH:D003924,3,Air Pollutants|Diethylhexyl Phthalate|Particulate Matter,0,
embryonic camera-type eye morphogenesis,GO:0048596,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
embryonic camera-type eye morphogenesis,GO:0048596,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,PAX6
embryonic camera-type eye morphogenesis,GO:0048596,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Warfarin,0,
embryonic camera-type eye morphogenesis,GO:0048596,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,PAX6
embryonic cleavage,GO:0040016,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Resveratrol,0,
embryonic cleavage,GO:0040016,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
embryonic cleavage,GO:0040016,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Cyclophosphamide|Diethylhexyl Phthalate|Dronabinol|Resveratrol,0,
embryonic cleavage,GO:0040016,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Cyclophosphamide|Genistein|Lipopolysaccharides|Resveratrol,0,
embryonic cleavage,GO:0040016,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|bisphenol S|Diethylhexyl Phthalate|Genistein|mono-(2-ethylhexyl)phthalate|Resveratrol,1,KL
embryonic cranial skeleton morphogenesis,GO:0048701,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
embryonic cranial skeleton morphogenesis,GO:0048701,"Diabetes Mellitus, Type 1",MESH:D003922,1,Warfarin,0,
embryonic cranial skeleton morphogenesis,GO:0048701,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR140
embryonic digestive tract development,GO:0048566,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TNF
embryonic digestive tract development,GO:0048566,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
embryonic digestive tract development,GO:0048566,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNF
embryonic digestive tract morphogenesis,GO:0048557,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HNF1B|TCF7L2
embryonic digit morphogenesis,GO:0042733,Diabetes Mellitus,MESH:D003920,2,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A",0,
embryonic digit morphogenesis,GO:0042733,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
embryonic digit morphogenesis,GO:0042733,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
embryonic digit morphogenesis,GO:0042733,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,ECE1
embryonic forelimb morphogenesis,GO:0035115,Diabetes Mellitus,MESH:D003920,2,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A",0,
embryonic forelimb morphogenesis,GO:0035115,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
embryonic forelimb morphogenesis,GO:0035115,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
embryonic forelimb morphogenesis,GO:0035115,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
embryonic genitalia morphogenesis,GO:0030538,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TCF7L2
embryonic heart tube development,GO:0035050,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,EDN1|S1PR2
embryonic heart tube development,GO:0035050,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,ECE1|EDN1|EDNRA|HHEX
embryonic heart tube elongation,GO:0036306,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
embryonic heart tube elongation,GO:0036306,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
embryonic heart tube elongation,GO:0036306,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
embryonic heart tube elongation,GO:0036306,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
embryonic heart tube formation,GO:0003144,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP2
embryonic heart tube morphogenesis,GO:0003143,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR2
embryonic heart tube morphogenesis,GO:0003143,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SMAD5
embryonic hemopoiesis,GO:0035162,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
embryonic hemopoiesis,GO:0035162,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nitric Oxide,0,
embryonic hemopoiesis,GO:0035162,"Diabetes Mellitus, Type 1",MESH:D003922,1,Nitric Oxide,1,SH2B3
embryonic hemopoiesis,GO:0035162,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,1,HHEX
embryonic hindgut morphogenesis,GO:0048619,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TCF7L2
embryonic hindlimb morphogenesis,GO:0035116,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
embryonic hindlimb morphogenesis,GO:0035116,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate,0,
embryonic hindlimb morphogenesis,GO:0035116,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
embryonic hindlimb morphogenesis,GO:0035116,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate|Phthalic Acids,0,
embryonic limb morphogenesis,GO:0030326,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
embryonic limb morphogenesis,GO:0030326,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HNF1A
embryonic limb morphogenesis,GO:0030326,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HNF1A|NOTCH2
embryonic liver development,GO:1990402,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,2,INSR|TGFB1
embryonic liver development,GO:1990402,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
embryonic liver development,GO:1990402,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cysteine|perfluorooctanoic acid,0,
embryonic morphogenesis,GO:0048598,Diabetes Mellitus,MESH:D003920,3,puerarin|Raloxifene Hydrochloride|Resveratrol,0,
embryonic morphogenesis,GO:0048598,"Diabetes Mellitus, Experimental",MESH:D003921,3,Dronabinol|puerarin|Resveratrol,0,
embryonic morphogenesis,GO:0048598,"Diabetes Mellitus, Type 1",MESH:D003922,2,Genistein|Resveratrol,0,
embryonic morphogenesis,GO:0048598,"Diabetes Mellitus, Type 2",MESH:D003924,2,Genistein|Resveratrol,1,HNF1B
embryonic olfactory bulb interneuron precursor migration,GO:0021831,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
embryonic organ development,GO:0048568,Diabetes Mellitus,MESH:D003920,2,Rosiglitazone|Troglitazone,0,
embryonic organ development,GO:0048568,"Diabetes Mellitus, Experimental",MESH:D003921,2,Rosiglitazone|Troglitazone,2,TP53|TRP53
embryonic organ development,GO:0048568,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,1,DDIT3
embryonic organ development,GO:0048568,"Diabetes Mellitus, Type 2",MESH:D003924,3,Genistein|Rosiglitazone|Troglitazone,1,HHEX
embryonic organ morphogenesis,GO:0048562,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NEUROD1
embryonic organ morphogenesis,GO:0048562,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NEUROD1
embryonic pattern specification,GO:0009880,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,EGFR|RETN|SMAD5
embryonic placenta development,GO:0001892,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Cadmium|Particulate Matter,0,
embryonic placenta development,GO:0001892,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|tributyltin,0,
embryonic placenta development,GO:0001892,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
embryonic placenta development,GO:0001892,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Cadmium|Particulate Matter|perfluorooctanoic acid,2,EGFR|MIR127
embryonic placenta morphogenesis,GO:0060669,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
embryonic placenta morphogenesis,GO:0060669,"Diabetes Mellitus, Type 2",MESH:D003924,4,Particulate Matter|perfluorodecanoic acid|perfluorohexanesulfonic acid|Vehicle Emissions,0,
embryonic retina morphogenesis in camera-type eye,GO:0060059,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
embryonic skeletal system development,GO:0048706,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
embryonic skeletal system development,GO:0048706,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,1,ITPR3
embryonic skeletal system development,GO:0048706,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDNRA
embryonic skeletal system morphogenesis,GO:0048704,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
embryonic viscerocranium morphogenesis,GO:0048703,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,EDN1|S1PR2
embryonic viscerocranium morphogenesis,GO:0048703,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,ECE1|EDN1|MIR140
enamel mineralization,GO:0070166,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARA
enamel mineralization,GO:0070166,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARA
encapsulation of foreign target,GO:0035010,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
endocannabinoid signaling pathway,GO:0071926,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Docosahexaenoic Acids,0,
endocannabinoid signaling pathway,GO:0071926,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dronabinol|Hydrogen Peroxide,0,
endocannabinoid signaling pathway,GO:0071926,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
endocannabinoid signaling pathway,GO:0071926,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
endocardial cushion morphogenesis,GO:0003203,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NOS3
endocardial cushion morphogenesis,GO:0003203,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
endocardial cushion morphogenesis,GO:0003203,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOS3
endocardium formation,GO:0060214,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
endochondral bone morphogenesis,GO:0060350,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
endochondral ossification,GO:0001958,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
endochondral ossification,GO:0001958,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
endochondral ossification,GO:0001958,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
endochondral ossification,GO:0001958,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,3,CBS|ENPP1|INPPL1
endocrine pancreas development,GO:0031018,"Diabetes Mellitus, Experimental",MESH:D003921,0,,7,GCK|IL6|KCNJ11|NEUROD1|NKX6-1|PDX1|SREBF1
endocrine pancreas development,GO:0031018,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
endocrine pancreas development,GO:0031018,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
endocrine pancreas development,GO:0031018,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
endocrine pancreas development,GO:0031018,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,HNF1A|IL6|KCNJ11|PAX4
endocrine pancreas development,GO:0031018,"Diabetes Mellitus, Type 2",MESH:D003924,0,,19,ADAMTS9|C2CD4A|CDKAL1|GCK|GCKR|HNF1A|HNF1B|HNF4A|IL6|KCNJ11|NEUROD1|NKX6-1|NOTCH2|PAX4|PDX1|PEPD|SLC30A8|THADA|ZFAND3
endocrine signaling,GO:0038002,Diabetes Mellitus,MESH:D003920,1,Pesticides,0,
endocrine signaling,GO:0038002,"Diabetes Mellitus, Type 2",MESH:D003924,1,Pesticides,0,
endocytic recycling,GO:0032456,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,VPS26A
endocytosis,GO:0006897,Diabetes Mellitus,MESH:D003920,4,"2,4,5,2',4',5'-hexachlorobiphenyl|Plant Extracts|Prednisolone|Troglitazone",1,RAC1
endocytosis,GO:0006897,"Diabetes Mellitus, Experimental",MESH:D003921,2,Plant Extracts|Troglitazone,3,BCL2L1|CAV1|CAV3
endocytosis,GO:0006897,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
endocytosis,GO:0006897,"Diabetes Mellitus, Type 2",MESH:D003924,2,Plant Extracts|Troglitazone,4,BCL2L1|DGKD|INPPL1|PIK3CG
endodermal cell differentiation,GO:0035987,Diabetes Mellitus,MESH:D003920,0,,1,FN1
endodermal cell differentiation,GO:0035987,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,MMP2|MMP9
endodermal cell fate specification,GO:0001714,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF1B
endoderm development,GO:0007492,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,S1PR2|TGFB1
endoderm development,GO:0007492,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HHEX|HNF1B
endoderm formation,GO:0001706,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF1B
endonucleolytic cleavage involved in tRNA processing,GO:1905267,Diabetes Mellitus,MESH:D003920,1,arsenite,0,
endonucleolytic cleavage involved in tRNA processing,GO:1905267,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Hydrogen Peroxide,0,
endonucleolytic cleavage involved in tRNA processing,GO:1905267,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,0,
endoplasmic reticulum calcium ion homeostasis,GO:0032469,Diabetes Mellitus,MESH:D003920,3,"2,2',4,4'-tetrabromodiphenyl ether|Lead|Ozone",0,
endoplasmic reticulum calcium ion homeostasis,GO:0032469,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,ATP2A2|ATP2A3|BAX|BCL2
endoplasmic reticulum calcium ion homeostasis,GO:0032469,"Diabetes Mellitus, Type 2",MESH:D003924,2,Calcium|Lead,6,ATP2A2|ATP2A3|BAX|BCL2|KCNK16|WFS1
endoplasmic reticulum cisternal network maintenance,GO:0071785,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,0,
endoplasmic reticulum cisternal network maintenance,GO:0071785,"Diabetes Mellitus, Experimental",MESH:D003921,1,honokiol,0,
endoplasmic reticulum cisternal network maintenance,GO:0071785,"Diabetes Mellitus, Type 2",MESH:D003924,1,Curcumin,0,
endoplasmic reticulum organization,GO:0007029,Diabetes Mellitus,MESH:D003920,1,Lead,0,
endoplasmic reticulum organization,GO:0007029,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dibutyl Phthalate|honokiol|sodium arsenite|Taurine,1,PCX
endoplasmic reticulum organization,GO:0007029,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Taurine,0,
endoplasmic reticulum organization,GO:0007029,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dibutyl Phthalate|Ethanol|Lead,1,PCX
endoplasmic reticulum unfolded protein response,GO:0030968,"ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS",OMIM:616192,0,,1,DNAJC3
endoplasmic reticulum unfolded protein response,GO:0030968,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ATF3|FGF21|IFNG
endoplasmic reticulum unfolded protein response,GO:0030968,"Diabetes Mellitus, Type 1",MESH:D003922,0,,4,CASP12|DDIT3|FGF21|IFNG
endoplasmic reticulum unfolded protein response,GO:0030968,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,ATF3|FGF21|PTPN1|WFS1
endosomal lumen acidification,GO:0048388,Diabetes Mellitus,MESH:D003920,1,Iron,0,
endosomal lumen acidification,GO:0048388,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
endosomal lumen acidification,GO:0048388,"Diabetes Mellitus, Type 1",MESH:D003922,1,Iron,0,
endosomal lumen acidification,GO:0048388,"Diabetes Mellitus, Type 2",MESH:D003924,2,Iron|Manganese,0,
endosomal transport,GO:0016197,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SNAP25
endosomal transport,GO:0016197,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CLEC16A
endosomal transport,GO:0016197,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SNAP25
endosome to lysosome transport,GO:0008333,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CLEC16A
endothelial cell activation,GO:0042118,Diabetes Mellitus,MESH:D003920,1,Copper,0,
endothelial cell activation,GO:0042118,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
endothelial cell activation,GO:0042118,"Diabetes Mellitus, Type 2",MESH:D003924,1,Copper,0,
endothelial cell apoptotic process,GO:0072577,Diabetes Mellitus,MESH:D003920,0,,1,MAP3K5
endothelial cell apoptotic process,GO:0072577,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,FGF21|ID1|MAP3K5|TNF
endothelial cell apoptotic process,GO:0072577,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,FGF21|IL10|TNF
endothelial cell apoptotic process,GO:0072577,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,BRAF|FGF21|ID1|TNF
endothelial cell-cell adhesion,GO:0071603,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
endothelial cell-cell adhesion,GO:0071603,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
endothelial cell chemotaxis,GO:0035767,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
endothelial cell chemotaxis,GO:0035767,"Diabetes Mellitus, Experimental",MESH:D003921,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",1,VEGFA
endothelial cell chemotaxis to vascular endothelial growth factor,GO:0090668,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
endothelial cell development,GO:0001885,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GPX1
endothelial cell development,GO:0001885,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GPX1
endothelial cell-matrix adhesion,GO:0090673,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
endothelial cell-matrix adhesion,GO:0090673,"Diabetes Mellitus, Experimental",MESH:D003921,2,Resveratrol|sodium arsenite,0,
endothelial cell-matrix adhesion,GO:0090673,"Diabetes Mellitus, Type 1",MESH:D003922,2,Resveratrol|sodium arsenite,0,
endothelial cell-matrix adhesion,GO:0090673,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,1,ADAMTS9
endothelial cell migration,GO:0043542,Diabetes Mellitus,MESH:D003920,0,,1,FN1
endothelial cell migration,GO:0043542,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,NOS3|S100A6|VEGFA
endothelial cell migration,GO:0043542,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
endothelial cell migration,GO:0043542,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NOS3|S100A6
endothelial cell morphogenesis,GO:0001886,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,1,ID1
endothelial cell morphogenesis,GO:0001886,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,1,ID1
endothelial cell proliferation,GO:0001935,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CAV1|HMOX1|NOS2|VEGFA
endothelial cell proliferation,GO:0001935,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HMOX1|NOS2
endothelial microparticle formation,GO:0072565,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
endothelial microparticle formation,GO:0072565,"Diabetes Mellitus, Experimental",MESH:D003921,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
endothelial to hematopoietic transition,GO:0098508,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
endothelial tube formation,GO:0120331,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dibutyl Phthalate,0,
endothelial tube formation,GO:0120331,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dibutyl Phthalate,0,
endothelial tube lumen extension,GO:0097498,Diabetes Mellitus,MESH:D003920,1,Hexachlorobenzene,0,
endothelial tube lumen extension,GO:0097498,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
endothelial tube lumen extension involved in blood vessel lumen ensheathment,GO:1902355,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
endothelial tube lumen extension involved in blood vessel lumen ensheathment,GO:1902355,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Vehicle Emissions,0,
endothelial tube morphogenesis,GO:0061154,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
endothelial tube morphogenesis,GO:0061154,"Diabetes Mellitus, Experimental",MESH:D003921,2,Nicotine|Resveratrol,0,
endothelial tube morphogenesis,GO:0061154,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
endothelial tube morphogenesis,GO:0061154,"Diabetes Mellitus, Type 2",MESH:D003924,4,Curcumin|Glutathione|Nicotine|Resveratrol,0,
endothelin maturation,GO:0034959,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
endothelin maturation,GO:0034959,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,1,ECE1
endothelin receptor signaling pathway,GO:0086100,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
endothelin receptor signaling pathway,GO:0086100,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
endothelin receptor signaling pathway,GO:0086100,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,3,EDN1|EDNRA|EDNRB
endothelin receptor signaling pathway involved in heart process,GO:0086101,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
endothelin receptor signaling pathway involved in heart process,GO:0086101,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EDN1|EDNRA
energy derivation by oxidation of organic compounds,GO:0015980,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
energy derivation by oxidation of organic compounds,GO:0015980,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
energy derivation by oxidation of organic compounds,GO:0015980,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
energy derivation by oxidation of organic compounds,GO:0015980,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
energy homeostasis,GO:0097009,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|Ozone|Resveratrol,2,LEPR|SIRT1
energy homeostasis,GO:0097009,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dietary Fats|Hemin|Resveratrol|sodium arsenite,5,CPT1B|LEP|LEPR|PPARGC1A|SIRT1
energy homeostasis,GO:0097009,"Diabetes Mellitus, Type 1",MESH:D003922,4,decabromobiphenyl ether|Resveratrol|sodium arsenite|Thioctic Acid,1,STAT3
energy homeostasis,GO:0097009,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|Dietary Fats|Hemin|Resveratrol,11,CD36|IGF2BP2|LEP|LEPR|MIR377|MIR409|MIR485|MIR487B|PPARGC1A|SIRT1|TMEM18
energy reserve metabolic process,GO:0006112,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,1,LEPR
energy reserve metabolic process,GO:0006112,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ADRB3|LEP|LEPR
energy reserve metabolic process,GO:0006112,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,3,KL|LEP|LEPR
engulfment of apoptotic cell,GO:0043652,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
enkephalin processing,GO:0034230,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCSK2
enkephalin processing,GO:0034230,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PCSK2
enteric nervous system development,GO:0048484,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
enteric nervous system development,GO:0048484,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
enteric nervous system development,GO:0048484,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
enteric nervous system development,GO:0048484,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,2,EDNRA|EDNRB
enteric smooth muscle cell differentiation,GO:0035645,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDNRB
enteroendocrine cell differentiation,GO:0035883,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NEUROD1|PDX1
enteroendocrine cell differentiation,GO:0035883,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NEUROD1|PDX1
entrainment of circadian clock by photoperiod,GO:0043153,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
entry of bacterium into host cell,GO:0035635,"Diabetes Mellitus, Experimental",MESH:D003921,1,"Cholesterol, LDL",0,
entry of bacterium into host cell,GO:0035635,"Diabetes Mellitus, Type 2",MESH:D003924,1,"Cholesterol, LDL",0,
enucleate erythrocyte development,GO:0048822,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MAEA
enzyme-linked receptor protein signaling pathway,GO:0007167,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
eosinophil activation involved in immune response,GO:0002278,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
eosinophil activation involved in immune response,GO:0002278,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
eosinophil chemotaxis,GO:0048245,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CX3CL1
eosinophil differentiation,GO:0030222,Diabetes Mellitus,MESH:D003920,1,Lead,0,
eosinophil differentiation,GO:0030222,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lead,0,
eosinophil extravasation,GO:0072682,Diabetes Mellitus,MESH:D003920,5,Air Pollutants|bisphenol A|Ozone|Particulate Matter|Resveratrol,0,
eosinophil extravasation,GO:0072682,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Resveratrol,0,
eosinophil extravasation,GO:0072682,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Resveratrol,0,
eosinophil extravasation,GO:0072682,"Diabetes Mellitus, Type 2",MESH:D003924,5,Air Pollutants|bisphenol A|Particulate Matter|Resveratrol|Vehicle Emissions,0,
eosinophil homeostasis,GO:1990959,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|Atrazine|Particulate Matter,0,
eosinophil homeostasis,GO:1990959,"Diabetes Mellitus, Type 2",MESH:D003924,6,Air Pollutants|Atrazine|Bromine|Particulate Matter|perfluorooctanoic acid|Vehicle Emissions,0,
eosinophil migration,GO:0072677,Diabetes Mellitus,MESH:D003920,7,Air Pollutants|bisphenol A|Cadmium|lipoxin A4|Ozone|Particulate Matter|Sulfur Dioxide,0,
eosinophil migration,GO:0072677,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
eosinophil migration,GO:0072677,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Lipopolysaccharides,0,
eosinophil migration,GO:0072677,"Diabetes Mellitus, Type 2",MESH:D003924,5,Air Pollutants|bisphenol A|Cadmium|Particulate Matter|Vehicle Emissions,0,
ephrin receptor signaling pathway,GO:0048013,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,INSR|MMP2|MMP9
ephrin receptor signaling pathway,GO:0048013,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
ephrin receptor signaling pathway,GO:0048013,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
epidermal growth factor receptor signaling pathway,GO:0007173,Diabetes Mellitus,MESH:D003920,3,"2,4,5,2',4',5'-hexachlorobiphenyl|bisphenol A|Chlordan",0,
epidermal growth factor receptor signaling pathway,GO:0007173,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,INSR
epidermal growth factor receptor signaling pathway,GO:0007173,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
epidermal growth factor receptor signaling pathway,GO:0007173,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
epidermal growth factor receptor signaling pathway,GO:0007173,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,3,AKT1|BRAF|EGFR
epidermis development,GO:0008544,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,ATP2A2|INSR|PPARA|STS
epidermis development,GO:0008544,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
epidermis development,GO:0008544,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HLA-DRB1
epidermis development,GO:0008544,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,ATP2A2|EGFR|PPARA
epidermis morphogenesis,GO:0048730,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TP53
epididymis development,GO:1905867,Diabetes Mellitus,MESH:D003920,5,Arsenic|Dichlorodiphenyl Dichloroethylene|Flavonoids|Pesticides|Streptozocin,0,
epididymis development,GO:1905867,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dibutyl Phthalate|Diethylhexyl Phthalate|sodium arsenite|Streptozocin,0,
epididymis development,GO:1905867,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Streptozocin,0,
epididymis development,GO:1905867,"Diabetes Mellitus, Type 2",MESH:D003924,9,Arsenic|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|diethyl phthalate|Malathion|Pesticides|Phthalic Acids|Streptozocin,0,
epigenetic regulation of gene expression,GO:0040029,Diabetes Mellitus,MESH:D003920,5,Arsenic|bisphenol A|Cadmium|DDT|Dieldrin,1,A
epigenetic regulation of gene expression,GO:0040029,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Dietary Fats|Diethylhexyl Phthalate|sodium arsenite,1,GPX1
epigenetic regulation of gene expression,GO:0040029,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
epigenetic regulation of gene expression,GO:0040029,"Diabetes Mellitus, Type 2",MESH:D003924,10,Arsenic|bisphenol A|bisphenol S|Cadmium|Dietary Fats|Diethylhexyl Phthalate|mono-(2-ethylhexyl)phthalate|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid,3,A|GPX1|MIR127
epinephrine biosynthetic process,GO:0042418,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
epinephrine biosynthetic process,GO:0042418,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
epinephrine metabolic process,GO:0042414,Diabetes Mellitus,MESH:D003920,4,Air Pollutants|bisphenol A|Ozone|Particulate Matter,0,
epinephrine metabolic process,GO:0042414,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
epinephrine metabolic process,GO:0042414,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
epinephrine metabolic process,GO:0042414,"Diabetes Mellitus, Type 2",MESH:D003924,3,Air Pollutants|bisphenol A|Particulate Matter,0,
epinephrine transport,GO:0048241,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
epinephrine uptake,GO:0051625,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
epithelial cell apoptotic process,GO:1904019,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,BAX|BCL2|CASP3|HMOX1
epithelial cell apoptotic process,GO:1904019,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,BAX|BCL2|CASP3|HMOX1
epithelial cell-cell adhesion,GO:0090136,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Resveratrol,0,
epithelial cell-cell adhesion,GO:0090136,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Resveratrol|sodium arsenite,0,
epithelial cell-cell adhesion,GO:0090136,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|sodium arsenite,0,
epithelial cell-cell adhesion,GO:0090136,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Curcumin|Resveratrol,0,
epithelial cell development,GO:0002064,"Diabetes Mellitus, Experimental",MESH:D003921,1,Sodium Glutamate,1,PAX6
epithelial cell development,GO:0002064,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAX6
epithelial cell differentiation,GO:0030855,Diabetes Mellitus,MESH:D003920,0,,2,CPT1A|PPARG
epithelial cell differentiation,GO:0030855,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CPT1A|PAX6|PPARG|VEGFA
epithelial cell differentiation,GO:0030855,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,CPT1A|PAX6|PPARG
epithelial cell fate commitment,GO:0072148,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
epithelial cell fate commitment,GO:0072148,"Diabetes Mellitus, Experimental",MESH:D003921,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
epithelial cell maturation,GO:0002070,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
epithelial cell migration,GO:0010631,Diabetes Mellitus,MESH:D003920,1,Ozone,1,IRS1
epithelial cell migration,GO:0010631,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,2,IRS1|IRS2
epithelial cell migration,GO:0010631,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
epithelial cell migration,GO:0010631,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,IRS1|IRS2|PROX1
epithelial cell morphogenesis,GO:0003382,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
epithelial cell morphogenesis,GO:0003382,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR205
epithelial cell proliferation,GO:0050673,Diabetes Mellitus,MESH:D003920,1,bisphenol A,2,NCF1|PPARG
epithelial cell proliferation,GO:0050673,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,7,BAX|BCL2L1|NCF1|PDX1|PPARG|TGFB1|VEGFA
epithelial cell proliferation,GO:0050673,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
epithelial cell proliferation,GO:0050673,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,7,BAX|BCL2L1|EGFR|HNF1B|PDX1|PPARG|TCF7L2
epithelial cell proliferation involved in lung morphogenesis,GO:0060502,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
epithelial cell proliferation involved in Malpighian tubule morphogenesis,GO:0061331,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
epithelial cell proliferation involved in mammary gland duct elongation,GO:0060750,"Diabetes Mellitus, Type 1",MESH:D003922,1,decabromobiphenyl ether,0,
epithelial cell proliferation involved in salivary gland morphogenesis,GO:0060664,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IL6|TNF
epithelial cell proliferation involved in salivary gland morphogenesis,GO:0060664,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IL6|TNF
epithelial cell proliferation involved in salivary gland morphogenesis,GO:0060664,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,IL6|TNF
epithelial cilium movement involved in extracellular fluid movement,GO:0003351,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,0,
epithelial fluid transport,GO:0042045,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
epithelial fluid transport,GO:0042045,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
epithelial fluid transport,GO:0042045,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,2,EDN1|EDNRB
epithelial structure maintenance,GO:0010669,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Chlorpyrifos|Tobacco Smoke Pollution,0,
epithelial structure maintenance,GO:0010669,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Glucose|sodium arsenite,0,
epithelial structure maintenance,GO:0010669,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
epithelial structure maintenance,GO:0010669,"Diabetes Mellitus, Type 2",MESH:D003924,5,alpha-Tocopherol|bisphenol A|epigallocatechin gallate|Glucose|Vehicle Emissions,1,MIR204
epithelial to mesenchymal transition,GO:0001837,Diabetes Mellitus,MESH:D003920,8,Air Pollutants|Arsenic|arsenite|bisphenol A|Ozone|Particulate Matter|Resveratrol|Tetrachlorodibenzodioxin,0,
epithelial to mesenchymal transition,GO:0001837,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Dibutyl Phthalate|Glucose|Losartan|Resveratrol|sodium arsenite,2,IGF1|TGFB1
epithelial to mesenchymal transition,GO:0001837,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Lipopolysaccharides|Resveratrol|sodium arsenite|Tetrachlorodibenzodioxin,2,IGF1|STAT3
epithelial to mesenchymal transition,GO:0001837,"Diabetes Mellitus, Type 2",MESH:D003924,8,Air Pollutants|Arsenic|bisphenol A|Dibutyl Phthalate|Glucose|Nickel|Particulate Matter|Resveratrol,0,
epithelial tube formation,GO:0072175,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
epithelium development,GO:0060429,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,MMP9|RELA|TP53
epithelium development,GO:0060429,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,HNF1B|NFKB1|TCF7L2
epoxide metabolic process,GO:0097176,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
epoxide metabolic process,GO:0097176,"Diabetes Mellitus, Experimental",MESH:D003921,1,Streptozocin,0,
epoxide metabolic process,GO:0097176,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
epoxide metabolic process,GO:0097176,"Diabetes Mellitus, Type 2",MESH:D003924,1,Streptozocin,0,
epoxygenase P450 pathway,GO:0019373,Diabetes Mellitus,MESH:D003920,1,Cyclosporine,0,
epoxygenase P450 pathway,GO:0019373,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP1A1|CYP4A10
epoxygenase P450 pathway,GO:0019373,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP1A2
ERAD pathway,GO:0036503,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,WFS1
ERBB2-EGFR signaling pathway,GO:0038134,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
ERBB2 signaling pathway,GO:0038128,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
ERBB2 signaling pathway,GO:0038128,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
ERBB signaling pathway,GO:0038127,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
ERK1 and ERK2 cascade,GO:0070371,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Plant Extracts|Reactive Oxygen Species|Resveratrol,0,
ERK1 and ERK2 cascade,GO:0070371,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|ginsenoside Re|mangiferin|Plant Extracts|Resveratrol|Sertraline,2,AGT|EDN1
ERK1 and ERK2 cascade,GO:0070371,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Reactive Oxygen Species|Resveratrol,1,CTSH
ERK1 and ERK2 cascade,GO:0070371,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|ginsenoside Re|mangiferin|Plant Extracts|Reactive Oxygen Species|Resveratrol,3,BRAF|EDN1|INPPL1
ER-nucleus signaling pathway,GO:0006984,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ATP2A2
ER-nucleus signaling pathway,GO:0006984,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ATP2A2
ER overload response,GO:0006983,Diabetes Mellitus,MESH:D003920,0,,1,INS2
ER overload response,GO:0006983,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,2,TP53|TRP53
ER overload response,GO:0006983,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,2,DDIT3|INS2
ER overload response,GO:0006983,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,1,WFS1
ER to Golgi ceramide transport,GO:0035621,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
erythrocyte aggregation,GO:0034117,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
erythrocyte aggregation,GO:0034117,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,0,
erythrocyte development,GO:0048821,Diabetes Mellitus,MESH:D003920,4,Lead|Niacin|Pesticides|Troglitazone,0,
erythrocyte development,GO:0048821,"Diabetes Mellitus, Experimental",MESH:D003921,2,Fenretinide|Troglitazone,1,TP53
erythrocyte development,GO:0048821,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SH2B3
erythrocyte development,GO:0048821,"Diabetes Mellitus, Type 2",MESH:D003924,3,Lead|Pesticides|Troglitazone,1,MAEA
erythrocyte differentiation,GO:0030218,Diabetes Mellitus,MESH:D003920,4,"2,4,5,2',4',5'-hexachlorobiphenyl|Arsenic|Chlorodiphenyl (54% Chlorine)|Troglitazone",0,
erythrocyte differentiation,GO:0030218,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
erythrocyte differentiation,GO:0030218,"Diabetes Mellitus, Experimental",MESH:D003921,6,Cyclophosphamide|Fenretinide|Hemin|Quercetin|sodium arsenite|Troglitazone,2,CASP3|FGF21
erythrocyte differentiation,GO:0030218,"Diabetes Mellitus, Type 1",MESH:D003922,2,Cyclophosphamide|sodium arsenite,1,FGF21
erythrocyte differentiation,GO:0030218,"Diabetes Mellitus, Type 2",MESH:D003924,4,Arsenic|Folic Acid|Hemin|Troglitazone,6,CASP3|FGF21|HMGA1|KCNQ1|MIR144|SMAD5
erythrocyte enucleation,GO:0043131,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
erythrocyte homeostasis,GO:0034101,Diabetes Mellitus,MESH:D003920,6,bisphenol A|Cadmium|Chlorpyrifos|Iron|Lead|Zinc,0,
erythrocyte homeostasis,GO:0034101,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
erythrocyte homeostasis,GO:0034101,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Cyclophosphamide|Monocrotophos|Quercetin|sodium arsenite|thymoquinone,1,HMOX1
erythrocyte homeostasis,GO:0034101,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Cyclophosphamide|decabromobiphenyl ether|Iron|sodium arsenite,0,
erythrocyte homeostasis,GO:0034101,"Diabetes Mellitus, Type 2",MESH:D003924,8,bisphenol A|Cadmium|Calcium|Iron|Lead|Malathion|titanium dioxide|Zinc,1,HMOX1
erythrocyte maturation,GO:0043249,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Resveratrol,0,
erythrocyte maturation,GO:0043249,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,1,TP53
erythrocyte maturation,GO:0043249,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
erythrocyte maturation,GO:0043249,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,1,MAEA
erythrophore differentiation,GO:0048773,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SOD2
erythrophore differentiation,GO:0048773,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SOD2
establishment of blood-brain barrier,GO:0060856,"Diabetes Mellitus, Experimental",MESH:D003921,1,Clioquinol,0,
establishment of blood-nerve barrier,GO:0008065,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
establishment of blood-nerve barrier,GO:0008065,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,1,AGT
establishment of blood-nerve barrier,GO:0008065,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
establishment of blood-nerve barrier,GO:0008065,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
establishment of cell polarity,GO:0030010,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Particulate Matter|Pravastatin,0,
establishment of cell polarity,GO:0030010,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Diethylhexyl Phthalate,0,
establishment of cell polarity,GO:0030010,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Lipopolysaccharides,1,STAT3
establishment of cell polarity,GO:0030010,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Diethylhexyl Phthalate|Diethylnitrosamine|Particulate Matter|Vehicle Emissions,0,
establishment of endothelial barrier,GO:0061028,Diabetes Mellitus,MESH:D003920,5,"2,4,5,2',4',5'-hexachlorobiphenyl|bisphenol A|Blood Glucose|Dichlorodiphenyl Dichloroethylene|Hexachlorobenzene",0,
establishment of endothelial barrier,GO:0061028,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Blood Glucose|Glucose,1,ICAM1
establishment of endothelial barrier,GO:0061028,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
establishment of endothelial barrier,GO:0061028,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|Blood Glucose|Dichlorodiphenyl Dichloroethylene|Glucose|perfluorooctane sulfonic acid|perfluorooctanoic acid,3,EDNRA|EDNRB|ICAM1
establishment of endothelial intestinal barrier,GO:0090557,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Particulate Matter,0,
establishment of endothelial intestinal barrier,GO:0090557,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,ICAM1
establishment of endothelial intestinal barrier,GO:0090557,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|decabromobiphenyl ether|Lipopolysaccharides,0,
establishment of endothelial intestinal barrier,GO:0090557,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Lactic Acid|Particulate Matter,1,ICAM1
establishment of epithelial cell apical/basal polarity,GO:0045198,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
establishment of localization in cell,GO:0051649,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,BAX|BCL2|CAV1|CAV3|CYBA|NOS3|PRKCE|SNAP25
establishment of localization in cell,GO:0051649,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,NOS1|NOS3|SLC11A1
establishment of localization in cell,GO:0051649,"Diabetes Mellitus, Type 2",MESH:D003924,0,,9,BAX|BCL2|CYBA|ENPP1|GP2|KCNU1|NOS3|SLC22A3|SNAP25
establishment of meiotic spindle localization,GO:0051295,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
establishment of meiotic spindle localization,GO:0051295,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
establishment of meiotic spindle localization,GO:0051295,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Resveratrol,0,
establishment of meiotic spindle localization,GO:0051295,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
establishment of mitochondrion localization,GO:0051654,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,0,
establishment of mitotic spindle orientation,GO:0000132,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
establishment of mitotic spindle orientation,GO:0000132,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,INPPL1|PAX6
establishment of organelle localization,GO:0051656,"Diabetes Mellitus, Type 2",MESH:D003924,1,Malathion,0,
establishment of planar polarity,GO:0001736,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
establishment of protein localization,GO:0045184,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PRKCA
establishment of protein localization,GO:0045184,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS1
establishment of protein localization,GO:0045184,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PLEKHA1
establishment of protein localization to membrane,GO:0090150,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BRAF
establishment of protein localization to mitochondrial membrane,GO:0090151,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctane sulfonic acid,0,
establishment of protein localization to mitochondrion,GO:0072655,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,1,HK1
establishment of protein localization to mitochondrion,GO:0072655,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
establishment of protein localization to mitochondrion,GO:0072655,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|HK1
establishment of protein localization to organelle,GO:0072594,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CD68
establishment of protein localization to plasma membrane,GO:0061951,Diabetes Mellitus,MESH:D003920,6,Methylprednisolone|Pioglitazone|Prednisone|Resveratrol|Rosiglitazone|Thioridazine,0,
establishment of protein localization to plasma membrane,GO:0061951,"Diabetes Mellitus, Experimental",MESH:D003921,5,Pioglitazone|Quercetin|Resveratrol|Rosiglitazone|Ursolic Acid,0,
establishment of protein localization to plasma membrane,GO:0061951,"Diabetes Mellitus, Type 1",MESH:D003922,2,Genistein|Resveratrol,0,
establishment of protein localization to plasma membrane,GO:0061951,"Diabetes Mellitus, Type 2",MESH:D003924,4,Genistein|Pioglitazone|Resveratrol|Rosiglitazone,0,
establishment of Sertoli cell barrier,GO:0097368,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Streptozocin,0,
establishment of Sertoli cell barrier,GO:0097368,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dibutyl Phthalate|Streptozocin,1,ICAM1
establishment of Sertoli cell barrier,GO:0097368,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,0,
establishment of Sertoli cell barrier,GO:0097368,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Dibutyl Phthalate|mono-(2-ethylhexyl)phthalate|perfluorooctane sulfonic acid|Streptozocin,1,ICAM1
establishment of skin barrier,GO:0061436,Diabetes Mellitus,MESH:D003920,3,Resveratrol|Selenium|Tobacco Smoke Pollution,0,
establishment of skin barrier,GO:0061436,"Diabetes Mellitus, Experimental",MESH:D003921,2,Quercetin|Resveratrol,0,
establishment of skin barrier,GO:0061436,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
establishment of skin barrier,GO:0061436,"Diabetes Mellitus, Type 2",MESH:D003924,4,conduritol epoxide|epigallocatechin gallate|Ethanol|Resveratrol,0,
establishment of tissue polarity,GO:0007164,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF4A
establishment or maintenance of apical/basal cell polarity,GO:0035088,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
establishment or maintenance of cell polarity,GO:0007163,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
establishment or maintenance of epithelial cell apical/basal polarity,GO:0045197,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOTCH2
establishment or maintenance of transmembrane electrochemical gradient,GO:0010248,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
establishment or maintenance of transmembrane electrochemical gradient,GO:0010248,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
estradiol secretion,GO:0035938,Diabetes Mellitus,MESH:D003920,6,Aldrin|bisphenol A|DDT|Dieldrin|Tetrachlorodibenzodioxin|triphenyltin,0,
estradiol secretion,GO:0035938,"Diabetes Mellitus, Experimental",MESH:D003921,7,bisphenol A|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Dronabinol|sodium arsenite|tributyltin,0,
estradiol secretion,GO:0035938,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Genistein|Lipopolysaccharides|sodium arsenite|Tetrachlorodibenzodioxin,0,
estradiol secretion,GO:0035938,"Diabetes Mellitus, Type 2",MESH:D003924,10,bisphenol A|bisphenol S|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|diethyl phthalate|Genistein|mono-(2-ethylhexyl)phthalate|perfluorooctanoic acid|Phthalic Acids,0,
estrogen biosynthetic process,GO:0006703,Diabetes Mellitus,MESH:D003920,5,Atrazine|bisphenol A|Cadmium|Tetrachlorodibenzodioxin|Uranium,0,
estrogen biosynthetic process,GO:0006703,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Dietary Fats|Nicotine|sodium arsenite,0,
estrogen biosynthetic process,GO:0006703,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|decabromobiphenyl ether|Genistein|sodium arsenite|Tetrachlorodibenzodioxin,0,
estrogen biosynthetic process,GO:0006703,"Diabetes Mellitus, Type 2",MESH:D003924,10,Atrazine|bisphenol A|Cadmium|Dietary Fats|Genistein|Linagliptin|Nicotine|perfluorooctane sulfonic acid|Silver|titanium dioxide,0,
estrogen catabolic process,GO:0006711,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
estrogen catabolic process,GO:0006711,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,0,
estrogen catabolic process,GO:0006711,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
estrogen catabolic process,GO:0006711,"Diabetes Mellitus, Type 2",MESH:D003924,3,daidzein|Genistein|Plant Extracts,0,
estrogen metabolic process,GO:0008210,Diabetes Mellitus,MESH:D003920,10,"2,4,5,2',4',5'-hexachlorobiphenyl|Arsenic|Atrazine|bisphenol A|Chlorpyrifos|Copper|Plant Extracts|Resveratrol|Streptozocin|Tetrachlorodibenzodioxin",0,
estrogen metabolic process,GO:0008210,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
estrogen metabolic process,GO:0008210,"Diabetes Mellitus, Experimental",MESH:D003921,14,bisphenol A|Cyclophosphamide|Dibutyl Phthalate|Diethylhexyl Phthalate|Fructose|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Streptozocin|Taurine|tributyltin|triphenyltin chloride|Vitamin E,2,CYP1A1|CYP3A11
estrogen metabolic process,GO:0008210,"Diabetes Mellitus, Type 1",MESH:D003922,8,bisphenol A|Cyclophosphamide|Genistein|Resveratrol|sodium arsenite|Streptozocin|Taurine|Tetrachlorodibenzodioxin,0,
estrogen metabolic process,GO:0008210,"Diabetes Mellitus, Type 2",MESH:D003924,15,Arsenic|Atrazine|bisphenol A|bisphenol S|Copper|Curcumin|Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate|Fructose|Genistein|perfluorooctane sulfonic acid|Plant Extracts|Resveratrol|Streptozocin,3,CYP1A2|CYP3A2|PLEKHA1
estrogen secretion,GO:0035937,Diabetes Mellitus,MESH:D003920,5,Arsenic|bisphenol A|Chlorpyrifos|Copper|Plant Extracts,0,
estrogen secretion,GO:0035937,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Dibutyl Phthalate|Plant Extracts|Sodium Glutamate|tributyltin,0,
estrogen secretion,GO:0035937,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
estrogen secretion,GO:0035937,"Diabetes Mellitus, Type 2",MESH:D003924,8,Arsenic|Ascorbic Acid|bisphenol A|bisphenol S|Copper|Dibutyl Phthalate|Plant Extracts|titanium dioxide,0,
estrone secretion,GO:0035943,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,0,
estrone secretion,GO:0035943,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dibutyl Phthalate|Diethylhexyl Phthalate,0,
estrone secretion,GO:0035943,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
estrone secretion,GO:0035943,"Diabetes Mellitus, Type 2",MESH:D003924,4,Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate|perfluorooctanoic acid,0,
estrous cycle,GO:0044849,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Dichlorodiphenyl Dichloroethylene|Metformin|Raloxifene Hydrochloride|Tetrachlorodibenzodioxin,0,
estrous cycle,GO:0044849,"Diabetes Mellitus, Experimental",MESH:D003921,8,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate|Metformin|Niacinamide|Quercetin|sodium arsenite|tributyltin,0,
estrous cycle,GO:0044849,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Dehydroepiandrosterone|Niacinamide|sodium arsenite|Tetrachlorodibenzodioxin,0,
estrous cycle,GO:0044849,"Diabetes Mellitus, Type 2",MESH:D003924,9,bisphenol A|bisphenol S|Curcumin|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|diethyl phthalate|Metformin|Niacinamide,1,ETS1
estrous cycle phase,GO:0060206,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
estrous cycle phase,GO:0060206,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Dietary Fats|Diethylhexyl Phthalate|tributyltin,0,
estrous cycle phase,GO:0060206,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Genistein,0,
estrous cycle phase,GO:0060206,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Dietary Fats|Diethylhexyl Phthalate|Genistein,0,
estrus,GO:0060209,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Dichlorodiphenyl Dichloroethylene,0,
estrus,GO:0060209,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Dietary Fats,0,
estrus,GO:0060209,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|decabromobiphenyl ether|Genistein,0,
estrus,GO:0060209,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|daidzein|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Genistein,0,
ethanolamine metabolic process,GO:0006580,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
ethanolamine metabolic process,GO:0006580,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
ethanol metabolic process,GO:0006067,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
ether lipid biosynthetic process,GO:0008611,"Diabetes Mellitus, Type 2",MESH:D003924,1,mono-(2-ethylhexyl)phthalate,0,
ethylene metabolic process,GO:0009692,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
evoked excitatory postsynaptic potential,GO:0098817,Diabetes Mellitus,MESH:D003920,1,Serotonin,0,
evoked excitatory postsynaptic potential,GO:0098817,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
evoked excitatory postsynaptic potential,GO:0098817,"Diabetes Mellitus, Type 2",MESH:D003924,1,Calcium,0,
evoked neurotransmitter secretion,GO:0061670,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctane sulfonic acid,0,
excitatory postsynaptic potential,GO:0060079,Diabetes Mellitus,MESH:D003920,6,Cadmium|Magnesium|Potassium|Serotonin|Sulpiride|Tacrolimus,0,
excitatory postsynaptic potential,GO:0060079,"Diabetes Mellitus, Experimental",MESH:D003921,3,Capsaicin|Nicotine|Tacrolimus,1,S1PR2
excitatory postsynaptic potential,GO:0060079,"Diabetes Mellitus, Type 1",MESH:D003922,2,Norepinephrine|Tacrolimus,0,
excitatory postsynaptic potential,GO:0060079,"Diabetes Mellitus, Type 2",MESH:D003924,5,Cadmium|Calcium|Magnesium|Nicotine|Topiramate,1,AKT1
excretion,GO:0007588,Diabetes Mellitus,MESH:D003920,1,Metformin,0,
excretion,GO:0007588,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
excretion,GO:0007588,"Diabetes Mellitus, Experimental",MESH:D003921,5,"Aldosterone|Metformin|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Quercetin|sodium arsenite",0,
excretion,GO:0007588,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
excretion,GO:0007588,"Diabetes Mellitus, Type 2",MESH:D003924,2,Curcumin|Metformin,0,
execution phase of apoptosis,GO:0097194,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,AIFM1|BAX|CASP3
execution phase of apoptosis,GO:0097194,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,AIFM1
execution phase of apoptosis,GO:0097194,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,AKT1|BAX|CASP3|CASP8
exocrine pancreas development,GO:0031017,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,IGF1|INSR|PDX1
exocrine pancreas development,GO:0031017,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
exocrine pancreas development,GO:0031017,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
exocrine pancreas development,GO:0031017,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
exocrine pancreas development,GO:0031017,"Diabetes Mellitus, Type 2",MESH:D003924,1,mono-(2-ethylhexyl)phthalate,3,HHEX|PDX1|TCF7L2
exocytosis,GO:0006887,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
exocytosis,GO:0006887,"Diabetes Mellitus, Experimental",MESH:D003921,2,Quercetin|sodium arsenite,1,SNAP25
exocytosis,GO:0006887,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
exocytosis,GO:0006887,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,1,SNAP25
exosomal secretion,GO:1990182,Diabetes Mellitus,MESH:D003920,3,arsenite|Lead|Particulate Matter,0,
exosomal secretion,GO:1990182,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
exosomal secretion,GO:1990182,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
exosomal secretion,GO:1990182,"Diabetes Mellitus, Type 2",MESH:D003924,4,Lead|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid,0,
exploration behavior,GO:0035640,Diabetes Mellitus,MESH:D003920,17,Air Pollutants|Arsenic|arsenite|Atrazine|bisphenol A|Cadmium|Chlorpyrifos|Diazinon|Gallic Acid|Lead|Particulate Matter|Pioglitazone|repaglinide|Resveratrol|Streptozocin|Tacrolimus|Zinc,0,
exploration behavior,GO:0035640,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
exploration behavior,GO:0035640,"Diabetes Mellitus, Experimental",MESH:D003921,14,"bisphenol A|Diethylhexyl Phthalate|Dronabinol|Gallic Acid|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Pioglitazone|Quercetin|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|tributyltin|Vitamin E",0,
exploration behavior,GO:0035640,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|Vitamin A,0,
exploration behavior,GO:0035640,"Diabetes Mellitus, Type 2",MESH:D003924,17,Air Pollutants|Arsenic|Ascorbic Acid|Atrazine|bisphenol A|bisphenol S|Cadmium|Diethylhexyl Phthalate|Ethanol|Lead|Nicotine|Particulate Matter|Pioglitazone|Resveratrol|Streptozocin|Vehicle Emissions|Zinc,0,
export from cell,GO:0140352,Diabetes Mellitus,MESH:D003920,1,Potassium,0,
export from cell,GO:0140352,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
extracellular exosome assembly,GO:0071971,Diabetes Mellitus,MESH:D003920,1,Lead,0,
extracellular exosome assembly,GO:0071971,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lead,0,
extracellular matrix assembly,GO:0085029,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
extracellular matrix assembly,GO:0085029,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dietary Fats|Losartan|sodium arsenite|Streptozocin,1,TGFB1
extracellular matrix assembly,GO:0085029,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Streptozocin,0,
extracellular matrix assembly,GO:0085029,"Diabetes Mellitus, Type 2",MESH:D003924,3,Boron|Dietary Fats|Streptozocin,0,
extracellular matrix disassembly,GO:0022617,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,MMP2|MMP9
extracellular matrix organization,GO:0030198,Diabetes Mellitus,MESH:D003920,1,puerarin,1,FN1
extracellular matrix organization,GO:0030198,"Diabetes Mellitus, Experimental",MESH:D003921,2,puerarin|sodium arsenite,4,AGT|MMP2|MMP9|TNF
extracellular matrix organization,GO:0030198,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,1,TNF
extracellular matrix organization,GO:0030198,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ADAMTS9|TNF
extracellular structure organization,GO:0043062,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
extracellular vesicle biogenesis,GO:0140112,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
extracellular vesicle biogenesis,GO:0140112,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
extraembryonic membrane development,GO:1903867,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
extraembryonic membrane development,GO:1903867,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
extrinsic apoptotic signaling pathway,GO:0097191,"Diabetes Mellitus, Experimental",MESH:D003921,1,Sertraline,5,BAX|FAS|IFNG|TGFB1|TNF
extrinsic apoptotic signaling pathway,GO:0097191,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IFNG|TNF
extrinsic apoptotic signaling pathway,GO:0097191,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,BAX|CASP8|FAS|TNF|TNFRSF1B
extrinsic apoptotic signaling pathway in absence of ligand,GO:0097192,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,BAX|BCL2|BCL2L1|CX3CL1|FAS|FOXO3|IGF1|IL1B
extrinsic apoptotic signaling pathway in absence of ligand,GO:0097192,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
extrinsic apoptotic signaling pathway in absence of ligand,GO:0097192,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,BAX|BCL2|BCL2L1|BCL2L11|FAS
extrinsic apoptotic signaling pathway via death domain receptors,GO:0008625,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
extrinsic apoptotic signaling pathway via death domain receptors,GO:0008625,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,5,BAX|BCL2|FAS|TNF|TNFRSF1A
extrinsic apoptotic signaling pathway via death domain receptors,GO:0008625,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
extrinsic apoptotic signaling pathway via death domain receptors,GO:0008625,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,6,BAX|BCL2|CASP8|FAS|TNF|TNFRSF1A
eye-antennal disc morphogenesis,GO:0007455,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
eye blink reflex,GO:0060082,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
eye development,GO:0001654,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,1,PAX6
eye development,GO:0001654,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol S|Ethanol,2,EGFR|PAX6
eyelid development in camera-type eye,GO:0061029,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
eye morphogenesis,GO:0048592,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
eye morphogenesis,GO:0048592,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
eye morphogenesis,GO:0048592,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
eye morphogenesis,GO:0048592,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|perfluorooctanoic acid|perfluoroundecanoic acid,0,
eye photoreceptor cell development,GO:0042462,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PAX6|VEGFA
eye photoreceptor cell development,GO:0042462,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAX6
eye photoreceptor cell differentiation,GO:0001754,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PDX1
eye photoreceptor cell differentiation,GO:0001754,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
eye photoreceptor cell differentiation,GO:0001754,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PDX1
face development,GO:0060324,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
face development,GO:0060324,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,2,BRAF|EDNRA
face morphogenesis,GO:0060325,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,EDN1|MMP2|TGFB1
face morphogenesis,GO:0060325,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,EDN1|NOTCH2|PLEKHA1|TCF7L2
fasciculation of motor neuron axon,GO:0097156,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP2
Fas signaling pathway,GO:0036337,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,FAS
Fas signaling pathway,GO:0036337,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,FAS
fat cell differentiation,GO:0045444,Diabetes Mellitus,MESH:D003920,12,Arsenic|bisphenol A|Cadmium|Chlorpyrifos|DDT|Parathion|Pioglitazone|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Tetrachlorodibenzodioxin|Troglitazone,1,PPARG
fat cell differentiation,GO:0045444,"Diabetes Mellitus, Experimental",MESH:D003921,16,Benzamides|bisphenol A|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Glucose|Hydrogen Peroxide|Pioglitazone|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|tributyltin|Triglycerides|triphenyltin chloride|Troglitazone,4,GPX1|INSR|PPARG|SREBF1
fat cell differentiation,GO:0045444,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
fat cell differentiation,GO:0045444,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
fat cell differentiation,GO:0045444,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|decabromobiphenyl ether|Genistein|Reactive Oxygen Species|Resveratrol|sodium arsenite|Tetrachlorodibenzodioxin,0,
fat cell differentiation,GO:0045444,"Diabetes Mellitus, Type 2",MESH:D003924,25,Arsenic|Ascorbic Acid|bisphenol A|bisphenol S|Cadmium|daidzein|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|epigallocatechin gallate|Genistein|Glucose|Malathion|Pantothenic Acid|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Sitagliptin Phosphate|Triglycerides|Troglitazone,7,AKT2|ENPP1|GPX1|PPARG|RETN|TCF7L2|TMEM18
fat cell proliferation,GO:0070341,Diabetes Mellitus,MESH:D003920,5,Air Pollutants|bisphenol A|Cadmium|Methylprednisolone|Particulate Matter,0,
fat cell proliferation,GO:0070341,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
fat cell proliferation,GO:0070341,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Cyclophosphamide|Dietary Fats|Dietary Sucrose|Monocrotophos,0,
fat cell proliferation,GO:0070341,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Cyclophosphamide|Lipopolysaccharides,0,
fat cell proliferation,GO:0070341,"Diabetes Mellitus, Type 2",MESH:D003924,9,Air Pollutants|bisphenol A|Cadmium|Dietary Fats|mono-(2-ethylhexyl)phthalate|Particulate Matter|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid,0,
fat pad development,GO:0060613,Diabetes Mellitus,MESH:D003920,6,bisphenol A|Docosahexaenoic Acids|Metformin|Olanzapine|Resveratrol|Tetrachlorodibenzodioxin,0,
fat pad development,GO:0060613,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Dietary Fats|Metformin|Resveratrol|Sodium Glutamate|Taurine,0,
fat pad development,GO:0060613,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Resveratrol|Taurine|Tetrachlorodibenzodioxin,0,
fat pad development,GO:0060613,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|Dietary Fats|Ethanol|Metformin|perfluorohexanesulfonic acid|Resveratrol,1,ENPP1
fatty acid beta-oxidation,GO:0006635,Diabetes Mellitus,MESH:D003920,5,arsenite|bisphenol A|Olanzapine|Resveratrol|Streptozocin,2,ADIPOQ|CPT1A
fatty acid beta-oxidation,GO:0006635,"Diabetes Mellitus, Experimental",MESH:D003921,7,bisphenol A|Dietary Fats|Diethylhexyl Phthalate|Glucose|mangiferin|Resveratrol|Streptozocin,4,ACOX1|CPT1A|CPT1B|LEP
fatty acid beta-oxidation,GO:0006635,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|Streptozocin,0,
fatty acid beta-oxidation,GO:0006635,"Diabetes Mellitus, Type 2",MESH:D003924,8,bisphenol A|Dietary Fats|Diethylhexyl Phthalate|Glucose|mangiferin|mono-(2-ethylhexyl)phthalate|Resveratrol|Streptozocin,3,ADIPOQ|CPT1A|LEP
fatty acid beta-oxidation using acyl-CoA oxidase,GO:0033540,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,1,ACOX1
fatty acid beta-oxidation using acyl-CoA oxidase,GO:0033540,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|perfluorooctanoic acid,0,
fatty acid biosynthetic process,GO:0006633,Diabetes Mellitus,MESH:D003920,11,"2,2',4,4'-tetrabromodiphenyl ether|aroclor 1260|bisphenol A|Docosahexaenoic Acids|Glyburide|Ozone|Particulate Matter|Plant Extracts|Resveratrol|Streptozocin|Zinc",0,
fatty acid biosynthetic process,GO:0006633,"Diabetes Mellitus, Experimental",MESH:D003921,13,"bisphenol A|Coconut Oil|Dietary Fats|Diethylhexyl Phthalate|Fatty Acids, Nonesterified|Fructose|ginsenoside Re|Glyburide|mangiferin|Plant Extracts|Resveratrol|Streptozocin|Vitamin E",1,ACSL1
fatty acid biosynthetic process,GO:0006633,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
fatty acid biosynthetic process,GO:0006633,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Lipopolysaccharides|Resveratrol|Streptozocin,1,HNF1A
fatty acid biosynthetic process,GO:0006633,"Diabetes Mellitus, Type 2",MESH:D003924,17,"bisphenol A|bisphenol S|Dietary Fats|Diethylhexyl Phthalate|Ethanol|Fatty Acids, Nonesterified|Fructose|ginsenoside Re|Glyburide|mangiferin|Particulate Matter|perfluorooctane sulfonic acid|Plant Extracts|Resveratrol|Streptozocin|Vehicle Emissions|Zinc",2,HNF1A|LIPC
fatty acid catabolic process,GO:0009062,Diabetes Mellitus,MESH:D003920,2,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants",0,
fatty acid catabolic process,GO:0009062,"Diabetes Mellitus, Experimental",MESH:D003921,3,"Fatty Acids, Nonesterified|Glucose|Sodium Glutamate",2,ACOX1|LEP
fatty acid catabolic process,GO:0009062,"Diabetes Mellitus, Type 2",MESH:D003924,4,"Air Pollutants|Fatty Acids, Nonesterified|Glucose|Vehicle Emissions",2,LEP|USP48
fatty acid derivative biosynthetic process,GO:1901570,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
fatty acid derivative biosynthetic process,GO:1901570,"Diabetes Mellitus, Experimental",MESH:D003921,3,Dietary Fats|Diethylhexyl Phthalate|Resveratrol,1,ACOX1
fatty acid derivative biosynthetic process,GO:1901570,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
fatty acid derivative biosynthetic process,GO:1901570,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dietary Fats|Diethylhexyl Phthalate|Resveratrol,0,
fatty acid derivative catabolic process,GO:1901569,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Parathion,0,
fatty acid derivative metabolic process,GO:1901568,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Chlorpyrifos,0,
fatty acid derivative metabolic process,GO:1901568,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dietary Fats|Taurine,0,
fatty acid derivative metabolic process,GO:1901568,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Taurine,0,
fatty acid derivative metabolic process,GO:1901568,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Dietary Fats,0,
fatty acid elongation,GO:0030497,Diabetes Mellitus,MESH:D003920,1,"2,2',4,4'-tetrabromodiphenyl ether",0,
"fatty acid elongation, unsaturated fatty acid",GO:0019368,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
fatty acid homeostasis,GO:0055089,Diabetes Mellitus,MESH:D003920,9,Atrazine|bisphenol A|Cadmium|Dichlorvos|Docosahexaenoic Acids|Plant Extracts|Resveratrol|Streptozocin|Sulpiride,3,INS|INS2|SIRT1
fatty acid homeostasis,GO:0055089,"Diabetes Mellitus, Experimental",MESH:D003921,12,"bisphenol A|Coconut Oil|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Fatty Acids, Nonesterified|Hydrogen Peroxide|mangiferin|Plant Extracts|Resveratrol|sodium arsenite|Streptozocin",3,GPAM|INS1|SIRT1
fatty acid homeostasis,GO:0055089,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
fatty acid homeostasis,GO:0055089,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Dichlorvos|Resveratrol|sodium arsenite|Streptozocin,2,INS|INS2
fatty acid homeostasis,GO:0055089,"Diabetes Mellitus, Type 2",MESH:D003924,11,"Atrazine|bisphenol A|Cadmium|Dietary Fats|Diethylhexyl Phthalate|Fatty Acids, Nonesterified|mangiferin|perfluorooctane sulfonic acid|Plant Extracts|Resveratrol|Streptozocin",3,INS|INS1|SIRT1
fatty acid metabolic process,GO:0006631,Diabetes Mellitus,MESH:D003920,19,"Air Pollutants|Arachidonic Acids|aroclor 1260|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpyrifos|Dichlorodiphenyl Dichloroethylene|Docosahexaenoic Acids|docosapentaenoic acid|Fatty Acids, Omega-3|Metformin|Ozone|Particulate Matter|Polychlorinated Biphenyls|Resveratrol|Rosiglitazone|Streptozocin|Uranium",2,CPT1A|PPARG
fatty acid metabolic process,GO:0006631,"Diabetes Mellitus, Experimental",MESH:D003921,21,"bisphenol A|Coconut Oil|corilagin|Dietary Fats|Dietary Sucrose|Dietary Sugars|Fatty Acids, Nonesterified|Fatty Acids, Omega-3|Fructose|Lithocholic Acid|Manganese|Metformin|Monocrotophos|Palm Oil|Resveratrol|Rosiglitazone|sodium arsenite|Streptozocin|swietenine|Taurine|tianhuang",11,ACOT1|ACOX1|ACSL1|CPT1A|CPT1B|CYP1A1|CYP4A10|CYP4A14|GPAM|PPARA|PPARG
fatty acid metabolic process,GO:0006631,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|Palm Oil|Resveratrol|sodium arsenite|Streptozocin|Taurine|Thioctic Acid,0,
fatty acid metabolic process,GO:0006631,"Diabetes Mellitus, Type 2",MESH:D003924,20,"Air Pollutants|bisphenol A|bisphenol S|Cadmium|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Dietary Sugars|Ethanol|Fatty Acids, Nonesterified|Folic Acid|Fructose|Lithocholic Acid|Manganese|Metformin|Particulate Matter|perfluorooctanoic acid|Polychlorinated Biphenyls|Resveratrol|Rosiglitazone|Streptozocin",7,C3|CD36|CPT1A|ENPP1|LIPC|PPARA|PPARG
fatty acid oxidation,GO:0019395,Diabetes Mellitus,MESH:D003920,7,Aspirin|Bezafibrate|Docosahexaenoic Acids|Olanzapine|Resveratrol|Rosiglitazone|Troglitazone,3,ADIPOQ|CP|PPARG
fatty acid oxidation,GO:0019395,"Diabetes Mellitus, Experimental",MESH:D003921,7,Bezafibrate|Dietary Fats|Glucose|Resveratrol|Rosiglitazone|tesaglitazar|Troglitazone,3,ACOX1|PPARG|PPARGC1A
fatty acid oxidation,GO:0019395,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
fatty acid oxidation,GO:0019395,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,1,CP
fatty acid oxidation,GO:0019395,"Diabetes Mellitus, Type 2",MESH:D003924,8,Bezafibrate|Dietary Fats|Glucose|Nickel|Resveratrol|Rosiglitazone|Troglitazone|Vehicle Emissions,5,ADIPOQ|CD36|MIR214|PPARG|PPARGC1A
fatty acid primary amide biosynthetic process,GO:0062112,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAM
fatty acid transport,GO:0015908,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Cyclosporine|Niacin|Resveratrol|Rosiglitazone,0,
fatty acid transport,GO:0015908,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Diethylhexyl Phthalate|mangiferin|picolinic acid|Resveratrol|Rosiglitazone,1,ACSL1
fatty acid transport,GO:0015908,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
fatty acid transport,GO:0015908,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Resveratrol,1,HNF1A
fatty acid transport,GO:0015908,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|Diethylhexyl Phthalate|mangiferin|Pantothenic Acid|Resveratrol|Rosiglitazone,2,CD36|HNF1A
Fc-epsilon receptor signaling pathway,GO:0038095,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
Fc-epsilon receptor signaling pathway,GO:0038095,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
Fc-epsilon receptor signaling pathway,GO:0038095,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,1,PRKCQ
Fc-epsilon receptor signaling pathway,GO:0038095,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038096,Diabetes Mellitus,MESH:D003920,1,Iron,0,
Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038096,"Diabetes Mellitus, Experimental",MESH:D003921,2,Hydrogen Peroxide|Superoxides,4,IFNG|NOS2|PRKCD|PRKCE
Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038096,"Diabetes Mellitus, Type 1",MESH:D003922,2,Iron|Superoxides,1,IFNG
Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038096,"Diabetes Mellitus, Type 2",MESH:D003924,2,Iron|Superoxides,1,NOS2
fear-induced aggressive behavior,GO:0002122,"Diabetes Mellitus, Type 2",MESH:D003924,1,Curcumin,0,
fear response,GO:0042596,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
fear response,GO:0042596,"Diabetes Mellitus, Type 2",MESH:D003924,1,Folic Acid,0,
feeding behavior,GO:0007631,Diabetes Mellitus,MESH:D003920,16,aroclor 1260|Arsenic|arsenite|bisphenol A|Cadmium|Chlorpyrifos|Lead|Mercury|Ozone|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Sulfur Dioxide|Tobacco Smoke Pollution|Zinc,0,
feeding behavior,GO:0007631,"Diabetes Mellitus, Experimental",MESH:D003921,13,bisphenol A|Coconut Oil|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Fructose|Quercetin|Rosiglitazone|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|tributyltin,0,
feeding behavior,GO:0007631,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Mercury|sodium arsenite|Streptozocin|Thioctic Acid|Vitamin A,0,
feeding behavior,GO:0007631,"Diabetes Mellitus, Type 2",MESH:D003924,16,Arsenic|bisphenol A|bisphenol S|Cadmium|Curcumin|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Ethanol|Fructose|Lead|Mercury|Rosiglitazone|Streptozocin|Zinc,2,GCG|GLP1R
female germ-line cyst formation,GO:0048135,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
female germ-line cyst formation,GO:0048135,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dichlorodiphenyl Dichloroethylene,0,
female gonad development,GO:0008585,Diabetes Mellitus,MESH:D003920,3,Atrazine|bisphenol A|Tetrachlorodibenzodioxin,0,
female gonad development,GO:0008585,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Nicotine|sodium arsenite,1,SERPINE1
female gonad development,GO:0008585,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Tetrachlorodibenzodioxin,0,
female gonad development,GO:0008585,"Diabetes Mellitus, Type 2",MESH:D003924,4,Atrazine|bisphenol A|bisphenol S|Nicotine,1,PLEKHA1
female gonad morphogenesis,GO:0061040,Diabetes Mellitus,MESH:D003920,1,"o,p'-DDT",0,
female gonad morphogenesis,GO:0061040,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
female mating behavior,GO:0060180,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
female mating behavior,GO:0060180,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
female mating behavior,GO:0060180,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
female mating behavior,GO:0060180,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
female meiosis chromosome segregation,GO:0016321,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorodecanoic acid,0,
female meiosis I,GO:0007144,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
female meiosis I,GO:0007144,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
female meiosis II,GO:0007147,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
female meiosis II,GO:0007147,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
female meiotic chromosome movement towards spindle pole,GO:0016345,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
female pregnancy,GO:0007565,Diabetes Mellitus,MESH:D003920,6,Air Pollutants|bisphenol A|Dichlorodiphenyl Dichloroethylene|Nitrogen Oxides|Polychlorinated Biphenyls|Tetrachlorodibenzodioxin,2,CP|LEPR
female pregnancy,GO:0007565,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,11,ACE|AGT|BCL2|IGF1|LEP|LEPR|MMP2|NOS3|STS|TGFB1|VEGFA
female pregnancy,GO:0007565,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
female pregnancy,GO:0007565,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Tetrachlorodibenzodioxin,6,ABCC8|CP|HSD11B2|IGF1|NOS1|NOS3
female pregnancy,GO:0007565,"Diabetes Mellitus, Type 2",MESH:D003924,5,Air Pollutants|bisphenol A|bisphenol S|Dichlorodiphenyl Dichloroethylene|Polychlorinated Biphenyls,8,ABCC8|BCL2|ETS1|LEP|LEPR|NOS3|SFRP4|SLC2A1
female pronucleus assembly,GO:0035038,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorodecanoic acid,0,
ferroptosis,GO:0097707,Diabetes Mellitus,MESH:D003920,7,bisphenol A|Cadmium|Iron|Lead|Particulate Matter|Resveratrol|Selenium,0,
ferroptosis,GO:0097707,"Diabetes Mellitus, Experimental",MESH:D003921,10,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid|astaxanthine|bisphenol A|Glucose|Hydrogen Peroxide|Malondialdehyde|Quercetin|Resveratrol|sodium arsenite|Vitamin E",0,
ferroptosis,GO:0097707,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Iron|Resveratrol|sodium arsenite,0,
ferroptosis,GO:0097707,"Diabetes Mellitus, Type 2",MESH:D003924,11,astaxanthine|bisphenol A|Cadmium|Ethanol|Glucose|Glutathione|Iron|Lead|Malondialdehyde|Particulate Matter|Resveratrol,0,
fertilization,GO:0009566,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Chlorpyrifos|Copper|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution,0,
fertilization,GO:0009566,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
fertilization,GO:0009566,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Cyclophosphamide|Dibutyl Phthalate|Diethylhexyl Phthalate,2,BAX|BCL2L1
fertilization,GO:0009566,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Cyclophosphamide|Tetrachlorodibenzodioxin,0,
fertilization,GO:0009566,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|bisphenol S|Copper|Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate,3,BAX|BCL2L1|KCNU1
fetal process involved in parturition,GO:0060138,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
fetal process involved in parturition,GO:0060138,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
fetal process involved in parturition,GO:0060138,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
fetal process involved in parturition,GO:0060138,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
fever generation,GO:0001660,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IL1B
fibrinolysis,GO:0042730,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SERPINE1
fibroblast activation,GO:0072537,Diabetes Mellitus,MESH:D003920,1,Tungsten,0,
fibroblast activation,GO:0072537,"Diabetes Mellitus, Type 2",MESH:D003924,1,Folic Acid,0,
fibroblast apoptotic process,GO:0044346,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CASP3
fibroblast apoptotic process,GO:0044346,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CASP12
fibroblast apoptotic process,GO:0044346,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP3
fibroblast growth factor receptor signaling pathway,GO:0008543,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,FGF21|INSR
fibroblast growth factor receptor signaling pathway,GO:0008543,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
fibroblast growth factor receptor signaling pathway,GO:0008543,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,FGF21
fibroblast growth factor receptor signaling pathway,GO:0008543,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,EGFR|ENPP1|FGF21|KL|TCF7L2
fibroblast migration,GO:0010761,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Resveratrol,0,
fibroblast migration,GO:0010761,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Resveratrol,0,
fibroblast migration,GO:0010761,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Resveratrol,0,
fibroblast migration,GO:0010761,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Resveratrol,1,AKT1
fibroblast proliferation,GO:0048144,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,AGT|CAV1|GPX1|TP53|TRP53
fibroblast proliferation,GO:0048144,"Diabetes Mellitus, Type 1",MESH:D003922,1,Norepinephrine,0,
fibroblast proliferation,GO:0048144,"Diabetes Mellitus, Type 2",MESH:D003924,1,Curcumin,2,EDNRA|GPX1
filopodium assembly,GO:0046847,Diabetes Mellitus,MESH:D003920,1,Clozapine,0,
filopodium assembly,GO:0046847,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,1,S1PR2
filopodium assembly,GO:0046847,"Diabetes Mellitus, Type 2",MESH:D003924,3,Clozapine|Ethanol|Manganese,0,
fin morphogenesis,GO:0033334,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP9
fin regeneration,GO:0031101,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
fin regeneration,GO:0031101,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,IL1B|MMP9|SIRT1|TNFRSF1A
fin regeneration,GO:0031101,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,GRB14|MIR203A|SIRT1|TNFRSF1A
flagellated sperm motility,GO:0030317,Diabetes Mellitus,MESH:D003920,4,aroclor 1260|bisphenol A|Chlorpyrifos|Plant Extracts,0,
flagellated sperm motility,GO:0030317,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Dronabinol|Nitric Oxide|Plant Extracts|Quercetin,0,
flagellated sperm motility,GO:0030317,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Nitric Oxide|Thioctic Acid,0,
flagellated sperm motility,GO:0030317,"Diabetes Mellitus, Type 2",MESH:D003924,4,alpha-Tocopherol|bisphenol A|epigallocatechin gallate|Plant Extracts,1,MIR200A
flavone metabolic process,GO:0051552,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARGC1A
flavone metabolic process,GO:0051552,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARGC1A
flavonoid metabolic process,GO:0009812,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
flavonoid metabolic process,GO:0009812,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
flavonoid metabolic process,GO:0009812,"Diabetes Mellitus, Type 2",MESH:D003924,1,Genistein,0,
flight behavior,GO:0007629,"Diabetes Mellitus, Experimental",MESH:D003921,1,Eucalyptol,0,
foam cell differentiation,GO:0090077,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
foam cell differentiation,GO:0090077,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cholesterol|Resveratrol,0,
foam cell differentiation,GO:0090077,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
foam cell differentiation,GO:0090077,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
focal adhesion assembly,GO:0048041,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
focal adhesion assembly,GO:0048041,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dronabinol|sodium arsenite,1,BCL2
focal adhesion assembly,GO:0048041,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
focal adhesion assembly,GO:0048041,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,BCL2
folic acid metabolic process,GO:0046655,Diabetes Mellitus,MESH:D003920,3,Arsenic|Chlorpyrifos|Dichlorodiphenyl Dichloroethylene,0,
folic acid metabolic process,GO:0046655,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|sodium arsenite,0,
folic acid metabolic process,GO:0046655,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
folic acid metabolic process,GO:0046655,"Diabetes Mellitus, Type 2",MESH:D003924,5,Arsenic|Curcumin|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Folic Acid,0,
folic acid transport,GO:0015884,Diabetes Mellitus,MESH:D003920,1,Trifluoperazine,0,
folic acid transport,GO:0015884,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
folic acid transport,GO:0015884,"Diabetes Mellitus, Type 2",MESH:D003924,1,Folic Acid,0,
follicle-stimulating hormone secretion,GO:0046884,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Particulate Matter|Sodium Selenite,0,
follicle-stimulating hormone secretion,GO:0046884,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|sodium arsenite|Sodium Selenite,0,
follicle-stimulating hormone secretion,GO:0046884,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
follicle-stimulating hormone secretion,GO:0046884,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Particulate Matter,0,
follicular B cell differentiation,GO:0002316,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
follicular fluid formation in ovarian follicle antrum,GO:0001548,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
follicular fluid formation in ovarian follicle antrum,GO:0001548,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
follicular fluid formation in ovarian follicle antrum,GO:0001548,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
follicular fluid formation in ovarian follicle antrum,GO:0001548,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
forebrain development,GO:0030900,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
forebrain development,GO:0030900,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PAX6|PPARGC1A
forebrain development,GO:0030900,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
forebrain development,GO:0030900,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Folic Acid,3,HHEX|PAX6|PPARGC1A
forebrain dorsal/ventral pattern formation,GO:0021798,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
forebrain dorsal/ventral pattern formation,GO:0021798,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAX6
forebrain generation of neurons,GO:0021872,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
forebrain-midbrain boundary formation,GO:0021905,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
forebrain-midbrain boundary formation,GO:0021905,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAX6
forebrain morphogenesis,GO:0048853,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HHEX
formate biosynthetic process,GO:0015943,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,0,
formation of peptidyl-cystine persulfide by sulphur transfer from H2S,GO:0044527,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
formation of peptidyl-cystine persulfide by sulphur transfer from H2S,GO:0044527,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
formation of peptidyl-cystine persulfide by sulphur transfer from H2S,GO:0044527,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
formation of peptidyl-cystine persulfide by sulphur transfer from H2S,GO:0044527,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
forward locomotion,GO:0043056,Diabetes Mellitus,MESH:D003920,1,Serotonin,0,
frontal suture morphogenesis,GO:0060364,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
fructosamine biosynthetic process,GO:0030391,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
fructosamine biosynthetic process,GO:0030391,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dietary Fats|Quercetin|Resveratrol|Sodium Glutamate,0,
fructosamine biosynthetic process,GO:0030391,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
fructosamine biosynthetic process,GO:0030391,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Resveratrol,0,
fructosamine metabolic process,GO:0030389,Diabetes Mellitus,MESH:D003920,1,bexagliflozin,0,
fructosamine metabolic process,GO:0030389,"Diabetes Mellitus, Experimental",MESH:D003921,1,Fructosamine,0,
fructosamine metabolic process,GO:0030389,"Diabetes Mellitus, Type 2",MESH:D003924,1,bexagliflozin,0,
"fructose 1,6-bisphosphate metabolic process",GO:0030388,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PFKM
"fructose 1,6-bisphosphate metabolic process",GO:0030388,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CCND2
"fructose 2,6-bisphosphate metabolic process",GO:0006003,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GCK
"fructose 2,6-bisphosphate metabolic process",GO:0006003,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
"fructose 2,6-bisphosphate metabolic process",GO:0006003,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CCND2|GCK
fructose 6-phosphate metabolic process,GO:0006002,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,GCK|HK1|PFKM
fructose 6-phosphate metabolic process,GO:0006002,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
fructose 6-phosphate metabolic process,GO:0006002,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,GCK|HK1
fructose biosynthetic process,GO:0046370,Diabetes Mellitus,MESH:D003920,3,DDT|Flavonoids|Streptozocin,0,
fructose biosynthetic process,GO:0046370,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
fructose biosynthetic process,GO:0046370,"Diabetes Mellitus, Experimental",MESH:D003921,4,Cyclophosphamide|Fructose|Glucose|Streptozocin,0,
fructose biosynthetic process,GO:0046370,"Diabetes Mellitus, Type 1",MESH:D003922,3,Cyclophosphamide|Streptozocin|Uric Acid,0,
fructose biosynthetic process,GO:0046370,"Diabetes Mellitus, Type 2",MESH:D003924,3,Fructose|Glucose|Streptozocin,0,
fructose metabolic process,GO:0006000,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Dichlorodiphenyl Dichloroethylene,0,
fructose metabolic process,GO:0006000,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Fructose,0,
fructose metabolic process,GO:0006000,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
fructose metabolic process,GO:0006000,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Dichlorodiphenyl Dichloroethylene|Fructose,0,
fructose transmembrane transport,GO:0015755,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC2A2
fructose transmembrane transport,GO:0015755,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A2
fucose biosynthetic process,GO:0042353,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylnitrosamine,0,
fucose metabolic process,GO:0006004,Diabetes Mellitus,MESH:D003920,2,Streptozocin|Zinc,0,
fucose metabolic process,GO:0006004,"Diabetes Mellitus, Experimental",MESH:D003921,1,Streptozocin,0,
fucose metabolic process,GO:0006004,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
fucose metabolic process,GO:0006004,"Diabetes Mellitus, Type 2",MESH:D003924,2,Streptozocin|Zinc,0,
fucose transmembrane transport,GO:0015756,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A1
fusion of sperm to egg plasma membrane involved in single fertilization,GO:0007342,"Diabetes Mellitus, Type 2",MESH:D003924,1,alpha-Tocopherol,0,
G0 to G1 transition,GO:0045023,Diabetes Mellitus,MESH:D003920,10,Arsenic|Berberine|bisphenol A|Cadmium|Copper|Gallic Acid|Metformin|osthol|Plant Extracts|Resveratrol,0,
G0 to G1 transition,GO:0045023,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
G0 to G1 transition,GO:0045023,"Diabetes Mellitus, Experimental",MESH:D003921,20,"7-hydroxycoumarin|Berberine|Biguanides|bisphenol A|Clioquinol|Diethylhexyl Phthalate|Fructose|Gallic Acid|Glucose|Hydrogen Peroxide|Manganese|Metformin|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|Quercetin|Resveratrol|S-allylcysteine|sodium arsenite|Valsartan|Vitamin E",0,
G0 to G1 transition,GO:0045023,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Calcitriol|Genistein|Resveratrol|sodium arsenite,0,
G0 to G1 transition,GO:0045023,"Diabetes Mellitus, Type 2",MESH:D003924,22,Arsenic|Berberine|bisphenol A|bisphenol S|Cadmium|Copper|coumarin|Curcumin|Diethylhexyl Phthalate|Diethylnitrosamine|Folic Acid|Fructose|Genistein|Glucose|Malathion|Manganese|Metformin|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts|Resveratrol|titanium dioxide,0,
G1 phase,GO:0051318,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
G1/S transition of mitotic cell cycle,GO:0000082,"Diabetes Mellitus, Experimental",MESH:D003921,2,Hydrogen Peroxide|sodium arsenite,1,BCL2
G1/S transition of mitotic cell cycle,GO:0000082,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
G1/S transition of mitotic cell cycle,GO:0000082,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol S|Kangen-karyu,2,BCL2|CCND2
G2/M transition of mitotic cell cycle,GO:0000086,Diabetes Mellitus,MESH:D003920,12,"Arsenic|bisphenol A|Cadmium|Chlorpyrifos|Copper|Gallic Acid|Metformin|osthol|Plant Extracts|pregna-4,17-diene-3,16-dione|Resveratrol|Zinc",0,
G2/M transition of mitotic cell cycle,GO:0000086,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
G2/M transition of mitotic cell cycle,GO:0000086,"Diabetes Mellitus, Experimental",MESH:D003921,17,"7-hydroxycoumarin|Biguanides|bisphenol A|Cyclophosphamide|Dronabinol|Fructose|Gallic Acid|Glucose|Manganese|Metformin|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Valsartan|Vitamin E",0,
G2/M transition of mitotic cell cycle,GO:0000086,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Calcitriol|Cyclophosphamide|Genistein|Resveratrol|sodium arsenite,0,
G2/M transition of mitotic cell cycle,GO:0000086,"Diabetes Mellitus, Type 2",MESH:D003924,20,Arsenic|bisphenol A|bisphenol S|Cadmium|Copper|Curcumin|Diethylnitrosamine|Folic Acid|Fructose|Genistein|Glucose|Malathion|Manganese|Metformin|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts|Resveratrol|titanium dioxide|Zinc,0,
G2 phase,GO:0051319,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
galactose biosynthetic process,GO:0046369,Diabetes Mellitus,MESH:D003920,1,"2,2',4,4'-tetrabromodiphenyl ether",0,
galactose biosynthetic process,GO:0046369,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
galactose biosynthetic process,GO:0046369,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
galactose metabolic process,GO:0006012,Diabetes Mellitus,MESH:D003920,4,Atrazine|bisphenol A|Dichlorodiphenyl Dichloroethylene|Resveratrol,0,
galactose metabolic process,GO:0006012,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Resveratrol|Vitamin E,1,PPARGC1A
galactose metabolic process,GO:0006012,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Resveratrol,0,
galactose metabolic process,GO:0006012,"Diabetes Mellitus, Type 2",MESH:D003924,5,Atrazine|bisphenol A|Dichlorodiphenyl Dichloroethylene|Ethanol|Resveratrol,1,PPARGC1A
galactose transmembrane transport,GO:0015757,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC2A2
galactose transmembrane transport,GO:0015757,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC2A2
gallbladder development,GO:0061010,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HHEX
gamete generation,GO:0007276,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,Diabetes Mellitus,MESH:D003920,3,Dichlorvos|Methylprednisolone|Plant Preparations,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,"Diabetes Mellitus, Experimental",MESH:D003921,2,Nicotine|Plant Preparations,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,"Diabetes Mellitus, Type 1",MESH:D003922,1,Dichlorvos,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,"Diabetes Mellitus, Type 2",MESH:D003924,4,Curcumin|epigallocatechin gallate|Nicotine|Topiramate,0,
gamma-aminobutyric acid import,GO:0051939,"Diabetes Mellitus, Experimental",MESH:D003921,1,Sodium Glutamate,0,
gamma-aminobutyric acid import,GO:0051939,"Diabetes Mellitus, Type 1",MESH:D003922,1,Norepinephrine,0,
gamma-aminobutyric acid metabolic process,GO:0009448,Diabetes Mellitus,MESH:D003920,3,Chlorpyrifos|Plant Extracts|Streptozocin,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Diabetes Mellitus, Experimental",MESH:D003921,6,Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Glucose|Plant Extracts|Streptozocin,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Diabetes Mellitus, Type 2",MESH:D003924,9,2-palmitoylglycerol|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Glucose|perfluorooctane sulfonic acid|Plant Extracts|Sitagliptin Phosphate|Streptozocin,0,
gamma-aminobutyric acid signaling pathway,GO:0007214,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Polychlorinated Biphenyls,0,
gamma-aminobutyric acid signaling pathway,GO:0007214,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
gamma-aminobutyric acid signaling pathway,GO:0007214,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
gamma-aminobutyric acid signaling pathway,GO:0007214,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Ethanol|Polychlorinated Biphenyls,0,
ganglion development,GO:0061548,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
ganglion development,GO:0061548,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
ganglion development,GO:0061548,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
ganglion development,GO:0061548,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
ganglioside metabolic process,GO:0001573,Diabetes Mellitus,MESH:D003920,1,"2,4,5,2',4',5'-hexachlorobiphenyl",0,
gap junction assembly,GO:0016264,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
gap junction assembly,GO:0016264,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
gap junction assembly,GO:0016264,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
gap junction assembly,GO:0016264,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
gap junction-mediated intercellular transport,GO:1990349,Diabetes Mellitus,MESH:D003920,5,"2,4,5,2',4',5'-hexachlorobiphenyl|bisphenol A|Cadmium|DDT|Resveratrol",0,
gap junction-mediated intercellular transport,GO:1990349,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Dronabinol|Nicotine|Resveratrol,0,
gap junction-mediated intercellular transport,GO:1990349,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|Thioctic Acid,0,
gap junction-mediated intercellular transport,GO:1990349,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Cadmium|Nicotine|Resveratrol,0,
gastric acid secretion,GO:0001696,"Diabetes Mellitus, Experimental",MESH:D003921,1,platycodin D,0,
gastric acid secretion,GO:0001696,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
gastric motility,GO:0035482,"Diabetes Mellitus, Experimental",MESH:D003921,1,honokiol,0,
gastrin-induced gastric acid secretion,GO:0001698,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
gastrulation,GO:0007369,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
gastrulation with mouth forming second,GO:0001702,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|YWHAH
GDP-mannose biosynthetic process,GO:0009298,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HK1
GDP-mannose biosynthetic process,GO:0009298,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HK1|OGG1
GDP-mannose biosynthetic process from mannose,GO:0061728,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HK1
GDP-mannose biosynthetic process from mannose,GO:0061728,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HK1
GDP-mannose metabolic process,GO:0019673,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
GDP metabolic process,GO:0046710,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,0,
GDP metabolic process,GO:0046710,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
gene expression,GO:0010467,Diabetes Mellitus,MESH:D003920,15,2-hydroxyfluorene|2-naphthol|Air Pollutants|Arsenic|bisphenol A|Cadmium|Chromium|Dichlorodiphenyl Dichloroethylene|Nitrogen Dioxide|Nitrogen Oxides|Ozone|Particulate Matter|Selenium|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution,3,ADIPOQ|CP|SOD1
gene expression,GO:0010467,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Chromium|Nitric Oxide|sodium arsenite,7,EDN1|FAS|IL6|PAX6|PPARA|SOD1|TGFB1
gene expression,GO:0010467,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Nitric Oxide|sodium arsenite|Tetrachlorodibenzodioxin,4,CP|DDIT3|IL6|STAT3
gene expression,GO:0010467,"Diabetes Mellitus, Type 2",MESH:D003924,7,Air Pollutants|Arsenic|bisphenol A|Cadmium|Chromium|Dichlorodiphenyl Dichloroethylene|Particulate Matter,21,ADIPOQ|AKT1|ECE1|EDN1|EDNRA|EDNRB|ENPP1|FAS|HMGA1|HNF1B|HNF4A|IL6|INPPL1|MIR144|MIR409|MIR423|NFATC2|NFKB1|PAX6|PPARA|SOD1
generation of neurons,GO:0048699,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
generation of neurons,GO:0048699,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
generation of neurons,GO:0048699,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
generation of neurons,GO:0048699,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
generation of neurons,GO:0048699,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
generation of precursor metabolites and energy,GO:0006091,Diabetes Mellitus,MESH:D003920,0,,4,A|ADIPOQ|LEPR|POMC
generation of precursor metabolites and energy,GO:0006091,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,ACOX1|ADRB3|LEPR|PDX1
generation of precursor metabolites and energy,GO:0006091,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lactic Acid,5,A|ADIPOQ|ENPP1|LEPR|PDX1
genitalia development,GO:0048806,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF1B
genomic imprinting,GO:0071514,Diabetes Mellitus,MESH:D003920,4,bisphenol A|DDT|Dichlorodiphenyl Dichloroethylene|Pesticides,1,ZFP57
genomic imprinting,GO:0071514,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
genomic imprinting,GO:0071514,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,2,HYMAI|ZFP57
genomic imprinting,GO:0071514,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
genomic imprinting,GO:0071514,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Dichlorodiphenyl Dichloroethylene|Pesticides,0,
germ-band shortening,GO:0007390,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
germ-band shortening,GO:0007390,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
germ cell development,GO:0007281,Diabetes Mellitus,MESH:D003920,5,Arsenic|bisphenol A|Dichlorodiphenyl Dichloroethylene|Particulate Matter|Tetrachlorodibenzodioxin,0,
germ cell development,GO:0007281,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate,2,BAX|BCL2L1
germ cell development,GO:0007281,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Tetrachlorodibenzodioxin,1,STAT3
germ cell development,GO:0007281,"Diabetes Mellitus, Type 2",MESH:D003924,9,Arsenic|bisphenol A|bisphenol S|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|diethyl phthalate|Particulate Matter|perfluorooctane sulfonic acid,4,AKT1|BAX|BCL2L1|SMAD5
germ cell migration,GO:0008354,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
germ cell migration,GO:0008354,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Diethylhexyl Phthalate,1,TGFB1
germ cell migration,GO:0008354,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
germ cell migration,GO:0008354,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Diethylhexyl Phthalate,0,
germ cell proliferation,GO:0036093,"Diabetes Mellitus, Type 1",MESH:D003922,1,decabromobiphenyl ether,0,
germ cell proliferation,GO:0036093,"Diabetes Mellitus, Type 2",MESH:D003924,1,Amoxicillin,0,
germinal center B cell differentiation,GO:0002314,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IL6
germinal center B cell differentiation,GO:0002314,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL6
germinal center B cell differentiation,GO:0002314,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IL6
germ-line stem cell population maintenance,GO:0030718,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
ghrelin secretion,GO:0036321,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
ghrelin secretion,GO:0036321,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,0,
gland morphogenesis,GO:0022612,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Coumaphos,0,
gland morphogenesis,GO:0022612,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
gland morphogenesis,GO:0022612,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2
glandular epithelial cell differentiation,GO:0002067,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
glandular epithelial cell differentiation,GO:0002067,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,2,CAV1|PAX6
glandular epithelial cell differentiation,GO:0002067,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
glandular epithelial cell differentiation,GO:0002067,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,PAX6
glial cell activation,GO:0061900,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
glial cell activation,GO:0061900,"Diabetes Mellitus, Experimental",MESH:D003921,2,Manganese|Sodium Glutamate,0,
glial cell activation,GO:0061900,"Diabetes Mellitus, Type 2",MESH:D003924,3,Air Pollutants|Manganese|Particulate Matter,0,
glial cell apoptotic process,GO:0034349,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,BAX|BCL2|CASP3
glial cell apoptotic process,GO:0034349,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,BAX|BCL2|CASP3
glial cell-derived neurotrophic factor receptor signaling pathway,GO:0035860,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
glial cell development,GO:0021782,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP2
glial cell differentiation,GO:0010001,Diabetes Mellitus,MESH:D003920,2,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A",0,
glial cell differentiation,GO:0010001,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Dronabinol,1,IGF1
glial cell differentiation,GO:0010001,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,IGF1
glial cell differentiation,GO:0010001,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Curcumin,0,
glial cell growth,GO:0042065,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
glial cell growth,GO:0042065,"Diabetes Mellitus, Type 1",MESH:D003922,1,decabromobiphenyl ether,0,
glial cell growth,GO:0042065,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Vehicle Emissions,0,
glial cell migration,GO:0008347,Diabetes Mellitus,MESH:D003920,0,,2,FN1|RAC1
glial cell-neuron signaling,GO:0150098,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNFRSF1B
glial cell proliferation,GO:0014009,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
glial cell proliferation,GO:0014009,"Diabetes Mellitus, Experimental",MESH:D003921,1,Sodium Glutamate,3,LEPR|TP53|TRP53
glial cell proliferation,GO:0014009,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LEPR
gliogenesis,GO:0042063,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,RETN
globus pallidus development,GO:0021759,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
globus pallidus development,GO:0021759,"Diabetes Mellitus, Type 2",MESH:D003924,1,Manganese,0,
glomerular basement membrane development,GO:0032836,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
glomerular basement membrane development,GO:0032836,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Streptozocin,0,
glomerular basement membrane development,GO:0032836,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
glomerular basement membrane development,GO:0032836,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Streptozocin,0,
glomerular capillary formation,GO:0072104,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOTCH2
glomerular endothelium development,GO:0072011,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
glomerular endothelium development,GO:0072011,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EDN1|EDNRA
glomerular filtration,GO:0003094,Diabetes Mellitus,MESH:D003920,13,Arsenic|Aspirin|Cadmium|Cyclosporine|Indapamide|Lead|Metformin|Particulate Matter|Pesticides|Pravastatin|Streptozocin|Tacrolimus|Telmisartan,0,
glomerular filtration,GO:0003094,"Diabetes Mellitus, Experimental",MESH:D003921,13,Diltiazem|Enalapril|Inositol|Losartan|Metformin|Naproxen|Nicotine|Nitric Oxide|Phlorhizin|Streptozocin|Tacrolimus|Telmisartan|Vitamin E,1,EDN1
glomerular filtration,GO:0003094,"Diabetes Mellitus, Type 1",MESH:D003922,5,Lipopolysaccharides|Nitric Oxide|Norepinephrine|Streptozocin|Tacrolimus,0,
glomerular filtration,GO:0003094,"Diabetes Mellitus, Type 2",MESH:D003924,18,"Angiotensin-Converting Enzyme Inhibitors|Arsenic|Cadmium|Calcium|Drugs, Chinese Herbal|Enalapril|Irbesartan|Lead|Metformin|Nicotine|Nitrendipine|Particulate Matter|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pesticides|Streptozocin|Telmisartan",2,EDN1|EDNRA
glomerulus development,GO:0032835,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
glomerulus development,GO:0032835,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2|EDNRA
glucagon secretion,GO:0070091,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Dichlorodiphenyl Dichloroethylene|Streptozocin,0,
glucagon secretion,GO:0070091,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Diethylhexyl Phthalate|Glucose|Imatinib Mesylate|Streptozocin,1,IL6
glucagon secretion,GO:0070091,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Imatinib Mesylate|Streptozocin,1,IL6
glucagon secretion,GO:0070091,"Diabetes Mellitus, Type 2",MESH:D003924,7,bisphenol A|bisphenol S|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|Glucose|perfluorooctanoic acid|Streptozocin,1,IL6
glucarate biosynthetic process,GO:0019393,Diabetes Mellitus,MESH:D003920,1,DDT,0,
glucocorticoid biosynthetic process,GO:0006704,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HSD11B1
glucocorticoid catabolic process,GO:0006713,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,HSD11B1|YWHAH
glucocorticoid metabolic process,GO:0008211,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
glucocorticoid metabolic process,GO:0008211,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
glucocorticoid metabolic process,GO:0008211,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HSD11B2
glucocorticoid metabolic process,GO:0008211,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol S|Ethanol,0,
glucocorticoid receptor signaling pathway,GO:0042921,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,YWHAH
gluconeogenesis,GO:0006094,Diabetes Mellitus,MESH:D003920,15,"2,2',4,4'-tetrabromodiphenyl ether|Atrazine|bisphenol A|Blood Glucose|Chlorpropamide|DDT|Dichlorodiphenyl Dichloroethylene|Glyburide|Metformin|Phenformin|Pravastatin|Prednisone|Resveratrol|Rosiglitazone|Streptozocin",1,LEPR
gluconeogenesis,GO:0006094,"Diabetes Mellitus, Experimental",MESH:D003921,19,Biguanides|bisphenol A|Blood Glucose|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Diltiazem|Fructose|ginsenoside Re|Glucose|Glyburide|Inositol|Metformin|Nicotine|Quercetin|Resveratrol|Rosiglitazone|Sodium Glutamate|Streptozocin,7,ATF3|GPD2|LEPR|PCK1|PCX|PPARA|PPARGC1A
gluconeogenesis,GO:0006094,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|decabromobiphenyl ether|Norepinephrine|Resveratrol|Streptozocin,0,
gluconeogenesis,GO:0006094,"Diabetes Mellitus, Type 2",MESH:D003924,25,3-((4-chlorobenzyl)oxy)-N-((1S)-1-phenylethyl)-2-thiophenecarboxamide|Atrazine|bisphenol A|bisphenol S|Blood Glucose|Boron|Calcium|Chlorpropamide|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|Ethanol|Fructose|ginsenoside Re|Glucose|Glyburide|Lactic Acid|Metformin|Nicotine|perfluorooctane sulfonic acid|perfluorooctanoic acid|Resveratrol|Rosiglitazone|Streptozocin|Tolbutamide,7,ATF3|GCG|GPD2|LEPR|PCX|PPARA|PPARGC1A
glucosamine metabolic process,GO:0006041,Diabetes Mellitus,MESH:D003920,1,Uranium,0,
glucose 6-phosphate metabolic process,GO:0051156,Diabetes Mellitus,MESH:D003920,2,Berberine|Metformin,0,
glucose 6-phosphate metabolic process,GO:0051156,"Diabetes Mellitus, Experimental",MESH:D003921,3,Berberine|Glucose|Metformin,2,GCK|HK1
glucose 6-phosphate metabolic process,GO:0051156,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
glucose 6-phosphate metabolic process,GO:0051156,"Diabetes Mellitus, Type 2",MESH:D003924,4,Berberine|Glucose|Metformin|perfluorooctanoic acid,2,GCK|HK1
glucose catabolic process,GO:0006007,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Chlordan|DDT|Resveratrol,0,
glucose catabolic process,GO:0006007,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Dietary Fats|Diethylhexyl Phthalate|Glucose|Manganese|Resveratrol,1,GCK
glucose catabolic process,GO:0006007,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
glucose catabolic process,GO:0006007,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Resveratrol,0,
glucose catabolic process,GO:0006007,"Diabetes Mellitus, Type 2",MESH:D003924,7,bisphenol A|Curcumin|Dietary Fats|Diethylhexyl Phthalate|Glucose|Manganese|Resveratrol,1,GCK
glucose catabolic process to lactate,GO:0019659,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
glucose catabolic process to lactate,GO:0019659,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
glucose catabolic process to lactate,GO:0019659,"Diabetes Mellitus, Type 2",MESH:D003924,2,Atrazine|epigallocatechin gallate,0,
glucose catabolic process to lactate via pyruvate,GO:0019661,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
glucose homeostasis,GO:0042593,Diabetes Mellitus,MESH:D003920,32,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|Alloxan|Arsenic|arsenite|Atrazine|bexagliflozin|bisphenol A|Blood Glucose|Cadmium|Chlorpyrifos|DDT|Diazinon|Dichlorvos|Fatty Acids, Omega-3|Glucocorticoids|Glyburide|Lead|Mercury|Metformin|methylarsonite|Nitrogen Dioxide|Particulate Matter|Plant Extracts|Plant Preparations|Resveratrol|Rosiglitazone|Streptozocin|Sulpiride|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Zinc",8,ADIPOQ|CP|INS|INS2|IRS1|LEPR|POMC|PPARG
glucose homeostasis,GO:0042593,"Diabetes Mellitus, Experimental",MESH:D003921,30,"Alloxan|bisphenol A|Blood Glucose|cobaltiprotoporphyrin|corilagin|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Enalapril|Fatty Acids, Omega-3|Fructose|Glucose|Glyburide|Metformin|Monocrotophos|Niacinamide|Nicotine|Plant Extracts|Plant Preparations|platycodin D|Propolis|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Streptozocin|Taurine|thymoquinone|tributyltin|Vitamin E",17,CAV3|FOXO3|GCK|IL6|INS1|INSR|IRS1|LEP|LEPR|NEUROD1|PAX6|PCK1|PDK4|PDX1|PFKM|PPARG|SLC2A4
glucose homeostasis,GO:0042593,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
glucose homeostasis,GO:0042593,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
glucose homeostasis,GO:0042593,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
glucose homeostasis,GO:0042593,"Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism",MESH:C565705,0,,1,GLIS3
glucose homeostasis,GO:0042593,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
glucose homeostasis,GO:0042593,"Diabetes Mellitus, Type 1",MESH:D003922,12,Alloxan|bisphenol A|decabromobiphenyl ether|Dichlorvos|Lipopolysaccharides|Mercury|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Taurine|Tetrachlorodibenzodioxin,8,CP|GLIS3|HNF1A|IL6|INS|INS2|PAX4|STAT3
glucose homeostasis,GO:0042593,"Diabetes Mellitus, Type 2",MESH:D003924,47,Air Pollutants|Alloxan|Arsenic|Atrazine|bexagliflozin|bisphenol A|bisphenol S|Blood Glucose|Cadmium|Curcumin|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|diethyl phthalate|efavirenz|Enalapril|epigallocatechin gallate|Ethanol|Folic Acid|Fructose|fumosorinone|Glucose|Glyburide|Kangen-karyu|Lead|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Niacinamide|Nickel|Nicotine|Panax notoginseng extract|Particulate Matter|Pentoxifylline|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|perfluoroundecanoic acid|Plant Extracts|platyconic acid|Resveratrol|Rosiglitazone|Streptozocin|TAK-875|Zinc,29,ADIPOQ|AKT1|AKT2|ENPP1|GCG|GCK|GCKR|GLIS3|HECTD4|HMGA1|HNF1A|HNF4A|IL6|INS|INS1|IRS1|LEP|LEPR|MTNR1B|NEUROD1|NOTCH2|PAX4|PAX6|PDX1|PPARG|SLC2A4|SLC30A8|TCF7L2|WFS1
glucose import,GO:0046323,Diabetes Mellitus,MESH:D003920,21,"2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Alloxan|Arsenic|bisphenol A|Cadmium|Chlordan|Chlorodiphenyl (54% Chlorine)|Cyclosporine|DDT|Dichlorodiphenyl Dichloroethylene|Heptachlor|Hexachlorobenzene|Lead|Particulate Matter|Pioglitazone|Plant Extracts|Rosiglitazone|Sodium Selenite|Streptozocin|Tacrolimus",0,
glucose import,GO:0046323,"Diabetes Mellitus, Experimental",MESH:D003921,17,Alloxan|Benzamides|bisphenol A|Diethylhexyl Phthalate|Dronabinol|ginsenoside Re|Glucose|honokiol|Pioglitazone|Plant Extracts|Quercetin|Rosiglitazone|sodium arsenite|Sodium Selenite|Streptozocin|Tacrolimus|Taurine,2,SLC2A2|SLC2A4
glucose import,GO:0046323,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
glucose import,GO:0046323,"Diabetes Mellitus, Type 1",MESH:D003922,8,Alloxan|bisphenol A|Lipopolysaccharides|Norepinephrine|sodium arsenite|Streptozocin|Tacrolimus|Taurine,1,HNF1A
glucose import,GO:0046323,"Diabetes Mellitus, Type 2",MESH:D003924,19,Air Pollutants|Alloxan|Arsenic|bisphenol A|Cadmium|Canagliflozin|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|ginsenoside Re|Glucose|Lead|mono-(2-ethylhexyl)phthalate|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Plant Extracts|Rosiglitazone|Streptozocin,5,ENPP1|HNF1A|SLC2A1|SLC2A2|SLC2A4
glucose import across plasma membrane,GO:0098708,Diabetes Mellitus,MESH:D003920,2,Resveratrol|Rosiglitazone,0,
glucose import across plasma membrane,GO:0098708,"Diabetes Mellitus, Experimental",MESH:D003921,3,Glucose|Resveratrol|Rosiglitazone,0,
glucose import across plasma membrane,GO:0098708,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
glucose import across plasma membrane,GO:0098708,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol S|Calcium|Glucose|Resveratrol|Rosiglitazone,1,SLC2A1
glucose import in response to insulin stimulus,GO:0044381,Diabetes Mellitus,MESH:D003920,3,Arsenic|bisphenol A|Pioglitazone,0,
glucose import in response to insulin stimulus,GO:0044381,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Glucose|Pioglitazone,1,SLC2A4
glucose import in response to insulin stimulus,GO:0044381,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
glucose import in response to insulin stimulus,GO:0044381,"Diabetes Mellitus, Type 2",MESH:D003924,5,Arsenic|bisphenol A|Glucose|mono-(2-ethylhexyl)phthalate|Pioglitazone,1,SLC2A4
glucose mediated signaling pathway,GO:0010255,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NKX6-1|PDX1
glucose mediated signaling pathway,GO:0010255,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NKX6-1|PDX1
glucose metabolic process,GO:0006006,Diabetes Mellitus,MESH:D003920,29,Air Pollutants|Alloxan|Arsenic|arsenite|Atrazine|bexagliflozin|bisphenol A|Blood Glucose|Cadmium|Chlorpyrifos|Glyburide|Lead|Mercury|Metformin|Methylprednisolone|Nitrogen Dioxide|Ozone|Particulate Matter|Pioglitazone|Resveratrol|Selenium|Sodium Selenite|Streptozocin|Sulfonylurea Compounds|Sulfur Dioxide|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Tungsten|Zinc,4,ADIPOQ|CPT1A|INS|INS2
glucose metabolic process,GO:0006006,"Diabetes Mellitus, Experimental",MESH:D003921,22,Alloxan|bisphenol A|Blood Glucose|Dietary Fats|Diethylhexyl Phthalate|Diltiazem|Exenatide|Glucose|Glyburide|Imatinib Mesylate|Lithocholic Acid|Metformin|Palm Oil|Pioglitazone|Resveratrol|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|tianhuang|tributyltin|triphenyltin chloride,12,CPT1A|GCK|HK1|IAPP|INS1|IRS2|KCNJ11|LEP|PCK1|PDX1|PPARA|TNF
glucose metabolic process,GO:0006006,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
glucose metabolic process,GO:0006006,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
glucose metabolic process,GO:0006006,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
glucose metabolic process,GO:0006006,"Diabetes Mellitus, Type 1",MESH:D003922,12,Alloxan|bisphenol A|Dehydroepiandrosterone|Imatinib Mesylate|Lipopolysaccharides|Mercury|Palm Oil|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin|Thioctic Acid,4,INS|INS2|KCNJ11|TNF
glucose metabolic process,GO:0006006,"Diabetes Mellitus, Type 2",MESH:D003924,32,Air Pollutants|Alloxan|Arsenic|Atrazine|bexagliflozin|bisphenol A|Blood Glucose|Cadmium|Calcium|Canagliflozin|Cysteine|Dietary Fats|Diethylhexyl Phthalate|diethyl phthalate|Ethanol|Exenatide|Folic Acid|Glucose|Glyburide|Lactic Acid|Lead|Lithocholic Acid|Mercury|Metformin|Particulate Matter|perfluorooctanoic acid|Phthalic Acids|Pioglitazone|Resveratrol|Streptozocin|Sulfonylurea Compounds|Zinc,21,ADIPOQ|AKT1|AKT2|CPT1A|GCK|GCKR|HECTD4|HK1|IAPP|INPPL1|INS|INS1|IRS2|KCNJ11|KCNQ1|LEP|MIR423|PDX1|PPARA|TCF7L2|TNF
glucose transmembrane transport,GO:1904659,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Cadmium|Plant Extracts,1,INS2
glucose transmembrane transport,GO:1904659,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Dietary Fats|ginsenoside Re|Glucose|Plant Extracts|Quercetin,3,INS1|SLC2A2|SLC2A4
glucose transmembrane transport,GO:1904659,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,INS2
glucose transmembrane transport,GO:1904659,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|Cadmium|Dietary Fats|ginsenoside Re|Glucose|Plant Extracts,4,INS1|SLC2A1|SLC2A2|SLC2A4
glucosylceramide biosynthetic process,GO:0006679,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
glucosylceramide biosynthetic process,GO:0006679,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
glucosylceramide biosynthetic process,GO:0006679,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
glucosylceramide biosynthetic process,GO:0006679,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
glucosylceramide metabolic process,GO:0006678,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
glucosylceramide metabolic process,GO:0006678,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
glucosylceramide metabolic process,GO:0006678,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
glucosylceramide metabolic process,GO:0006678,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
glucuronate metabolic process,GO:0019585,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
glucuronate metabolic process,GO:0019585,"Diabetes Mellitus, Type 2",MESH:D003924,1,Atrazine,0,
glutamate biosynthetic process,GO:0006537,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Chlorpyrifos|Methylprednisolone|Streptozocin|Tobacco Smoke Pollution,0,
glutamate biosynthetic process,GO:0006537,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
glutamate biosynthetic process,GO:0006537,"Diabetes Mellitus, Experimental",MESH:D003921,4,"bisphenol A|Diethylhexyl Phthalate|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Streptozocin",0,
glutamate biosynthetic process,GO:0006537,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,0,
glutamate biosynthetic process,GO:0006537,"Diabetes Mellitus, Type 2",MESH:D003924,8,bisphenol A|bisphenol S|Diethylhexyl Phthalate|epigallocatechin gallate|perfluorooctane sulfonic acid|perfluorooctanoic acid|Streptozocin|Topiramate,0,
glutamate catabolic process,GO:0006538,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
glutamate metabolic process,GO:0006536,Diabetes Mellitus,MESH:D003920,6,bisphenol A|Dichlorodiphenyl Dichloroethylene|Gallic Acid|Ozone|Particulate Matter|Telmisartan,0,
glutamate metabolic process,GO:0006536,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Dronabinol|Gallic Acid|Monocrotophos|Telmisartan,0,
glutamate metabolic process,GO:0006536,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Genistein,0,
glutamate metabolic process,GO:0006536,"Diabetes Mellitus, Type 2",MESH:D003924,10,Amoxicillin|bisphenol A|Dichlorodiphenyl Dichloroethylene|Ethanol|Genistein|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Sitagliptin Phosphate|Telmisartan,2,GCLC|GCLM
glutamate secretion,GO:0014047,Diabetes Mellitus,MESH:D003920,3,"2,2',4,4'-tetrabromodiphenyl ether|Cadmium|Potassium",0,
glutamate secretion,GO:0014047,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|Calcium,0,
"glutamate secretion, neurotransmission",GO:0061535,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
"glutamate secretion, neurotransmission",GO:0061535,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ABCC8
"glutamate secretion, neurotransmission",GO:0061535,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ABCC8
glutamine biosynthetic process,GO:0006542,Diabetes Mellitus,MESH:D003920,2,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A",0,
glutamine biosynthetic process,GO:0006542,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dietary Fats|Diethylhexyl Phthalate,0,
glutamine biosynthetic process,GO:0006542,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
glutamine biosynthetic process,GO:0006542,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Dietary Fats|Diethylhexyl Phthalate|perfluorooctanoic acid,0,
glutamine family amino acid metabolic process,GO:0009064,"Diabetes Mellitus, Type 2",MESH:D003924,1,Malathion,0,
glutamine metabolic process,GO:0006541,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Particulate Matter,0,
glutamine metabolic process,GO:0006541,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,1,UCP2
glutamine metabolic process,GO:0006541,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Thioctic Acid,0,
glutamine metabolic process,GO:0006541,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Particulate Matter,1,UCP2
glutathione biosynthetic process,GO:0006750,Diabetes Mellitus,MESH:D003920,52,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5-Trichlorophenoxyacetic Acid|Air Pollutants|Alloxan|Arsenic|arsenite|Aspirin|Atrazine|Berberine|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpromazine|Chlorpyrifos|Chromium|Clozapine|Copper|Cyclosporine|DDT|Dichlorvos|Docosahexaenoic Acids|Fatty Acids, Omega-3|Gallic Acid|Gliclazide|Glyburide|Hexachlorobenzene|Iron|Lead|Liraglutide|Mercury|Metals, Heavy|Metformin|o,p'-DDT|Ozone|Particulate Matter|Pioglitazone|Plant Extracts|Plant Preparations|Polychlorinated Biphenyls|Pyruvaldehyde|Resveratrol|Rosiglitazone|Selenium|Serotonin|Sodium Selenite|Streptozocin|Tacrolimus|Telmisartan|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Troglitazone|Zinc",0,
glutathione biosynthetic process,GO:0006750,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
glutathione biosynthetic process,GO:0006750,"Diabetes Mellitus, Experimental",MESH:D003921,56,"Aldosterone|Alloxan|Berberine|bisphenol A|Cholesterol|Chromium|cinnamaldehyde|Coconut Oil|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Exenatide|Fatty Acids, Omega-3|Fructose|Gallic Acid|ginsenoside Re|Gliclazide|Glucose|Glyburide|Hemin|honokiol|Hydrogen Peroxide|Inositol|Losartan|Manganese|mangiferin|Metformin|Monocrotophos|Niacinamide|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|pimagedine|pinitol|Pioglitazone|Plant Extracts|Plant Preparations|Propolis|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|Tacrolimus|tangeretin|Taurine|Telmisartan|thymoquinone|tributyltin|Troglitazone|Ursolic Acid|Vitamin E|Zinc Compounds",0,
glutathione biosynthetic process,GO:0006750,"Diabetes Mellitus, Type 1",MESH:D003922,17,Alloxan|bisphenol A|Cyclophosphamide|decabromobiphenyl ether|Dichlorvos|Genistein|Iron|Lipopolysaccharides|Mercury|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|Taurine|Tetrachlorodibenzodioxin|Thioctic Acid,0,
glutathione biosynthetic process,GO:0006750,"Diabetes Mellitus, Type 2",MESH:D003924,65,"Air Pollutants|Alloxan|alpha-Tocopherol|Arsenic|Ascorbic Acid|Atrazine|Berberine|bisphenol A|Boron|Cadmium|Chromium|cinnamaldehyde|Clozapine|Copper|Curcumin|Cysteine|daidzein|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Drugs, Chinese Herbal|epigallocatechin gallate|Ethanol|Exenatide|Folic Acid|Fructose|Genistein|ginsenoside Re|Gliclazide|Glucose|Glutathione|Glyburide|Hemin|Irbesartan|Iron|Lead|Liraglutide|Malathion|Manganese|mangiferin|Mercury|Metformin|Niacinamide|Nickel|Nicotine|Orlistat|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Plant Extracts|Polychlorinated Biphenyls|procyanidin B2|Resveratrol|Rosiglitazone|Silver|Sitagliptin Phosphate|Streptozocin|Telmisartan|titanium dioxide|Topiramate|Troglitazone|Vehicle Emissions|Zinc",3,GCLC|GCLM|SLC1A2
glutathione catabolic process,GO:0006751,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Risperidone|Tobacco Smoke Pollution|Trifluoperazine,0,
glutathione catabolic process,GO:0006751,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Dietary Fats|Fructose|methylamine|sodium arsenite,0,
glutathione catabolic process,GO:0006751,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Thioctic Acid,0,
glutathione catabolic process,GO:0006751,"Diabetes Mellitus, Type 2",MESH:D003924,7,alpha-Tocopherol|benidipine|bisphenol A|Curcumin|Dietary Fats|Fructose|Glutathione,0,
glutathione derivative biosynthetic process,GO:1901687,Diabetes Mellitus,MESH:D003920,13,"Arsenic|Arsenicals|bisphenol A|Chlorpyrifos|Copper|Glyburide|Metals, Heavy|Plant Extracts|Resveratrol|Rosiglitazone|Sodium Selenite|Streptozocin|Sulfur Dioxide",0,
glutathione derivative biosynthetic process,GO:1901687,"Diabetes Mellitus, Experimental",MESH:D003921,15,bisphenol A|Dibutyl Phthalate|Glucose|Glyburide|Hydrogen Peroxide|Plant Extracts|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sodium arsenite|Sodium Selenite|Streptozocin|tangeretin|tributyltin,0,
glutathione derivative biosynthetic process,GO:1901687,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Genistein|Resveratrol|sodium arsenite|Streptozocin,0,
glutathione derivative biosynthetic process,GO:1901687,"Diabetes Mellitus, Type 2",MESH:D003924,19,alpha-Tocopherol|Arsenic|Ascorbic Acid|bisphenol A|bisphenol S|Copper|Dibutyl Phthalate|Diethylnitrosamine|Ethanol|Genistein|Glucose|Glutathione|Glyburide|perfluorooctane sulfonic acid|Plant Extracts|Resveratrol|Rosiglitazone|Silver|Streptozocin,1,GSTM1
glutathione metabolic process,GO:0006749,Diabetes Mellitus,MESH:D003920,53,"2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Alloxan|aroclor 1260|Arsenic|Arsenicals|arsenite|Aspirin|Atrazine|Berberine|Bezafibrate|bisphenol A|Blood Glucose|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpyrifos|Copper|Cyclosporine|Dichlorodiphenyl Dichloroethylene|Dichlorvos|Docosahexaenoic Acids|Fatty Acids, Omega-3|Flavonoids|Gallic Acid|Glyburide|Heptachlor|Iron|Lead|Mercury|Metformin|Methylprednisolone|Niacin|o,p'-DDT|Ozone|Parathion|Particulate Matter|Perindopril|Pioglitazone|Plant Extracts|Plant Preparations|puerarin|Pyruvaldehyde|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Sulfur Dioxide|Telmisartan|Tobacco Smoke Pollution|Troglitazone|Zinc",1,SOD1
glutathione metabolic process,GO:0006749,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
glutathione metabolic process,GO:0006749,"Diabetes Mellitus, Experimental",MESH:D003921,66,"7-hydroxycoumarin|Alloxan|Anthocyanins|astaxanthine|Berberine|Bezafibrate|bisphenol A|Blood Glucose|Capsaicin|Cholesterol|cinnamaldehyde|Clioquinol|cobaltiprotoporphyrin|corilagin|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Diosmin|Dronabinol|Enalapril|Fatty Acids, Nonesterified|Fatty Acids, Omega-3|Fenretinide|fenugreek seed meal|Fructose|Gallic Acid|Glucose|Glyburide|Hemin|Hydrogen Peroxide|Imatinib Mesylate|Lithocholic Acid|Malondialdehyde|Manganese|mangiferin|Metformin|Monocrotophos|Naproxen|Niacinamide|Nicotine|pimagedine|Pioglitazone|Plant Extracts|Plant Preparations|Propolis|pterostilbene|puerarin|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|Sertraline|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|Taurine|Telmisartan|Tetracyclines|thymoquinone|tributyltin|Troglitazone|Valsartan|Vitamin E",4,GPX1|GSR|SOD1|SOD2
glutathione metabolic process,GO:0006749,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
glutathione metabolic process,GO:0006749,"Diabetes Mellitus, Type 1",MESH:D003922,19,Alloxan|bisphenol A|Calcitriol|Cyclophosphamide|decabromobiphenyl ether|Dichlorvos|Genistein|Imatinib Mesylate|Iron|Lipopolysaccharides|Mercury|Niacinamide|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Taurine|Thioctic Acid|Uric Acid,0,
glutathione metabolic process,GO:0006749,"Diabetes Mellitus, Type 2",MESH:D003924,66,"Air Pollutants|Alloxan|alpha-Tocopherol|Arsenic|Ascorbic Acid|astaxanthine|Atrazine|Berberine|Bezafibrate|bisphenol A|bisphenol S|Blood Glucose|Cadmium|cinnamaldehyde|Copper|Curcumin|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Diosmin|efavirenz|Enalapril|epigallocatechin gallate|Ethanol|Fatty Acids, Nonesterified|Folic Acid|Fructose|Genistein|Glucose|Glutathione|Glyburide|Hemin|Iron|Lead|Linagliptin|Lithocholic Acid|Malathion|Malondialdehyde|Manganese|mangiferin|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Niacinamide|Nicotine|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Plant Extracts|Reactive Oxygen Species|Resveratrol|Rosiglitazone|S-Adenosylmethionine|Silver|Sitagliptin Phosphate|Streptozocin|Telmisartan|titanium dioxide|Topiramate|Troglitazone|Vehicle Emissions|Vildagliptin|Zinc",6,GCLC|GCLM|GPX1|GSTM1|SOD1|SOD2
glutathione transmembrane transport,GO:0034775,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
glutathione transmembrane transport,GO:0034775,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
glutathione transport,GO:0034635,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
glutathione transport,GO:0034635,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
glutathione transport,GO:0034635,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Resveratrol,0,
glutathione transport,GO:0034635,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glutathione|Resveratrol,0,
glyceraldehyde-3-phosphate biosynthetic process,GO:0046166,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PCK1|PCX
glyceraldehyde-3-phosphate biosynthetic process,GO:0046166,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PCX
glyceraldehyde-3-phosphate metabolic process,GO:0019682,Diabetes Mellitus,MESH:D003920,1,Metformin,0,
glyceraldehyde-3-phosphate metabolic process,GO:0019682,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Metformin,0,
glyceraldehyde-3-phosphate metabolic process,GO:0019682,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glucose|Metformin,0,
glycerol-3-phosphate biosynthetic process,GO:0046167,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
glycerol-3-phosphate metabolic process,GO:0006072,Diabetes Mellitus,MESH:D003920,1,Metformin,0,
glycerol-3-phosphate metabolic process,GO:0006072,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Metformin,2,GPAM|GPD2
glycerol-3-phosphate metabolic process,GO:0006072,"Diabetes Mellitus, Type 2",MESH:D003924,3,Ethanol|Glucose|Metformin,1,GPD2
glycerol biosynthetic process,GO:0006114,Diabetes Mellitus,MESH:D003920,1,DDT,0,
glycerol biosynthetic process,GO:0006114,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Sodium Glutamate,1,LEP
glycerol biosynthetic process,GO:0006114,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,1,LEP
glycerol biosynthetic process from pyruvate,GO:0046327,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
glycerol biosynthetic process from pyruvate,GO:0046327,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,1,PCK1
glycerol biosynthetic process from pyruvate,GO:0046327,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
glycerol biosynthetic process from pyruvate,GO:0046327,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
glycerol catabolic process,GO:0019563,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GPD2
glycerol catabolic process,GO:0019563,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GPD2
glycerolipid biosynthetic process,GO:0045017,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
glycerolipid biosynthetic process,GO:0045017,"Diabetes Mellitus, Type 2",MESH:D003924,2,Diethylhexyl Phthalate|mono-(2-ethylhexyl)phthalate,0,
glycerolipid metabolic process,GO:0046486,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
glycerolipid metabolic process,GO:0046486,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dichlorodiphenyl Dichloroethylene|perfluorohexanesulfonic acid,1,DGKD
glycerol metabolic process,GO:0006071,Diabetes Mellitus,MESH:D003920,3,Arsenic|bisphenol A|Rosiglitazone,0,
glycerol metabolic process,GO:0006071,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Rosiglitazone,0,
glycerol metabolic process,GO:0006071,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
glycerol metabolic process,GO:0006071,"Diabetes Mellitus, Type 2",MESH:D003924,4,Arsenic|bisphenol A|mono-(2-ethylhexyl)phthalate|Rosiglitazone,0,
glycerol transmembrane transport,GO:0015793,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
glycerol transmembrane transport,GO:0015793,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Plant Extracts,0,
glycerol transmembrane transport,GO:0015793,"Diabetes Mellitus, Type 1",MESH:D003922,1,Norepinephrine,0,
glycerol transmembrane transport,GO:0015793,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glucose|Plant Extracts,0,
glycerophosphate shuttle,GO:0006127,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,GPD2
glycerophosphate shuttle,GO:0006127,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GPD2
glycerophospholipid biosynthetic process,GO:0046474,"Diabetes Mellitus, Type 2",MESH:D003924,1,mono-(2-ethylhexyl)phthalate,0,
glycerophospholipid catabolic process,GO:0046475,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
glycerophospholipid metabolic process,GO:0006650,Diabetes Mellitus,MESH:D003920,4,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|Fatty Acids, Omega-3|Particulate Matter",0,
glycerophospholipid metabolic process,GO:0006650,"Diabetes Mellitus, Experimental",MESH:D003921,2,"Dietary Fats|Fatty Acids, Omega-3",1,GPAM
glycerophospholipid metabolic process,GO:0006650,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
glycerophospholipid metabolic process,GO:0006650,"Diabetes Mellitus, Type 2",MESH:D003924,9,Air Pollutants|Dietary Fats|Folic Acid|Malathion|Particulate Matter|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluoroundecanoic acid|Vehicle Emissions,0,
glycine biosynthetic process,GO:0006545,Diabetes Mellitus,MESH:D003920,5,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A|DDT|Methylprednisolone|Tobacco Smoke Pollution",0,
glycine biosynthetic process,GO:0006545,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
glycine biosynthetic process,GO:0006545,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
glycine biosynthetic process,GO:0006545,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
glycine metabolic process,GO:0006544,Diabetes Mellitus,MESH:D003920,3,Arsenic|Cadmium|Dichlorodiphenyl Dichloroethylene,0,
glycine metabolic process,GO:0006544,"Diabetes Mellitus, Type 2",MESH:D003924,4,Arsenic|Cadmium|Dichlorodiphenyl Dichloroethylene|perfluorooctanoic acid,0,
glycogen biosynthetic process,GO:0005978,Diabetes Mellitus,MESH:D003920,7,Alloxan|Glyburide|Pioglitazone|Plant Extracts|Rosiglitazone|Sodium Selenite|Streptozocin,0,
glycogen biosynthetic process,GO:0005978,"Diabetes Mellitus, Experimental",MESH:D003921,14,Alloxan|Dietary Fats|Glucose|Glyburide|mangiferin|Nicotine|Pioglitazone|Plant Extracts|Propolis|Quercetin|Rosiglitazone|Sodium Selenite|Streptozocin|Taurine,1,GCK
glycogen biosynthetic process,GO:0005978,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
glycogen biosynthetic process,GO:0005978,"Diabetes Mellitus, Type 1",MESH:D003922,4,Alloxan|Lipopolysaccharides|Streptozocin|Taurine,0,
glycogen biosynthetic process,GO:0005978,"Diabetes Mellitus, Type 2",MESH:D003924,14,Alloxan|alpha-Tocopherol|bisphenol S|Dietary Fats|Folic Acid|Glucose|Glyburide|mangiferin|Nicotine|perfluorooctanoic acid|Pioglitazone|Plant Extracts|Rosiglitazone|Streptozocin,3,AKT1|AKT2|GCK
glycogen catabolic process,GO:0005980,Diabetes Mellitus,MESH:D003920,2,Glyburide|Potassium,1,ADRB1
glycogen catabolic process,GO:0005980,"Diabetes Mellitus, Experimental",MESH:D003921,5,Dietary Fats|Diltiazem|Fructose|Glyburide|Naproxen,1,PFKM
glycogen catabolic process,GO:0005980,"Diabetes Mellitus, Type 1",MESH:D003922,1,Norepinephrine,0,
glycogen catabolic process,GO:0005980,"Diabetes Mellitus, Type 2",MESH:D003924,8,bisphenol S|Calcium|Dietary Fats|Fructose|Glutathione|Glyburide|Malathion|Tolbutamide,0,
glycogen cell differentiation involved in embryonic placenta development,GO:0060709,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
glycogen metabolic process,GO:0005977,Diabetes Mellitus,MESH:D003920,14,Air Pollutants|Arsenic|arsenite|bisphenol A|Cadmium|Chlorpyrifos|Dichlorodiphenyl Dichloroethylene|Mercury|Metformin|Ozone|Particulate Matter|Plant Extracts|Sodium Selenite|Streptozocin,1,LEPR
glycogen metabolic process,GO:0005977,"Diabetes Mellitus, Experimental",MESH:D003921,17,bisphenol A|chebulagic acid|Cholesterol|Coconut Oil|Dietary Fats|Diethylhexyl Phthalate|eupafolin|Fructose|Metformin|Niacinamide|Plant Extracts|Quercetin|sodium arsenite|Sodium Selenite|Streptozocin|tributyltin|Vitamin E,1,LEPR
glycogen metabolic process,GO:0005977,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Mercury|Niacinamide|sodium arsenite|Streptozocin|Vitamin A,0,
glycogen metabolic process,GO:0005977,"Diabetes Mellitus, Type 2",MESH:D003924,15,Air Pollutants|Arsenic|Ascorbic Acid|bisphenol A|Cadmium|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|Fructose|Mercury|Metformin|Niacinamide|Particulate Matter|Plant Extracts|Streptozocin,4,AKT1|LEPR|PPP1R3A|TCF7L2
glycolate metabolic process,GO:0009441,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
glycolate metabolic process,GO:0009441,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,IGF1
glycolate metabolic process,GO:0009441,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,IGF1
glycolate metabolic process,GO:0009441,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
glycolipid metabolic process,GO:0006664,"Diabetes Mellitus, Experimental",MESH:D003921,4,Bile Acids and Salts|Cholesterol|Glucose|Triglycerides,0,
glycolipid metabolic process,GO:0006664,"Diabetes Mellitus, Type 2",MESH:D003924,3,Glucose|Lactic Acid|Triglycerides,0,
glycolysis from storage polysaccharide through glucose-1-phosphate,GO:0093001,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PFKM
glycolytic process,GO:0006096,Diabetes Mellitus,MESH:D003920,11,Arsenic|Aspirin|bisphenol A|Cadmium|DDT|Dichlorodiphenyl Dichloroethylene|Glyburide|Lead|Metformin|Niacin|Rosiglitazone,0,
glycolytic process,GO:0006096,"Diabetes Mellitus, Experimental",MESH:D003921,10,bisphenol A|Dietary Fats|Diethylhexyl Phthalate|Diltiazem|Glucose|Glyburide|Hemin|Metformin|Rosiglitazone|sodium arsenite,5,GCK|HK1|PFKM|PKLR|UCP2
glycolytic process,GO:0006096,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
glycolytic process,GO:0006096,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Dehydroepiandrosterone|Lipopolysaccharides|sodium arsenite,0,
glycolytic process,GO:0006096,"Diabetes Mellitus, Type 2",MESH:D003924,19,Arsenic|bisphenol A|bisphenol S|Cadmium|Calcium|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|Glucose|Glyburide|Hemin|Lactic Acid|Lead|Malathion|Metformin|mono-(2-ethylhexyl)phthalate|Rosiglitazone|Tolbutamide|Vehicle Emissions,4,ENPP1|GCK|HK1|UCP2
glycolytic process through fructose-6-phosphate,GO:0061615,Diabetes Mellitus,MESH:D003920,1,Metformin,0,
glycolytic process through fructose-6-phosphate,GO:0061615,"Diabetes Mellitus, Experimental",MESH:D003921,1,Metformin,1,PFKM
glycolytic process through fructose-6-phosphate,GO:0061615,"Diabetes Mellitus, Type 2",MESH:D003924,1,Metformin,0,
glycolytic process through glucose-6-phosphate,GO:0061620,Diabetes Mellitus,MESH:D003920,1,Metformin,0,
glycolytic process through glucose-6-phosphate,GO:0061620,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Metformin,0,
glycolytic process through glucose-6-phosphate,GO:0061620,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glucose|Metformin,0,
glycoprotein biosynthetic process,GO:0009101,Diabetes Mellitus,MESH:D003920,0,,1,INS2
glycoprotein biosynthetic process,GO:0009101,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,INS2
glycoprotein biosynthetic process,GO:0009101,"Diabetes Mellitus, Type 2",MESH:D003924,3,"Diethylnitrosamine|Drugs, Chinese Herbal|Ethanol",0,
glycoprotein metabolic process,GO:0009100,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
glycoprotein metabolic process,GO:0009100,"Diabetes Mellitus, Experimental",MESH:D003921,2,Diethylhexyl Phthalate|Streptozocin,0,
glycoprotein metabolic process,GO:0009100,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
glycoprotein metabolic process,GO:0009100,"Diabetes Mellitus, Type 2",MESH:D003924,2,Diethylhexyl Phthalate|Streptozocin,0,
glycosaminoglycan metabolic process,GO:0030203,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
glycoside metabolic process,GO:0016137,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,1,NOS2
glycoside metabolic process,GO:0016137,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
glycoside metabolic process,GO:0016137,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOS2
glycoside transport,GO:1901656,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
glycoside transport,GO:1901656,"Diabetes Mellitus, Type 2",MESH:D003924,1,epigallocatechin gallate,0,
glycosphingolipid biosynthetic process,GO:0006688,Diabetes Mellitus,MESH:D003920,2,Cyclosporine|Ozone,0,
glycosphingolipid metabolic process,GO:0006687,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
glycosphingolipid metabolic process,GO:0006687,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
glycosylation,GO:0070085,Diabetes Mellitus,MESH:D003920,2,Aspirin|Streptozocin,0,
glycosylation,GO:0070085,"Diabetes Mellitus, Experimental",MESH:D003921,3,Glucose|Streptozocin|Vitamin E,0,
glycosylation,GO:0070085,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
glycosylation,GO:0070085,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glucose|Streptozocin,0,
GMP biosynthetic process,GO:0006177,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
GMP biosynthetic process,GO:0006177,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
Golgi organization,GO:0007030,"Diabetes Mellitus, Experimental",MESH:D003921,1,Taurine,0,
Golgi organization,GO:0007030,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
Golgi to vacuole transport,GO:0006896,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AP3S2
gonad development,GO:0008406,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2L1
gonad development,GO:0008406,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2L1|EGFR
G protein-coupled acetylcholine receptor signaling pathway,GO:0007213,Diabetes Mellitus,MESH:D003920,1,Parathion,0,
G protein-coupled acetylcholine receptor signaling pathway,GO:0007213,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|sodium arsenite,1,CHRM2
G protein-coupled acetylcholine receptor signaling pathway,GO:0007213,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,1,CHRM2
G protein-coupled acetylcholine receptor signaling pathway,GO:0007213,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
G protein-coupled adenosine receptor signaling pathway,GO:0001973,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADCY5
G protein-coupled receptor signaling pathway,GO:0007186,Diabetes Mellitus,MESH:D003920,0,,5,ADRB1|INS|INS2|PPARG|RAC1
G protein-coupled receptor signaling pathway,GO:0007186,"Diabetes Mellitus, Experimental",MESH:D003921,0,,13,ADRA1A|AGT|BDKRB1|CCL20|CHRM2|CX3CL1|EDN1|INS1|INSR|PPARG|S1PR2|S1PR4|S1PR5
G protein-coupled receptor signaling pathway,GO:0007186,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
G protein-coupled receptor signaling pathway,GO:0007186,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
G protein-coupled receptor signaling pathway,GO:0007186,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
G protein-coupled receptor signaling pathway,GO:0007186,"Diabetes Mellitus, Type 1",MESH:D003922,0,,5,CCL20|CHRM2|INS|INS2|ITPR3
G protein-coupled receptor signaling pathway,GO:0007186,"Diabetes Mellitus, Type 2",MESH:D003924,1,TAK-875,17,AKT1|C3|ECE1|EDN1|EDNRA|EDNRB|GCG|GLP1R|GNB3|INS|INS1|MTNR1B|PIK3CG|PPARG|SCTR|SFRP4|THADA
G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,GO:0007199,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,AGT|NOS2
G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,GO:0007199,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOS2
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",GO:0007187,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ADRB3|CHRM2
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",GO:0007187,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CHRM2
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",GO:0007187,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MTNR1B
granulocyte activation,GO:0036230,Diabetes Mellitus,MESH:D003920,1,Reactive Oxygen Species,0,
granulocyte activation,GO:0036230,"Diabetes Mellitus, Type 1",MESH:D003922,1,Reactive Oxygen Species,0,
granulocyte activation,GO:0036230,"Diabetes Mellitus, Type 2",MESH:D003924,1,Reactive Oxygen Species,0,
granulocyte differentiation,GO:0030851,Diabetes Mellitus,MESH:D003920,1,"2,4,5,2',4',5'-hexachlorobiphenyl",0,
granulocyte differentiation,GO:0030851,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
granuloma formation,GO:0002432,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
granuloma formation,GO:0002432,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
granulosa cell proliferation,GO:1990739,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
granulosa cell proliferation,GO:1990739,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
granulosa cell proliferation,GO:1990739,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
gravitaxis,GO:0042332,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
gravitaxis,GO:0042332,"Diabetes Mellitus, Experimental",MESH:D003921,2,sodium arsenite|Taurine,0,
gravitaxis,GO:0042332,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Taurine,0,
gravitaxis,GO:0042332,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
grooming behavior,GO:0007625,Diabetes Mellitus,MESH:D003920,7,bisphenol A|Cadmium|Chlorpyrifos|Coumaphos|Lead|Pioglitazone|repaglinide,0,
grooming behavior,GO:0007625,"Diabetes Mellitus, Experimental",MESH:D003921,7,bisphenol A|Dronabinol|Manganese|mangiferin|Nicotine|Pioglitazone|Taurine,0,
grooming behavior,GO:0007625,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Taurine,0,
grooming behavior,GO:0007625,"Diabetes Mellitus, Type 2",MESH:D003924,9,Ascorbic Acid|bisphenol A|Cadmium|Ethanol|Lead|Manganese|mangiferin|Nicotine|Pioglitazone,0,
growth,GO:0040007,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Cadmium|Copper|Dichlorodiphenyl Dichloroethylene|Hexachlorobenzene,0,
growth,GO:0040007,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
growth,GO:0040007,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Lipopolysaccharides|sodium arsenite,0,
growth,GO:0040007,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|bisphenol S|Cadmium|Copper|Dichlorodiphenyl Dichloroethylene,0,
growth hormone receptor signaling pathway,GO:0060396,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IGF1
growth hormone receptor signaling pathway,GO:0060396,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IGF1|STAT3
growth hormone receptor signaling pathway via JAK-STAT,GO:0060397,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
growth hormone receptor signaling pathway via JAK-STAT,GO:0060397,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
growth hormone receptor signaling pathway via JAK-STAT,GO:0060397,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,2,STAT3|TYK2
growth hormone receptor signaling pathway via JAK-STAT,GO:0060397,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,PTPN1
growth involved in heart morphogenesis,GO:0003241,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
growth involved in heart morphogenesis,GO:0003241,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
growth involved in heart morphogenesis,GO:0003241,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
growth involved in heart morphogenesis,GO:0003241,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
growth plate cartilage chondrocyte development,GO:0003431,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
growth plate cartilage chondrocyte development,GO:0003431,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
growth plate cartilage chondrocyte development,GO:0003431,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
growth plate cartilage chondrocyte development,GO:0003431,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
growth plate cartilage chondrocyte proliferation,GO:0003419,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
growth plate cartilage chondrocyte proliferation,GO:0003419,"Diabetes Mellitus, Type 2",MESH:D003924,1,Manganese,0,
growth plate cartilage development,GO:0003417,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP9
GTP biosynthetic process,GO:0006183,Diabetes Mellitus,MESH:D003920,1,Polychlorinated Biphenyls,0,
GTP biosynthetic process,GO:0006183,"Diabetes Mellitus, Type 2",MESH:D003924,1,Polychlorinated Biphenyls,0,
GTP metabolic process,GO:0046039,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
guanine biosynthetic process,GO:0046099,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
guanine biosynthetic process,GO:0046099,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
guanine metabolic process,GO:0046098,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
guanine transmembrane transport,GO:1903716,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
guanosine biosynthetic process,GO:0046114,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
guanosine biosynthetic process,GO:0046114,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
habenula development,GO:0021986,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
habenula development,GO:0021986,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PAX6|TCF7L2
habituation,GO:0046959,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
habituation,GO:0046959,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Nicotine,0,
habituation,GO:0046959,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|decabromobiphenyl ether,0,
habituation,GO:0046959,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Nicotine,0,
hair cycle,GO:0042633,Diabetes Mellitus,MESH:D003920,0,,1,PTGS2
hair cycle,GO:0042633,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PTGS2
hair cycle process,GO:0022405,Diabetes Mellitus,MESH:D003920,1,Mercury,0,
hair cycle process,GO:0022405,"Diabetes Mellitus, Type 1",MESH:D003922,1,Mercury,0,
hair cycle process,GO:0022405,"Diabetes Mellitus, Type 2",MESH:D003924,1,Mercury,0,
hair follicle development,GO:0001942,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,RELA
hair follicle development,GO:0001942,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
hair follicle morphogenesis,GO:0031069,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
hair follicle morphogenesis,GO:0031069,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2
haltere development,GO:0007482,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
hatching,GO:0035188,Diabetes Mellitus,MESH:D003920,12,"Air Pollutants|Atrazine|Berberine|bisphenol A|Cadmium|Chlorpyrifos|o,p'-DDT|Particulate Matter|Plant Extracts|terbufos|Tobacco Smoke Pollution|Zinc",0,
hatching,GO:0035188,"Diabetes Mellitus, Experimental",MESH:D003921,8,Berberine|bisphenol A|Dibutyl Phthalate|Dronabinol|honokiol|Imatinib Mesylate|Plant Extracts|sodium arsenite,0,
hatching,GO:0035188,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Genistein|Imatinib Mesylate|sodium arsenite,0,
hatching,GO:0035188,"Diabetes Mellitus, Type 2",MESH:D003924,13,Air Pollutants|Atrazine|Berberine|bisphenol A|bisphenol S|Cadmium|Dibutyl Phthalate|Folic Acid|Genistein|mono-(2-ethylhexyl)phthalate|Particulate Matter|Plant Extracts|Zinc,0,
head development,GO:0060322,Diabetes Mellitus,MESH:D003920,11,"2,2',4,4'-tetrabromodiphenyl ether|Arsenic|Atrazine|bisphenol A|Dichlorodiphenyl Dichloroethylene|Hexachlorobenzene|Lead|Mercury|Metals, Heavy|o,p'-DDT|Selenium",0,
head development,GO:0060322,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
head development,GO:0060322,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Mercury|sodium arsenite,0,
head development,GO:0060322,"Diabetes Mellitus, Type 2",MESH:D003924,9,Arsenic|Atrazine|bisphenol A|bisphenol S|Dichlorodiphenyl Dichloroethylene|Ethanol|Lead|Mercury|mono(2-ethyl-5-hydroxyhexyl) phthalate,1,EDNRA
head involution,GO:0008258,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
head morphogenesis,GO:0060323,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
head morphogenesis,GO:0060323,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Diethylhexyl Phthalate,0,
head morphogenesis,GO:0060323,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
head morphogenesis,GO:0060323,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Diethylhexyl Phthalate|Ethanol,1,BRAF
heart contraction,GO:0060047,Diabetes Mellitus,MESH:D003920,11,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|Arsenic|bisphenol A|Cadmium|Copper|Lead|Nitrogen Dioxide|Ozone|Particulate Matter|Rosiglitazone",1,SOD1
heart contraction,GO:0060047,"Diabetes Mellitus, Experimental",MESH:D003921,6,astaxanthine|bisphenol A|Diethylhexyl Phthalate|Manganese|Nicotine|Rosiglitazone,3,ACE|GPX1|SOD1
heart contraction,GO:0060047,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
heart contraction,GO:0060047,"Diabetes Mellitus, Type 2",MESH:D003924,13,Air Pollutants|Arsenic|astaxanthine|bisphenol A|Cadmium|Copper|Diethylhexyl Phthalate|Lead|Manganese|Nickel|Nicotine|Particulate Matter|Rosiglitazone,2,GPX1|SOD1
heart development,GO:0007507,Diabetes Mellitus,MESH:D003920,7,Air Pollutants|Arsenic|bisphenol A|Cadmium|Copper|Particulate Matter|Resveratrol,2,FN1|PPARG
heart development,GO:0007507,"Diabetes Mellitus, Experimental",MESH:D003921,6,astaxanthine|bisphenol A|Diethylhexyl Phthalate|Manganese|Resveratrol|sodium arsenite,13,CASP3|CAV1|EDN1|ID1|MMP2|MMP9|PPARA|PPARG|S1PR2|SOD2|TGFB1|TP53|TRP53
heart development,GO:0007507,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Genistein|Resveratrol|sodium arsenite,1,PTPN22
heart development,GO:0007507,"Diabetes Mellitus, Type 2",MESH:D003924,15,Air Pollutants|Arsenic|astaxanthine|bisphenol A|Cadmium|Copper|Diethylhexyl Phthalate|epigallocatechin gallate|Ethanol|Folic Acid|Genistein|Manganese|Nickel|Particulate Matter|Resveratrol,16,ADCY5|CASP3|CASP8|ECE1|EDN1|EDNRA|ENPP1|FTO|HHEX|HMGA1|ID1|KCNQ1|PAM|PPARA|PPARG|SOD2
heart formation,GO:0060914,"Diabetes Mellitus, Type 2",MESH:D003924,1,Folic Acid,0,
heart growth,GO:0060419,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
heart growth,GO:0060419,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
heart looping,GO:0001947,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Tetrachlorodibenzodioxin,0,
heart looping,GO:0001947,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
heart looping,GO:0001947,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Tetrachlorodibenzodioxin,0,
heart looping,GO:0001947,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,2,NOTCH2|SMAD5
heart morphogenesis,GO:0003007,Diabetes Mellitus,MESH:D003920,0,,1,CAT
heart morphogenesis,GO:0003007,"Diabetes Mellitus, Experimental",MESH:D003921,0,,5,CAT|INSR|S1PR2|SOD2|VEGFA
heart morphogenesis,GO:0003007,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
heart morphogenesis,GO:0003007,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CAT
heart morphogenesis,GO:0003007,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CAT|SOD2
heart process,GO:0003015,Diabetes Mellitus,MESH:D003920,2,Ozone|Streptozocin,0,
heart process,GO:0003015,"Diabetes Mellitus, Experimental",MESH:D003921,1,Streptozocin,1,EDN1
heart process,GO:0003015,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
heart process,GO:0003015,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Streptozocin,3,EDN1|EDNRA|EGFR
heart rudiment development,GO:0003313,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,OGG1
heart rudiment formation,GO:0003315,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR2
heart trabecula formation,GO:0060347,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV3
heart valve morphogenesis,GO:0003179,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
heart valve morphogenesis,GO:0003179,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ADAMTS9
heat acclimation,GO:0010286,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
heat acclimation,GO:0010286,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
heat acclimation,GO:0010286,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
heat acclimation,GO:0010286,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
heat dissipation,GO:0031653,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
heat generation,GO:0031649,Diabetes Mellitus,MESH:D003920,0,,1,ADRB1
heat generation,GO:0031649,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ADRB3
helper T cell chemotaxis,GO:0035704,Diabetes Mellitus,MESH:D003920,1,Cyclosporine,0,
helper T cell enhancement of B cell mediated immune response,GO:0035399,Diabetes Mellitus,MESH:D003920,1,Dichlorvos,0,
helper T cell enhancement of B cell mediated immune response,GO:0035399,"Diabetes Mellitus, Type 1",MESH:D003922,1,Dichlorvos,0,
hemangioblast cell differentiation,GO:0060217,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HHEX
hematopoietic progenitor cell differentiation,GO:0002244,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,ATF3|TGFB1|TP53|TRP53
hematopoietic progenitor cell differentiation,GO:0002244,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ATF3
hematopoietic stem cell differentiation,GO:0060218,Diabetes Mellitus,MESH:D003920,2,Cadmium|Resveratrol,0,
hematopoietic stem cell differentiation,GO:0060218,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,5,ACE|BCL2|IL6|TP53|TRP53
hematopoietic stem cell differentiation,GO:0060218,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,3,IL6|NOS1|SH2B3
hematopoietic stem cell differentiation,GO:0060218,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|Resveratrol,4,BCL2|IL6|MIR125B1|MIR181C
hematopoietic stem cell homeostasis,GO:0061484,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TP53
hematopoietic stem cell migration,GO:0035701,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,MMP2|MMP9
hematopoietic stem cell migration to bone marrow,GO:0097241,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
hematopoietic stem cell proliferation,GO:0071425,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Pesticides,0,
hematopoietic stem cell proliferation,GO:0071425,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
hematopoietic stem cell proliferation,GO:0071425,"Diabetes Mellitus, Experimental",MESH:D003921,1,Cyclophosphamide,1,TP53
hematopoietic stem cell proliferation,GO:0071425,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
hematopoietic stem cell proliferation,GO:0071425,"Diabetes Mellitus, Type 2",MESH:D003924,1,Pesticides,0,
heme biosynthetic process,GO:0006783,Diabetes Mellitus,MESH:D003920,2,Dichlorodiphenyl Dichloroethylene|Hexachlorobenzene,0,
heme biosynthetic process,GO:0006783,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
heme biosynthetic process,GO:0006783,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,HNF1A
heme biosynthetic process,GO:0006783,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dichlorodiphenyl Dichloroethylene,1,HNF1A
heme catabolic process,GO:0042167,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
heme catabolic process,GO:0042167,"Diabetes Mellitus, Experimental",MESH:D003921,2,cobaltiprotoporphyrin|Hemin,1,HMOX1
heme catabolic process,GO:0042167,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
heme catabolic process,GO:0042167,"Diabetes Mellitus, Type 2",MESH:D003924,2,Curcumin|Hemin,1,HMOX1
heme metabolic process,GO:0042168,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Iron|Sodium Selenite,0,
heme metabolic process,GO:0042168,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Heme|Sodium Selenite,1,HMOX1
heme metabolic process,GO:0042168,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Iron,0,
heme metabolic process,GO:0042168,"Diabetes Mellitus, Type 2",MESH:D003924,5,alpha-Tocopherol|bisphenol A|Diethylnitrosamine|Heme|Iron,2,HMOX1|HPX
heme oxidation,GO:0006788,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HMOX1
heme oxidation,GO:0006788,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HMOX1
heme transport,GO:0015886,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HPX
hemocyte development,GO:0007516,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
hemocyte migration,GO:0035099,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
hemoglobin biosynthetic process,GO:0042541,Diabetes Mellitus,MESH:D003920,10,Air Pollutants|arsenite|Chlorpyrifos|Gallic Acid|Lead|Nitrogen Dioxide|Particulate Matter|Pesticides|Plant Extracts|Tetrachlorodibenzodioxin,0,
hemoglobin biosynthetic process,GO:0042541,"Diabetes Mellitus, Experimental",MESH:D003921,5,Eucalyptol|Gallic Acid|Hemin|Plant Extracts|sodium arsenite,0,
hemoglobin biosynthetic process,GO:0042541,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Tetrachlorodibenzodioxin,0,
hemoglobin biosynthetic process,GO:0042541,"Diabetes Mellitus, Type 2",MESH:D003924,10,Air Pollutants|Ethanol|Folic Acid|Hemin|Lead|Particulate Matter|Pesticides|Plant Extracts|S-Adenosylmethionine|titanium dioxide,0,
hemoglobin catabolic process,GO:0042540,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Sodium Selenite,0,
hemoglobin catabolic process,GO:0042540,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Sodium Selenite,0,
hemoglobin catabolic process,GO:0042540,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
hemoglobin catabolic process,GO:0042540,"Diabetes Mellitus, Type 2",MESH:D003924,3,alpha-Tocopherol|bisphenol A|Curcumin,0,
hemoglobin metabolic process,GO:0020027,Diabetes Mellitus,MESH:D003920,7,bisphenol A|Chlorpyrifos|Iron|Particulate Matter|Streptozocin|Tobacco Smoke Pollution|Zinc,1,CAT
hemoglobin metabolic process,GO:0020027,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
hemoglobin metabolic process,GO:0020027,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Cyclophosphamide|Heme|Hemin|sodium arsenite|Streptozocin,1,CAT
hemoglobin metabolic process,GO:0020027,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Cyclophosphamide|Iron|Lipopolysaccharides|sodium arsenite|Streptozocin,1,CAT
hemoglobin metabolic process,GO:0020027,"Diabetes Mellitus, Type 2",MESH:D003924,11,bisphenol A|Calcium|Curcumin|Folic Acid|Heme|Hemin|Iron|mono-(2-ethylhexyl)phthalate|Particulate Matter|Streptozocin|Zinc,2,CAT|HPX
hemopoiesis,GO:0030097,Diabetes Mellitus,MESH:D003920,8,Arsenic|bisphenol A|Cadmium|Gallic Acid|Lead|Mercury|Resveratrol|Uranium,0,
hemopoiesis,GO:0030097,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Gallic Acid|Resveratrol|sodium arsenite,2,BCL2|SOD2
hemopoiesis,GO:0030097,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Mercury|Resveratrol|sodium arsenite,3,IL10|IL20|SH2B3
hemopoiesis,GO:0030097,"Diabetes Mellitus, Type 2",MESH:D003924,6,Arsenic|bisphenol A|Cadmium|Lead|Mercury|Resveratrol,4,BCL2|HHEX|NOTCH2|SOD2
heparan sulfate proteoglycan biosynthetic process,GO:0015012,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
heparin metabolic process,GO:0030202,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EDNRA|EDNRB
hepatic duct development,GO:0061011,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HHEX
hepatic immune response,GO:0002384,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IL6
hepatic immune response,GO:0002384,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL6
hepatic immune response,GO:0002384,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IL6
hepaticobiliary system development,GO:0061008,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HHEX
hepaticobiliary system process,GO:0061007,Diabetes Mellitus,MESH:D003920,2,Cadmium|Mercury,0,
hepaticobiliary system process,GO:0061007,"Diabetes Mellitus, Type 1",MESH:D003922,1,Mercury,0,
hepaticobiliary system process,GO:0061007,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|Mercury,0,
hepatic stellate cell activation,GO:0035733,Diabetes Mellitus,MESH:D003920,2,arsenite|morroniside,0,
hepatic stellate cell activation,GO:0035733,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dietary Fats|Dietary Sucrose|Fructose|sodium arsenite,0,
hepatic stellate cell activation,GO:0035733,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
hepatic stellate cell activation,GO:0035733,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dietary Fats|Ethanol|Fructose,1,GCLM
hepatic stellate cell proliferation,GO:1990922,Diabetes Mellitus,MESH:D003920,1,arsenite,0,
hepatic stellate cell proliferation,GO:1990922,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
hepatic stellate cell proliferation,GO:1990922,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
hepatoblast differentiation,GO:0061017,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HHEX|HNF1B
hepatocyte apoptotic process,GO:0097284,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,BCL2L1|FAS
hepatocyte apoptotic process,GO:0097284,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,BCL2L1|CASP8|FAS|PIK3CG
hepatocyte cell migration,GO:0002194,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
hepatocyte differentiation,GO:0070365,"Diabetes Mellitus, Experimental",MESH:D003921,2,Niacinamide|Quercetin,2,CYP1A1|PCK1
hepatocyte differentiation,GO:0070365,"Diabetes Mellitus, Type 1",MESH:D003922,2,Dehydroepiandrosterone|Niacinamide,1,STAT3
hepatocyte differentiation,GO:0070365,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ascorbic Acid|Niacinamide,4,HHEX|HNF1B|HNF4A|PROX1
hepatocyte growth factor receptor signaling pathway,GO:0048012,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
hepatocyte growth factor receptor signaling pathway,GO:0048012,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
hepatocyte growth factor receptor signaling pathway,GO:0048012,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
hepatocyte growth factor receptor signaling pathway,GO:0048012,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
hepatocyte homeostasis,GO:0036333,"Diabetes Mellitus, Type 2",MESH:D003924,1,Folic Acid,0,
hepatocyte proliferation,GO:0072574,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IL6
hepatocyte proliferation,GO:0072574,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL6
hepatocyte proliferation,GO:0072574,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,IL6|NOTCH2|PROX1
hepoxilin biosynthetic process,GO:0051122,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GSTM1
heterochromatin formation,GO:0031507,Diabetes Mellitus,MESH:D003920,3,Atrazine|Mercury|Selenium,1,SIRT1
heterochromatin formation,GO:0031507,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
heterochromatin formation,GO:0031507,"Diabetes Mellitus, Type 1",MESH:D003922,1,Mercury,0,
heterochromatin formation,GO:0031507,"Diabetes Mellitus, Type 2",MESH:D003924,3,Atrazine|Mercury|perfluorooctanoic acid,1,SIRT1
heterocycle metabolic process,GO:0046483,Diabetes Mellitus,MESH:D003920,2,Niacin|Selenium,0,
heterocycle metabolic process,GO:0046483,"Diabetes Mellitus, Experimental",MESH:D003921,2,Niacinamide|sodium arsenite,0,
heterocycle metabolic process,GO:0046483,"Diabetes Mellitus, Type 1",MESH:D003922,2,Niacinamide|sodium arsenite,0,
heterocycle metabolic process,GO:0046483,"Diabetes Mellitus, Type 2",MESH:D003924,3,Ethanol|Niacinamide|perfluorooctanoic acid,0,
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007157,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ICAM1
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007157,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ICAM1|NOTCH2
heterotypic cell-cell adhesion,GO:0034113,Diabetes Mellitus,MESH:D003920,2,Docosahexaenoic Acids|Particulate Matter,0,
heterotypic cell-cell adhesion,GO:0034113,"Diabetes Mellitus, Experimental",MESH:D003921,4,Diethylhexyl Phthalate|Dronabinol|Hydrogen Peroxide|pimagedine,0,
heterotypic cell-cell adhesion,GO:0034113,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
heterotypic cell-cell adhesion,GO:0034113,"Diabetes Mellitus, Type 2",MESH:D003924,2,Diethylhexyl Phthalate|Particulate Matter,0,
hexokinase-dependent signaling,GO:0009747,"Diabetes Mellitus, Experimental",MESH:D003921,1,Taurine,0,
hexokinase-dependent signaling,GO:0009747,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
hexose biosynthetic process,GO:0019319,"Diabetes Mellitus, Experimental",MESH:D003921,1,Taurine,0,
hexose biosynthetic process,GO:0019319,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
hexose biosynthetic process,GO:0019319,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylnitrosamine,0,
hexose metabolic process,GO:0019318,Diabetes Mellitus,MESH:D003920,2,Streptozocin|Zinc,0,
hexose metabolic process,GO:0019318,"Diabetes Mellitus, Experimental",MESH:D003921,2,Fructose|Streptozocin,2,GCK|HK1
hexose metabolic process,GO:0019318,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
hexose metabolic process,GO:0019318,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
hexose metabolic process,GO:0019318,"Diabetes Mellitus, Type 2",MESH:D003924,3,Fructose|Streptozocin|Zinc,2,GCK|HK1
hexose transmembrane transport,GO:0008645,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
hexose transmembrane transport,GO:0008645,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,1,SLC2A2
hexose transmembrane transport,GO:0008645,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
hexose transmembrane transport,GO:0008645,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,1,SLC2A2
high-density lipoprotein particle assembly,GO:0034380,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
high-density lipoprotein particle assembly,GO:0034380,"Diabetes Mellitus, Experimental",MESH:D003921,1,"Cholesterol, HDL",0,
high-density lipoprotein particle assembly,GO:0034380,"Diabetes Mellitus, Type 2",MESH:D003924,1,"Cholesterol, HDL",0,
high-density lipoprotein particle clearance,GO:0034384,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
high-density lipoprotein particle remodeling,GO:0034375,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
hindbrain development,GO:0030902,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NEUROD1|PAX6
hindbrain development,GO:0030902,"Diabetes Mellitus, Permanent Neonatal, with Cerebellar Agenesis",MESH:C563796,0,,1,PTF1A
hindbrain development,GO:0030902,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Folic Acid,3,HNF1B|NEUROD1|PAX6
hippocampal interneuron differentiation,GO:0097410,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
hippocampal pyramidal neuron differentiation,GO:0097432,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
hippocampal pyramidal neuron differentiation,GO:0097432,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,0,
hippocampus development,GO:0021766,Diabetes Mellitus,MESH:D003920,4,Air Pollutants|bisphenol A|Particulate Matter|Selenium,1,KIF5B
hippocampus development,GO:0021766,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,2,CASP3|INSR
hippocampus development,GO:0021766,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
hippocampus development,GO:0021766,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
hippocampus development,GO:0021766,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|bisphenol A|Ethanol|Particulate Matter,2,CASP3|ENPP1
histamine biosynthetic process,GO:0001694,Diabetes Mellitus,MESH:D003920,1,Polychlorinated Biphenyls,0,
histamine biosynthetic process,GO:0001694,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cromolyn Sodium|Quercetin,0,
histamine biosynthetic process,GO:0001694,"Diabetes Mellitus, Type 2",MESH:D003924,1,Polychlorinated Biphenyls,0,
histamine metabolic process,GO:0001692,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
histamine metabolic process,GO:0001692,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,1,SLC22A3
histamine secretion,GO:0001821,Diabetes Mellitus,MESH:D003920,6,bisphenol A|Metformin|Plant Extracts|Plant Preparations|Resveratrol|Streptozocin,0,
histamine secretion,GO:0001821,"Diabetes Mellitus, Experimental",MESH:D003921,9,bisphenol A|Dietary Fats|Metformin|Plant Extracts|Plant Preparations|platycodin D|Quercetin|Resveratrol|Streptozocin,1,EDN1
histamine secretion,GO:0001821,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|Streptozocin,0,
histamine secretion,GO:0001821,"Diabetes Mellitus, Type 2",MESH:D003924,8,bisphenol A|Calcium|Dietary Fats|Metformin|perfluorooctanoic acid|Plant Extracts|Resveratrol|Streptozocin,2,EDN1|EDNRA
histamine secretion by mast cell,GO:0002553,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
histamine secretion by mast cell,GO:0002553,"Diabetes Mellitus, Experimental",MESH:D003921,2,Plant Extracts|Quercetin,0,
histamine secretion by mast cell,GO:0002553,"Diabetes Mellitus, Type 2",MESH:D003924,2,perfluorooctanoic acid|Plant Extracts,0,
histamine secretion involved in inflammatory response,GO:0002441,Diabetes Mellitus,MESH:D003920,1,Berberine,0,
histamine secretion involved in inflammatory response,GO:0002441,"Diabetes Mellitus, Experimental",MESH:D003921,1,Berberine,0,
histamine secretion involved in inflammatory response,GO:0002441,"Diabetes Mellitus, Type 2",MESH:D003924,2,Berberine|Calcium,0,
histamine secretion mediated by immunoglobulin,GO:0097280,Diabetes Mellitus,MESH:D003920,9,Allergens|Cyclosporine|Gallic Acid|Perphenazine|Potassium|Prednisolone|Sulpiride|Tacrolimus|Trifluoperazine,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Diabetes Mellitus, Experimental",MESH:D003921,9,Capsaicin|Cromolyn Sodium|Gallic Acid|Glucose|Quercetin|Streptomycin|Tacrolimus|Thromboxane B2|Vitamin E,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Diabetes Mellitus, Type 1",MESH:D003922,4,Calcitriol|Lipopolysaccharides|Norepinephrine|Tacrolimus,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Diabetes Mellitus, Type 2",MESH:D003924,5,Calcium|Ethanol|Glucose|Malathion|Nitrendipine,0,
"histamine secretion, neurotransmission",GO:0061538,Diabetes Mellitus,MESH:D003920,1,Potassium,0,
histamine transport,GO:0051608,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
histamine uptake,GO:0051615,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC22A3
histidine biosynthetic process,GO:0000105,"Diabetes Mellitus, Experimental",MESH:D003921,2,Diethylhexyl Phthalate|sodium arsenite,0,
histidine biosynthetic process,GO:0000105,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
histidine biosynthetic process,GO:0000105,"Diabetes Mellitus, Type 2",MESH:D003924,3,Diethylhexyl Phthalate|perfluorooctane sulfonic acid|perfluorooctanoic acid,0,
histidine metabolic process,GO:0006547,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
histidine metabolic process,GO:0006547,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dichlorodiphenyl Dichloroethylene,0,
histone acetylation,GO:0016573,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Lead,0,
histone acetylation,GO:0016573,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
histone acetylation,GO:0016573,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
histone acetylation,GO:0016573,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Lead,0,
histone H2A-K5 acetylation,GO:0043977,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
histone H2A ubiquitination,GO:0033522,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
histone H2A ubiquitination,GO:0033522,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
histone H2B conserved C-terminal lysine ubiquitination,GO:0071894,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
histone H2B conserved C-terminal lysine ubiquitination,GO:0071894,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Streptozocin,0,
histone H2B conserved C-terminal lysine ubiquitination,GO:0071894,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
histone H2B conserved C-terminal lysine ubiquitination,GO:0071894,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Streptozocin,0,
histone H3 acetylation,GO:0043966,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Metformin|Resveratrol|Streptozocin|Tobacco Smoke Pollution,0,
histone H3 acetylation,GO:0043966,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
histone H3 acetylation,GO:0043966,"Diabetes Mellitus, Experimental",MESH:D003921,14,"bellidifolin|bisphenol A|Clioquinol|Dietary Fats|Diethylhexyl Phthalate|Glucose|Hydrogen Peroxide|Metformin|Niacinamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Quercetin|Resveratrol|sodium arsenite|Streptozocin",0,
histone H3 acetylation,GO:0043966,"Diabetes Mellitus, Type 1",MESH:D003922,8,bisphenol A|Genistein|Lipopolysaccharides|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Warfarin,0,
histone H3 acetylation,GO:0043966,"Diabetes Mellitus, Type 2",MESH:D003924,13,Ascorbic Acid|bisphenol A|Curcumin|Dietary Fats|Diethylhexyl Phthalate|Genistein|Glucose|Metformin|mono-(2-ethylhexyl)phthalate|Niacinamide|Resveratrol|Silver|Streptozocin,0,
histone H3 deacetylation,GO:0070932,"Diabetes Mellitus, Experimental",MESH:D003921,1,honokiol,0,
histone H3 deacetylation,GO:0070932,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
histone H3-K14 acetylation,GO:0044154,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Resveratrol,0,
histone H3-K14 acetylation,GO:0044154,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Dronabinol|Hydrogen Peroxide|Nicotine|Resveratrol|sodium arsenite,0,
histone H3-K14 acetylation,GO:0044154,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Lipopolysaccharides|Resveratrol|sodium arsenite,0,
histone H3-K14 acetylation,GO:0044154,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Curcumin|Nicotine|Resveratrol,0,
histone H3-K18 acetylation,GO:0043971,Diabetes Mellitus,MESH:D003920,2,Arsenic|Arsenicals,0,
histone H3-K18 acetylation,GO:0043971,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dietary Fats|Hydrogen Peroxide|Manganese|sodium arsenite,0,
histone H3-K18 acetylation,GO:0043971,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
histone H3-K18 acetylation,GO:0043971,"Diabetes Mellitus, Type 2",MESH:D003924,3,Arsenic|Dietary Fats|Manganese,0,
histone H3-K23 acetylation,GO:0043972,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
histone H3-K23 acetylation,GO:0043972,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
histone H3-K23 acetylation,GO:0043972,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
histone H3-K27 acetylation,GO:0043974,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Resveratrol,0,
histone H3-K27 acetylation,GO:0043974,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Nicotine|Resveratrol|sodium arsenite,0,
histone H3-K27 acetylation,GO:0043974,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|sodium arsenite,0,
histone H3-K27 acetylation,GO:0043974,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Ethanol|Nicotine|perfluorodecanoic acid|Resveratrol,0,
histone H3-K27 demethylation,GO:0071557,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,0,
histone H3-K27 methylation,GO:0070734,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,0,
histone H3-K27 trimethylation,GO:0098532,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Dichlorodiphenyl Dichloroethylene|Lead|Resveratrol|Tobacco Smoke Pollution,0,
histone H3-K27 trimethylation,GO:0098532,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
histone H3-K27 trimethylation,GO:0098532,"Diabetes Mellitus, Experimental",MESH:D003921,6,"bisphenol A|Dietary Fats|Dronabinol|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Resveratrol|sodium arsenite",0,
histone H3-K27 trimethylation,GO:0098532,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|sodium arsenite,0,
histone H3-K27 trimethylation,GO:0098532,"Diabetes Mellitus, Type 2",MESH:D003924,6,bisphenol A|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylnitrosamine|Lead|Resveratrol,0,
histone H3-K36 dimethylation,GO:0097676,Diabetes Mellitus,MESH:D003920,2,Arsenic|bisphenol A,0,
histone H3-K36 dimethylation,GO:0097676,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Dietary Fats,0,
histone H3-K36 dimethylation,GO:0097676,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Lipopolysaccharides,0,
histone H3-K36 dimethylation,GO:0097676,"Diabetes Mellitus, Type 2",MESH:D003924,7,Arsenic|bisphenol A|bisphenol S|Dietary Fats|Diethylnitrosamine|Ethanol|mono-(2-ethylhexyl)phthalate,0,
histone H3-K36 methylation,GO:0010452,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
histone H3-K36 methylation,GO:0010452,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
histone H3-K36 methylation,GO:0010452,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
histone H3-K36 methylation,GO:0010452,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|bisphenol S|Ethanol,0,
histone H3-K36 trimethylation,GO:0097198,Diabetes Mellitus,MESH:D003920,3,Arsenic|bisphenol A|Reactive Oxygen Species,0,
histone H3-K36 trimethylation,GO:0097198,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Diethylhexyl Phthalate|sodium arsenite,0,
histone H3-K36 trimethylation,GO:0097198,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Reactive Oxygen Species|sodium arsenite,0,
histone H3-K36 trimethylation,GO:0097198,"Diabetes Mellitus, Type 2",MESH:D003924,7,Arsenic|bisphenol A|Diethylhexyl Phthalate|Diethylnitrosamine|Ethanol|mono-(2-ethylhexyl)phthalate|Reactive Oxygen Species,0,
histone H3-K4 acetylation,GO:0043973,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
histone H3-K4 acetylation,GO:0043973,"Diabetes Mellitus, Type 2",MESH:D003924,2,Genistein|mono-(2-ethylhexyl)phthalate,0,
histone H3-K4 demethylation,GO:0034720,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
histone H3-K4 demethylation,GO:0034720,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
histone H3-K4 dimethylation,GO:0044648,Diabetes Mellitus,MESH:D003920,5,Arsenic|arsenite|bisphenol A|Iron|Lead,0,
histone H3-K4 dimethylation,GO:0044648,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Glucose|sodium arsenite,0,
histone H3-K4 dimethylation,GO:0044648,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Iron|sodium arsenite,0,
histone H3-K4 dimethylation,GO:0044648,"Diabetes Mellitus, Type 2",MESH:D003924,8,Arsenic|bisphenol A|Ethanol|Folic Acid|Glucose|Iron|Lead|Nickel,0,
histone H3-K4 methylation,GO:0051568,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
histone H3-K4 methylation,GO:0051568,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Glucose|sodium arsenite,0,
histone H3-K4 methylation,GO:0051568,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
histone H3-K4 methylation,GO:0051568,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Ethanol|Glucose,0,
histone H3-K4 monomethylation,GO:0097692,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
histone H3-K4 monomethylation,GO:0097692,"Diabetes Mellitus, Experimental",MESH:D003921,4,Glucose|Hydrogen Peroxide|sodium arsenite|Streptozocin,0,
histone H3-K4 monomethylation,GO:0097692,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Streptozocin,0,
histone H3-K4 monomethylation,GO:0097692,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glucose|Streptozocin,0,
histone H3-K4 trimethylation,GO:0080182,Diabetes Mellitus,MESH:D003920,10,Arsenic|arsenite|Atrazine|bisphenol A|Cadmium|DDT|Dichlorodiphenyl Dichloroethylene|Lead|Streptozocin|Tobacco Smoke Pollution,0,
histone H3-K4 trimethylation,GO:0080182,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
histone H3-K4 trimethylation,GO:0080182,"Diabetes Mellitus, Experimental",MESH:D003921,7,"bisphenol A|Diethylhexyl Phthalate|Glucose|Hydrogen Peroxide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|sodium arsenite|Streptozocin",0,
histone H3-K4 trimethylation,GO:0080182,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|decabromobiphenyl ether|sodium arsenite|Streptozocin,0,
histone H3-K4 trimethylation,GO:0080182,"Diabetes Mellitus, Type 2",MESH:D003924,13,Arsenic|Atrazine|bisphenol A|Cadmium|Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|Ethanol|Glucose|Lead|mono-(2-ethylhexyl)phthalate|perfluorodecanoic acid|perfluorooctanoic acid|Streptozocin,0,
histone H3-K56 acetylation,GO:0097043,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
histone H3-K56 acetylation,GO:0097043,"Diabetes Mellitus, Experimental",MESH:D003921,1,Niacinamide,0,
histone H3-K56 acetylation,GO:0097043,"Diabetes Mellitus, Type 1",MESH:D003922,2,Niacinamide|Tetrachlorodibenzodioxin,0,
histone H3-K56 acetylation,GO:0097043,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Niacinamide,0,
histone H3-K79 methylation,GO:0034729,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
histone H3-K79 methylation,GO:0034729,"Diabetes Mellitus, Type 2",MESH:D003924,2,Diethylhexyl Phthalate|mono-(2-ethylhexyl)phthalate,0,
histone H3-K9 acetylation,GO:0043970,Diabetes Mellitus,MESH:D003920,9,Arsenic|arsenite|bisphenol A|Dichlorodiphenyl Dichloroethylene|Lead|Plant Extracts|Resveratrol|Streptozocin|Tetrachlorodibenzodioxin,0,
histone H3-K9 acetylation,GO:0043970,"Diabetes Mellitus, Experimental",MESH:D003921,9,bisphenol A|Dronabinol|Hydrogen Peroxide|Niacinamide|Nicotine|Plant Extracts|Resveratrol|sodium arsenite|Streptozocin,0,
histone H3-K9 acetylation,GO:0043970,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|Genistein|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin,0,
histone H3-K9 acetylation,GO:0043970,"Diabetes Mellitus, Type 2",MESH:D003924,14,Arsenic|bisphenol A|Dichlorodiphenyl Dichloroethylene|epigallocatechin gallate|Ethanol|Genistein|Lead|mono-(2-ethylhexyl)phthalate|Niacinamide|Nicotine|perfluorooctane sulfonic acid|Plant Extracts|Resveratrol|Streptozocin,0,
histone H3-K9 deacetylation,GO:1990619,"Diabetes Mellitus, Experimental",MESH:D003921,1,Lithocholic Acid,0,
histone H3-K9 deacetylation,GO:1990619,"Diabetes Mellitus, Type 2",MESH:D003924,1,Lithocholic Acid,0,
histone H3-K9 demethylation,GO:0033169,"Diabetes Mellitus, Experimental",MESH:D003921,2,Quercetin|sodium arsenite,0,
histone H3-K9 demethylation,GO:0033169,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
histone H3-K9 dimethylation,GO:0036123,Diabetes Mellitus,MESH:D003920,7,Arsenic|bisphenol A|Cadmium|Copper|Iron|Lead|Reactive Oxygen Species,0,
histone H3-K9 dimethylation,GO:0036123,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Diethylhexyl Phthalate|Dronabinol|Nitric Oxide|sodium arsenite,0,
histone H3-K9 dimethylation,GO:0036123,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Iron|Nitric Oxide|Reactive Oxygen Species|sodium arsenite,0,
histone H3-K9 dimethylation,GO:0036123,"Diabetes Mellitus, Type 2",MESH:D003924,11,Arsenic|bisphenol A|Cadmium|Copper|Diethylhexyl Phthalate|Ethanol|Folic Acid|Iron|Lead|perfluorooctanoic acid|Reactive Oxygen Species,0,
histone H3-K9 methylation,GO:0051567,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
histone H3-K9 methylation,GO:0051567,"Diabetes Mellitus, Experimental",MESH:D003921,4,Diethylhexyl Phthalate|Glucose|Nitric Oxide|sodium arsenite,0,
histone H3-K9 methylation,GO:0051567,"Diabetes Mellitus, Type 1",MESH:D003922,2,Nitric Oxide|sodium arsenite,0,
histone H3-K9 methylation,GO:0051567,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Diethylhexyl Phthalate|Glucose,0,
histone H3-K9 trimethylation,GO:0036124,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Zinc,0,
histone H3-K9 trimethylation,GO:0036124,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dronabinol|sodium arsenite,0,
histone H3-K9 trimethylation,GO:0036124,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
histone H3-K9 trimethylation,GO:0036124,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Ethanol|perfluorodecanoic acid|Zinc,0,
histone H4 acetylation,GO:0043967,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
histone H4 acetylation,GO:0043967,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
histone H4 acetylation,GO:0043967,"Diabetes Mellitus, Experimental",MESH:D003921,4,"bisphenol A|Diethylhexyl Phthalate|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Quercetin",0,
histone H4 acetylation,GO:0043967,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Warfarin,0,
histone H4 acetylation,GO:0043967,"Diabetes Mellitus, Type 2",MESH:D003924,5,Ascorbic Acid|bisphenol A|Curcumin|Diethylhexyl Phthalate|mono-(2-ethylhexyl)phthalate,0,
histone H4 deacetylation,GO:0070933,"Diabetes Mellitus, Experimental",MESH:D003921,1,honokiol,0,
histone H4-K12 acetylation,GO:0043983,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Cadmium,0,
histone H4-K12 acetylation,GO:0043983,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
histone H4-K12 acetylation,GO:0043983,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Cyclophosphamide|Dronabinol|sodium arsenite,0,
histone H4-K12 acetylation,GO:0043983,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Cyclophosphamide|sodium arsenite,0,
histone H4-K12 acetylation,GO:0043983,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Cadmium|epigallocatechin gallate,0,
histone H4-K16 acetylation,GO:0043984,Diabetes Mellitus,MESH:D003920,3,Arsenic|arsenite|Tobacco Smoke Pollution,0,
histone H4-K16 acetylation,GO:0043984,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
histone H4-K16 acetylation,GO:0043984,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
histone H4-K16 acetylation,GO:0043984,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Ethanol,0,
histone H4-K16 deacetylation,GO:1990678,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
histone H4-K16 deacetylation,GO:1990678,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Streptozocin,0,
histone H4-K16 deacetylation,GO:1990678,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
histone H4-K16 deacetylation,GO:1990678,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Streptozocin,0,
histone H4-K20 trimethylation,GO:0034773,Diabetes Mellitus,MESH:D003920,2,Tobacco Smoke Pollution|Zinc,0,
histone H4-K20 trimethylation,GO:0034773,"Diabetes Mellitus, Experimental",MESH:D003921,2,Hydrogen Peroxide|sodium arsenite,0,
histone H4-K20 trimethylation,GO:0034773,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
histone H4-K20 trimethylation,GO:0034773,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Zinc,0,
histone H4-K5 acetylation,GO:0043981,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
histone H4-K5 acetylation,GO:0043981,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
histone H4-K8 acetylation,GO:0043982,Diabetes Mellitus,MESH:D003920,1,Arsenicals,0,
histone H4-K8 acetylation,GO:0043982,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
histone H4-K8 acetylation,GO:0043982,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
histone methylation,GO:0016571,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
histone methylation,GO:0016571,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
histone methylation,GO:0016571,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
histone methylation,GO:0016571,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
histone modification,GO:0016570,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
histone modification,GO:0016570,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
homeostasis of number of cells,GO:0048872,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
homeostasis of number of cells,GO:0048872,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
homeostasis of number of cells within a tissue,GO:0048873,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Tetrachlorodibenzodioxin,1,RAC1
homeostasis of number of cells within a tissue,GO:0048873,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
homeostasis of number of cells within a tissue,GO:0048873,"Diabetes Mellitus, Experimental",MESH:D003921,3,"bisphenol A|Manganese|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",4,BAX|BCL2|NOS3|VEGFA
homeostasis of number of cells within a tissue,GO:0048873,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Tetrachlorodibenzodioxin,1,NOS3
homeostasis of number of cells within a tissue,GO:0048873,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Manganese,3,BAX|BCL2|NOS3
homocysteine biosynthetic process,GO:0071268,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
homocysteine biosynthetic process,GO:0071268,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
homocysteine catabolic process,GO:0043418,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
homocysteine metabolic process,GO:0050667,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Lead,0,
homocysteine metabolic process,GO:0050667,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dietary Fats|sodium arsenite,0,
homocysteine metabolic process,GO:0050667,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
homocysteine metabolic process,GO:0050667,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Dietary Fats|Folic Acid|Lead,1,CBS
homologous chromosome orientation involved in meiotic metaphase I plate congression,GO:0031619,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
homologous chromosome orientation involved in meiotic metaphase I plate congression,GO:0031619,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
homologous chromosome orientation involved in meiotic metaphase I plate congression,GO:0031619,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Resveratrol,0,
homologous chromosome orientation involved in meiotic metaphase I plate congression,GO:0031619,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
homologous chromosome pairing at meiosis,GO:0007129,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
homologous chromosome pairing at meiosis,GO:0007129,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
homologous chromosome pairing at meiosis,GO:0007129,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|decabromobiphenyl ether,0,
homologous chromosome pairing at meiosis,GO:0007129,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
homologous recombination,GO:0035825,"Diabetes Mellitus, Experimental",MESH:D003921,2,Hydrogen Peroxide|Propolis,0,
homologous recombination,GO:0035825,"Diabetes Mellitus, Type 1",MESH:D003922,1,decabromobiphenyl ether,0,
homotypic cell-cell adhesion,GO:0034109,Diabetes Mellitus,MESH:D003920,4,"Arsenic|bisphenol A|o,p'-DDT|Particulate Matter",0,
homotypic cell-cell adhesion,GO:0034109,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dronabinol|sodium arsenite,0,
homotypic cell-cell adhesion,GO:0034109,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Calcitriol|sodium arsenite,0,
homotypic cell-cell adhesion,GO:0034109,"Diabetes Mellitus, Type 2",MESH:D003924,4,Arsenic|bisphenol A|Particulate Matter|perfluorooctanoic acid,0,
hormone biosynthetic process,GO:0042446,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP1A1
hormone biosynthetic process,GO:0042446,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP1A2
hormone catabolic process,GO:0042447,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACE
hormone catabolic process,GO:0042447,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ECE1
hormone-mediated signaling pathway,GO:0009755,Diabetes Mellitus,MESH:D003920,0,,2,A|PPARG
hormone-mediated signaling pathway,GO:0009755,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,PPARA|PPARG|REN
hormone-mediated signaling pathway,GO:0009755,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,A|PPARA|PPARG
hormone metabolic process,GO:0042445,Diabetes Mellitus,MESH:D003920,4,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|bisphenol A|Polychlorinated Biphenyls",0,
hormone metabolic process,GO:0042445,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,3,ACE|AGT|LEP
hormone metabolic process,GO:0042445,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|decabromobiphenyl ether|Lipopolysaccharides,0,
hormone metabolic process,GO:0042445,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|perfluorooctane sulfonic acid|Polychlorinated Biphenyls,2,ENPP1|LEP
hormone secretion,GO:0046879,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GLP1R
host-mediated regulation of intestinal microbiota composition,GO:0048874,Diabetes Mellitus,MESH:D003920,11,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|bisphenol A|Cadmium|Chlorpyrifos|Lead|Mercury|Metformin|Particulate Matter|Selenium|Streptozocin",0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Diabetes Mellitus, Experimental",MESH:D003921,9,Bile Acids and Salts|bisphenol A|Dietary Fats|Dronabinol|Manganese|Metformin|sodium arsenite|Sodium Glutamate|Streptozocin,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Lipopolysaccharides|Mercury|sodium arsenite|Streptozocin,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Diabetes Mellitus, Type 2",MESH:D003924,13,Air Pollutants|bisphenol A|bisphenol S|Cadmium|Dietary Fats|Ethanol|Lead|Manganese|Mercury|Metformin|Particulate Matter|perfluorooctane sulfonic acid|Streptozocin,0,
HRI-mediated signaling,GO:0140468,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
humoral immune response,GO:0006959,Diabetes Mellitus,MESH:D003920,4,Dichlorodiphenyl Dichloroethylene|Hexachlorobenzene|Lead|Polychlorinated Biphenyls,0,
humoral immune response,GO:0006959,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,BCL2|IFNG|IL6|TNF
humoral immune response,GO:0006959,"Diabetes Mellitus, Type 1",MESH:D003922,0,,5,HLA-DQB1|HLA-DRB1|IFNG|IL6|TNF
humoral immune response,GO:0006959,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dichlorodiphenyl Dichloroethylene|Lead|Polychlorinated Biphenyls,5,BCL2|IL6|NOTCH2|ST6GAL1|TNF
humoral immune response mediated by circulating immunoglobulin,GO:0002455,Diabetes Mellitus,MESH:D003920,3,"Arsenic|Fatty Acids, Omega-3|Mercury",0,
humoral immune response mediated by circulating immunoglobulin,GO:0002455,"Diabetes Mellitus, Experimental",MESH:D003921,2,"Fatty Acids, Omega-3|ginsenoside Re",0,
humoral immune response mediated by circulating immunoglobulin,GO:0002455,"Diabetes Mellitus, Type 1",MESH:D003922,1,Mercury,0,
humoral immune response mediated by circulating immunoglobulin,GO:0002455,"Diabetes Mellitus, Type 2",MESH:D003924,6,Arsenic|ginsenoside Re|Mercury|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid,0,
hyaluronan biosynthetic process,GO:0030213,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IL1B
hyaluronan catabolic process,GO:0030214,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,SLC9A1|TGFB1
hyaluronan metabolic process,GO:0030212,Diabetes Mellitus,MESH:D003920,1,Cyclosporine,0,
hyaluronan metabolic process,GO:0030212,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
hyaluronan metabolic process,GO:0030212,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
hydrocarbon metabolic process,GO:0120252,Diabetes Mellitus,MESH:D003920,3,2-naphthol|Pravastatin|Selenium,0,
hydrocarbon metabolic process,GO:0120252,"Diabetes Mellitus, Experimental",MESH:D003921,2,sodium arsenite|Taurine,0,
hydrocarbon metabolic process,GO:0120252,"Diabetes Mellitus, Type 1",MESH:D003922,2,sodium arsenite|Taurine,0,
hydrogen peroxide biosynthetic process,GO:0050665,Diabetes Mellitus,MESH:D003920,21,Alloxan|Arsenic|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpyrifos|Cyclosporine|Diazoxide|Docosahexaenoic Acids|Gallic Acid|Lead|Mercury|Metformin|Particulate Matter|Plant Extracts|Pravastatin|Prednisolone|Pyruvaldehyde|Resveratrol|Streptozocin|Sulfur Dioxide,3,CYBB|NCF1|SOD1
hydrogen peroxide biosynthetic process,GO:0050665,"Diabetes Mellitus, Experimental",MESH:D003921,20,7-hydroxycoumarin|Alloxan|Anthocyanins|bisphenol A|Coconut Oil|Dietary Fats|Gallic Acid|Glucose|Hydrogen Peroxide|Manganese|Metformin|methylamine|Nitric Oxide|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Streptozocin|Taurine|tributyltin,7,ACOX1|CYBA|CYBB|CYP1A1|NCF1|SOD1|SOD2
hydrogen peroxide biosynthetic process,GO:0050665,"Diabetes Mellitus, Type 1",MESH:D003922,10,Alloxan|bisphenol A|Genistein|Lipopolysaccharides|Mercury|Nitric Oxide|Resveratrol|sodium arsenite|Streptozocin|Taurine,0,
hydrogen peroxide biosynthetic process,GO:0050665,"Diabetes Mellitus, Type 2",MESH:D003924,28,Alloxan|Arsenic|Ascorbic Acid|bisphenol A|bisphenol S|Cadmium|Calcium|Curcumin|Cysteine|Dietary Fats|epigallocatechin gallate|Ethanol|Folic Acid|Genistein|Glucose|Glutathione|Lead|Malathion|Manganese|Mercury|Metformin|Nickel|Particulate Matter|perfluorooctanoic acid|Plant Extracts|Resveratrol|Streptozocin|titanium dioxide,4,CYBA|CYP1A2|SOD1|SOD2
hydrogen peroxide catabolic process,GO:0042744,Diabetes Mellitus,MESH:D003920,1,Copper,1,CAT
hydrogen peroxide catabolic process,GO:0042744,"Diabetes Mellitus, Experimental",MESH:D003921,3,Hydrogen Peroxide|Manganese|sodium arsenite,3,CAT|GPX1|MPO
hydrogen peroxide catabolic process,GO:0042744,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,1,CAT
hydrogen peroxide catabolic process,GO:0042744,"Diabetes Mellitus, Type 2",MESH:D003924,4,Calcium|Copper|Glutathione|Manganese,3,CAT|GPX1|HBA1
hydrogen peroxide metabolic process,GO:0042743,Diabetes Mellitus,MESH:D003920,12,Air Pollutants|Arsenic|arsenite|Atrazine|bisphenol A|Cadmium|Chlorpyrifos|Ozone|Resveratrol|Selenium|Sodium Selenite|Streptozocin,0,
hydrogen peroxide metabolic process,GO:0042743,"Diabetes Mellitus, Experimental",MESH:D003921,12,bisphenol A|Dietary Fats|Hydrogen Peroxide|Losartan|Manganese|Nitric Oxide|Resveratrol|sarpogrelate|sodium arsenite|Sodium Selenite|Streptozocin|Vitamin E,1,SOD2
hydrogen peroxide metabolic process,GO:0042743,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|Nitric Oxide|Resveratrol|sodium arsenite|Streptozocin|Thioctic Acid,0,
hydrogen peroxide metabolic process,GO:0042743,"Diabetes Mellitus, Type 2",MESH:D003924,12,Air Pollutants|Arsenic|Ascorbic Acid|Atrazine|bisphenol A|Cadmium|Curcumin|Dietary Fats|Ethanol|Manganese|Resveratrol|Streptozocin,2,EGFR|SOD2
hydrogen sulfide biosynthetic process,GO:0070814,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
hydrogen sulfide biosynthetic process,GO:0070814,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
hydrogen sulfide biosynthetic process,GO:0070814,"Diabetes Mellitus, Type 2",MESH:D003924,3,Arsenic|Cysteine|Glucose,1,CBS
hydrogen sulfide metabolic process,GO:0070813,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
hydrogen sulfide metabolic process,GO:0070813,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
hydrogen sulfide metabolic process,GO:0070813,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
hydrogen sulfide metabolic process,GO:0070813,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
hydroperoxide metabolic process,GO:2001290,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
hydroperoxide metabolic process,GO:2001290,"Diabetes Mellitus, Experimental",MESH:D003921,3,Cyclophosphamide|Hydrogen Peroxide|tributyltin,0,
hydroperoxide metabolic process,GO:2001290,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
hydroxyproline transport,GO:0034589,Diabetes Mellitus,MESH:D003920,1,"pregna-4,17-diene-3,16-dione",0,
hypermethylation of CpG island,GO:0044027,Diabetes Mellitus,MESH:D003920,7,"2,4,5,2',4',5'-hexachlorobiphenyl|Agent Orange|Arsenic|oxychlordane|Polychlorinated Biphenyls|Resveratrol|Tetrachlorodibenzodioxin",1,ZFP57
hypermethylation of CpG island,GO:0044027,"Diabetes Mellitus, Experimental",MESH:D003921,2,Nicotine|Resveratrol,0,
hypermethylation of CpG island,GO:0044027,"Diabetes Mellitus, Transient Neonatal, 1",MESH:C563322,0,,1,ZFP57
hypermethylation of CpG island,GO:0044027,"Diabetes Mellitus, Type 1",MESH:D003922,2,Resveratrol|Tetrachlorodibenzodioxin,0,
hypermethylation of CpG island,GO:0044027,"Diabetes Mellitus, Type 2",MESH:D003924,6,Agent Orange|Arsenic|Curcumin|Nicotine|Polychlorinated Biphenyls|Resveratrol,0,
hyperosmotic response,GO:0006972,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
hypersensitivity,GO:0002524,Diabetes Mellitus,MESH:D003920,1,Tobacco Smoke Pollution,0,
hypersensitivity,GO:0002524,"Diabetes Mellitus, Type 2",MESH:D003924,1,Vehicle Emissions,0,
hypochlorous acid biosynthetic process,GO:0002149,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MPO
hypochlorous acid biosynthetic process,GO:0002149,"Diabetes Mellitus, Type 2",MESH:D003924,2,epigallocatechin gallate|Nickel,0,
hypomethylation of CpG island,GO:0044029,Diabetes Mellitus,MESH:D003920,8,"2,2',4,4'-tetrabromodiphenyl ether|Agent Orange|Air Pollutants|Arsenicals|bisphenol A|Nitrogen Dioxide|Nitrogen Oxides|Tetrachlorodibenzodioxin",0,
hypomethylation of CpG island,GO:0044029,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sodium arsenite,0,
hypomethylation of CpG island,GO:0044029,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Tetrachlorodibenzodioxin,0,
hypomethylation of CpG island,GO:0044029,"Diabetes Mellitus, Type 2",MESH:D003924,4,Agent Orange|Air Pollutants|bisphenol A|Curcumin,1,OGG1
hypothalamus cell differentiation,GO:0021979,Diabetes Mellitus,MESH:D003920,1,Serotonin,0,
hypothalamus development,GO:0021854,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
hypothalamus development,GO:0021854,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BAX|ETS1
hypotonic response,GO:0006971,"Diabetes Mellitus, Experimental",MESH:D003921,1,Taurine,0,
hypotonic response,GO:0006971,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
hypoxanthine biosynthetic process,GO:0046101,"Diabetes Mellitus, Experimental",MESH:D003921,2,Diethylhexyl Phthalate|sodium arsenite,0,
hypoxanthine biosynthetic process,GO:0046101,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
hypoxanthine biosynthetic process,GO:0046101,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,0,
hypoxanthine metabolic process,GO:0046100,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
hypoxanthine metabolic process,GO:0046100,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
hypoxanthine metabolic process,GO:0046100,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
hypoxanthine metabolic process,GO:0046100,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
hypoxia-inducible factor-1alpha signaling pathway,GO:0097411,Diabetes Mellitus,MESH:D003920,0,,1,CYBB
hypoxia-inducible factor-1alpha signaling pathway,GO:0097411,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYBB
icosanoid biosynthetic process,GO:0046456,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
icosanoid biosynthetic process,GO:0046456,"Diabetes Mellitus, Experimental",MESH:D003921,1,Thromboxane B2,1,CYP4A10
icosanoid metabolic process,GO:0006690,Diabetes Mellitus,MESH:D003920,3,Docosahexaenoic Acids|Streptozocin|Tetrachlorodibenzodioxin,0,
icosanoid metabolic process,GO:0006690,"Diabetes Mellitus, Experimental",MESH:D003921,3,sodium arsenite|Streptozocin|Thromboxane B2,0,
icosanoid metabolic process,GO:0006690,"Diabetes Mellitus, Type 1",MESH:D003922,3,sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin,0,
icosanoid metabolic process,GO:0006690,"Diabetes Mellitus, Type 2",MESH:D003924,1,Streptozocin,0,
icosanoid secretion,GO:0032309,"Diabetes Mellitus, Experimental",MESH:D003921,1,Thromboxane B2,0,
icosanoid secretion,GO:0032309,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
I-kappaB kinase/NF-kappaB signaling,GO:0007249,Diabetes Mellitus,MESH:D003920,4,Flavonoids|Plant Extracts|Reactive Oxygen Species|Zinc,0,
I-kappaB kinase/NF-kappaB signaling,GO:0007249,"Diabetes Mellitus, Experimental",MESH:D003921,4,ginsenoside Re|mangiferin|Plant Extracts|sodium arsenite,1,RELA
I-kappaB kinase/NF-kappaB signaling,GO:0007249,"Diabetes Mellitus, Type 1",MESH:D003922,3,Lipopolysaccharides|Reactive Oxygen Species|sodium arsenite,0,
I-kappaB kinase/NF-kappaB signaling,GO:0007249,"Diabetes Mellitus, Type 2",MESH:D003924,6,ginsenoside Re|mangiferin|Plant Extracts|Reactive Oxygen Species|Vildagliptin|Zinc,2,AKT1|NFKB1
I-kappaB phosphorylation,GO:0007252,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
I-kappaB phosphorylation,GO:0007252,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
I-kappaB phosphorylation,GO:0007252,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Resveratrol,0,
I-kappaB phosphorylation,GO:0007252,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
imaginal disc-derived wing hair site selection,GO:0035320,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
imaginal disc-derived wing morphogenesis,GO:0007476,Diabetes Mellitus,MESH:D003920,0,,1,CP
imaginal disc-derived wing morphogenesis,GO:0007476,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CP
imaginal disc-derived wing morphogenesis,GO:0007476,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,EGFR|GCLC
imaginal disc-derived wing vein morphogenesis,GO:0008586,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
imaginal disc-derived wing vein specification,GO:0007474,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
imaginal disc development,GO:0007444,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
imaginal disc eversion,GO:0007561,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP2
"imaginal disc fusion, thorax closure",GO:0046529,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP2
immune complex formation,GO:0097281,Diabetes Mellitus,MESH:D003920,1,Mercury,0,
immune complex formation,GO:0097281,"Diabetes Mellitus, Type 1",MESH:D003922,1,Mercury,0,
immune complex formation,GO:0097281,"Diabetes Mellitus, Type 2",MESH:D003924,1,Mercury,0,
immune response,GO:0006955,Diabetes Mellitus,MESH:D003920,3,Mercury|Tobacco Smoke Pollution|Zinc,0,
immune response,GO:0006955,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,0,,1,TNFSF8
immune response,GO:0006955,"Diabetes Mellitus, Experimental",MESH:D003921,2,Quercetin|sodium arsenite,10,ATF3|BDKRB1|CCL20|CX3CL1|FAS|IFNG|IL1B|IL6|TNF|TNFRSF1A
immune response,GO:0006955,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
immune response,GO:0006955,"Diabetes Mellitus, Insulin-Dependent, 12",MESH:C563326,0,,1,CTLA4
immune response,GO:0006955,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
immune response,GO:0006955,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
immune response,GO:0006955,"Diabetes Mellitus, Type 1",MESH:D003922,3,Genistein|Mercury|sodium arsenite,12,CCL20|CTSH|HLA-DQA1|HLA-DQB1|HLA-DRB1|IFNG|IL10|IL19|IL2RA|IL6|TNF|TYK2
immune response,GO:0006955,"Diabetes Mellitus, Type 2",MESH:D003924,6,Genistein|Mercury|perfluorodecanoic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Zinc,13,ATF3|C3|CAPN10|CASP8|CD36|ENPP1|ETS1|FAS|IL6|PIK3CG|TNF|TNFRSF1A|TNFRSF1B
immune response-regulating cell surface receptor signaling pathway,GO:0002768,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TNFRSF1B
immune response-regulating signaling pathway,GO:0002764,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CTSH
immune system development,GO:0002520,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
immune system development,GO:0002520,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2
immune system process,GO:0002376,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,1,HK1
immune system process,GO:0002376,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,1,HP
immune system process,GO:0002376,"Diabetes Mellitus, Type 2",MESH:D003924,0,,5,ETS1|HK1|HP|INPPL1|PIK3CG
immunoglobulin mediated immune response,GO:0016064,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
immunoglobulin mediated immune response,GO:0016064,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,LEPR|PRKCD
immunoglobulin mediated immune response,GO:0016064,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,IL13RA1|LEPR
immunoglobulin production,GO:0002377,Diabetes Mellitus,MESH:D003920,8,bisphenol A|Dichlorodiphenyl Dichloroethylene|Hexachlorobenzene|Lead|Mercury|Ozone|Polychlorinated Biphenyls|Tetrachlorodibenzodioxin,0,
immunoglobulin production,GO:0002377,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,FAS
immunoglobulin production,GO:0002377,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|decabromobiphenyl ether|Mercury|Tetrachlorodibenzodioxin,0,
immunoglobulin production,GO:0002377,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Dichlorodiphenyl Dichloroethylene|Lead|Mercury|Polychlorinated Biphenyls,1,FAS
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,Diabetes Mellitus,MESH:D003920,8,Arsenic|Atrazine|bisphenol A|Mercury|Particulate Matter|Plant Extracts|Selenium|Tetrachlorodibenzodioxin,0,
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Diethylhexyl Phthalate|Manganese|Plant Extracts,0,
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Mercury|Tetrachlorodibenzodioxin,0,
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,"Diabetes Mellitus, Type 2",MESH:D003924,12,"Arsenic|Atrazine|bisphenol A|Diethylhexyl Phthalate|Drugs, Chinese Herbal|Manganese|Mercury|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts|Vehicle Emissions",1,ENPP1
import across plasma membrane,GO:0098739,"Diabetes Mellitus, Experimental",MESH:D003921,2,Bile Acids and Salts|Dibutyl Phthalate,0,
import across plasma membrane,GO:0098739,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dibutyl Phthalate,0,
import into cell,GO:0098657,Diabetes Mellitus,MESH:D003920,6,Chlorpromazine|Copper|Cyclosporine|Iron|Particulate Matter|Zinc,0,
import into cell,GO:0098657,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|tributyltin,0,
import into cell,GO:0098657,"Diabetes Mellitus, Type 1",MESH:D003922,2,Iron|Lipopolysaccharides,0,
import into cell,GO:0098657,"Diabetes Mellitus, Type 2",MESH:D003924,8,Calcium|Copper|epigallocatechin gallate|Glucose|Iron|Particulate Matter|Vehicle Emissions|Zinc,0,
import into nucleus,GO:0051170,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Lead,0,
import into nucleus,GO:0051170,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
import into nucleus,GO:0051170,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Lipopolysaccharides,1,BACH2
import into nucleus,GO:0051170,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Lead,0,
IMP salvage,GO:0032264,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HECTD4
indole metabolic process,GO:0042431,Diabetes Mellitus,MESH:D003920,3,Atrazine|Serotonin|Uranium,0,
indole metabolic process,GO:0042431,"Diabetes Mellitus, Type 2",MESH:D003924,1,Atrazine,0,
induction by symbiont of defense-related host reactive oxygen species production,GO:0052064,"Diabetes Mellitus, Experimental",MESH:D003921,1,cobaltiprotoporphyrin,0,
induction of positive chemotaxis,GO:0050930,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,PRKCA|VEGFA
inflammasome complex assembly,GO:0140632,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Uric Acid,0,
inflammatory cell apoptotic process,GO:0006925,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
inflammatory cell apoptotic process,GO:0006925,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,FAS|IFNG
inflammatory cell apoptotic process,GO:0006925,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IFNG
inflammatory cell apoptotic process,GO:0006925,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,2,FAS|HMGA1
inflammatory response,GO:0006954,Diabetes Mellitus,MESH:D003920,36,Air Pollutants|Allergens|Arsenic|Aspirin|Atrazine|Berberine|bisphenol A|Cadmium|Chlorpyrifos|Copper|Cyclosporine|Diazinon|Docosahexaenoic Acids|Flavonoids|Gallic Acid|Gliclazide|Glyburide|Iron|Lead|lipoxin A4|Mercury|Metformin|Methylprednisolone|Nitrogen Oxides|Ozone|Particulate Matter|Perindopril|Pioglitazone|Plant Extracts|Prednisone|repaglinide|Resveratrol|Streptozocin|Sulfur Dioxide|Tobacco Smoke Pollution|Zinc,6,AOC3|CP|CYBB|NCF1|PPARG|RAC1
inflammatory response,GO:0006954,"Diabetes Mellitus, Experimental",MESH:D003921,34,Berberine|bisphenol A|Cholesterol|cinnamaldehyde|Coconut Oil|corilagin|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Diosmin|Dronabinol|Fructose|Gallic Acid|Gliclazide|Glyburide|Losartan|Metformin|Nicotine|Nitric Oxide|Palm Oil|Pioglitazone|Plant Extracts|platycodin D|Quercetin|Resveratrol|S-allylcysteine|sodium arsenite|Sodium Glutamate|Streptozocin|thymoquinone|tianhuang|tributyltin|Ursolic Acid,16,AOC3|BDKRB1|CCL20|CX3CL1|CYBA|CYBB|HK1|IL1B|IL6|NCF1|NOS2|PPARG|RELA|TGFB1|TNF|TNFRSF1A
inflammatory response,GO:0006954,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
inflammatory response,GO:0006954,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
inflammatory response,GO:0006954,"Diabetes Mellitus, Type 1",MESH:D003922,12,bisphenol A|Genistein|Iron|Lipopolysaccharides|Mercury|Nitric Oxide|Palm Oil|Resveratrol|sodium arsenite|Streptozocin|Thioctic Acid|Uric Acid,10,CCL20|CP|CRP|IL27|IL2RA|IL6|PRKCQ|SLC11A1|STAT3|TNF
inflammatory response,GO:0006954,"Diabetes Mellitus, Type 2",MESH:D003924,43,Air Pollutants|Arsenic|Ascorbic Acid|Atrazine|Berberine|bisphenol A|bisphenol S|Cadmium|cinnamaldehyde|Copper|Curcumin|Dibutyl Phthalate|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|Diethylnitrosamine|Diosmin|epigallocatechin gallate|Ethanol|Fructose|Genistein|Gliclazide|Glyburide|Irbesartan|Iron|Lead|Mercury|Metformin|Nickel|Nicotine|Particulate Matter|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|perfluoroundecanoic acid|Pioglitazone|Plant Extracts|Resveratrol|Streptozocin|Vehicle Emissions|Vildagliptin|Zinc,16,AKT1|C3|CDO1|CYBA|HK1|HMGA1|IL6|MIR130B|MIR221|NFKB1|NOS2|PIK3CG|PPARG|TNF|TNFRSF1A|TNFRSF1B
inflammatory response to antigenic stimulus,GO:0002437,Diabetes Mellitus,MESH:D003920,4,Air Pollutants|bisphenol A|Particulate Matter|Resveratrol,0,
inflammatory response to antigenic stimulus,GO:0002437,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Diethylhexyl Phthalate|Resveratrol,2,CD68|IL1B
inflammatory response to antigenic stimulus,GO:0002437,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
inflammatory response to antigenic stimulus,GO:0002437,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
inflammatory response to antigenic stimulus,GO:0002437,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Resveratrol,2,HLA-DRB1|IL2RA
inflammatory response to antigenic stimulus,GO:0002437,"Diabetes Mellitus, Type 2",MESH:D003924,8,Air Pollutants|bisphenol A|Diethylhexyl Phthalate|Particulate Matter|perfluorooctanoic acid|Resveratrol|Sitagliptin Phosphate|Vehicle Emissions,2,ENPP1|NOTCH2
inflammatory response to wounding,GO:0090594,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,IL6|MMP9|TNF
inflammatory response to wounding,GO:0090594,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IL6|TNF
inflammatory response to wounding,GO:0090594,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,IL6|TNF
inhibin secretion,GO:0032334,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
inhibin secretion,GO:0032334,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
inhibin secretion,GO:0032334,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
inhibin secretion,GO:0032334,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
inhibition of non-skeletal tissue mineralization,GO:0140928,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
inhibitory chemical synaptic transmission,GO:0098977,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
inhibitory chemical synaptic transmission,GO:0098977,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
inhibitory chemical synaptic transmission,GO:0098977,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
inhibitory chemical synaptic transmission,GO:0098977,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
inhibitory postsynaptic potential,GO:0060080,Diabetes Mellitus,MESH:D003920,5,Chlorpromazine|Clozapine|Risperidone|Serotonin|Sulpiride,1,ADRB1
inhibitory postsynaptic potential,GO:0060080,"Diabetes Mellitus, Experimental",MESH:D003921,2,Capsaicin|Nicotine,1,CX3CL1
inhibitory postsynaptic potential,GO:0060080,"Diabetes Mellitus, Type 2",MESH:D003924,5,Calcium|Clozapine|Nicotine|Orlistat|Topiramate,0,
initiation of primordial ovarian follicle growth,GO:0001544,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Particulate Matter,0,
initiation of primordial ovarian follicle growth,GO:0001544,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Diethylhexyl Phthalate|Dronabinol,1,FOXO3
initiation of primordial ovarian follicle growth,GO:0001544,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
initiation of primordial ovarian follicle growth,GO:0001544,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Diethylhexyl Phthalate|Particulate Matter,0,
innate immune response,GO:0045087,Diabetes Mellitus,MESH:D003920,3,Arsenic|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution,5,ALPK1|CYBB|MAP3K5|NCF1|PPARG
innate immune response,GO:0045087,"Diabetes Mellitus, Experimental",MESH:D003921,0,,10,CYBA|CYBB|HK1|MAP3K5|NCF1|NQO1|PPARG|RELA|SOD2|TNFRSF1A
innate immune response,GO:0045087,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Tetrachlorodibenzodioxin,2,CRP|IL27
innate immune response,GO:0045087,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,10,C3|CCDC92|CYBA|GP2|HK1|NFKB1|PIK3CG|PPARG|SOD2|TNFRSF1A
innate immune response in mucosa,GO:0002227,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NOS2
innate immune response in mucosa,GO:0002227,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOS2
innate vocalization behavior,GO:0098582,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Tetrachlorodibenzodioxin,0,
innate vocalization behavior,GO:0098582,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
innate vocalization behavior,GO:0098582,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Tetrachlorodibenzodioxin,0,
innate vocalization behavior,GO:0098582,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,AUTS2
inner cell mass cell differentiation,GO:0001826,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF1B
inner cell mass cell proliferation,GO:0001833,Diabetes Mellitus,MESH:D003920,2,Pyruvaldehyde|Resveratrol,0,
inner cell mass cell proliferation,GO:0001833,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
inner cell mass cell proliferation,GO:0001833,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
inner cell mass cell proliferation,GO:0001833,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
inner ear auditory receptor cell differentiation,GO:0042491,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
inner ear auditory receptor cell differentiation,GO:0042491,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ABCC8
inner ear auditory receptor cell differentiation,GO:0042491,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ABCC8
inner ear development,GO:0048839,Diabetes Mellitus,MESH:D003920,0,,1,LEPR
inner ear development,GO:0048839,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,IGF1|LEPR|NEUROD1|TGFB1
inner ear development,GO:0048839,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
inner ear development,GO:0048839,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,KCNQ1|LEPR|NEUROD1|PROX1
inner ear morphogenesis,GO:0042472,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
inner ear morphogenesis,GO:0042472,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ABCC8
inner ear morphogenesis,GO:0042472,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ABCC8|KCNQ1
inner ear receptor cell development,GO:0060119,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,NEUROD1
inner ear receptor cell development,GO:0060119,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
inner ear receptor cell development,GO:0060119,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NEUROD1
inner ear receptor cell stereocilium organization,GO:0060122,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
inner ear receptor cell stereocilium organization,GO:0060122,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,ABCC8
inner ear receptor cell stereocilium organization,GO:0060122,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ABCC8
inner mitochondrial membrane organization,GO:0007007,Diabetes Mellitus,MESH:D003920,1,Cyclosporine,0,
inner mitochondrial membrane organization,GO:0007007,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
inner mitochondrial membrane organization,GO:0007007,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
innervation,GO:0060384,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
innervation,GO:0060384,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Nicotine,0,
innervation,GO:0060384,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
innervation,GO:0060384,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Nicotine,1,C3
inorganic anion import across plasma membrane,GO:0098658,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ascorbic Acid,0,
inorganic cation import across plasma membrane,GO:0098659,Diabetes Mellitus,MESH:D003920,4,Cadmium|Reactive Oxygen Species|Resveratrol|Serotonin,0,
inorganic cation import across plasma membrane,GO:0098659,"Diabetes Mellitus, Experimental",MESH:D003921,3,Hydrogen Peroxide|Losartan|Resveratrol,0,
inorganic cation import across plasma membrane,GO:0098659,"Diabetes Mellitus, Type 1",MESH:D003922,2,Reactive Oxygen Species|Resveratrol,0,
inorganic cation import across plasma membrane,GO:0098659,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Reactive Oxygen Species|Resveratrol,0,
inorganic cation transmembrane transport,GO:0098662,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nitric Oxide,1,KCNJ11
inorganic cation transmembrane transport,GO:0098662,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
inorganic cation transmembrane transport,GO:0098662,"Diabetes Mellitus, Transient Neonatal, 3",MESH:C566432,0,,1,KCNJ11
inorganic cation transmembrane transport,GO:0098662,"Diabetes Mellitus, Type 1",MESH:D003922,1,Nitric Oxide,2,ABCC8|KCNJ11
inorganic cation transmembrane transport,GO:0098662,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,ABCC8|KCNJ11
inorganic diphosphate transport,GO:0030505,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
inorganic ion homeostasis,GO:0098771,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Copper|Lead|Selenium,0,
inorganic ion homeostasis,GO:0098771,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
inorganic ion homeostasis,GO:0098771,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
inorganic ion homeostasis,GO:0098771,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Copper|Lead,0,
inosine metabolic process,GO:0046102,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,0,
inosine transport,GO:0035340,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC29A3
inositol biosynthetic process,GO:0006021,Diabetes Mellitus,MESH:D003920,1,DDT,0,
inositol biosynthetic process,GO:0006021,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
inositol biosynthetic process,GO:0006021,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
inositol metabolic process,GO:0006020,Diabetes Mellitus,MESH:D003920,2,Dichlorodiphenyl Dichloroethylene|Lead,0,
inositol metabolic process,GO:0006020,"Diabetes Mellitus, Experimental",MESH:D003921,3,Dietary Fats|Inositol|Vitamin E,0,
inositol metabolic process,GO:0006020,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dichlorodiphenyl Dichloroethylene|Dietary Fats|Lead,0,
inositol phosphate biosynthetic process,GO:0032958,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
inositol phosphate metabolic process,GO:0043647,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
inositol phosphate metabolic process,GO:0043647,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
inositol trisphosphate metabolic process,GO:0032957,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,INPPL1
insecticide metabolic process,GO:0017143,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,1,CYP1A1
insecticide metabolic process,GO:0017143,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
insulin-like growth factor receptor signaling pathway,GO:0048009,Diabetes Mellitus,MESH:D003920,0,,1,IRS1
insulin-like growth factor receptor signaling pathway,GO:0048009,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,4,IGF1|INSR|IRS1|IRS2
insulin-like growth factor receptor signaling pathway,GO:0048009,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
insulin-like growth factor receptor signaling pathway,GO:0048009,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
insulin-like growth factor receptor signaling pathway,GO:0048009,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Ethanol,4,AKT1|EGFR|IRS1|IRS2
insulin metabolic process,GO:1901142,Diabetes Mellitus,MESH:D003920,16,"Alloxan|bisphenol A|Cadmium|DDT|Gallic Acid|Metformin|Molybdenum|o,p'-DDT|Ozone|Particulate Matter|Plant Extracts|Resveratrol|Selenium|Streptozocin|Tungsten|Zinc",0,
insulin metabolic process,GO:1901142,"Diabetes Mellitus, Experimental",MESH:D003921,12,Alloxan|bisphenol A|Dietary Fats|Gallic Acid|Manganese|Metformin|Plant Extracts|Resveratrol|sodium arsenite|Streptozocin|Taurine|thymoquinone,1,PAX6
insulin metabolic process,GO:1901142,"Diabetes Mellitus, Type 1",MESH:D003922,7,Alloxan|bisphenol A|Resveratrol|sodium arsenite|Streptozocin|Taurine|Thioctic Acid,0,
insulin metabolic process,GO:1901142,"Diabetes Mellitus, Type 2",MESH:D003924,12,Alloxan|bisphenol A|Cadmium|Calcium|Dietary Fats|Manganese|Metformin|Particulate Matter|Plant Extracts|Resveratrol|Streptozocin|Zinc,2,PAX6|TCF7L2
insulin processing,GO:0030070,Diabetes Mellitus,MESH:D003920,1,Streptozocin,1,INS2
insulin processing,GO:0030070,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Streptozocin,1,PCSK2
insulin processing,GO:0030070,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,1,INS2
insulin processing,GO:0030070,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Streptozocin,2,PCSK2|SLC30A8
insulin receptor internalization,GO:0038016,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,1,CAV1
insulin receptor internalization,GO:0038016,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,0,
insulin receptor recycling,GO:0038020,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PTPN1
insulin receptor signaling pathway,GO:0008286,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Plant Preparations|puerarin|Streptozocin,3,INS|INS2|IRS1
insulin receptor signaling pathway,GO:0008286,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Plant Preparations|puerarin|Streptozocin,7,IGF1|INS1|INSR|IRS1|IRS2|PDK4|SREBF1
insulin receptor signaling pathway,GO:0008286,"Diabetes Mellitus, Insulin-Dependent, 2",MESH:C565100,0,,1,INS
insulin receptor signaling pathway,GO:0008286,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
insulin receptor signaling pathway,GO:0008286,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,3,IGF1|INS|INS2
insulin receptor signaling pathway,GO:0008286,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Streptozocin,10,AKT1|AKT2|EGFR|GRB14|HMGA1|INS|INS1|IRS1|IRS2|PTPN1
insulin receptor signaling pathway via phosphatidylinositol 3-kinase,GO:0038028,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
insulin receptor signaling pathway via phosphatidylinositol 3-kinase,GO:0038028,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,0,
insulin secretion,GO:0030073,Diabetes Mellitus,MESH:D003920,4,Alloxan|bisphenol A|Polychlorinated Biphenyls|Pyruvaldehyde,0,
insulin secretion,GO:0030073,"Diabetes Mellitus, Experimental",MESH:D003921,7,Alloxan|bisphenol A|Dietary Fats|ginsenoside Re|honokiol|Niacinamide|pimagedine,6,LEP|NEUROD1|PDX1|PRKCE|SNAP25|SREBF1
insulin secretion,GO:0030073,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
insulin secretion,GO:0030073,"Diabetes Mellitus, Type 1",MESH:D003922,3,Alloxan|bisphenol A|Niacinamide,1,HNF1A
insulin secretion,GO:0030073,"Diabetes Mellitus, Type 2",MESH:D003924,6,Alloxan|bisphenol A|Dietary Fats|ginsenoside Re|Niacinamide|Polychlorinated Biphenyls,9,GLP1R|HMGA1|HNF1A|HNF1B|LEP|NEUROD1|PDX1|SLC30A8|SNAP25
insulin secretion involved in cellular response to glucose stimulus,GO:0035773,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
insulin secretion involved in cellular response to glucose stimulus,GO:0035773,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
integrated stress response signaling,GO:0140467,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
integrin activation,GO:0033622,Diabetes Mellitus,MESH:D003920,0,,1,FN1
integrin activation,GO:0033622,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CX3CL1
integrin-mediated signaling pathway,GO:0007229,Diabetes Mellitus,MESH:D003920,0,,1,FN1
integrin-mediated signaling pathway,GO:0007229,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ITGA1
interferon-mediated signaling pathway,GO:0140888,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
interferon-mediated signaling pathway,GO:0140888,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
interkinetic nuclear migration,GO:0022027,Diabetes Mellitus,MESH:D003920,0,,1,KIF1A
interkinetic nuclear migration,GO:0022027,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
interkinetic nuclear migration,GO:0022027,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HHEX|PAX6
interleukin-10-mediated signaling pathway,GO:0140105,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,IL10|STAT3|TYK2
interleukin-10 production,GO:0032613,Diabetes Mellitus,MESH:D003920,4,"bisphenol A|Fatty Acids, Omega-3|Mercury|Particulate Matter",0,
interleukin-10 production,GO:0032613,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,CBP30 compound,0,
interleukin-10 production,GO:0032613,"Diabetes Mellitus, Experimental",MESH:D003921,2,"bisphenol A|Fatty Acids, Omega-3",1,PRKCD
interleukin-10 production,GO:0032613,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Lipopolysaccharides|Mercury,0,
interleukin-10 production,GO:0032613,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Mercury|Particulate Matter|Vehicle Emissions,0,
interleukin-11-mediated signaling pathway,GO:0038154,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
interleukin-12-mediated signaling pathway,GO:0035722,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TYK2
interleukin-12 production,GO:0032615,Diabetes Mellitus,MESH:D003920,1,Plant Preparations,0,
interleukin-12 production,GO:0032615,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Preparations,2,IFNG|PRKCD
interleukin-12 production,GO:0032615,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,1,IFNG
interleukin-12 production,GO:0032615,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
interleukin-13-mediated signaling pathway,GO:0035772,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IL13RA1
interleukin-13 production,GO:0032616,Diabetes Mellitus,MESH:D003920,2,Chromium|Lead,0,
interleukin-13 production,GO:0032616,"Diabetes Mellitus, Experimental",MESH:D003921,1,Chromium,0,
interleukin-13 production,GO:0032616,"Diabetes Mellitus, Type 2",MESH:D003924,3,Chromium|Lead|Sitagliptin Phosphate,0,
interleukin-15-mediated signaling pathway,GO:0035723,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
interleukin-17 production,GO:0032620,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
interleukin-17 production,GO:0032620,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,CBP30 compound,0,
interleukin-17 production,GO:0032620,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
interleukin-17 production,GO:0032620,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Lipopolysaccharides,0,
interleukin-17 production,GO:0032620,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
interleukin-18-mediated signaling pathway,GO:0035655,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
interleukin-1 alpha production,GO:0032610,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,CBP30 compound,0,
interleukin-1 beta production,GO:0032611,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
interleukin-1 beta production,GO:0032611,"Diabetes Mellitus, Experimental",MESH:D003921,1,ginsenoside Re,1,IL1B
interleukin-1 beta production,GO:0032611,"Diabetes Mellitus, Type 1",MESH:D003922,2,Calcitriol|Lipopolysaccharides,0,
interleukin-1 beta production,GO:0032611,"Diabetes Mellitus, Type 2",MESH:D003924,3,Arsenic|ginsenoside Re|Vehicle Emissions,0,
interleukin-1-mediated signaling pathway,GO:0070498,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IL1B|RELA
interleukin-1 production,GO:0032612,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
interleukin-23-mediated signaling pathway,GO:0038155,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,STAT3|TYK2
interleukin-23 production,GO:0032627,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
interleukin-27 production,GO:0032631,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
interleukin-2-mediated signaling pathway,GO:0038110,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
interleukin-2-mediated signaling pathway,GO:0038110,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IL2RA|STAT3
interleukin-2 production,GO:0032623,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
interleukin-2 production,GO:0032623,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,CBP30 compound,0,
interleukin-2 production,GO:0032623,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,GPAM
interleukin-2 production,GO:0032623,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Lipopolysaccharides,2,PRKCQ|SLC11A1
interleukin-2 production,GO:0032623,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
interleukin-3 production,GO:0032632,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
interleukin-4 production,GO:0032633,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOTCH2
interleukin-5 production,GO:0032634,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
interleukin-5 production,GO:0032634,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Vehicle Emissions,0,
interleukin-6-mediated signaling pathway,GO:0070102,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IL6
interleukin-6-mediated signaling pathway,GO:0070102,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,IL6|STAT3
interleukin-6-mediated signaling pathway,GO:0070102,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IL6
interleukin-6 production,GO:0032635,Diabetes Mellitus,MESH:D003920,6,"Air Pollutants|Fatty Acids, Omega-3|Mercury|Nitrogen Dioxide|Ozone|Sulfur Dioxide",0,
interleukin-6 production,GO:0032635,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,CBP30 compound,0,
interleukin-6 production,GO:0032635,"Diabetes Mellitus, Experimental",MESH:D003921,2,"Fatty Acids, Omega-3|mangiferin",2,IL1B|TNF
interleukin-6 production,GO:0032635,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Mercury,2,IL19|TNF
interleukin-6 production,GO:0032635,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|mangiferin|Mercury|Vehicle Emissions,2,CD36|TNF
interleukin-7-mediated signaling pathway,GO:0038111,Diabetes Mellitus,MESH:D003920,1,Tungsten,0,
interleukin-7 production,GO:0032636,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
interleukin-7 production,GO:0032636,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
interleukin-8 production,GO:0032637,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,CBP30 compound,0,
interleukin-8 production,GO:0032637,"Diabetes Mellitus, Type 2",MESH:D003924,1,Vehicle Emissions,0,
interleukin-9-mediated signaling pathway,GO:0038113,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
inter-male aggressive behavior,GO:0002121,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
inter-male aggressive behavior,GO:0002121,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
inter-male aggressive behavior,GO:0002121,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
inter-male aggressive behavior,GO:0002121,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Ethanol,0,
intermediate-density lipoprotein particle remodeling,GO:0034373,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,LIPC
intermediate filament cytoskeleton organization,GO:0045104,Diabetes Mellitus,MESH:D003920,1,Pyruvaldehyde,0,
intermediate filament cytoskeleton organization,GO:0045104,"Diabetes Mellitus, Experimental",MESH:D003921,1,Malondialdehyde,0,
intermediate filament cytoskeleton organization,GO:0045104,"Diabetes Mellitus, Type 2",MESH:D003924,1,Malondialdehyde,0,
interneuron axon guidance,GO:0097376,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR200A
interneuron migration,GO:1904936,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
intestinal absorption,GO:0050892,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
intestinal absorption,GO:0050892,"Diabetes Mellitus, Experimental",MESH:D003921,3,Dietary Fats|Dronabinol|ginsenoside Re,1,LEP
intestinal absorption,GO:0050892,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Dietary Fats|ginsenoside Re,3,CD36|KCNQ1|LEP
intestinal cholesterol absorption,GO:0030299,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
intestinal D-glucose absorption,GO:0001951,Diabetes Mellitus,MESH:D003920,2,Arsenic|Lead,0,
intestinal D-glucose absorption,GO:0001951,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Lead,0,
intestinal epithelial cell development,GO:0060576,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
intestinal epithelial cell development,GO:0060576,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
intestinal epithelial cell development,GO:0060576,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
intestinal epithelial cell development,GO:0060576,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Folic Acid,0,
intestinal epithelial cell maturation,GO:0060574,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
intestinal epithelial cell maturation,GO:0060574,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
intestinal epithelial cell maturation,GO:0060574,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
intestinal epithelial cell maturation,GO:0060574,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
intestinal epithelial structure maintenance,GO:0060729,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Blood Glucose|Pioglitazone,1,NR1I2
intestinal epithelial structure maintenance,GO:0060729,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
intestinal epithelial structure maintenance,GO:0060729,"Diabetes Mellitus, Experimental",MESH:D003921,5,"bisphenol A|Blood Glucose|Dietary Fats|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Pioglitazone",1,TP53
intestinal epithelial structure maintenance,GO:0060729,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Lipopolysaccharides|Thioctic Acid,0,
intestinal epithelial structure maintenance,GO:0060729,"Diabetes Mellitus, Type 2",MESH:D003924,8,bisphenol A|Blood Glucose|Curcumin|Dietary Fats|Ethanol|Orlistat|Pioglitazone|Vildagliptin,1,TCF7L2
intestinal motility,GO:0120054,Diabetes Mellitus,MESH:D003920,1,Blood Glucose,0,
intestinal motility,GO:0120054,"Diabetes Mellitus, Experimental",MESH:D003921,3,Blood Glucose|honokiol|Nicotine,0,
intestinal motility,GO:0120054,"Diabetes Mellitus, Type 2",MESH:D003924,2,Blood Glucose|Nicotine,0,
intestinal stem cell homeostasis,GO:0036335,Diabetes Mellitus,MESH:D003920,0,,1,CAT
intestinal stem cell homeostasis,GO:0036335,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAT
intestinal stem cell homeostasis,GO:0036335,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CAT
intestinal stem cell homeostasis,GO:0036335,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CAT
intestine smooth muscle contraction,GO:0014827,"Diabetes Mellitus, Experimental",MESH:D003921,2,ginsenoside Re|Imatinib Mesylate,0,
intestine smooth muscle contraction,GO:0014827,"Diabetes Mellitus, Type 1",MESH:D003922,1,Imatinib Mesylate,0,
intestine smooth muscle contraction,GO:0014827,"Diabetes Mellitus, Type 2",MESH:D003924,2,Calcium|ginsenoside Re,0,
intracellular cholesterol transport,GO:0032367,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NUS1
intracellular distribution of mitochondria,GO:0048312,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
intracellular distribution of mitochondria,GO:0048312,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
intracellular estrogen receptor signaling pathway,GO:0030520,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Raloxifene Hydrochloride,0,
intracellular estrogen receptor signaling pathway,GO:0030520,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|ginsenoside Re,0,
intracellular estrogen receptor signaling pathway,GO:0030520,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Genistein,0,
intracellular estrogen receptor signaling pathway,GO:0030520,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Genistein|ginsenoside Re|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid,0,
intracellular pH elevation,GO:0051454,"Diabetes Mellitus, Experimental",MESH:D003921,1,sarpogrelate,0,
intracellular pH reduction,GO:0051452,Diabetes Mellitus,MESH:D003920,3,Arsenic|Cadmium|Metformin,0,
intracellular pH reduction,GO:0051452,"Diabetes Mellitus, Experimental",MESH:D003921,3,Glucose|Metformin|sarpogrelate,0,
intracellular pH reduction,GO:0051452,"Diabetes Mellitus, Type 2",MESH:D003924,5,Arsenic|Cadmium|Glucose|Lactic Acid|Metformin,0,
intracellular protein transport,GO:0006886,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,YWHAH
intracellular protein transport,GO:0006886,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,AP3S2|RETN|VPS26A
intracellular receptor signaling pathway,GO:0030522,Diabetes Mellitus,MESH:D003920,0,,2,NR1I2|NR1I3
intracellular receptor signaling pathway,GO:0030522,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SREBF1
intracellular receptor signaling pathway,GO:0030522,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
intracellular receptor signaling pathway,GO:0030522,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF4A
intracellular sequestering of iron ion,GO:0006880,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ZFAND3
intracellular signal transduction,GO:0035556,Diabetes Mellitus,MESH:D003920,1,Zinc,1,RAC1
intracellular signal transduction,GO:0035556,"Diabetes Mellitus, Experimental",MESH:D003921,0,,10,ADRA1A|CASP3|EDN1|HMOX1|LEP|NOS2|PRKCA|PRKCD|PRKCE|RELA
intracellular signal transduction,GO:0035556,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,PRKCQ|SH2B3|TYK2
intracellular signal transduction,GO:0035556,"Diabetes Mellitus, Type 2",MESH:D003924,1,Zinc,13,ADCY5|AKT1|CASP3|CNKSR2|DGKD|EDN1|EGFR|GRB14|HMOX1|LEP|NOS2|NOTCH2|PRKCB
intracellular steroid hormone receptor signaling pathway,GO:0030518,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ESRRA|PPARA
intracellular steroid hormone receptor signaling pathway,GO:0030518,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HNF4A|PPARA
intracellular transport,GO:0046907,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AP3S2
intrahepatic bile duct development,GO:0035622,Diabetes Mellitus,MESH:D003920,1,Zinc,0,
intrahepatic bile duct development,GO:0035622,"Diabetes Mellitus, Experimental",MESH:D003921,1,Taurine,0,
intrahepatic bile duct development,GO:0035622,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
intrahepatic bile duct development,GO:0035622,"Diabetes Mellitus, Type 2",MESH:D003924,1,Zinc,2,MIR30A|NOTCH2
intramembranous ossification,GO:0001957,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP2
intrinsic apoptotic signaling pathway,GO:0097193,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,1,SIRT1
intrinsic apoptotic signaling pathway,GO:0097193,"Diabetes Mellitus, Experimental",MESH:D003921,3,Plant Extracts|platycodin D|Sertraline,5,BAX|CASP3|PRKCA|SIRT1|TP53
intrinsic apoptotic signaling pathway,GO:0097193,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CASP12
intrinsic apoptotic signaling pathway,GO:0097193,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,3,BAX|CASP3|SIRT1
intrinsic apoptotic signaling pathway by p53 class mediator,GO:0072332,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,BAX|TP53|TRP53
intrinsic apoptotic signaling pathway by p53 class mediator,GO:0072332,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008630,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008630,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,BAX|BCL2|BCL2L1|HMOX1|SIRT1|SOD2|TNF|TNFRSF1A
intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008630,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,TNF
intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008630,"Diabetes Mellitus, Type 2",MESH:D003924,0,,10,BAX|BCL2|BCL2L1|BCL2L11|HMOX1|SIRT1|SOD2|TNF|TNFRSF1A|TNFRSF1B
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042771,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042771,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,SIRT1|TP53|TRP53
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042771,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070059,Diabetes Mellitus,MESH:D003920,1,bisphenol A,2,INS2|MAP3K5
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070059,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,9,AIFM1|ATP2A3|BAX|BCL2|CASP3|MAP3K5|PDX1|TP53|TRP53
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070059,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,4,AIFM1|CASP12|DDIT3|INS2
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070059,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,5,ATP2A3|BAX|BCL2|CASP3|PDX1
intrinsic apoptotic signaling pathway in response to hypoxia,GO:1990144,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
intrinsic apoptotic signaling pathway in response to nitrosative stress,GO:1990442,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,DDIT3
intrinsic apoptotic signaling pathway in response to osmotic stress,GO:0008627,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CASP3
intrinsic apoptotic signaling pathway in response to osmotic stress,GO:0008627,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP3
intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008631,Diabetes Mellitus,MESH:D003920,1,Reactive Oxygen Species,1,MAP3K5
intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008631,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,5,BCL2|GPX1|MAP3K5|PRKCD|SOD2
intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008631,"Diabetes Mellitus, Type 1",MESH:D003922,1,Reactive Oxygen Species,0,
intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008631,"Diabetes Mellitus, Type 2",MESH:D003924,1,Reactive Oxygen Species,3,BCL2|GPX1|SOD2
in utero embryonic development,GO:0001701,"Diabetes Mellitus, Experimental",MESH:D003921,0,,6,BCL2L1|EDN1|NOS3|TP53|TRP53|VEGFA
in utero embryonic development,GO:0001701,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,NOS3
in utero embryonic development,GO:0001701,"Diabetes Mellitus, Type 2",MESH:D003924,0,,9,BCL2L1|BCL2L11|CMIP|EDN1|EDNRA|HHEX|NOS3|NOTCH2|TCF7L2
iodide transport,GO:0015705,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
iodide transport,GO:0015705,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Quercetin,0,
iodide transport,GO:0015705,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
iodide transport,GO:0015705,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,KCNQ1
IRE1-mediated unfolded protein response,GO:0036498,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PTPN1
IRES-dependent viral translational initiation,GO:0075522,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
IRES-dependent viral translational initiation,GO:0075522,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
iris morphogenesis,GO:0061072,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
iris morphogenesis,GO:0061072,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAX6
iron import into cell,GO:0033212,Diabetes Mellitus,MESH:D003920,4,Antimony|Docosahexaenoic Acids|Iron|Resveratrol,0,
iron import into cell,GO:0033212,"Diabetes Mellitus, Experimental",MESH:D003921,4,Dietary Fats|Diethylhexyl Phthalate|Quercetin|Resveratrol,0,
iron import into cell,GO:0033212,"Diabetes Mellitus, Type 1",MESH:D003922,2,Iron|Resveratrol,0,
iron import into cell,GO:0033212,"Diabetes Mellitus, Type 2",MESH:D003924,5,Dietary Fats|Diethylhexyl Phthalate|Iron|mono-(2-ethylhexyl)phthalate|Resveratrol,0,
iron ion homeostasis,GO:0055072,Diabetes Mellitus,MESH:D003920,9,Atrazine|bisphenol A|Cadmium|Iron|Ozone|Rosiglitazone|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Zinc,0,
iron ion homeostasis,GO:0055072,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
iron ion homeostasis,GO:0055072,"Diabetes Mellitus, Experimental",MESH:D003921,7,bisphenol A|Cyclophosphamide|Dietary Fats|Diethylhexyl Phthalate|Quercetin|Rosiglitazone|sodium arsenite,0,
iron ion homeostasis,GO:0055072,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|Cyclophosphamide|Iron|Lipopolysaccharides|sodium arsenite|Tetrachlorodibenzodioxin|Vitamin A,0,
iron ion homeostasis,GO:0055072,"Diabetes Mellitus, Type 2",MESH:D003924,10,Atrazine|bisphenol A|Cadmium|Dietary Fats|Diethylhexyl Phthalate|Ethanol|Folic Acid|Iron|Rosiglitazone|Zinc,0,
iron ion import across cell outer membrane,GO:0098706,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
iron ion import across cell outer membrane,GO:0098706,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
iron ion import across plasma membrane,GO:0098711,Diabetes Mellitus,MESH:D003920,2,Iron|Zinc,0,
iron ion import across plasma membrane,GO:0098711,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
iron ion import across plasma membrane,GO:0098711,"Diabetes Mellitus, Type 1",MESH:D003922,1,Iron,0,
iron ion import across plasma membrane,GO:0098711,"Diabetes Mellitus, Type 2",MESH:D003924,3,Iron|Manganese|Zinc,0,
iron ion transmembrane transport,GO:0034755,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
iron ion transport,GO:0006826,Diabetes Mellitus,MESH:D003920,2,Iron|Ozone,1,CP
iron ion transport,GO:0006826,"Diabetes Mellitus, Experimental",MESH:D003921,2,Diltiazem|mangiferin,0,
iron ion transport,GO:0006826,"Diabetes Mellitus, Noninsulin-Dependent, 1",MESH:C563359,0,,1,CAPN10
iron ion transport,GO:0006826,"Diabetes Mellitus, Type 1",MESH:D003922,1,Iron,2,CP|SLC11A1
iron ion transport,GO:0006826,"Diabetes Mellitus, Type 2",MESH:D003924,2,Iron|mangiferin,2,CAPN10|ZFAND3
irritable aggressive behavior,GO:0002123,"Diabetes Mellitus, Type 2",MESH:D003924,1,Curcumin,0,
ISG15-protein conjugation,GO:0032020,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UBE2E2
islet amyloid polypeptide processing,GO:0034231,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PCSK2
islet amyloid polypeptide processing,GO:0034231,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PCSK2
isocitrate metabolic process,GO:0006102,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
isocitrate metabolic process,GO:0006102,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Ascorbic Acid,0,
isoleucine biosynthetic process,GO:0009097,Diabetes Mellitus,MESH:D003920,4,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A|DDT|Polychlorinated Biphenyls",0,
isoleucine biosynthetic process,GO:0009097,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Dietary Fats,0,
isoleucine biosynthetic process,GO:0009097,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
isoleucine biosynthetic process,GO:0009097,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Dietary Fats|perfluorooctanoic acid|Polychlorinated Biphenyls,0,
isoleucine metabolic process,GO:0006549,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
isoleucine metabolic process,GO:0006549,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dichlorodiphenyl Dichloroethylene,0,
JNK cascade,GO:0007254,Diabetes Mellitus,MESH:D003920,5,bisphenol A|Plant Extracts|Reactive Oxygen Species|Resveratrol|Sodium Selenite,2,MAP3K5|RAC1
JNK cascade,GO:0007254,"Diabetes Mellitus, Experimental",MESH:D003921,7,bisphenol A|mangiferin|Plant Extracts|Resveratrol|Sertraline|sodium arsenite|Sodium Selenite,3,IL1B|MAP3K5|TNF
JNK cascade,GO:0007254,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Reactive Oxygen Species|Resveratrol|sodium arsenite,1,TNF
JNK cascade,GO:0007254,"Diabetes Mellitus, Type 2",MESH:D003924,7,"bisphenol A|Curcumin|Drugs, Chinese Herbal|mangiferin|Plant Extracts|Reactive Oxygen Species|Resveratrol",3,MAPK8IP1|NFKB1|TNF
JUN phosphorylation,GO:0007258,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
JUN phosphorylation,GO:0007258,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MAPK8IP1
juvenile hormone mediated signaling pathway,GO:0035626,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
juvenile hormone metabolic process,GO:0006716,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
juvenile hormone metabolic process,GO:0006716,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
juxtaglomerular apparatus development,GO:0072051,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,REN
juxtaglomerular apparatus development,GO:0072051,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR125B1
keratinization,GO:0031424,Diabetes Mellitus,MESH:D003920,2,Tetrachlorodibenzodioxin|Tobacco Smoke Pollution,0,
keratinization,GO:0031424,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
keratinocyte differentiation,GO:0030216,Diabetes Mellitus,MESH:D003920,1,Air Pollutants,1,PTGS2
keratinocyte differentiation,GO:0030216,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CASP3|PAX6|PTGS2
keratinocyte differentiation,GO:0030216,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Calcium,2,CASP3|PAX6
ketone body biosynthetic process,GO:0046951,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
ketone body biosynthetic process,GO:0046951,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
kidney development,GO:0001822,Diabetes Mellitus,MESH:D003920,2,Cadmium|Mercury,1,CAT
kidney development,GO:0001822,"Diabetes Mellitus, Experimental",MESH:D003921,0,,8,ACE|AGT|BAX|BCL2|CAT|MMP9|REN|VEGFA
kidney development,GO:0001822,"Diabetes Mellitus, Type 1",MESH:D003922,1,Mercury,1,CAT
kidney development,GO:0001822,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|Mercury,8,BAX|BCL2|BCL2L11|CAT|ENPP1|HNF1B|PROX1|WFS1
kidney morphogenesis,GO:0060993,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF1B
killing of cells of another organism,GO:0031640,Diabetes Mellitus,MESH:D003920,0,,1,POMC
killing of cells of another organism,GO:0031640,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CCL20
killing of cells of another organism,GO:0031640,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CCL20
Kit signaling pathway,GO:0038109,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
Kit signaling pathway,GO:0038109,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
Kit signaling pathway,GO:0038109,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
kynurenic acid metabolic process,GO:0034275,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Phorate,0,
kynurenic acid metabolic process,GO:0034275,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
labyrinthine layer blood vessel development,GO:0060716,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
labyrinthine layer development,GO:0060711,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
labyrinthine layer development,GO:0060711,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|perfluorohexanesulfonic acid,1,MIR127
lacrimal gland development,GO:0032808,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
lacrimal gland development,GO:0032808,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAX6
lactate biosynthetic process,GO:0019249,Diabetes Mellitus,MESH:D003920,14,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|Atrazine|bisphenol A|Chlordan|Chlorpromazine|Clozapine|Copper|Docosahexaenoic Acids|Metformin|Particulate Matter|Resveratrol|Risperidone|Streptozocin",1,INS2
lactate biosynthetic process,GO:0019249,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
lactate biosynthetic process,GO:0019249,"Diabetes Mellitus, Experimental",MESH:D003921,10,"bisphenol A|Dietary Fats|Glucose|Metformin|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Resveratrol|sodium arsenite|Streptozocin|tributyltin",0,
lactate biosynthetic process,GO:0019249,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|decabromobiphenyl ether|Resveratrol|sodium arsenite|Streptozocin,1,INS2
lactate biosynthetic process,GO:0019249,"Diabetes Mellitus, Type 2",MESH:D003924,16,Air Pollutants|Atrazine|bisphenol A|Clozapine|Copper|Dietary Fats|Folic Acid|Glucose|Lactic Acid|Metformin|mono-(2-ethylhexyl)phthalate|Nicotine|Particulate Matter|perfluorooctane sulfonic acid|Resveratrol|Streptozocin,0,
lactate biosynthetic process from pyruvate,GO:0019244,Diabetes Mellitus,MESH:D003920,1,"Metals, Heavy",0,
lactate metabolic process,GO:0006089,Diabetes Mellitus,MESH:D003920,13,Arsenic|bisphenol A|Cadmium|Chlorpyrifos|Lead|Mercury|Particulate Matter|puerarin|Resveratrol|Rosiglitazone|Streptozocin|Tobacco Smoke Pollution|Zinc,0,
lactate metabolic process,GO:0006089,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
lactate metabolic process,GO:0006089,"Diabetes Mellitus, Experimental",MESH:D003921,11,bisphenol A|Cyclophosphamide|Exenatide|Fructose|Glucose|puerarin|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Streptozocin,0,
lactate metabolic process,GO:0006089,"Diabetes Mellitus, Type 1",MESH:D003922,8,bisphenol A|Cyclophosphamide|Genistein|Lipopolysaccharides|Mercury|Resveratrol|sodium arsenite|Streptozocin,0,
lactate metabolic process,GO:0006089,"Diabetes Mellitus, Type 2",MESH:D003924,21,Arsenic|Ascorbic Acid|bisphenol A|Cadmium|Cysteine|efavirenz|Ethanol|Exenatide|Fructose|Genistein|Glucose|Lactic Acid|Lead|Mercury|mono-(2-ethylhexyl)phthalate|Particulate Matter|perfluorooctanoic acid|Resveratrol|Rosiglitazone|Streptozocin|Zinc,0,
lactate transport,GO:0015727,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Cadmium|Cyclosporine,0,
lactate transport,GO:0015727,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
lactate transport,GO:0015727,"Diabetes Mellitus, Experimental",MESH:D003921,2,"bisphenol A|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
lactate transport,GO:0015727,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
lactate transport,GO:0015727,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Cadmium|Lactic Acid,0,
lactation,GO:0007595,Diabetes Mellitus,MESH:D003920,0,,1,CP
lactation,GO:0007595,"Diabetes Mellitus, Experimental",MESH:D003921,0,,4,CAV1|COX2|PPARA|VEGFA
lactation,GO:0007595,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CP
lactation,GO:0007595,"Diabetes Mellitus, Type 2",MESH:D003924,2,Folic Acid|perfluorooctanoic acid,5,CDO1|MIR222|MIR27A|PAM|PPARA
lactic acid secretion,GO:0046722,Diabetes Mellitus,MESH:D003920,2,Cadmium|Dichlorodiphenyl Dichloroethylene,0,
lactic acid secretion,GO:0046722,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
lactic acid secretion,GO:0046722,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
lactic acid secretion,GO:0046722,"Diabetes Mellitus, Type 2",MESH:D003924,5,Cadmium|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Lactic Acid|mono-(2-ethylhexyl)phthalate,0,
lactone catabolic process,GO:1901335,Diabetes Mellitus,MESH:D003920,0,,1,PON1
lactone metabolic process,GO:1901334,"Diabetes Mellitus, Experimental",MESH:D003921,1,Vitamin E,0,
lactone metabolic process,GO:1901334,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
lactose metabolic process,GO:0005988,Diabetes Mellitus,MESH:D003920,4,Arsenic|Cadmium|Mercury|Sodium Selenite,0,
lactose metabolic process,GO:0005988,"Diabetes Mellitus, Experimental",MESH:D003921,1,Sodium Selenite,0,
lactose metabolic process,GO:0005988,"Diabetes Mellitus, Type 1",MESH:D003922,1,Mercury,0,
lactose metabolic process,GO:0005988,"Diabetes Mellitus, Type 2",MESH:D003924,3,Arsenic|Cadmium|Mercury,0,
L-alanine catabolic process,GO:0042853,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
L-alanine catabolic process,GO:0042853,"Diabetes Mellitus, Type 2",MESH:D003924,1,Genistein,0,
"L-alanine catabolic process, by transamination",GO:0019481,Diabetes Mellitus,MESH:D003920,3,Flavonoids|Plant Extracts|puerarin,0,
"L-alanine catabolic process, by transamination",GO:0019481,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
"L-alanine catabolic process, by transamination",GO:0019481,"Diabetes Mellitus, Experimental",MESH:D003921,3,Cyclophosphamide|Plant Extracts|puerarin,0,
"L-alanine catabolic process, by transamination",GO:0019481,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
"L-alanine catabolic process, by transamination",GO:0019481,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
L-alanine oxidation to D-lactate and ammonia,GO:0019479,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
L-alanine oxidation to D-lactate and ammonia,GO:0019479,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glucose|Lactic Acid,0,
L-alanine transport,GO:0015808,"Diabetes Mellitus, Type 2",MESH:D003924,2,perfluorooctane sulfonic acid|perfluorooctanoic acid,0,
L-alpha-amino acid transmembrane transport,GO:1902475,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
lamellipodium assembly,GO:0030032,Diabetes Mellitus,MESH:D003920,1,bisphenol A,1,RAC1
lamellipodium assembly,GO:0030032,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
lamellipodium assembly,GO:0030032,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
lamellipodium assembly,GO:0030032,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Ethanol,0,
lamellipodium morphogenesis,GO:0072673,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
lamellipodium morphogenesis,GO:0072673,"Diabetes Mellitus, Type 2",MESH:D003924,1,Manganese,0,
Langerhans cell differentiation,GO:0061520,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
L-arginine transmembrane transport,GO:1903826,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
larval behavior,GO:0030537,Diabetes Mellitus,MESH:D003920,2,2-naphthol|Pesticides,0,
larval behavior,GO:0030537,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dronabinol|sodium arsenite,0,
larval behavior,GO:0030537,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
larval behavior,GO:0030537,"Diabetes Mellitus, Type 2",MESH:D003924,1,Pesticides,0,
larval development,GO:0002164,Diabetes Mellitus,MESH:D003920,7,2-naphthol|Arsenic|arsenite|bisphenol A|Cadmium|Chlorpyrifos|Particulate Matter,0,
larval development,GO:0002164,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Diethylhexyl Phthalate|Hydrogen Peroxide|Imatinib Mesylate|Quercetin|sodium arsenite,0,
larval development,GO:0002164,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Calcitriol|Imatinib Mesylate|sodium arsenite|Vitamin A,0,
larval development,GO:0002164,"Diabetes Mellitus, Type 2",MESH:D003924,8,Arsenic|bisphenol A|bisphenol S|Cadmium|Diethylhexyl Phthalate|Particulate Matter|perfluorohexanesulfonic acid|Vehicle Emissions,0,
larval heart development,GO:0007508,Diabetes Mellitus,MESH:D003920,1,arsenite,0,
larval locomotory behavior,GO:0008345,Diabetes Mellitus,MESH:D003920,7,Air Pollutants|Arsenic|arsenite|bisphenol A|Chlorpyrifos|Copper|Particulate Matter,0,
larval locomotory behavior,GO:0008345,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
larval locomotory behavior,GO:0008345,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
larval locomotory behavior,GO:0008345,"Diabetes Mellitus, Type 2",MESH:D003924,9,Air Pollutants|Arsenic|bisphenol A|bisphenol S|Copper|epigallocatechin gallate|Particulate Matter|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid,0,
larval somatic muscle development,GO:0007526,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CRP
L-ascorbic acid biosynthetic process,GO:0019853,Diabetes Mellitus,MESH:D003920,7,Atrazine|Cadmium|Cyclosporine|Glyburide|Polychlorinated Biphenyls|Streptozocin|Zinc,0,
L-ascorbic acid biosynthetic process,GO:0019853,"Diabetes Mellitus, Experimental",MESH:D003921,7,Dietary Fats|Glyburide|Quercetin|S-allylcysteine|Streptozocin|thymoquinone|Vitamin E,0,
L-ascorbic acid biosynthetic process,GO:0019853,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
L-ascorbic acid biosynthetic process,GO:0019853,"Diabetes Mellitus, Type 2",MESH:D003924,8,Ascorbic Acid|Atrazine|Cadmium|Dietary Fats|Glyburide|Polychlorinated Biphenyls|Streptozocin|Zinc,0,
L-ascorbic acid metabolic process,GO:0019852,Diabetes Mellitus,MESH:D003920,7,Arsenic|Cadmium|Glyburide|Iron|Metformin|Resveratrol|Streptozocin,0,
L-ascorbic acid metabolic process,GO:0019852,"Diabetes Mellitus, Experimental",MESH:D003921,10,corilagin|Diethylhexyl Phthalate|Dronabinol|Fructose|Glyburide|Hydrogen Peroxide|Metformin|Resveratrol|sodium arsenite|Streptozocin,0,
L-ascorbic acid metabolic process,GO:0019852,"Diabetes Mellitus, Type 1",MESH:D003922,4,Iron|Resveratrol|sodium arsenite|Streptozocin,0,
L-ascorbic acid metabolic process,GO:0019852,"Diabetes Mellitus, Type 2",MESH:D003924,14,alpha-Tocopherol|Arsenic|Ascorbic Acid|Cadmium|Diethylhexyl Phthalate|Diethylnitrosamine|epigallocatechin gallate|Ethanol|Fructose|Glyburide|Iron|Metformin|Resveratrol|Streptozocin,2,GCLC|SLC2A1
L-ascorbic acid transmembrane transport,GO:0015882,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
L-ascorbic acid transmembrane transport,GO:0015882,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
L-ascorbic acid transmembrane transport,GO:0015882,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ascorbic Acid,0,
L-aspartate import across plasma membrane,GO:0140009,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
L-aspartate transmembrane transport,GO:0070778,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
L-aspartate transmembrane transport,GO:0070778,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,SLC1A2|UCP2
late distal convoluted tubule development,GO:0072068,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARGC1A
late distal convoluted tubule development,GO:0072068,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PPARGC1A
lateral inhibition,GO:0046331,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
lateral inhibition,GO:0046331,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,MMP2|SIRT1
lateral inhibition,GO:0046331,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
lauric acid metabolic process,GO:0048252,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CYP4A10
lauric acid metabolic process,GO:0048252,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctane sulfonic acid,0,
L-cysteine catabolic process,GO:0019448,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CBS|CDO1
L-cysteine catabolic process to taurine,GO:0019452,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CDO1
L-cysteine metabolic process,GO:0046439,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CDO1
L-cystine transport,GO:0015811,"Diabetes Mellitus, Type 1",MESH:D003922,1,Vitamin A,0,
L-dopa metabolic process,GO:1903184,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
lead ion transport,GO:0015692,Diabetes Mellitus,MESH:D003920,2,Lead|Zinc,0,
lead ion transport,GO:0015692,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
lead ion transport,GO:0015692,"Diabetes Mellitus, Type 2",MESH:D003924,4,Dietary Fats|Lead|titanium dioxide|Zinc,0,
learned vocalization behavior or vocal learning,GO:0098598,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
learned vocalization behavior or vocal learning,GO:0098598,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
learned vocalization behavior or vocal learning,GO:0098598,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAX6
learning,GO:0007612,Diabetes Mellitus,MESH:D003920,13,"2,2',4,4'-tetrabromodiphenyl ether|2,4,5,2',4',5'-hexachlorobiphenyl|Air Pollutants|Arsenic|bisphenol A|Chlorpyrifos|Lead|Particulate Matter|Plant Extracts|Resveratrol|Streptozocin|Tetrachlorodibenzodioxin|Zinc",1,PTGS2
learning,GO:0007612,"Diabetes Mellitus, Experimental",MESH:D003921,14,bisphenol A|Coconut Oil|Dietary Fats|Diethylhexyl Phthalate|Fructose|Glucose|Manganese|mangiferin|Monocrotophos|Nicotine|Plant Extracts|Resveratrol|sodium arsenite|Streptozocin,2,INSR|PTGS2
learning,GO:0007612,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
learning,GO:0007612,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|decabromobiphenyl ether|Lipopolysaccharides|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin,0,
learning,GO:0007612,"Diabetes Mellitus, Type 2",MESH:D003924,22,Air Pollutants|Arsenic|bisphenol A|Dietary Fats|Diethylhexyl Phthalate|epigallocatechin gallate|Folic Acid|Fructose|Glucose|Lead|Manganese|mangiferin|mono-(2-ethylhexyl)phthalate|Nicotine|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts|Resveratrol|Sitagliptin Phosphate|Streptozocin|Zinc,0,
learning or memory,GO:0007611,Diabetes Mellitus,MESH:D003920,12,Air Pollutants|Arsenic|arsenite|bisphenol A|Cadmium|Lead|Ozone|Parathion|Particulate Matter|Pesticides|Polychlorinated Biphenyls|Zinc,0,
learning or memory,GO:0007611,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate,5,CASP3|IL1B|PRKCA|SLC2A4|STS
learning or memory,GO:0007611,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Calcitriol|decabromobiphenyl ether,0,
learning or memory,GO:0007611,"Diabetes Mellitus, Type 2",MESH:D003924,13,Air Pollutants|Arsenic|bisphenol A|Cadmium|Dibutyl Phthalate|Diethylhexyl Phthalate|Kangen-karyu|Lead|Particulate Matter|Pesticides|Polychlorinated Biphenyls|Vehicle Emissions|Zinc,4,CASP3|EGFR|GLP1R|SLC2A4
left/right axis specification,GO:0070986,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOTCH2
left/right pattern formation,GO:0060972,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,FTO|MIR92B
left ventricular cardiac muscle tissue morphogenesis,GO:0003220,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDNRA
leg disc proximal/distal pattern formation,GO:0007479,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
lens development in camera-type eye,GO:0002088,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PAX6
lens development in camera-type eye,GO:0002088,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,ADAMTS9|PAX6|PROX1
lens fiber cell differentiation,GO:0070306,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
lens fiber cell differentiation,GO:0070306,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PSMD6
lens fiber cell morphogenesis,GO:0070309,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
lens morphogenesis in camera-type eye,GO:0002089,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
lens placode formation involved in camera-type eye formation,GO:0046619,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
leptin-mediated signaling pathway,GO:0033210,Diabetes Mellitus,MESH:D003920,0,,2,LEPR|SIRT1
leptin-mediated signaling pathway,GO:0033210,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,3,LEP|LEPR|SIRT1
leptin-mediated signaling pathway,GO:0033210,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,STAT3
leptin-mediated signaling pathway,GO:0033210,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,3,LEP|LEPR|SIRT1
leucine biosynthetic process,GO:0009098,Diabetes Mellitus,MESH:D003920,1,DDT,0,
leucine biosynthetic process,GO:0009098,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
leucine biosynthetic process,GO:0009098,"Diabetes Mellitus, Type 2",MESH:D003924,2,Diethylhexyl Phthalate|perfluorooctanoic acid,0,
leucine metabolic process,GO:0006551,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
leucine metabolic process,GO:0006551,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dichlorodiphenyl Dichloroethylene|perfluorooctanoic acid,0,
leukocyte activation,GO:0045321,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Reactive Oxygen Species,0,
leukocyte activation,GO:0045321,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,1,EDN1
leukocyte activation,GO:0045321,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Reactive Oxygen Species,0,
leukocyte activation,GO:0045321,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Reactive Oxygen Species,1,EDN1
leukocyte activation involved in immune response,GO:0002366,"Diabetes Mellitus, Type 1",MESH:D003922,1,manganese tetrakis-(N-ethyl-2 pyridyl) porphyrin,0,
leukocyte activation involved in inflammatory response,GO:0002269,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
leukocyte adhesion to vascular endothelial cell,GO:0061756,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
leukocyte adhesion to vascular endothelial cell,GO:0061756,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
leukocyte adhesion to vascular endothelial cell,GO:0061756,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
leukocyte adhesive activation,GO:0050902,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
leukocyte adhesive activation,GO:0050902,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CX3CL1
leukocyte adhesive activation,GO:0050902,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
leukocyte apoptotic process,GO:0071887,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CASP3
leukocyte apoptotic process,GO:0071887,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP3
leukocyte cell-cell adhesion,GO:0007159,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ICAM1
leukocyte cell-cell adhesion,GO:0007159,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
leukocyte cell-cell adhesion,GO:0007159,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ICAM1
leukocyte chemotaxis,GO:0030595,Diabetes Mellitus,MESH:D003920,7,Aspirin|Chlorpromazine|Methylprednisolone|Prednisolone|Telmisartan|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution,0,
leukocyte chemotaxis,GO:0030595,"Diabetes Mellitus, Experimental",MESH:D003921,7,Losartan|Niacinamide|Nicotine|Nitric Oxide|pimagedine|Telmisartan|Vitamin E,1,CX3CL1
leukocyte chemotaxis,GO:0030595,"Diabetes Mellitus, Type 1",MESH:D003922,5,Lipopolysaccharides|Niacinamide|Nitric Oxide|Norepinephrine|Tetrachlorodibenzodioxin,1,IL10
leukocyte chemotaxis,GO:0030595,"Diabetes Mellitus, Type 2",MESH:D003924,6,Ascorbic Acid|Cysteine|Niacinamide|Nicotine|Pentoxifylline|Telmisartan,0,
leukocyte chemotaxis involved in inflammatory response,GO:0002232,Diabetes Mellitus,MESH:D003920,3,Blood Glucose|Ozone|Resveratrol,0,
leukocyte chemotaxis involved in inflammatory response,GO:0002232,"Diabetes Mellitus, Experimental",MESH:D003921,7,Blood Glucose|Dietary Fats|honokiol|pterostilbene|Quercetin|Resveratrol|sodium arsenite,0,
leukocyte chemotaxis involved in inflammatory response,GO:0002232,"Diabetes Mellitus, Type 1",MESH:D003922,3,Lipopolysaccharides|Resveratrol|sodium arsenite,0,
leukocyte chemotaxis involved in inflammatory response,GO:0002232,"Diabetes Mellitus, Type 2",MESH:D003924,6,Blood Glucose|Dietary Fats|Diethylnitrosamine|Ethanol|Nickel|Resveratrol,0,
leukocyte degranulation,GO:0043299,Diabetes Mellitus,MESH:D003920,1,Tacrolimus,0,
leukocyte degranulation,GO:0043299,"Diabetes Mellitus, Experimental",MESH:D003921,4,Cromolyn Sodium|Eucalyptol|Nicotine|Tacrolimus,0,
leukocyte degranulation,GO:0043299,"Diabetes Mellitus, Type 1",MESH:D003922,3,Lipopolysaccharides|Tacrolimus|Vitamin A,0,
leukocyte degranulation,GO:0043299,"Diabetes Mellitus, Type 2",MESH:D003924,3,Malathion|Nicotine|Pentoxifylline,0,
leukocyte homeostasis,GO:0001776,Diabetes Mellitus,MESH:D003920,13,Berberine|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpyrifos|Gallic Acid|Lead|Nitrogen Dioxide|Particulate Matter|Plant Extracts|Polychlorinated Biphenyls|Resveratrol|Sulfur Dioxide|Tobacco Smoke Pollution,0,
leukocyte homeostasis,GO:0001776,"Diabetes Mellitus, Experimental",MESH:D003921,7,Berberine|Gallic Acid|Monocrotophos|Plant Extracts|Resveratrol|sodium arsenite|thymoquinone,2,BAX|BCL2
leukocyte homeostasis,GO:0001776,"Diabetes Mellitus, Type 1",MESH:D003922,4,decabromobiphenyl ether|Lipopolysaccharides|Resveratrol|sodium arsenite,0,
leukocyte homeostasis,GO:0001776,"Diabetes Mellitus, Type 2",MESH:D003924,9,Berberine|Cadmium|Lead|Malathion|Particulate Matter|Plant Extracts|Polychlorinated Biphenyls|Resveratrol|titanium dioxide,3,BAX|BCL2|BCL2L11
leukocyte mediated cytotoxicity,GO:0001909,Diabetes Mellitus,MESH:D003920,1,Tacrolimus,1,NCF1
leukocyte mediated cytotoxicity,GO:0001909,"Diabetes Mellitus, Experimental",MESH:D003921,1,Tacrolimus,1,NCF1
leukocyte mediated cytotoxicity,GO:0001909,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tacrolimus,0,
leukocyte migration,GO:0050900,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|Particulate Matter|Tobacco Smoke Pollution,0,
leukocyte migration,GO:0050900,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,3,ICAM1|IL1B|TNF
leukocyte migration,GO:0050900,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
leukocyte migration,GO:0050900,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,1,TNF
leukocyte migration,GO:0050900,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|Dietary Fats|Particulate Matter|Vehicle Emissions,2,ICAM1|TNF
leukocyte migration involved in immune response,GO:0002522,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Particulate Matter,0,
leukocyte migration involved in immune response,GO:0002522,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
leukocyte migration involved in immune response,GO:0002522,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Warfarin,0,
leukocyte migration involved in immune response,GO:0002522,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Particulate Matter|Vehicle Emissions,0,
leukocyte migration involved in inflammatory response,GO:0002523,Diabetes Mellitus,MESH:D003920,39,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|aroclor 1260|Arsenic|arsenite|Aspirin|Atrazine|Berberine|bisphenol A|Cadmium|Chlorpyrifos|Copper|Cyclosporine|Fatty Acids, Omega-3|Gallic Acid|Glyburide|Iron|Lead|lipoxin A4|Mercury|Metformin|Nitrogen Dioxide|Ozone|Particulate Matter|Pioglitazone|Plant Extracts|Prednisolone|pregna-4,17-diene-3,16-dione|Raloxifene Hydrochloride|Resveratrol|Risperidone|Selenium|Sodium Selenite|Streptozocin|Sulfur Dioxide|Telmisartan|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution|Zinc",1,AOC3
leukocyte migration involved in inflammatory response,GO:0002523,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Diabetes Mellitus, Experimental",MESH:D003921,36,"astaxanthine|Berberine|bisphenol A|chebulagic acid|corilagin|costunolide|Cromolyn Sodium|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Diosmin|Dronabinol|Fatty Acids, Omega-3|Fructose|Gallic Acid|Glyburide|Imatinib Mesylate|Lithocholic Acid|Losartan|Metformin|Pioglitazone|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|Taurine|Telmisartan|thymoquinone|tributyltin|triphenyltin chloride|Ursolic Acid|Valsartan|Vitamin E",3,AOC3|CX3CL1|TNF
leukocyte migration involved in inflammatory response,GO:0002523,"Diabetes Mellitus, Type 1",MESH:D003922,15,bisphenol A|Calcitriol|Cyclophosphamide|Imatinib Mesylate|Iron|Lipopolysaccharides|Mercury|Resveratrol|sodium arsenite|Streptozocin|Taurine|Tetrachlorodibenzodioxin|Thioctic Acid|Uric Acid|Vitamin A,1,TNF
leukocyte migration involved in inflammatory response,GO:0002523,"Diabetes Mellitus, Type 2",MESH:D003924,43,"2-((6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexyl)oxy)-1,1,2,2-tetrafluoroethanesulfonic acid|Air Pollutants|alpha-Tocopherol|Arsenic|Ascorbic Acid|astaxanthine|Atrazine|Berberine|bisphenol A|Cadmium|Copper|Curcumin|Dibutyl Phthalate|Dietary Fats|Diethylnitrosamine|Diosmin|Drugs, Chinese Herbal|epigallocatechin gallate|Ethanol|Folic Acid|Fructose|Glutathione|Glyburide|Iron|Lead|Linagliptin|Lithocholic Acid|Malathion|Mercury|Metformin|Nickel|Particulate Matter|perfluorooctanoic acid|Pioglitazone|Plant Extracts|procyanidin B2|Resveratrol|Streptozocin|TAK-875|Telmisartan|titanium dioxide|Vehicle Emissions|Zinc",1,TNF
leukocyte proliferation,GO:0070661,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
leukocyte proliferation,GO:0070661,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,1,TGFB1
leukocyte proliferation,GO:0070661,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
leukocyte proliferation,GO:0070661,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
leukocyte tethering or rolling,GO:0050901,Diabetes Mellitus,MESH:D003920,1,Tacrolimus,0,
leukocyte tethering or rolling,GO:0050901,"Diabetes Mellitus, Experimental",MESH:D003921,6,Enalapril|Glucose|Losartan|Nicotine|Nitric Oxide|Tacrolimus,2,LEP|TNF
leukocyte tethering or rolling,GO:0050901,"Diabetes Mellitus, Type 1",MESH:D003922,3,Lipopolysaccharides|Nitric Oxide|Tacrolimus,1,TNF
leukocyte tethering or rolling,GO:0050901,"Diabetes Mellitus, Type 2",MESH:D003924,3,Enalapril|Glucose|Nicotine,2,LEP|TNF
leukotriene B4 biosynthetic process,GO:0097251,Diabetes Mellitus,MESH:D003920,4,Rosiglitazone|Selenium|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution,0,
leukotriene B4 biosynthetic process,GO:0097251,"Diabetes Mellitus, Experimental",MESH:D003921,2,Rosiglitazone|Vitamin E,0,
leukotriene B4 biosynthetic process,GO:0097251,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
leukotriene B4 biosynthetic process,GO:0097251,"Diabetes Mellitus, Type 2",MESH:D003924,1,Rosiglitazone,0,
leukotriene biosynthetic process,GO:0019370,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
leukotriene biosynthetic process,GO:0019370,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
leukotriene biosynthetic process,GO:0019370,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
leukotriene biosynthetic process,GO:0019370,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Calcium,0,
leukotriene D4 biosynthetic process,GO:1901750,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
leukotriene D4 biosynthetic process,GO:1901750,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,0,
leukotriene metabolic process,GO:0006691,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,1,NCF1
leukotriene metabolic process,GO:0006691,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP4A10|NCF1
leukotriene metabolic process,GO:0006691,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
leukotriene production involved in inflammatory response,GO:0002540,Diabetes Mellitus,MESH:D003920,2,Rosiglitazone|Tobacco Smoke Pollution,0,
leukotriene production involved in inflammatory response,GO:0002540,"Diabetes Mellitus, Experimental",MESH:D003921,1,Rosiglitazone,0,
leukotriene production involved in inflammatory response,GO:0002540,"Diabetes Mellitus, Type 2",MESH:D003924,1,Rosiglitazone,0,
Lewis a epitope biosynthetic process,GO:0010493,Diabetes Mellitus,MESH:D003920,1,Uranium,0,
Leydig cell differentiation,GO:0033327,Diabetes Mellitus,MESH:D003920,3,Arsenic|bisphenol A|Streptozocin,0,
Leydig cell differentiation,GO:0033327,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Diethylhexyl Phthalate|Nicotine|sodium arsenite|Streptozocin,0,
Leydig cell differentiation,GO:0033327,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Streptozocin,0,
Leydig cell differentiation,GO:0033327,"Diabetes Mellitus, Type 2",MESH:D003924,8,Arsenic|Ascorbic Acid|bisphenol A|Diethylhexyl Phthalate|diethyl phthalate|Nicotine|perfluoroundecanoic acid|Streptozocin,1,PLEKHA1
Leydig cell proliferation,GO:0160024,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Chlorpyrifos,0,
Leydig cell proliferation,GO:0160024,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Cholesterol|Fructose|Glucose,0,
Leydig cell proliferation,GO:0160024,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
Leydig cell proliferation,GO:0160024,"Diabetes Mellitus, Type 2",MESH:D003924,4,Amoxicillin|bisphenol A|Fructose|Glucose,0,
L-glutamate import,GO:0051938,"Diabetes Mellitus, Type 2",MESH:D003924,1,Ethanol,0,
L-glutamate import across plasma membrane,GO:0098712,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SLC1A2
L-glutamate transmembrane transport,GO:0015813,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
L-glutamate transmembrane transport,GO:0015813,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
L-glutamate transmembrane transport,GO:0015813,"Diabetes Mellitus, Type 2",MESH:D003924,1,Amino Acids,1,SLC1A2
ligamentous ossification,GO:0036076,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
limb bud formation,GO:0060174,"Diabetes Mellitus, Experimental",MESH:D003921,1,Glucose,0,
limb bud formation,GO:0060174,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,0,
limb development,GO:0060173,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
limb development,GO:0060173,"Diabetes Mellitus, Type 1",MESH:D003922,1,Thioctic Acid,0,
limb development,GO:0060173,"Diabetes Mellitus, Type 2",MESH:D003924,3,Diethylhexyl Phthalate|Ethanol|Folic Acid,1,PAM
limb morphogenesis,GO:0035108,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BAX
limb morphogenesis,GO:0035108,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BAX
linoleic acid metabolic process,GO:0043651,Diabetes Mellitus,MESH:D003920,1,DDT,0,
linoleic acid metabolic process,GO:0043651,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,ACSL1|CYP4A10
linoleic acid metabolic process,GO:0043651,"Diabetes Mellitus, Type 2",MESH:D003924,5,mono-(2-ethylhexyl)phthalate|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctanoic acid|perfluoroundecanoic acid,0,
lipid biosynthetic process,GO:0008610,Diabetes Mellitus,MESH:D003920,23,"2,2',4,4'-tetrabromodiphenyl ether|2-naphthol|Aspirin|Berberine|Bezafibrate|bisphenol A|Chlorpromazine|Chlorpropamide|Clozapine|Cyclosporine|Fatty Acids, Omega-3|Gallic Acid|Iron|Metformin|Niacin|Plant Extracts|pregna-4,17-diene-3,16-dione|Resveratrol|Rosiglitazone|Streptozocin|Tetrachlorodibenzodioxin|Troglitazone|Zinc",1,INS2
lipid biosynthetic process,GO:0008610,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
lipid biosynthetic process,GO:0008610,"Diabetes Mellitus, Experimental",MESH:D003921,26,"Berberine|Bezafibrate|bisphenol A|Cholesterol|cobaltiprotoporphyrin|Dietary Fats|diphtheria toxin fragment A|Fatty Acids, Nonesterified|Fatty Acids, Omega-3|Fructose|Gallic Acid|Glucose|Hydrogen Peroxide|Manganese|Metformin|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Sodium Glutamate|Streptozocin|tributyltin|Triglycerides|Troglitazone",2,ACSL1|SREBF1
lipid biosynthetic process,GO:0008610,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
lipid biosynthetic process,GO:0008610,"Diabetes Mellitus, Type 1",MESH:D003922,8,bisphenol A|Calcitriol|Iron|Norepinephrine|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin,1,INS2
lipid biosynthetic process,GO:0008610,"Diabetes Mellitus, Type 2",MESH:D003924,29,"Berberine|Bezafibrate|bisphenol A|bisphenol S|Calcium|Chlorpropamide|Clozapine|Curcumin|Dietary Fats|Ethanol|Fatty Acids, Nonesterified|Fructose|Glucose|Iron|Manganese|Metformin|Nickel|Orlistat|perfluorooctane sulfonic acid|perfluorooctanoic acid|Phthalic Acids|Plant Extracts|Resveratrol|Rosiglitazone|Streptozocin|Topiramate|Triglycerides|Troglitazone|Zinc",0,
lipid catabolic process,GO:0016042,Diabetes Mellitus,MESH:D003920,57,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|Alloxan|Arsenic|arsenite|Aspirin|Atrazine|Berberine|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpyrifos|Copper|Cyclosporine|Diazinon|Dichlorodiphenyl Dichloroethylene|Dichlorvos|Docosahexaenoic Acids|docosapentaenoic acid|Fatty Acids, Omega-3|Flavonoids|Gallic Acid|Gliclazide|Glyburide|Hexachlorobenzene|Iron|Lead|Liraglutide|Magnesium|Mercury|Metformin|Molybdenum|Nateglinide|Niacin|Ozone|Particulate Matter|Perindopril|Pioglitazone|Plant Extracts|Plant Preparations|Pravastatin|Prednisolone|puerarin|Pyruvaldehyde|repaglinide|Resveratrol|Rosiglitazone|Selenium|Serotonin|Sodium Selenite|Streptozocin|Sulfur Dioxide|Sulpiride|Telmisartan|Tobacco Smoke Pollution|Trichlorfon|Zinc",3,CP|INS2|IRS1
lipid catabolic process,GO:0016042,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
lipid catabolic process,GO:0016042,"Diabetes Mellitus, Experimental",MESH:D003921,73,"7-hydroxycoumarin|8-epi-prostaglandin F2alpha|Alloxan|Anthocyanins|astaxanthine|Berberine|bisphenol A|Capsaicin|chebulagic acid|Cholesterol|cobaltiprotoporphyrin|Coconut Oil|costunolide|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Diosmin|Dronabinol|Enalapril|Exenatide|Fatty Acids, Nonesterified|Fatty Acids, Omega-3|FeCl tetrakis-2-(triethyleneglycolmonomethylether)pyridylporphyrin|fenugreek seed meal|Fructose|Gallic Acid|ginsenoside Re|Gliclazide|Glucose|Glyburide|Hemin|honokiol|Hydrogen Peroxide|Imatinib Mesylate|Inositol|Losartan|Malondialdehyde|Manganese|mangiferin|Metformin|Monocrotophos|Niacinamide|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|pimagedine|pinitol|Pioglitazone|Plant Extracts|Plant Preparations|Propolis|pterostilbene|puerarin|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sarpogrelate|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|tangeretin|Taurine|Telmisartan|Tetracyclines|thymoquinone|tributyltin|Triglycerides|Ursolic Acid|Valsartan|Vitamin E",1,IRS1
lipid catabolic process,GO:0016042,"Diabetes Mellitus, Type 1",MESH:D003922,20,Alloxan|bisphenol A|Cyclophosphamide|decabromobiphenyl ether|Dichlorvos|FeCl tetrakis-2-(triethyleneglycolmonomethylether)pyridylporphyrin|Genistein|Imatinib Mesylate|Iron|Lipopolysaccharides|Mercury|Niacinamide|Norepinephrine|Resveratrol|sodium arsenite|Streptozocin|Taurine|Thioctic Acid|Uric Acid|Warfarin,2,CP|INS2
lipid catabolic process,GO:0016042,"Diabetes Mellitus, Type 2",MESH:D003924,77,"8-epi-prostaglandin F2alpha|Air Pollutants|Alloxan|alpha-Tocopherol|Arsenic|Ascorbic Acid|astaxanthine|Atrazine|Benzoic Acid|Berberine|bisphenol A|bisphenol S|Boron|Bromine|Cadmium|Calcium|Copper|Curcumin|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Diosmin|Drugs, Chinese Herbal|Enalapril|epigallocatechin gallate|Ethanol|Exenatide|Fatty Acids, Nonesterified|Folic Acid|Fructose|Genistein|ginsenoside Re|Gliclazide|Glucose|Glutathione|Glyburide|Hemin|Irbesartan|Iron|Lead|Linagliptin|Liraglutide|Magnesium|Malathion|Malondialdehyde|Manganese|mangiferin|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Nelfinavir|Niacinamide|Nickel|Nicotine|Orlistat|Particulate Matter|Pentoxifylline|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Plant Extracts|procyanidin B2|Resveratrol|Rosiglitazone|Silver|Sitagliptin Phosphate|Streptozocin|Telmisartan|titanium dioxide|Tolbutamide|Topiramate|Triglycerides|Vehicle Emissions|Vildagliptin|Zinc",2,IRS1|LIPC
lipid droplet disassembly,GO:1905691,"Diabetes Mellitus, Experimental",MESH:D003921,1,Taurine,0,
lipid droplet disassembly,GO:1905691,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
lipid droplet formation,GO:0140042,Diabetes Mellitus,MESH:D003920,37,"2,2',4,4'-tetrabromodiphenyl ether|Air Pollutants|Antimony|aroclor 1260|Arsenic|arsenite|Atrazine|bisphenol A|Cadmium|Chlorpyrifos|Copper|Cyclosporine|Diazinon|Dichlorodiphenyl Dichloroethylene|Fatty Acids, Omega-3|Gallic Acid|Iron|Magnesium|Mercury|Metformin|Niacin|Olanzapine|Particulate Matter|Pioglitazone|Prednisolone|pregna-4,17-diene-3,16-dione|Raloxifene Hydrochloride|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Tacrolimus|terbufos|Tetrachlorodibenzodioxin|triphenyltin|Troglitazone",0,
lipid droplet formation,GO:0140042,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
lipid droplet formation,GO:0140042,"Diabetes Mellitus, Experimental",MESH:D003921,37,"Bile Acids and Salts|bisphenol A|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Dietary Sugars|Diethylhexyl Phthalate|Exenatide|Fatty Acids, Nonesterified|Fatty Acids, Omega-3|Fructose|Gallic Acid|Glucose|Hydrogen Peroxide|Inositol|Metformin|Niacinamide|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Pioglitazone|platycodin D|pterostilbene|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|swietenine|Tacrolimus|Taurine|tianhuang|tributyltin|Triglycerides|triphenyltin chloride|Troglitazone",0,
lipid droplet formation,GO:0140042,"Diabetes Mellitus, Type 1",MESH:D003922,14,bisphenol A|decabromobiphenyl ether|Genistein|Iron|Lipopolysaccharides|Mercury|Niacinamide|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|Taurine|Tetrachlorodibenzodioxin|Uric Acid,0,
lipid droplet formation,GO:0140042,"Diabetes Mellitus, Type 2",MESH:D003924,46,"Air Pollutants|Arsenic|Ascorbic Acid|Atrazine|bisphenol A|bisphenol S|Cadmium|Copper|Curcumin|daidzein|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Dietary Sugars|Diethylhexyl Phthalate|epigallocatechin gallate|Ethanol|Exenatide|Fatty Acids, Nonesterified|Folic Acid|Fructose|Genistein|Glucose|Iron|Lactic Acid|Magnesium|Malathion|Mercury|Metformin|mono-(2-ethylhexyl)phthalate|Niacinamide|Nicotine|Orlistat|Particulate Matter|perfluorodecanoic acid|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Resveratrol|Rosiglitazone|S-Adenosylmethionine|Sitagliptin Phosphate|Streptozocin|Triglycerides|Troglitazone",0,
lipid droplet organization,GO:0034389,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Rosiglitazone,0,
lipid droplet organization,GO:0034389,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Quercetin|Rosiglitazone,0,
lipid droplet organization,GO:0034389,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Lipopolysaccharides|Vitamin A,0,
lipid droplet organization,GO:0034389,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Ethanol|perfluorooctanoic acid|Rosiglitazone,0,
lipid homeostasis,GO:0055088,Diabetes Mellitus,MESH:D003920,9,"2,2',4,4'-tetrabromodiphenyl ether|Arsenic|arsenite|bisphenol A|Plant Extracts|Resveratrol|Rosiglitazone|Streptozocin|Tobacco Smoke Pollution",2,ADRB1|PPARG
lipid homeostasis,GO:0055088,"Diabetes Mellitus, Experimental",MESH:D003921,17,"bisphenol A|Cholesterol|Cholesterol, HDL|Cholesterol, LDL|Coconut Oil|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Fatty Acids, Nonesterified|Fructose|Plant Extracts|Quercetin|Resveratrol|Rosiglitazone|Streptozocin|tributyltin|Triglycerides",5,ACOX1|ATF3|GCK|IRS2|PPARG
lipid homeostasis,GO:0055088,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
lipid homeostasis,GO:0055088,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|Streptozocin,0,
lipid homeostasis,GO:0055088,"Diabetes Mellitus, Type 2",MESH:D003924,19,"Arsenic|Ascorbic Acid|bisphenol A|Cholesterol, HDL|Cholesterol, LDL|Dietary Fats|Diethylhexyl Phthalate|Ethanol|Fatty Acids, Nonesterified|Fructose|Kangen-karyu|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts|Resveratrol|Rosiglitazone|Streptozocin|Triglycerides",6,ATF3|GCK|HNF4A|IRS2|PPARG|THADA
lipid hydroxylation,GO:0002933,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,CYP1A1|CYP3A11
lipid hydroxylation,GO:0002933,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CYP3A2
lipid import into cell,GO:0140354,Diabetes Mellitus,MESH:D003920,6,"2,2',4,4'-tetrabromodiphenyl ether|Atrazine|Berberine|bisphenol A|pregna-4,17-diene-3,16-dione|Rosiglitazone",0,
lipid import into cell,GO:0140354,"Diabetes Mellitus, Experimental",MESH:D003921,7,Berberine|bisphenol A|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Rosiglitazone|Triglycerides,0,
lipid import into cell,GO:0140354,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
lipid import into cell,GO:0140354,"Diabetes Mellitus, Type 2",MESH:D003924,9,Atrazine|Berberine|bisphenol A|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|diethyl phthalate|Rosiglitazone|Triglycerides,0,
lipid localization,GO:0010876,"Diabetes Mellitus, Type 1",MESH:D003922,1,Thioctic Acid,0,
lipid localization,GO:0010876,"Diabetes Mellitus, Type 2",MESH:D003924,1,Folic Acid,0,
lipid metabolic process,GO:0006629,Diabetes Mellitus,MESH:D003920,18,Air Pollutants|Atrazine|bisphenol A|Cadmium|Chlorpromazine|Chromium|Copper|Dichlorodiphenyl Dichloroethylene|Docosahexaenoic Acids|docosapentaenoic acid|Lead|morroniside|Particulate Matter|Pioglitazone|Prednisone|Rosiglitazone|Selenium|Tobacco Smoke Pollution,1,PPARG
lipid metabolic process,GO:0006629,"Diabetes Mellitus, Experimental",MESH:D003921,19,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid|bisphenol A|Cholesterol|Cholesterol, HDL|Cholesterol, LDL|Chromium|Dietary Fats|Dronabinol|Fatty Acids, Nonesterified|Glucose|Hydrogen Peroxide|Inositol|Malondialdehyde|Pioglitazone|Quercetin|Rosiglitazone|sodium arsenite|tributyltin|Triglycerides",10,ACOX1|CPT1B|GPAM|GPX1|LEP|PCK1|PCX|PPARA|PPARG|SREBF1
lipid metabolic process,GO:0006629,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,3,HP|HSD11B2|PTPN22
lipid metabolic process,GO:0006629,"Diabetes Mellitus, Type 2",MESH:D003924,25,"2-palmitoylglycerol|Air Pollutants|Atrazine|bisphenol A|bisphenol S|Cadmium|Cholesterol, HDL|Cholesterol, LDL|Chromium|Copper|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Ethanol|Fatty Acids, Nonesterified|Folic Acid|Glucose|Lead|Malondialdehyde|Particulate Matter|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Rosiglitazone|Triglycerides",13,CD36|DGKD|GPX1|HNF4A|HP|INPPL1|JAZF1|LEP|LIPC|MIR423|PCX|PPARA|PPARG
lipid oxidation,GO:0034440,Diabetes Mellitus,MESH:D003920,50,"Air Pollutants|Alloxan|aroclor 1260|Arsenic|arsenite|Aspirin|Atrazine|Berberine|Bezafibrate|bisphenol A|Blood Glucose|Cadmium|Chlorpyrifos|Copper|Cyclosporine|Diazinon|Dichlorodiphenyl Dichloroethylene|Dichlorvos|Docosahexaenoic Acids|Fatty Acids, Omega-3|Gallic Acid|Glyburide|Heptachlor|Iron|Lead|Liraglutide|Mercury|Metals, Heavy|Metformin|Methylprednisolone|Ozone|Particulate Matter|Perindopril|Pesticides|Pioglitazone|Plant Extracts|Plant Preparations|Prednisolone|puerarin|Pyruvaldehyde|Reactive Oxygen Species|Resveratrol|Rosiglitazone|Selenium|Sodium Selenite|Streptozocin|Telmisartan|Tobacco Smoke Pollution|Trichlorfon|Zinc",0,
lipid oxidation,GO:0034440,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
lipid oxidation,GO:0034440,"Diabetes Mellitus, Experimental",MESH:D003921,65,"8-epi-prostaglandin F2alpha|Alloxan|Anthocyanins|astaxanthine|Berberine|Bezafibrate|Bile Acids and Salts|bisphenol A|Blood Glucose|Cholesterol|cinnamaldehyde|Clioquinol|cobaltiprotoporphyrin|Coconut Oil|corilagin|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Diosmin|Enalapril|Exenatide|Fatty Acids, Nonesterified|Fatty Acids, Omega-3|fenugreek seed meal|Fructose|Gallic Acid|ginsenoside Re|Glucose|Glyburide|Hemin|honokiol|Hydrogen Peroxide|Inositol|Lithocholic Acid|Losartan|Malondialdehyde|mangiferin|Metformin|Monocrotophos|Nicotine|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Phycocyanin|pimagedine|Pioglitazone|Plant Extracts|Plant Preparations|Propolis|puerarin|Quercetin|Resveratrol|Rosiglitazone|S-allylcysteine|sodium arsenite|Sodium Glutamate|Sodium Selenite|Streptozocin|swietenine|tangeretin|Taurine|Telmisartan|thymoquinone|tributyltin|Vitamin E",0,
lipid oxidation,GO:0034440,"Diabetes Mellitus, Lipoatrophic",MESH:D003923,1,Bezafibrate,0,
lipid oxidation,GO:0034440,"Diabetes Mellitus, Type 1",MESH:D003922,17,Alloxan|bisphenol A|Calcitriol|Cyclophosphamide|decabromobiphenyl ether|Dichlorvos|Genistein|Iron|Lipopolysaccharides|Mercury|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Taurine|Thioctic Acid|Uric Acid,0,
lipid oxidation,GO:0034440,"Diabetes Mellitus, Type 2",MESH:D003924,74,"8-epi-prostaglandin F2alpha|Air Pollutants|Alloxan|alpha-Tocopherol|Amino Acids|Arsenic|Ascorbic Acid|astaxanthine|Atrazine|Berberine|Bezafibrate|bisphenol A|bisphenol S|Blood Glucose|Cadmium|Calcium|cinnamaldehyde|Copper|Curcumin|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Diosmin|efavirenz|Enalapril|epigallocatechin gallate|Ethanol|Exenatide|Fatty Acids, Nonesterified|Folic Acid|Fructose|Genistein|ginsenoside Re|Glucose|Glutathione|Glyburide|Hemin|Iron|Lead|Linagliptin|Liraglutide|Lithocholic Acid|Malathion|Malondialdehyde|mangiferin|Mercury|Metformin|Nickel|Nicotine|nymphayol|Orlistat|Panax notoginseng extract|Particulate Matter|Pentoxifylline|perfluorooctanoic acid|perfluoroundecanoic acid|Pesticides|Pioglitazone|Plant Extracts|Reactive Oxygen Species|Resveratrol|Rosiglitazone|S-Adenosylmethionine|saxagliptin|Silver|Sitagliptin Phosphate|Streptozocin|Telmisartan|titanium dioxide|Vehicle Emissions|Vildagliptin|Zinc",0,
lipid phosphorylation,GO:0046834,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,DGKD
lipid storage,GO:0019915,Diabetes Mellitus,MESH:D003920,3,Chlorpyrifos|Plant Extracts|Rosiglitazone,0,
lipid storage,GO:0019915,"Diabetes Mellitus, Experimental",MESH:D003921,2,Plant Extracts|Rosiglitazone,1,CAV1
lipid storage,GO:0019915,"Diabetes Mellitus, Type 2",MESH:D003924,2,Plant Extracts|Rosiglitazone,1,CD36
lipid transport,GO:0006869,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylnitrosamine,1,CD36
lipid transport across blood-brain barrier,GO:1990379,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
lipid transport involved in lipid storage,GO:0010877,Diabetes Mellitus,MESH:D003920,1,Tetrachlorodibenzodioxin,0,
lipid transport involved in lipid storage,GO:0010877,"Diabetes Mellitus, Type 1",MESH:D003922,1,Tetrachlorodibenzodioxin,0,
lipoate metabolic process,GO:0009106,"Diabetes Mellitus, Type 1",MESH:D003922,1,Thioctic Acid,0,
lipopolysaccharide biosynthetic process,GO:0009103,Diabetes Mellitus,MESH:D003920,2,Diazinon|Streptozocin,0,
lipopolysaccharide biosynthetic process,GO:0009103,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Streptozocin,0,
lipopolysaccharide biosynthetic process,GO:0009103,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Streptozocin,0,
lipopolysaccharide biosynthetic process,GO:0009103,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Streptozocin,0,
lipopolysaccharide-mediated signaling pathway,GO:0031663,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,NOS3|PRKCE
lipopolysaccharide-mediated signaling pathway,GO:0031663,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,NOS3|PTPN22
lipopolysaccharide-mediated signaling pathway,GO:0031663,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|NOS3
lipopolysaccharide metabolic process,GO:0008653,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Dronabinol,0,
lipopolysaccharide metabolic process,GO:0008653,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
lipopolysaccharide metabolic process,GO:0008653,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Orlistat,0,
lipopolysaccharide transport,GO:0015920,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
lipopolysaccharide transport,GO:0015920,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|perfluorooctanoic acid,0,
lipoprotein biosynthetic process,GO:0042158,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Cadmium|Streptozocin,1,INS2
lipoprotein biosynthetic process,GO:0042158,"Diabetes Mellitus, Experimental",MESH:D003921,4,"bisphenol A|Cholesterol, HDL|Cholesterol, LDL|Streptozocin",0,
lipoprotein biosynthetic process,GO:0042158,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,1,INS2
lipoprotein biosynthetic process,GO:0042158,"Diabetes Mellitus, Type 2",MESH:D003924,5,"bisphenol A|Cadmium|Cholesterol, HDL|Cholesterol, LDL|Streptozocin",0,
lipoprotein catabolic process,GO:0042159,"Diabetes Mellitus, Type 2",MESH:D003924,1,diethyl phthalate,0,
lipoprotein lipid oxidation,GO:0034439,Diabetes Mellitus,MESH:D003920,1,Copper,0,
lipoprotein lipid oxidation,GO:0034439,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
lipoprotein lipid oxidation,GO:0034439,"Diabetes Mellitus, Type 2",MESH:D003924,4,alpha-Tocopherol|Ascorbic Acid|Copper|Curcumin,0,
lipoprotein metabolic process,GO:0042157,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Particulate Matter,0,
lipoprotein metabolic process,GO:0042157,"Diabetes Mellitus, Experimental",MESH:D003921,3,"bisphenol A|Cholesterol, HDL|Cholesterol, LDL",1,PPARA
lipoprotein metabolic process,GO:0042157,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
lipoprotein metabolic process,GO:0042157,"Diabetes Mellitus, Type 2",MESH:D003924,4,"bisphenol A|Cholesterol, HDL|Cholesterol, LDL|Particulate Matter",1,PPARA
lipoprotein oxidation,GO:0042161,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
lipoprotein oxidation,GO:0042161,"Diabetes Mellitus, Experimental",MESH:D003921,4,"Cholesterol, LDL|Quercetin|Resveratrol|Vitamin E",0,
lipoprotein oxidation,GO:0042161,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Resveratrol,0,
lipoprotein oxidation,GO:0042161,"Diabetes Mellitus, Type 2",MESH:D003924,3,"Cholesterol, LDL|diethyl phthalate|Resveratrol",0,
lipoprotein transport,GO:0042953,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
lipoprotein transport,GO:0042953,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,PPARG
lipoprotein transport,GO:0042953,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,CD36|MIR130B|PPARG|PRKCB
lipoxin A4 biosynthetic process,GO:2001303,Diabetes Mellitus,MESH:D003920,1,Aspirin,0,
lipoxin A4 biosynthetic process,GO:2001303,"Diabetes Mellitus, Experimental",MESH:D003921,1,Naproxen,0,
lipoxin A4 metabolic process,GO:2001302,Diabetes Mellitus,MESH:D003920,1,lipoxin A4,0,
lipoxygenase pathway,GO:0019372,Diabetes Mellitus,MESH:D003920,0,,1,PTGS2
lipoxygenase pathway,GO:0019372,"Diabetes Mellitus, Experimental",MESH:D003921,1,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid",2,GPX1|PTGS2
lipoxygenase pathway,GO:0019372,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,GPX1
liver development,GO:0001889,Diabetes Mellitus,MESH:D003920,2,Cadmium|Prednisone,1,CP
liver development,GO:0001889,"Diabetes Mellitus, Experimental",MESH:D003921,3,astaxanthine|Manganese|Quercetin,8,CYP1A1|INSR|PDX1|PKLR|RELA|SLC2A2|SOD2|SREBF1
liver development,GO:0001889,"Diabetes Mellitus, Insulin-Dependent, 20",MESH:C567286,0,,1,HNF1A
liver development,GO:0001889,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
liver development,GO:0001889,"Diabetes Mellitus, Type 1",MESH:D003922,1,Warfarin,4,CP|HNF1A|HP|NOS1
liver development,GO:0001889,"Diabetes Mellitus, Type 2",MESH:D003924,3,astaxanthine|Cadmium|Manganese,13,CCND2|EGFR|ENPP1|HHEX|HNF1A|HNF1B|HP|LIPC|NOTCH2|PDX1|PROX1|SLC2A2|SOD2
liver morphogenesis,GO:0072576,Diabetes Mellitus,MESH:D003920,1,Selenium,0,
liver morphogenesis,GO:0072576,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorohexanesulfonic acid,2,HHEX|NOTCH2
liver regeneration,GO:0097421,Diabetes Mellitus,MESH:D003920,0,,1,CPT1A
liver regeneration,GO:0097421,"Diabetes Mellitus, Experimental",MESH:D003921,0,,10,ATP2A3|BCL2|CPT1A|FAS|HMOX1|IL6|INSR|TGFB1|TNF|UCP2
liver regeneration,GO:0097421,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
liver regeneration,GO:0097421,"Diabetes Mellitus, Type 1",MESH:D003922,0,,3,IL10|IL6|TNF
liver regeneration,GO:0097421,"Diabetes Mellitus, Type 2",MESH:D003924,0,,9,ATP2A3|BCL2|CPT1A|EGFR|FAS|HMOX1|IL6|TNF|UCP2
L-methionine salvage,GO:0071267,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BHMT
lncRNA transcription,GO:0140742,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NFATC2
localization within membrane,GO:0051668,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
locomotion,GO:0040011,Diabetes Mellitus,MESH:D003920,6,bisphenol A|Chlorpyrifos|Coumaphos|Glyburide|Raloxifene Hydrochloride|Rosiglitazone,1,ATP6
locomotion,GO:0040011,"Diabetes Mellitus, Experimental",MESH:D003921,6,bisphenol A|Clioquinol|Dronabinol|Glyburide|Manganese|Rosiglitazone,0,
locomotion,GO:0040011,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Dehydroepiandrosterone,0,
locomotion,GO:0040011,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Ethanol|Glyburide|Manganese|Rosiglitazone,0,
locomotion involved in locomotory behavior,GO:0031987,Diabetes Mellitus,MESH:D003920,27,Air Pollutants|Arsenic|arsenite|Atrazine|bisphenol A|Cadmium|Chlorpyrifos|Chromium|Clozapine|Copper|Diazinon|Docosahexaenoic Acids|Lead|Metformin|Olanzapine|Particulate Matter|Pioglitazone|Plant Extracts|Pyruvaldehyde|repaglinide|Resveratrol|Risperidone|Serotonin|Streptozocin|Sulpiride|Tacrolimus|Zinc,0,
locomotion involved in locomotory behavior,GO:0031987,"Diabetes Mellitus, Experimental",MESH:D003921,22,bisphenol A|Chromium|Coconut Oil|Dietary Fats|Diethylhexyl Phthalate|Dronabinol|Glucose|Lithocholic Acid|Manganese|Metformin|Monocrotophos|Nicotine|Phycocyanin|Pioglitazone|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|Taurine|Vitamin E,0,
locomotion involved in locomotory behavior,GO:0031987,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|Lipopolysaccharides|Resveratrol|sodium arsenite|Streptozocin|Tacrolimus|Taurine,0,
locomotion involved in locomotory behavior,GO:0031987,"Diabetes Mellitus, Type 2",MESH:D003924,31,Air Pollutants|Arsenic|Ascorbic Acid|Atrazine|bisphenol A|bisphenol S|Cadmium|Chromium|Clozapine|Copper|Curcumin|Dietary Fats|Diethylhexyl Phthalate|epigallocatechin gallate|Ethanol|Glucose|Lead|Lithocholic Acid|Manganese|Metformin|Nickel|Nicotine|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Plant Extracts|Resveratrol|Streptozocin|Vehicle Emissions|Zinc,0,
locomotory behavior,GO:0007626,Diabetes Mellitus,MESH:D003920,9,"bisphenol A|Fatty Acids, Omega-3|Lead|Ozone|Particulate Matter|Prednisolone|Resveratrol|Selenium|Serotonin",1,SOD1
locomotory behavior,GO:0007626,"Diabetes Mellitus, Experimental",MESH:D003921,9,"bisphenol A|Dietary Fats|Dietary Sucrose|Diethylhexyl Phthalate|Dronabinol|Fatty Acids, Omega-3|Manganese|Resveratrol|Tetracyclines",3,SNAP25|SOD1|SOD2
locomotory behavior,GO:0007626,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Resveratrol|Vitamin A,0,
locomotory behavior,GO:0007626,"Diabetes Mellitus, Type 2",MESH:D003924,9,bisphenol A|Dietary Fats|Diethylhexyl Phthalate|Ethanol|Lead|Manganese|Particulate Matter|perfluorooctane sulfonic acid|Resveratrol,4,ADCY5|SNAP25|SOD1|SOD2
locomotory exploration behavior,GO:0035641,Diabetes Mellitus,MESH:D003920,7,Air Pollutants|Arsenic|bisphenol A|Cadmium|Parathion|Particulate Matter|Streptozocin,0,
locomotory exploration behavior,GO:0035641,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Dronabinol|Nicotine|sodium arsenite|Streptozocin,1,PRKCE
locomotory exploration behavior,GO:0035641,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Streptozocin,0,
locomotory exploration behavior,GO:0035641,"Diabetes Mellitus, Type 2",MESH:D003924,10,Air Pollutants|Arsenic|bisphenol A|Cadmium|Ethanol|Folic Acid|Nicotine|Particulate Matter|Streptozocin|Topiramate,0,
locus ceruleus development,GO:0021703,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
locus ceruleus development,GO:0021703,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
locus ceruleus development,GO:0021703,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
locus ceruleus development,GO:0021703,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
long-chain fatty acid biosynthetic process,GO:0042759,Diabetes Mellitus,MESH:D003920,0,,1,PTGS2
long-chain fatty acid biosynthetic process,GO:0042759,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,3,ACOX1|CYP1A1|PTGS2
long-chain fatty acid biosynthetic process,GO:0042759,"Diabetes Mellitus, Type 2",MESH:D003924,1,Diethylhexyl Phthalate,1,CYP1A2
long-chain fatty acid import across plasma membrane,GO:0015911,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,CD36|SLC2A1
long-chain fatty acid import into cell,GO:0044539,Diabetes Mellitus,MESH:D003920,1,Berberine,0,
long-chain fatty acid import into cell,GO:0044539,"Diabetes Mellitus, Experimental",MESH:D003921,1,Berberine,1,ACSL1
long-chain fatty acid import into cell,GO:0044539,"Diabetes Mellitus, Type 2",MESH:D003924,1,Berberine,1,CD36
long-chain fatty acid metabolic process,GO:0001676,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,1,CPT1A
long-chain fatty acid metabolic process,GO:0001676,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Sodium Glutamate,5,ACOT1|ACSL1|CPT1A|CYP1A1|CYP4A10
long-chain fatty acid metabolic process,GO:0001676,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dichlorodiphenyl Dichloroethylene|Dietary Fats,3,CD36|CPT1A|PAM
long-chain fatty acid transport,GO:0015909,Diabetes Mellitus,MESH:D003920,0,,1,PPARG
long-chain fatty acid transport,GO:0015909,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,CPT1B|PPARG|UCP2
long-chain fatty acid transport,GO:0015909,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,CD36|PPARG|UCP2
long-chain fatty-acyl-CoA biosynthetic process,GO:0035338,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ACSL1
long-term memory,GO:0007616,Diabetes Mellitus,MESH:D003920,2,"2,4,5,2',4',5'-hexachlorobiphenyl|Streptozocin",0,
long-term memory,GO:0007616,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,2,"Cyclophosphamide|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
long-term memory,GO:0007616,"Diabetes Mellitus, Experimental",MESH:D003921,8,"Cyclophosphamide|Diethylhexyl Phthalate|Dronabinol|Glucose|Monocrotophos|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|sodium arsenite|Streptozocin",2,SLC2A4|SNAP25
long-term memory,GO:0007616,"Diabetes Mellitus, Type 1",MESH:D003922,3,Cyclophosphamide|sodium arsenite|Streptozocin,0,
long-term memory,GO:0007616,"Diabetes Mellitus, Type 2",MESH:D003924,4,Diethylhexyl Phthalate|Ethanol|Glucose|Streptozocin,4,CCND2|GCLM|SLC2A4|SNAP25
long-term synaptic depression,GO:0060292,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
long-term synaptic depression,GO:0060292,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Dronabinol,0,
long-term synaptic depression,GO:0060292,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
long-term synaptic depression,GO:0060292,"Diabetes Mellitus, Type 2",MESH:D003924,2,alpha-Tocopherol|bisphenol A,0,
long-term synaptic potentiation,GO:0060291,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
long-term synaptic potentiation,GO:0060291,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Nicotine,1,SNAP25
long-term synaptic potentiation,GO:0060291,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,ITPR3
long-term synaptic potentiation,GO:0060291,"Diabetes Mellitus, Type 2",MESH:D003924,4,alpha-Tocopherol|bisphenol A|Ethanol|Nicotine,16,BRAF|ENPP1|MIR125B1|MIR127|MIR181C|MIR195|MIR204|MIR221|MIR222|MIR30A|MIR487B|MIR744|MIR92B|MIR98|MIRLET7D|SNAP25
low-density lipoprotein particle clearance,GO:0034383,Diabetes Mellitus,MESH:D003920,0,,1,ADIPOQ
low-density lipoprotein particle clearance,GO:0034383,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HMOX1
low-density lipoprotein particle clearance,GO:0034383,"Diabetes Mellitus, Type 2",MESH:D003924,2,Curcumin|Ethanol,4,ADIPOQ|CD36|HMOX1|LIPC
low-density lipoprotein particle mediated signaling,GO:0055096,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
low-density lipoprotein particle remodeling,GO:0034374,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|Quercetin,2,AGT|MPO
low-density lipoprotein particle remodeling,GO:0034374,"Diabetes Mellitus, Type 2",MESH:D003924,1,Glucose,1,LIPC
low-density lipoprotein receptor particle metabolic process,GO:0032799,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
low-density lipoprotein receptor particle metabolic process,GO:0032799,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
low-density lipoprotein receptor particle metabolic process,GO:0032799,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
low-density lipoprotein receptor particle metabolic process,GO:0032799,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
L-phenylalanine biosynthetic process,GO:0009094,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
L-phenylalanine biosynthetic process,GO:0009094,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Diethylhexyl Phthalate|sodium arsenite,0,
L-phenylalanine biosynthetic process,GO:0009094,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|sodium arsenite,0,
L-phenylalanine biosynthetic process,GO:0009094,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|bisphenol S|Diethylhexyl Phthalate|perfluorooctanoic acid,0,
L-phenylalanine metabolic process,GO:0006558,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|Nitrogen Dioxide|Particulate Matter,0,
L-phenylalanine metabolic process,GO:0006558,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|Malathion|Particulate Matter|perfluorooctanoic acid,0,
L-proline betaine biosynthetic process,GO:0019503,Diabetes Mellitus,MESH:D003920,1,Polychlorinated Biphenyls,0,
L-proline betaine biosynthetic process,GO:0019503,"Diabetes Mellitus, Type 2",MESH:D003924,1,Polychlorinated Biphenyls,0,
L-serine catabolic process,GO:0006565,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CBS
L-serine metabolic process,GO:0006563,Diabetes Mellitus,MESH:D003920,2,Niacin|Resveratrol,0,
L-serine metabolic process,GO:0006563,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
L-serine metabolic process,GO:0006563,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
L-serine metabolic process,GO:0006563,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,1,CBS
L-serine transport,GO:0015825,"Diabetes Mellitus, Type 2",MESH:D003924,2,perfluorooctane sulfonic acid|perfluorooctanoic acid,0,
"lumen formation, open tracheal system",GO:0035149,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
lung alveolus development,GO:0048286,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
lung alveolus development,GO:0048286,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,4,ACE|IGF1|TGFB1|VEGFA
lung alveolus development,GO:0048286,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
lung alveolus development,GO:0048286,"Diabetes Mellitus, Type 2",MESH:D003924,2,Air Pollutants|Particulate Matter,0,
lung development,GO:0030324,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Liraglutide|Particulate Matter,1,CP
lung development,GO:0030324,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,7,ACE|HSD11B1|IGF1|NOS3|SREBF1|TGFB1|VEGFA
lung development,GO:0030324,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,3,CP|IGF1|NOS3
lung development,GO:0030324,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Liraglutide|Particulate Matter|perfluorooctane sulfonic acid,4,CYP1A2|EGFR|NOS3|PROX1
lung goblet cell differentiation,GO:0060480,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
lung goblet cell differentiation,GO:0060480,"Diabetes Mellitus, Type 2",MESH:D003924,2,Curcumin|Particulate Matter,0,
lung growth,GO:0060437,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
lung growth,GO:0060437,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,1,MIR17HG
lung lobe morphogenesis,GO:0060463,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IGF1
lung lobe morphogenesis,GO:0060463,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
lung morphogenesis,GO:0060425,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ID1
lung morphogenesis,GO:0060425,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,HMGA1|ID1
lung vasculature development,GO:0060426,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,ID1|IGF1|VEGFA
lung vasculature development,GO:0060426,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IGF1
lung vasculature development,GO:0060426,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ID1
luteinization,GO:0001553,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Raloxifene Hydrochloride|Streptozocin|Tobacco Smoke Pollution,0,
luteinization,GO:0001553,"Diabetes Mellitus, Experimental",MESH:D003921,4,bisphenol A|Diethylhexyl Phthalate|Streptozocin|tributyltin,1,MMP2
luteinization,GO:0001553,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Streptozocin,0,
luteinization,GO:0001553,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|Diethylhexyl Phthalate|perfluorooctanoic acid|Streptozocin,1,PLEKHA1
luteinizing hormone secretion,GO:0032275,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
luteinizing hormone secretion,GO:0032275,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
luteinizing hormone secretion,GO:0032275,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
luteinizing hormone secretion,GO:0032275,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|perfluorooctane sulfonic acid|perfluorooctanoic acid,0,
luteolysis,GO:0001554,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CASP3
luteolysis,GO:0001554,"Diabetes Mellitus, Type 1",MESH:D003922,0,,2,CASP12|DDIT3
luteolysis,GO:0001554,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CASP3
lymphangiogenesis,GO:0001946,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
lymphangiogenesis,GO:0001946,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,HHEX|NOTCH2|PROX1
lymphatic endothelial cell differentiation,GO:0060836,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
lymphatic endothelial cell fate commitment,GO:0060838,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PROX1
lymph node development,GO:0048535,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
lymph node development,GO:0048535,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NFKB1
lymphocyte activation,GO:0046649,Diabetes Mellitus,MESH:D003920,5,Cadmium|Cyclosporine|Streptozocin|Tacrolimus|Tetrachlorodibenzodioxin,0,
lymphocyte activation,GO:0046649,"Diabetes Mellitus, Experimental",MESH:D003921,2,Streptozocin|Tacrolimus,0,
lymphocyte activation,GO:0046649,"Diabetes Mellitus, Type 1",MESH:D003922,6,Calcitriol|Lipopolysaccharides|Norepinephrine|Streptozocin|Tacrolimus|Tetrachlorodibenzodioxin,0,
lymphocyte activation,GO:0046649,"Diabetes Mellitus, Type 2",MESH:D003924,4,Angiotensin-Converting Enzyme Inhibitors|Cadmium|Pentoxifylline|Streptozocin,0,
lymphocyte activation involved in immune response,GO:0002285,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
lymphocyte activation involved in immune response,GO:0002285,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
lymphocyte apoptotic process,GO:0070227,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,BCL2|FAS
lymphocyte apoptotic process,GO:0070227,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,BCL2|BCL2L11|FAS
lymphocyte chemotaxis,GO:0048247,Diabetes Mellitus,MESH:D003920,3,Ozone|Particulate Matter|Tobacco Smoke Pollution,0,
lymphocyte chemotaxis,GO:0048247,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,2,CCL20|CX3CL1
lymphocyte chemotaxis,GO:0048247,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,1,CCL20
lymphocyte chemotaxis,GO:0048247,"Diabetes Mellitus, Type 2",MESH:D003924,4,Curcumin|Particulate Matter|titanium dioxide|Vehicle Emissions,0,
lymphocyte costimulation,GO:0031294,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,IL6
lymphocyte costimulation,GO:0031294,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IL6
lymphocyte costimulation,GO:0031294,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,IL6
lymphocyte homeostasis,GO:0002260,Diabetes Mellitus,MESH:D003920,11,Air Pollutants|Berberine|Chlorodiphenyl (54% Chlorine)|Chlorpyrifos|Clozapine|Molybdenum|Ozone|Particulate Matter|Plant Extracts|Polychlorinated Biphenyls|Zinc,0,
lymphocyte homeostasis,GO:0002260,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
lymphocyte homeostasis,GO:0002260,"Diabetes Mellitus, Experimental",MESH:D003921,5,Berberine|Cyclophosphamide|Plant Extracts|Quercetin|sodium arsenite,1,BCL2
lymphocyte homeostasis,GO:0002260,"Diabetes Mellitus, Type 1",MESH:D003922,4,Cyclophosphamide|decabromobiphenyl ether|Lipopolysaccharides|sodium arsenite,0,
lymphocyte homeostasis,GO:0002260,"Diabetes Mellitus, Type 2",MESH:D003924,11,Air Pollutants|Berberine|Clozapine|Diethylnitrosamine|Ethanol|Particulate Matter|Plant Extracts|Polychlorinated Biphenyls|titanium dioxide|Vehicle Emissions|Zinc,2,BCL2|BCL2L11
lymphocyte mediated immunity,GO:0002449,Diabetes Mellitus,MESH:D003920,4,Dichlorodiphenyl Dichloroethylene|Hexachlorobenzene|Lead|Polychlorinated Biphenyls,0,
lymphocyte mediated immunity,GO:0002449,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
lymphocyte mediated immunity,GO:0002449,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cyclophosphamide|mangiferin,0,
lymphocyte mediated immunity,GO:0002449,"Diabetes Mellitus, Type 1",MESH:D003922,1,Cyclophosphamide,0,
lymphocyte mediated immunity,GO:0002449,"Diabetes Mellitus, Type 2",MESH:D003924,4,Dichlorodiphenyl Dichloroethylene|Lead|mangiferin|Polychlorinated Biphenyls,0,
lymphocyte migration,GO:0072676,Diabetes Mellitus,MESH:D003920,9,Air Pollutants|arsenite|Atrazine|bisphenol A|Iron|Ozone|Particulate Matter|Sulfur Dioxide|Tobacco Smoke Pollution,0,
lymphocyte migration,GO:0072676,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Diethylhexyl Phthalate|Quercetin,0,
lymphocyte migration,GO:0072676,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Iron|Lipopolysaccharides,0,
lymphocyte migration,GO:0072676,"Diabetes Mellitus, Type 2",MESH:D003924,6,Air Pollutants|Atrazine|bisphenol A|Diethylhexyl Phthalate|Iron|Particulate Matter,0,
lymphocyte proliferation,GO:0046651,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
lymphocyte proliferation,GO:0046651,"Diabetes Mellitus, Insulin-Dependent, 10",MESH:C566602,0,,1,IL2RA
lymphocyte proliferation,GO:0046651,"Diabetes Mellitus, Type 1",MESH:D003922,2,decabromobiphenyl ether|Lipopolysaccharides,1,IL2RA
lymphocyte proliferation,GO:0046651,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|Boron|Particulate Matter|Vehicle Emissions,0,
lymphoid progenitor cell differentiation,GO:0002320,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
lymphoid progenitor cell differentiation,GO:0002320,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,BCL2|HMGA1
lymph vessel development,GO:0001945,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,MMP2
lymph vessel development,GO:0001945,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,PROX1|SMAD5
lymph vessel morphogenesis,GO:0036303,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,VEGFA
lysine biosynthetic process,GO:0009085,Diabetes Mellitus,MESH:D003920,3,bisphenol A|DDT|Polychlorinated Biphenyls,0,
lysine biosynthetic process,GO:0009085,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
lysine biosynthetic process,GO:0009085,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
lysine biosynthetic process,GO:0009085,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|Malathion|Polychlorinated Biphenyls,0,
lysine catabolic process,GO:0006554,"Diabetes Mellitus, Type 2",MESH:D003924,1,Malathion,0,
lysine metabolic process,GO:0006553,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
lysine metabolic process,GO:0006553,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dichlorodiphenyl Dichloroethylene,0,
lysosomal lumen acidification,GO:0007042,Diabetes Mellitus,MESH:D003920,5,Arsenic|Cadmium|Copper|Particulate Matter|Trifluoperazine,0,
lysosomal lumen acidification,GO:0007042,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
lysosomal lumen acidification,GO:0007042,"Diabetes Mellitus, Type 2",MESH:D003924,6,Arsenic|Cadmium|Copper|Manganese|Particulate Matter|Vehicle Emissions,0,
lysosomal lumen pH elevation,GO:0035752,Diabetes Mellitus,MESH:D003920,2,Berberine|Cadmium,0,
lysosomal lumen pH elevation,GO:0035752,"Diabetes Mellitus, Experimental",MESH:D003921,2,Berberine|Imatinib Mesylate,0,
lysosomal lumen pH elevation,GO:0035752,"Diabetes Mellitus, Type 1",MESH:D003922,1,Imatinib Mesylate,0,
lysosomal lumen pH elevation,GO:0035752,"Diabetes Mellitus, Type 2",MESH:D003924,5,Berberine|Cadmium|Curcumin|perfluorooctane sulfonic acid|Silver,0,
lysosomal membrane organization,GO:0097212,Diabetes Mellitus,MESH:D003920,5,Berberine|bisphenol A|Cadmium|Copper|Metformin,0,
lysosomal membrane organization,GO:0097212,"Diabetes Mellitus, Experimental",MESH:D003921,5,Berberine|bisphenol A|Diethylhexyl Phthalate|Metformin|Quercetin,0,
lysosomal membrane organization,GO:0097212,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
lysosomal membrane organization,GO:0097212,"Diabetes Mellitus, Type 2",MESH:D003924,7,Berberine|bisphenol A|Cadmium|Copper|Diethylhexyl Phthalate|Metformin|Nickel,0,
lysosomal protein catabolic process,GO:1905146,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
lysosomal protein catabolic process,GO:1905146,"Diabetes Mellitus, Experimental",MESH:D003921,1,Imatinib Mesylate,0,
lysosomal protein catabolic process,GO:1905146,"Diabetes Mellitus, Type 1",MESH:D003922,1,Imatinib Mesylate,1,CTSH
lysosomal protein catabolic process,GO:1905146,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
lysosome localization,GO:0032418,Diabetes Mellitus,MESH:D003920,0,,1,KIF5B
lysosome organization,GO:0007040,Diabetes Mellitus,MESH:D003920,4,"2,2',4,4'-tetrabromodiphenyl ether|Atrazine|Copper|Plant Extracts",0,
lysosome organization,GO:0007040,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cholesterol|Plant Extracts,0,
lysosome organization,GO:0007040,"Diabetes Mellitus, Type 2",MESH:D003924,3,Atrazine|Copper|Plant Extracts,0,
macroautophagy,GO:0016236,"Diabetes Mellitus, Experimental",MESH:D003921,1,Niacinamide,1,HMOX1
macroautophagy,GO:0016236,"Diabetes Mellitus, Type 1",MESH:D003922,1,Niacinamide,0,
macroautophagy,GO:0016236,"Diabetes Mellitus, Type 2",MESH:D003924,1,Niacinamide,1,HMOX1
macrophage activation,GO:0042116,Diabetes Mellitus,MESH:D003920,7,Arsenic|arsenite|bisphenol A|Cadmium|Ozone|Particulate Matter|Rosiglitazone,0,
macrophage activation,GO:0042116,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Rosiglitazone|sodium arsenite,0,
macrophage activation,GO:0042116,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Calcitriol|Lipopolysaccharides|sodium arsenite,1,SLC11A1
macrophage activation,GO:0042116,"Diabetes Mellitus, Type 2",MESH:D003924,6,Arsenic|bisphenol A|Cadmium|Curcumin|Particulate Matter|Rosiglitazone,0,
macrophage activation involved in immune response,GO:0002281,Diabetes Mellitus,MESH:D003920,4,"2,2',4,4'-tetrabromodiphenyl ether|Ozone|Particulate Matter|Tobacco Smoke Pollution",0,
macrophage activation involved in immune response,GO:0002281,"Diabetes Mellitus, Experimental",MESH:D003921,0,,3,IFNG|PRKCE|TNF
macrophage activation involved in immune response,GO:0002281,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,2,IFNG|TNF
macrophage activation involved in immune response,GO:0002281,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,1,TNF
macrophage chemotaxis,GO:0048246,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,5,CX3CL1|CYBA|IL1B|MMP2|MMP9
macrophage chemotaxis,GO:0048246,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,2,CYBA|EDNRB
macrophage colony-stimulating factor signaling pathway,GO:0038145,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
macrophage colony-stimulating factor signaling pathway,GO:0038145,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
macrophage colony-stimulating factor signaling pathway,GO:0038145,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
macrophage cytokine production,GO:0010934,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,IFNG|IL1B
macrophage cytokine production,GO:0010934,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,IFNG
macrophage cytokine production,GO:0010934,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CD36
macrophage derived foam cell differentiation,GO:0010742,Diabetes Mellitus,MESH:D003920,3,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A|Pravastatin",1,PPARG
macrophage derived foam cell differentiation,GO:0010742,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|sarpogrelate,2,PPARG|TGFB1
macrophage derived foam cell differentiation,GO:0010742,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
macrophage derived foam cell differentiation,GO:0010742,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,1,PPARG
macrophage differentiation,GO:0030225,Diabetes Mellitus,MESH:D003920,3,Metformin|Particulate Matter|Tetrachlorodibenzodioxin,1,SIRT1
macrophage differentiation,GO:0030225,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dibutyl Phthalate|Metformin,6,IFNG|IL6|MMP9|SIRT1|UCP2|VEGFA
macrophage differentiation,GO:0030225,"Diabetes Mellitus, Type 1",MESH:D003922,3,Calcitriol|Lipopolysaccharides|Tetrachlorodibenzodioxin,3,HLA-DRB1|IFNG|IL6
macrophage differentiation,GO:0030225,"Diabetes Mellitus, Type 2",MESH:D003924,5,"Dibutyl Phthalate|Drugs, Chinese Herbal|Metformin|Particulate Matter|Vehicle Emissions",5,CASP8|ENPP1|IL6|SIRT1|UCP2
macrophage homeostasis,GO:0061519,Diabetes Mellitus,MESH:D003920,5,Air Pollutants|bisphenol A|Dichlorodiphenyl Dichloroethylene|Particulate Matter|Tetrachlorodibenzodioxin,0,
macrophage homeostasis,GO:0061519,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
macrophage homeostasis,GO:0061519,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Tetrachlorodibenzodioxin,0,
macrophage homeostasis,GO:0061519,"Diabetes Mellitus, Type 2",MESH:D003924,5,Air Pollutants|bisphenol A|Dichlorodiphenyl Dichloroethylene|Particulate Matter|Vehicle Emissions,0,
macrophage migration,GO:1905517,Diabetes Mellitus,MESH:D003920,13,Air Pollutants|Arsenic|bisphenol A|Cadmium|Glyburide|Ozone|Particulate Matter|Perindopril|Resveratrol|Rosiglitazone|Streptozocin|Sulfur Dioxide|Tobacco Smoke Pollution,0,
macrophage migration,GO:1905517,"Diabetes Mellitus, Experimental",MESH:D003921,14,bisphenol A|Dietary Fats|Dietary Sucrose|Fructose|Glucose|Glyburide|Imatinib Mesylate|Losartan|Resveratrol|Rosiglitazone|sodium arsenite|Sodium Glutamate|Streptozocin|tianhuang,0,
macrophage migration,GO:1905517,"Diabetes Mellitus, Type 1",MESH:D003922,7,bisphenol A|Imatinib Mesylate|Lipopolysaccharides|Resveratrol|sodium arsenite|Streptozocin|Uric Acid,0,
macrophage migration,GO:1905517,"Diabetes Mellitus, Type 2",MESH:D003924,18,Air Pollutants|Arsenic|bisphenol A|bisphenol S|Cadmium|Curcumin|Dietary Fats|Fructose|Glucose|Glyburide|Malathion|Particulate Matter|Resveratrol|Rosiglitazone|Silver|Streptozocin|titanium dioxide|Vehicle Emissions,0,
macrophage proliferation,GO:0061517,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
macrophage proliferation,GO:0061517,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
macrophage proliferation,GO:0061517,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dichlorodiphenyl Dichloroethylene,0,
magnesium ion homeostasis,GO:0010960,Diabetes Mellitus,MESH:D003920,2,Atrazine|Magnesium,0,
magnesium ion homeostasis,GO:0010960,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
magnesium ion homeostasis,GO:0010960,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
magnesium ion homeostasis,GO:0010960,"Diabetes Mellitus, Type 2",MESH:D003924,2,Atrazine|Magnesium,1,ENPP1
magnesium ion transmembrane transport,GO:1903830,Diabetes Mellitus,MESH:D003920,2,Glyburide|Streptozocin,0,
magnesium ion transmembrane transport,GO:1903830,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glyburide|Streptozocin,0,
magnesium ion transmembrane transport,GO:1903830,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
magnesium ion transmembrane transport,GO:1903830,"Diabetes Mellitus, Type 2",MESH:D003924,2,Glyburide|Streptozocin,0,
magnesium ion transport,GO:0015693,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nickel,0,
maintenance of animal organ identity,GO:0048496,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
maintenance of blood-brain barrier,GO:0035633,Diabetes Mellitus,MESH:D003920,5,Blood Glucose|Cyclosporine|Lead|Particulate Matter|Resveratrol,1,PTGS2
maintenance of blood-brain barrier,GO:0035633,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
maintenance of blood-brain barrier,GO:0035633,"Diabetes Mellitus, Experimental",MESH:D003921,6,"Blood Glucose|Glucose|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Resveratrol|sodium arsenite|tributyltin",2,IL6|PTGS2
maintenance of blood-brain barrier,GO:0035633,"Diabetes Mellitus, Type 1",MESH:D003922,3,Lipopolysaccharides|Resveratrol|sodium arsenite,1,IL6
maintenance of blood-brain barrier,GO:0035633,"Diabetes Mellitus, Type 2",MESH:D003924,6,Blood Glucose|Ethanol|Glucose|Lead|Particulate Matter|Resveratrol,1,IL6
maintenance of blood vessel diameter homeostasis by renin-angiotensin,GO:0002034,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,AGT
maintenance of cell number,GO:0098727,Diabetes Mellitus,MESH:D003920,5,Atrazine|Lead|Plant Extracts|Streptozocin|triphenyltin,0,
maintenance of cell number,GO:0098727,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
maintenance of cell number,GO:0098727,"Diabetes Mellitus, Experimental",MESH:D003921,3,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Plant Extracts|Streptozocin",0,
maintenance of cell number,GO:0098727,"Diabetes Mellitus, Type 1",MESH:D003922,2,decabromobiphenyl ether|Streptozocin,0,
maintenance of cell number,GO:0098727,"Diabetes Mellitus, Type 2",MESH:D003924,5,Atrazine|efavirenz|Lead|Plant Extracts|Streptozocin,0,
maintenance of cell polarity,GO:0030011,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SLC9A1
maintenance of DNA repeat elements,GO:0043570,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,TCF7L2
maintenance of epithelial cell apical/basal polarity,GO:0045199,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
"maintenance of epithelial integrity, open tracheal system",GO:0035160,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
maintenance of gastrointestinal epithelium,GO:0030277,"Diabetes Mellitus, Type 2",MESH:D003924,1,Curcumin,0,
maintenance of location,GO:0051235,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
maintenance of location,GO:0051235,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Vehicle Emissions,0,
maintenance of location in cell,GO:0051651,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
maintenance of location in cell,GO:0051651,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
maintenance of nucleus location,GO:0051658,Diabetes Mellitus,MESH:D003920,0,,1,SIRT1
maintenance of nucleus location,GO:0051658,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SIRT1
maintenance of nucleus location,GO:0051658,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SIRT1
maintenance of protein location in cell,GO:0032507,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
maintenance of protein location in cell,GO:0032507,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
maintenance of protein location in cell,GO:0032507,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
maintenance of protein location in mitochondrion,GO:0072656,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
maintenance of protein location in mitochondrion,GO:0072656,"Diabetes Mellitus, Experimental",MESH:D003921,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",1,HK1
maintenance of protein location in mitochondrion,GO:0072656,"Diabetes Mellitus, Type 2",MESH:D003924,1,efavirenz,2,AKT1|HK1
maintenance of protein location in plasma membrane,GO:0072660,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
maintenance of protein location in plasma membrane,GO:0072660,"Diabetes Mellitus, Experimental",MESH:D003921,2,Glucose|sodium arsenite,0,
maintenance of protein location in plasma membrane,GO:0072660,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
maintenance of protein location in plasma membrane,GO:0072660,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Glucose,0,
maintenance of rDNA,GO:0043007,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CLEC16A
maintenance of synapse structure,GO:0099558,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|Dietary Sucrose,0,
maintenance of synapse structure,GO:0099558,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dietary Fats,0,
maintenance of translational fidelity,GO:1990145,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,CDKAL1
malate metabolic process,GO:0006108,"Diabetes Mellitus, Type 2",MESH:D003924,1,perfluorooctanoic acid,0,
malate transmembrane transport,GO:0071423,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,UCP2
malate transmembrane transport,GO:0071423,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,UCP2
male anatomical structure morphogenesis,GO:0090598,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
male anatomical structure morphogenesis,GO:0090598,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol S|Nicotine,0,
male courtship behavior,GO:0008049,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
male courtship behavior,GO:0008049,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Diethylhexyl Phthalate,0,
male courtship behavior,GO:0008049,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
male courtship behavior,GO:0008049,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Diethylhexyl Phthalate,1,RETN
"male courtship behavior, orientation prior to leg tapping and wing vibration",GO:0016543,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
"male courtship behavior, orientation prior to leg tapping and wing vibration",GO:0016543,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
"male courtship behavior, orientation prior to leg tapping and wing vibration",GO:0016543,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
"male courtship behavior, orientation prior to leg tapping and wing vibration",GO:0016543,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
"male courtship behavior, proboscis-mediated licking",GO:0016546,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
"male courtship behavior, proboscis-mediated licking",GO:0016546,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
"male courtship behavior, proboscis-mediated licking",GO:0016546,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
"male courtship behavior, proboscis-mediated licking",GO:0016546,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
"male courtship behavior, tapping to detect pheromone",GO:0016544,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
"male courtship behavior, tapping to detect pheromone",GO:0016544,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
"male courtship behavior, tapping to detect pheromone",GO:0016544,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
"male courtship behavior, tapping to detect pheromone",GO:0016544,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
"male courtship behavior, veined wing vibration",GO:0016545,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
"male courtship behavior, veined wing vibration",GO:0016545,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
"male courtship behavior, veined wing vibration",GO:0016545,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
"male courtship behavior, veined wing vibration",GO:0016545,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
male gamete generation,GO:0048232,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
male genitalia development,GO:0030539,Diabetes Mellitus,MESH:D003920,2,Dichlorodiphenyl Dichloroethylene|Pesticides,0,
male genitalia development,GO:0030539,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dichlorodiphenyl Dichloroethylene|Pesticides|Phthalic Acids,0,
male genitalia morphogenesis,GO:0048808,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
male genitalia morphogenesis,GO:0048808,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dibutyl Phthalate,0,
male genitalia morphogenesis,GO:0048808,"Diabetes Mellitus, Type 2",MESH:D003924,2,Atrazine|Dibutyl Phthalate,0,
male germ cell proliferation,GO:0002176,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Chlorpyrifos,0,
male germ cell proliferation,GO:0002176,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Dibutyl Phthalate,0,
male germ cell proliferation,GO:0002176,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
male germ cell proliferation,GO:0002176,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Dibutyl Phthalate,0,
male germ-line stem cell population maintenance,GO:0036098,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
male germ-line stem cell population maintenance,GO:0036098,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
male germ-line stem cell population maintenance,GO:0036098,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
male germ-line stem cell population maintenance,GO:0036098,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
male gonad development,GO:0008584,Diabetes Mellitus,MESH:D003920,13,"2,2',4,4'-tetrabromodiphenyl ether|Atrazine|bisphenol A|Cadmium|Chlorpyrifos|Dichlorodiphenyl Dichloroethylene|Lead|o,p'-DDT|Pesticides|Pioglitazone|Resveratrol|Streptozocin|Tetrachlorodibenzodioxin",1,LEPR
male gonad development,GO:0008584,"Diabetes Mellitus, Experimental",MESH:D003921,8,bisphenol A|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Pioglitazone|Resveratrol|sodium arsenite|Streptozocin,7,ACE|BAX|BCL2|BCL2L1|INSR|LEPR|REN
male gonad development,GO:0008584,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
male gonad development,GO:0008584,"Diabetes Mellitus, Type 1",MESH:D003922,6,bisphenol A|decabromobiphenyl ether|Resveratrol|sodium arsenite|Streptozocin|Tetrachlorodibenzodioxin,0,
male gonad development,GO:0008584,"Diabetes Mellitus, Type 2",MESH:D003924,16,Amoxicillin|Ascorbic Acid|Atrazine|bisphenol A|Cadmium|Dibutyl Phthalate|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Diethylhexyl Phthalate|diethyl phthalate|Lead|Pesticides|Phthalic Acids|Pioglitazone|Resveratrol|Streptozocin,6,BAX|BCL2|BCL2L1|BCL2L11|KCNQ1|LEPR
male mating behavior,GO:0060179,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Chlorpyrifos|Tetrachlorodibenzodioxin,0,
male mating behavior,GO:0060179,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Nicotine|sodium arsenite,0,
male mating behavior,GO:0060179,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|sodium arsenite|Tetrachlorodibenzodioxin,0,
male mating behavior,GO:0060179,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Nicotine,0,
male meiosis chromosome separation,GO:0051308,Diabetes Mellitus,MESH:D003920,2,Dichlorodiphenyl Dichloroethylene|Polychlorinated Biphenyls,0,
male meiosis chromosome separation,GO:0051308,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dichlorodiphenyl Dichloroethylene|Polychlorinated Biphenyls,0,
male meiosis I,GO:0007141,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
male meiosis I,GO:0007141,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
male meiosis I,GO:0007141,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
male meiosis I,GO:0007141,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
male meiotic nuclear division,GO:0007140,Diabetes Mellitus,MESH:D003920,2,Atrazine|bisphenol A,0,
male meiotic nuclear division,GO:0007140,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
male meiotic nuclear division,GO:0007140,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
male meiotic nuclear division,GO:0007140,"Diabetes Mellitus, Type 2",MESH:D003924,2,Atrazine|bisphenol A,0,
male sex determination,GO:0030238,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,INSR
male sex determination,GO:0030238,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
male sex differentiation,GO:0046661,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MIR144
male urethra development,GO:0061069,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dibutyl Phthalate,0,
male urethra development,GO:0061069,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dibutyl Phthalate,0,
malonyl-CoA biosynthetic process,GO:2001295,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
malonyl-CoA biosynthetic process,GO:2001295,"Diabetes Mellitus, Experimental",MESH:D003921,3,cobaltiprotoporphyrin|Dibutyl Phthalate|Streptozocin,0,
malonyl-CoA biosynthetic process,GO:2001295,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
malonyl-CoA biosynthetic process,GO:2001295,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dibutyl Phthalate|Streptozocin,0,
Malpighian tubule morphogenesis,GO:0007443,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
mammalian oogenesis stage,GO:0022605,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AKT1
mammary duct terminal end bud growth,GO:0060763,Diabetes Mellitus,MESH:D003920,4,bisphenol A|Resveratrol|Tetrachlorodibenzodioxin|Zinc,0,
mammary duct terminal end bud growth,GO:0060763,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Resveratrol,0,
mammary duct terminal end bud growth,GO:0060763,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Genistein|Resveratrol|Tetrachlorodibenzodioxin,0,
mammary duct terminal end bud growth,GO:0060763,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|bisphenol S|Genistein|Resveratrol|Zinc,0,
mammary gland alveolus development,GO:0060749,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
mammary gland alveolus development,GO:0060749,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,1,VEGFA
mammary gland branching involved in thelarche,GO:0060744,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
mammary gland bud formation,GO:0060615,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
mammary gland bud morphogenesis,GO:0060648,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,0,
mammary gland development,GO:0030879,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Olanzapine,1,IRS1
mammary gland development,GO:0030879,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,5,CAV1|IGF1|IRS1|IRS2|TGFB1
mammary gland development,GO:0030879,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,IGF1
mammary gland development,GO:0030879,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|bisphenol S|perfluorooctanoic acid,3,BCL2L11|IRS1|IRS2
mammary gland duct morphogenesis,GO:0060603,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Chlorpyrifos,0,
mammary gland duct morphogenesis,GO:0060603,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
mammary gland duct morphogenesis,GO:0060603,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
mammary gland duct morphogenesis,GO:0060603,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
mammary gland epithelial cell differentiation,GO:0060644,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|AKT2
mammary gland epithelium development,GO:0061180,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
mammary gland epithelium development,GO:0061180,"Diabetes Mellitus, Type 2",MESH:D003924,1,Atrazine,0,
mammary gland involution,GO:0060056,Diabetes Mellitus,MESH:D003920,0,,1,CP
mammary gland involution,GO:0060056,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,CAV1
mammary gland involution,GO:0060056,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CP
mammary gland involution,GO:0060056,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,NFKB1|SFRP4
mammary gland morphogenesis,GO:0060443,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
mammary gland morphogenesis,GO:0060443,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
mammary gland morphogenesis,GO:0060443,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
mammary gland morphogenesis,GO:0060443,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|perfluorodecanoic acid|perfluorooctane sulfonic acid,0,
mammary stem cell proliferation,GO:0002174,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
mammary stem cell proliferation,GO:0002174,"Diabetes Mellitus, Type 2",MESH:D003924,1,Cadmium,0,
manganese ion export across plasma membrane,GO:0140048,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
manganese ion export across plasma membrane,GO:0140048,"Diabetes Mellitus, Type 2",MESH:D003924,1,Manganese,0,
manganese ion homeostasis,GO:0055071,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
manganese ion homeostasis,GO:0055071,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
manganese ion homeostasis,GO:0055071,"Diabetes Mellitus, Type 2",MESH:D003924,3,Cadmium|Ethanol|Manganese,0,
manganese ion transmembrane transport,GO:0071421,Diabetes Mellitus,MESH:D003920,1,Iron,0,
manganese ion transmembrane transport,GO:0071421,"Diabetes Mellitus, Experimental",MESH:D003921,1,Manganese,0,
manganese ion transmembrane transport,GO:0071421,"Diabetes Mellitus, Type 1",MESH:D003922,1,Iron,1,SLC11A1
manganese ion transmembrane transport,GO:0071421,"Diabetes Mellitus, Type 2",MESH:D003924,3,Iron|Manganese|Nickel,0,
manganese ion transport,GO:0006828,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
manganese ion transport,GO:0006828,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
manganese ion transport,GO:0006828,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,1,SLC11A1
manganese ion transport,GO:0006828,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
mannose metabolic process,GO:0006013,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
mannose metabolic process,GO:0006013,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,GCK|HK1
mannose metabolic process,GO:0006013,"Diabetes Mellitus, Permanent Neonatal",MESH:C563425,0,,1,GCK
mannose metabolic process,GO:0006013,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dichlorodiphenyl Dichloroethylene,2,GCK|HK1
mannosylation,GO:0097502,Diabetes Mellitus,MESH:D003920,3,Cadmium|Copper|Zinc,0,
mannosylation,GO:0097502,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
mannosylation,GO:0097502,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
mannosylation,GO:0097502,"Diabetes Mellitus, Type 2",MESH:D003924,4,Cadmium|Copper|Nickel|Zinc,0,
MAPK cascade,GO:0000165,Diabetes Mellitus,MESH:D003920,11,Cyclosporine|Pioglitazone|Plant Extracts|Raloxifene Hydrochloride|Reactive Oxygen Species|Rosiglitazone|Streptozocin|Tacrolimus|Telmisartan|Trifluoperazine|Troglitazone,1,MAP3K5
MAPK cascade,GO:0000165,"Diabetes Mellitus, Experimental",MESH:D003921,12,Aldosterone|Glucose|Hydrogen Peroxide|Nicotine|Pioglitazone|Plant Extracts|Rosiglitazone|Streptozocin|Tacrolimus|Telmisartan|Troglitazone|Vitamin E,7,ADRA1A|AGT|CAV1|CAV3|EDN1|MAP3K5|PRKCE
MAPK cascade,GO:0000165,"Diabetes Mellitus, Insulin-Dependent, 22",MESH:C567284,0,,1,CCR5
MAPK cascade,GO:0000165,"Diabetes Mellitus, Type 1",MESH:D003922,6,Genistein|Lipopolysaccharides|Norepinephrine|Reactive Oxygen Species|Streptozocin|Tacrolimus,1,SLC11A1
MAPK cascade,GO:0000165,"Diabetes Mellitus, Type 2",MESH:D003924,14,bisphenol S|Calcium|Curcumin|Genistein|Glucose|Nicotine|Pentoxifylline|Pioglitazone|Plant Extracts|Reactive Oxygen Species|Rosiglitazone|Streptozocin|Telmisartan|Troglitazone,7,BRAF|CD36|EDN1|EGFR|KSR2|MAPK8IP1|NFKB1
marginal zone B cell differentiation,GO:0002315,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,NOTCH2
mast cell activation,GO:0045576,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SERPINE1
mast cell chemotaxis,GO:0002551,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
mast cell degranulation,GO:0043303,Diabetes Mellitus,MESH:D003920,4,Air Pollutants|Chlorpromazine|Metformin|Streptozocin,0,
mast cell degranulation,GO:0043303,"Diabetes Mellitus, Experimental",MESH:D003921,5,Capsaicin|Dietary Fats|Metformin|Quercetin|Streptozocin,0,
mast cell degranulation,GO:0043303,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Streptozocin,0,
mast cell degranulation,GO:0043303,"Diabetes Mellitus, Type 2",MESH:D003924,5,Air Pollutants|Dietary Fats|Metformin|perfluorooctanoic acid|Streptozocin,1,PIK3CG
mast cell homeostasis,GO:0033023,Diabetes Mellitus,MESH:D003920,1,Cadmium,0,
mast cell homeostasis,GO:0033023,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cromolyn Sodium|Valsartan,0,
mast cell homeostasis,GO:0033023,"Diabetes Mellitus, Type 2",MESH:D003924,2,Cadmium|perfluorooctanoic acid,0,
mast cell migration,GO:0097531,Diabetes Mellitus,MESH:D003920,1,Berberine,0,
mast cell migration,GO:0097531,"Diabetes Mellitus, Experimental",MESH:D003921,4,Berberine|Cromolyn Sodium|Dietary Fats|Quercetin,0,
mast cell migration,GO:0097531,"Diabetes Mellitus, Type 2",MESH:D003924,3,Berberine|Dietary Fats|Malathion,0,
mast cell proliferation,GO:0070662,"Diabetes Mellitus, Experimental",MESH:D003921,1,tributyltin,0,
maternal behavior,GO:0042711,Diabetes Mellitus,MESH:D003920,3,Dichlorodiphenyl Dichloroethylene|Ozone|Particulate Matter,0,
maternal behavior,GO:0042711,"Diabetes Mellitus, Experimental",MESH:D003921,1,Diethylhexyl Phthalate,0,
maternal behavior,GO:0042711,"Diabetes Mellitus, Type 2",MESH:D003924,4,Dichlorodiphenyl Dichloroethylene|Diethylhexyl Phthalate|Particulate Matter|Vehicle Emissions,0,
"maternal determination of dorsal/ventral axis, ovarian follicular epithelium, soma encoded",GO:0008071,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
maternal placenta development,GO:0001893,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,AKT1|CD36
maternal process involved in female pregnancy,GO:0060135,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dibutyl Phthalate|Diethylhexyl Phthalate,1,FAS
maternal process involved in female pregnancy,GO:0060135,"Diabetes Mellitus, Type 1",MESH:D003922,1,Genistein,0,
maternal process involved in female pregnancy,GO:0060135,"Diabetes Mellitus, Type 2",MESH:D003924,3,Dibutyl Phthalate|Diethylhexyl Phthalate|Genistein,3,CBS|FAS|PAM
maternal process involved in parturition,GO:0060137,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
maternal process involved in parturition,GO:0060137,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,2,CYP1A1|EDN1
maternal process involved in parturition,GO:0060137,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
maternal process involved in parturition,GO:0060137,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,2,EDN1|EDNRA
mating,GO:0007618,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
mating,GO:0007618,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
mating,GO:0007618,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
mating,GO:0007618,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
mating behavior,GO:0007617,Diabetes Mellitus,MESH:D003920,1,Streptozocin,0,
mating behavior,GO:0007617,"Diabetes Mellitus, Experimental",MESH:D003921,2,Diethylhexyl Phthalate|Streptozocin,0,
mating behavior,GO:0007617,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
mating behavior,GO:0007617,"Diabetes Mellitus, Type 2",MESH:D003924,2,Diethylhexyl Phthalate|Streptozocin,0,
matrix metallopeptidase secretion,GO:1990773,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
matrix metallopeptidase secretion,GO:1990773,"Diabetes Mellitus, Experimental",MESH:D003921,1,Cholesterol,0,
matrix metallopeptidase secretion,GO:1990773,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,0,
mature conventional dendritic cell differentiation,GO:0097029,Diabetes Mellitus,MESH:D003920,1,Plant Extracts,0,
mature conventional dendritic cell differentiation,GO:0097029,"Diabetes Mellitus, Experimental",MESH:D003921,1,Plant Extracts,0,
mature conventional dendritic cell differentiation,GO:0097029,"Diabetes Mellitus, Type 1",MESH:D003922,1,Lipopolysaccharides,0,
mature conventional dendritic cell differentiation,GO:0097029,"Diabetes Mellitus, Type 2",MESH:D003924,1,Plant Extracts,0,
mechanosensory behavior,GO:0007638,"Diabetes Mellitus, Experimental",MESH:D003921,1,Nicotine,0,
mechanosensory behavior,GO:0007638,"Diabetes Mellitus, Type 2",MESH:D003924,1,Nicotine,0,
megakaryocyte development,GO:0035855,Diabetes Mellitus,MESH:D003920,2,Arsenic|Cadmium,0,
megakaryocyte development,GO:0035855,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SH2B3
megakaryocyte development,GO:0035855,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Cadmium,0,
megakaryocyte differentiation,GO:0030219,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
megakaryocyte differentiation,GO:0030219,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hemin,0,
megakaryocyte differentiation,GO:0030219,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Hemin,0,
meiosis I,GO:0007127,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2L11
meiosis I cell cycle process,GO:0061982,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
meiosis I cell cycle process,GO:0061982,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
meiosis I cell cycle process,GO:0061982,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|Resveratrol,0,
meiosis I cell cycle process,GO:0061982,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
meiosis I/meiosis II transition,GO:1990946,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dronabinol,0,
meiotic anaphase I,GO:0007133,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Chlorpyrifos,0,
meiotic anaphase I,GO:0007133,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
meiotic anaphase I,GO:0007133,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
meiotic anaphase I,GO:0007133,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
meiotic cell cycle,GO:0051321,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Cadmium,0,
meiotic cell cycle,GO:0051321,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|Nicotine,0,
meiotic cell cycle,GO:0051321,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
meiotic cell cycle,GO:0051321,"Diabetes Mellitus, Type 2",MESH:D003924,4,bisphenol A|bisphenol S|Cadmium|Nicotine,0,
meiotic cell cycle checkpoint signaling,GO:0033313,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
meiotic cell cycle checkpoint signaling,GO:0033313,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
meiotic cell cycle checkpoint signaling,GO:0033313,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
meiotic cell cycle checkpoint signaling,GO:0033313,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
meiotic cell cycle process,GO:1903046,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Chlorpyrifos,0,
meiotic cell cycle process,GO:1903046,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
meiotic cell cycle process,GO:1903046,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|decabromobiphenyl ether,0,
meiotic cell cycle process,GO:1903046,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Cadmium|Chlorpyrifos,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Cholesterol|Dronabinol,1,EDN1
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Cadmium,2,EDN1|EDNRA
meiotic chromosome separation,GO:0051307,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Mercury|Tetrachlorodibenzodioxin,0,
meiotic chromosome separation,GO:0051307,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate,0,
meiotic chromosome separation,GO:0051307,"Diabetes Mellitus, Type 1",MESH:D003922,3,bisphenol A|Mercury|Tetrachlorodibenzodioxin,0,
meiotic chromosome separation,GO:0051307,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol A|Dibutyl Phthalate|Diethylhexyl Phthalate|diethyl phthalate|Mercury,0,
meiotic DNA double-strand break formation,GO:0042138,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
meiotic DNA double-strand break formation,GO:0042138,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
meiotic DNA double-strand break formation,GO:0042138,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
meiotic DNA double-strand break formation,GO:0042138,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
meiotic DNA double-strand break processing,GO:0000706,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dibutyl Phthalate,0,
meiotic DNA double-strand break processing,GO:0000706,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dibutyl Phthalate,0,
meiotic DNA repair synthesis,GO:0000711,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
meiotic DNA repair synthesis,GO:0000711,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
meiotic DNA repair synthesis,GO:0000711,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
meiotic DNA repair synthesis,GO:0000711,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
meiotic metaphase I,GO:0007132,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,0,
meiotic metaphase II,GO:0007137,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Chlorpyrifos,0,
meiotic metaphase II,GO:0007137,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
meiotic metaphase II,GO:0007137,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Cyclophosphamide|Dronabinol,0,
meiotic metaphase II,GO:0007137,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Cyclophosphamide,0,
meiotic metaphase II,GO:0007137,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
meiotic metaphase II plate congression,GO:0043061,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
meiotic metaphase II plate congression,GO:0043061,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
meiotic metaphase II plate congression,GO:0043061,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
meiotic metaphase II plate congression,GO:0043061,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
meiotic metaphase plate congression,GO:0051311,"Diabetes Mellitus, Type 2",MESH:D003924,1,Malathion,0,
meiotic prophase I,GO:0007128,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
meiotic prophase I,GO:0007128,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
meiotic prophase I,GO:0007128,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
meiotic prophase I,GO:0007128,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|perfluorodecanoic acid,0,
meiotic recombination checkpoint signaling,GO:0051598,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
meiotic recombination checkpoint signaling,GO:0051598,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
meiotic recombination checkpoint signaling,GO:0051598,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
meiotic recombination checkpoint signaling,GO:0051598,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
meiotic spindle assembly,GO:0090306,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
meiotic spindle disassembly,GO:0051229,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,0,
meiotic spindle organization,GO:0000212,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
meiotic spindle organization,GO:0000212,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dibutyl Phthalate|Diethylhexyl Phthalate,0,
meiotic spindle organization,GO:0000212,"Diabetes Mellitus, Type 2",MESH:D003924,5,bisphenol S|Dibutyl Phthalate|Diethylhexyl Phthalate|Malathion|perfluorodecanoic acid,0,
meiotic telophase I,GO:0007134,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Chlorpyrifos,0,
meiotic telophase I,GO:0007134,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
meiotic telophase I,GO:0007134,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
meiotic telophase I,GO:0007134,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
melanin biosynthetic process,GO:0042438,Diabetes Mellitus,MESH:D003920,5,Copper|Particulate Matter|Plant Extracts|Resveratrol|Zinc,1,A
melanin biosynthetic process,GO:0042438,"Diabetes Mellitus, Experimental",MESH:D003921,4,Plant Extracts|Quercetin|Resveratrol|sodium arsenite,0,
melanin biosynthetic process,GO:0042438,"Diabetes Mellitus, Type 1",MESH:D003922,2,Resveratrol|sodium arsenite,0,
melanin biosynthetic process,GO:0042438,"Diabetes Mellitus, Type 2",MESH:D003924,5,Copper|Particulate Matter|Plant Extracts|Resveratrol|Zinc,1,A
melanin metabolic process,GO:0006582,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
melanin metabolic process,GO:0006582,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2
melanocyte differentiation,GO:0030318,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
melanocyte differentiation,GO:0030318,"Diabetes Mellitus, Type 2",MESH:D003924,0,,4,ADAMTS9|BCL2|EDNRB|ENPP1
melanocyte-stimulating hormone secretion,GO:0036160,Diabetes Mellitus,MESH:D003920,1,Gallic Acid,0,
melanocyte-stimulating hormone secretion,GO:0036160,"Diabetes Mellitus, Experimental",MESH:D003921,1,Gallic Acid,0,
melanosome assembly,GO:1903232,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,AP3S2
melanosome localization,GO:0032400,Diabetes Mellitus,MESH:D003920,1,Arsenic,0,
melanosome localization,GO:0032400,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
melanosome localization,GO:0032400,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
melanosome localization,GO:0032400,"Diabetes Mellitus, Type 2",MESH:D003924,1,Arsenic,1,ADCY5
melanosome organization,GO:0032438,Diabetes Mellitus,MESH:D003920,0,,1,A
melanosome organization,GO:0032438,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,A
melanosome transport,GO:0032402,Diabetes Mellitus,MESH:D003920,0,,1,A
melanosome transport,GO:0032402,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,A
melanotic encapsulation of foreign target,GO:0035011,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
melatonin biosynthetic process,GO:0030187,Diabetes Mellitus,MESH:D003920,2,bisphenol A|Parathion,0,
melatonin biosynthetic process,GO:0030187,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
melatonin biosynthetic process,GO:0030187,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Norepinephrine,0,
melatonin biosynthetic process,GO:0030187,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
melatonin metabolic process,GO:0030186,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
melatonin metabolic process,GO:0030186,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
melatonin metabolic process,GO:0030186,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
melatonin metabolic process,GO:0030186,"Diabetes Mellitus, Type 2",MESH:D003924,2,"bisphenol A|Drugs, Chinese Herbal",0,
membrane depolarization,GO:0051899,Diabetes Mellitus,MESH:D003920,9,Arsenic|bisphenol A|Cadmium|Chlorpyrifos|Diazoxide|Glyburide|Particulate Matter|puerarin|Streptozocin,0,
membrane depolarization,GO:0051899,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
membrane depolarization,GO:0051899,"Diabetes Mellitus, Experimental",MESH:D003921,9,bisphenol A|Cyclophosphamide|Glucose|Glyburide|Hydrogen Peroxide|Nicotine|puerarin|sodium arsenite|Streptozocin,2,CAV1|EDN1
membrane depolarization,GO:0051899,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Cyclophosphamide|Lipopolysaccharides|sodium arsenite|Streptozocin,0,
membrane depolarization,GO:0051899,"Diabetes Mellitus, Type 2",MESH:D003924,11,Arsenic|bisphenol A|Cadmium|Calcium|Glucose|Glyburide|Nicotine|Particulate Matter|perfluorooctanoic acid|Streptozocin|Vehicle Emissions,1,EDN1
membrane depolarization during action potential,GO:0086010,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,YWHAH
membrane disassembly,GO:0030397,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
membrane disassembly,GO:0030397,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
membrane fusion,GO:0061025,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,SNAP25
membrane fusion,GO:0061025,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SNAP25
membrane hyperpolarization,GO:0060081,Diabetes Mellitus,MESH:D003920,3,bisphenol A|Chlorides|Resveratrol,0,
membrane hyperpolarization,GO:0060081,"Diabetes Mellitus, Experimental",MESH:D003921,3,bisphenol A|Dronabinol|Resveratrol,0,
membrane hyperpolarization,GO:0060081,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Resveratrol,0,
membrane hyperpolarization,GO:0060081,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|Resveratrol,0,
membrane lipid catabolic process,GO:0046466,Diabetes Mellitus,MESH:D003920,48,Air Pollutants|Alloxan|Arsenic|Aspirin|Berberine|bisphenol A|Cadmium|Chlorodiphenyl (54% Chlorine)|Chlorpromazine|Chlorpyrifos|Copper|Cyclosporine|Docosahexaenoic Acids|Flavonoids|Glyburide|Hexachlorobenzene|Iron|Lead|Mercury|Metformin|Methylprednisolone|Niacin|Nitrogen Dioxide|Nitrogen Oxides|Olanzapine|Ozone|Parathion|Particulate Matter|Pioglitazone|Plant Extracts|Plant Preparations|Quetiapine Fumarate|Ramipril|Reactive Oxygen Species|Resveratrol|Risperidone|Rosiglitazone|Selenium|Serotonin|Sodium Selenite|Streptozocin|Tacrolimus|Telmisartan|Tetrachlorodibenzodioxin|Thioridazine|Tobacco Smoke Pollution|Tungsten|Zinc,0,
membrane lipid catabolic process,GO:0046466,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
membrane lipid catabolic process,GO:0046466,"Diabetes Mellitus, Experimental",MESH:D003921,47,8-epi-prostaglandin F2alpha|Alloxan|astaxanthine|Berberine|bisphenol A|Capsaicin|Cholesterol|Coconut Oil|Cromolyn Sodium|Cyclophosphamide|Dietary Fats|Diethylhexyl Phthalate|Diosmin|Enalapril|Fructose|Glucose|Glyburide|Hemin|honokiol|Hydrogen Peroxide|Losartan|Malondialdehyde|Manganese|mangiferin|Metformin|Naproxen|Nicotine|Nitric Oxide|pimagedine|Pioglitazone|Plant Extracts|Plant Preparations|Quercetin|Ramipril|Resveratrol|Rosiglitazone|sodium arsenite|Sodium Selenite|Streptozocin|Superoxides|Tacrolimus|Taurine|Telmisartan|thymoquinone|Tocotrienols|Valsartan|Vitamin E,0,
membrane lipid catabolic process,GO:0046466,"Diabetes Mellitus, Type 1",MESH:D003922,21,Alloxan|bisphenol A|Cyclophosphamide|decabromobiphenyl ether|Dehydroepiandrosterone|Iron|Lipopolysaccharides|Mercury|Nitric Oxide|Reactive Oxygen Species|Resveratrol|sodium arsenite|Streptozocin|Superoxides|Tacrolimus|Taurine|Tetrachlorodibenzodioxin|Thioctic Acid|Tocotrienols|Uric Acid|Vitamin A,0,
membrane lipid catabolic process,GO:0046466,"Diabetes Mellitus, Type 2",MESH:D003924,56,8-epi-prostaglandin F2alpha|Air Pollutants|Alloxan|alpha-Tocopherol|Arsenic|Ascorbic Acid|astaxanthine|benidipine|Berberine|bisphenol A|Boron|Cadmium|Calcium|Copper|Curcumin|Cysteine|Dietary Fats|Diethylhexyl Phthalate|Diethylnitrosamine|Diosmin|Enalapril|epigallocatechin gallate|Ethanol|Fructose|Glucose|Glutathione|Glyburide|Hemin|Iron|Lead|Malathion|Malondialdehyde|Manganese|mangiferin|Mercury|Metformin|Nickel|Nicotine|Nitrendipine|Particulate Matter|Pentoxifylline|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pioglitazone|Plant Extracts|Reactive Oxygen Species|Resveratrol|Rosiglitazone|S-Adenosylmethionine|Sitagliptin Phosphate|Streptozocin|Superoxides|Telmisartan|Topiramate|Vehicle Emissions|Zinc,0,
membrane organization,GO:0061024,Diabetes Mellitus,MESH:D003920,2,Chlorodiphenyl (54% Chlorine)|Particulate Matter,0,
membrane organization,GO:0061024,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
membrane organization,GO:0061024,"Diabetes Mellitus, Type 2",MESH:D003924,5,alpha-Tocopherol|Ascorbic Acid|coumarin|Glutathione|Particulate Matter,0,
membrane protein ectodomain proteolysis,GO:0006509,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,PRKCQ
membrane protein intracellular domain proteolysis,GO:0031293,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,TGFB1
membrane protein proteolysis,GO:0033619,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CTSH
membrane raft assembly,GO:0001765,"Diabetes Mellitus, Experimental",MESH:D003921,1,platycodin D,0,
membrane raft organization,GO:0031579,"Diabetes Mellitus, Experimental",MESH:D003921,2,Nicotine|Triglycerides,1,CAV3
membrane raft organization,GO:0031579,"Diabetes Mellitus, Type 2",MESH:D003924,2,Nicotine|Triglycerides,0,
membrane repolarization,GO:0086009,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
membrane repolarization during action potential,GO:0086011,"Diabetes Mellitus, Type 2",MESH:D003924,0,,2,KCNK16|KCNQ1
membrane repolarization during atrial cardiac muscle cell action potential,GO:0098914,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
membrane repolarization during cardiac muscle cell action potential,GO:0086013,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
membrane repolarization during ventricular cardiac muscle cell action potential,GO:0098915,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,KCNQ1
membrane to membrane docking,GO:0022614,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,ICAM1
membrane to membrane docking,GO:0022614,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ICAM1
membrane tubulation,GO:0097749,"Diabetes Mellitus, Type 2",MESH:D003924,1,Folic Acid,0,
memory,GO:0007613,Diabetes Mellitus,MESH:D003920,23,Air Pollutants|Arsenic|Aspirin|Atrazine|Berberine|bisphenol A|Cadmium|Chlorpyrifos|Copper|DDT|Diazinon|Docosahexaenoic Acids|Lead|Mercury|Particulate Matter|Plant Extracts|Polychlorinated Biphenyls|Pyruvaldehyde|Resveratrol|Risperidone|Streptozocin|Tobacco Smoke Pollution|Zinc,3,ADRB1|PTGS2|RAC1
memory,GO:0007613,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
memory,GO:0007613,"Diabetes Mellitus, Experimental",MESH:D003921,23,Berberine|bisphenol A|Coconut Oil|Cyclophosphamide|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|Dronabinol|Eucalyptol|Fructose|ginsenoside Re|Manganese|mangiferin|Nicotine|Phycocyanin|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Streptozocin|Taurine|tributyltin|Vitamin E,4,IGF1|IL1B|INSR|PTGS2
memory,GO:0007613,"Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans",MESH:C562710,0,,1,INSR
memory,GO:0007613,"Diabetes Mellitus, Transient Neonatal, 2",MESH:C563672,0,,1,ABCC8
memory,GO:0007613,"Diabetes Mellitus, Type 1",MESH:D003922,9,bisphenol A|Cyclophosphamide|decabromobiphenyl ether|Lipopolysaccharides|Mercury|Resveratrol|sodium arsenite|Streptozocin|Taurine,3,ABCC8|IGF1|ITPR3
memory,GO:0007613,"Diabetes Mellitus, Type 2",MESH:D003924,34,Air Pollutants|alpha-Tocopherol|Arsenic|Ascorbic Acid|Atrazine|Berberine|bisphenol A|bisphenol S|Cadmium|Copper|Dibutyl Phthalate|Dietary Fats|Diethylhexyl Phthalate|epigallocatechin gallate|Ethanol|Folic Acid|Fructose|ginsenoside Re|Lead|Linagliptin|Manganese|mangiferin|Mercury|Nickel|Nicotine|Particulate Matter|perfluorooctane sulfonic acid|Plant Extracts|Polychlorinated Biphenyls|Resveratrol|Sitagliptin Phosphate|Streptozocin|Vehicle Emissions|Zinc,2,ABCC8|GLP1R
memory T cell proliferation,GO:0061485,Diabetes Mellitus,MESH:D003920,1,Particulate Matter,0,
memory T cell proliferation,GO:0061485,"Diabetes Mellitus, Type 2",MESH:D003924,1,Particulate Matter,0,
menarche,GO:0042696,Diabetes Mellitus,MESH:D003920,5,Arsenic|Cadmium|DDT|Dichlorodiphenyl Dichloroethylene|Lead,0,
menarche,GO:0042696,"Diabetes Mellitus, Type 2",MESH:D003924,4,Arsenic|Cadmium|Dichlorodiphenyl Dichloroethylene|Lead,0,
menopause,GO:0042697,Diabetes Mellitus,MESH:D003920,3,Lead|Pesticides|Tobacco Smoke Pollution,0,
menopause,GO:0042697,"Diabetes Mellitus, Type 2",MESH:D003924,4,Lead|perfluorooctane sulfonic acid|perfluorooctanoic acid|Pesticides,0,
mercury ion transport,GO:0015694,Diabetes Mellitus,MESH:D003920,1,Mercury,0,
mercury ion transport,GO:0015694,"Diabetes Mellitus, Type 1",MESH:D003922,1,Mercury,0,
mercury ion transport,GO:0015694,"Diabetes Mellitus, Type 2",MESH:D003924,1,Mercury,0,
mesenchymal cell apoptotic process,GO:0097152,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EDNRA
mesenchymal cell apoptotic process involved in metanephros development,GO:1900200,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF1B
mesenchymal cell development,GO:0014031,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
mesenchymal cell development,GO:0014031,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2
mesenchymal cell differentiation,GO:0048762,Diabetes Mellitus,MESH:D003920,1,Tungsten,0,
mesenchymal cell differentiation involved in bone development,GO:1901706,Diabetes Mellitus,MESH:D003920,1,Berberine,0,
mesenchymal cell differentiation involved in bone development,GO:1901706,"Diabetes Mellitus, Experimental",MESH:D003921,1,Berberine,0,
mesenchymal cell differentiation involved in bone development,GO:1901706,"Diabetes Mellitus, Type 2",MESH:D003924,1,Berberine,1,MIR222
mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,GO:0072309,Diabetes Mellitus,MESH:D003920,1,Chlorpyrifos,0,
mesenchymal to epithelial transition,GO:0060231,Diabetes Mellitus,MESH:D003920,1,Atrazine,0,
mesenchymal to epithelial transition,GO:0060231,"Diabetes Mellitus, Type 2",MESH:D003924,1,Atrazine,0,
mesendoderm development,GO:0048382,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,SMIM43
mesodermal cell migration,GO:0008078,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
mesodermal cell migration,GO:0008078,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,S1PR2
mesoderm development,GO:0007498,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,RELA|VEGFA
mesonephric duct development,GO:0072177,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF1B
mesonephric duct formation,GO:0072181,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF1B
mesonephric tubule development,GO:0072164,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,HNF1B
mesonephros development,GO:0001823,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,REN
metabolic process,GO:0008152,Diabetes Mellitus,MESH:D003920,13,Arsenic|arsenite|bisphenol A|Chlorpyrifos|Dichlorodiphenyl Dichloroethylene|Docosahexaenoic Acids|Lead|Magnesium|Plant Extracts|Polychlorinated Biphenyls|Resveratrol|Serotonin|Tobacco Smoke Pollution,0,
metabolic process,GO:0008152,"Diabetes Mellitus, Experimental",MESH:D003921,13,bisphenol A|Capsaicin|Cholesterol|Dietary Fats|Glucose|Niacinamide|Plant Extracts|Quercetin|Resveratrol|sodium arsenite|Taurine|Tocotrienols|Ursolic Acid,0,
metabolic process,GO:0008152,"Diabetes Mellitus, Type 1",MESH:D003922,8,bisphenol A|Niacinamide|Norepinephrine|Resveratrol|sodium arsenite|Taurine|Tocotrienols|Uric Acid,0,
metabolic process,GO:0008152,"Diabetes Mellitus, Type 2",MESH:D003924,19,Aconitic Acid|Arsenic|bisphenol A|Calcium|Dichlorodiphenyl Dichloroethylene|Dietary Fats|Glucose|Lactic Acid|Lead|Magnesium|mono-(2-ethylhexyl)phthalate|Niacinamide|perfluorohexanesulfonic acid|perfluorooctane sulfonic acid|perfluorooctanoic acid|Plant Extracts|Polychlorinated Biphenyls|Resveratrol|S-Adenosylmethionine,5,ENPP1|MIR377|MIR409|MIR485|MIR487B
metal ion homeostasis,GO:0055065,Diabetes Mellitus,MESH:D003920,7,Cadmium|Chromium|Copper|Iron|Lead|Tobacco Smoke Pollution|Zinc,0,
metal ion homeostasis,GO:0055065,"Diabetes Mellitus, Experimental",MESH:D003921,5,Chromium|Dietary Fats|Manganese|sodium arsenite|tributyltin,0,
metal ion homeostasis,GO:0055065,"Diabetes Mellitus, Type 1",MESH:D003922,2,Iron|sodium arsenite,0,
metal ion homeostasis,GO:0055065,"Diabetes Mellitus, Type 2",MESH:D003924,9,Cadmium|Calcium|Chromium|Copper|Dietary Fats|Iron|Lead|Manganese|Zinc,0,
metal ion transport,GO:0030001,Diabetes Mellitus,MESH:D003920,4,Cadmium|Lead|Mercury|Selenium,0,
metal ion transport,GO:0030001,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dietary Fats|tributyltin,0,
metal ion transport,GO:0030001,"Diabetes Mellitus, Type 1",MESH:D003922,1,Mercury,1,SLC11A1
metal ion transport,GO:0030001,"Diabetes Mellitus, Type 2",MESH:D003924,6,Cadmium|Calcium|Dietary Fats|Lead|Mercury|Nickel,0,
metamorphosis,GO:0007552,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
metamorphosis,GO:0007552,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
metamorphosis,GO:0007552,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
metamorphosis,GO:0007552,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol A,0,
metanephros development,GO:0001656,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,BCL2
metanephros development,GO:0001656,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,CTSH
metanephros development,GO:0001656,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BCL2
metaphase plate congression,GO:0051310,"Diabetes Mellitus, Type 2",MESH:D003924,1,bisphenol S,0,
metestrus,GO:0060210,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
metestrus,GO:0060210,"Diabetes Mellitus, Experimental",MESH:D003921,2,bisphenol A|tributyltin,0,
metestrus,GO:0060210,"Diabetes Mellitus, Type 1",MESH:D003922,2,bisphenol A|Genistein,0,
metestrus,GO:0060210,"Diabetes Mellitus, Type 2",MESH:D003924,3,bisphenol A|daidzein|Genistein,0,
methane metabolic process,GO:0015947,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
methane metabolic process,GO:0015947,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
methionine biosynthetic process,GO:0009086,Diabetes Mellitus,MESH:D003920,2,"2,2',4,4'-tetrabromodiphenyl ether|DDT",0,
methionine biosynthetic process,GO:0009086,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
methionine biosynthetic process,GO:0009086,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
methionine biosynthetic process,GO:0009086,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,BHMT
methionine catabolic process,GO:0009087,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,MAT1A
methionine metabolic process,GO:0006555,Diabetes Mellitus,MESH:D003920,3,Dichlorodiphenyl Dichloroethylene|Particulate Matter|Resveratrol,0,
methionine metabolic process,GO:0006555,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
methionine metabolic process,GO:0006555,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
methionine metabolic process,GO:0006555,"Diabetes Mellitus, Type 2",MESH:D003924,5,Cysteine|Dichlorodiphenyl Dichloroethylene|Particulate Matter|Resveratrol|S-Adenosylmethionine,0,
methotrexate transport,GO:0051958,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
methotrexate transport,GO:0051958,"Diabetes Mellitus, Experimental",MESH:D003921,1,Resveratrol,0,
methotrexate transport,GO:0051958,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
methotrexate transport,GO:0051958,"Diabetes Mellitus, Type 2",MESH:D003924,2,Folic Acid|Resveratrol,0,
methylation,GO:0032259,Diabetes Mellitus,MESH:D003920,3,Arsenic|Particulate Matter|Polychlorinated Biphenyls,0,
methylation,GO:0032259,"Diabetes Mellitus, Experimental",MESH:D003921,1,sodium arsenite,0,
methylation,GO:0032259,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
methylation,GO:0032259,"Diabetes Mellitus, Type 2",MESH:D003924,7,Arsenic|Calcium|Curcumin|Folic Acid|Particulate Matter|Polychlorinated Biphenyls|Vehicle Emissions,2,BHMT|CYP1A2
methyl-branched fatty acid metabolic process,GO:0097089,Diabetes Mellitus,MESH:D003920,1,Dichlorodiphenyl Dichloroethylene,0,
methyl-branched fatty acid metabolic process,GO:0097089,"Diabetes Mellitus, Type 2",MESH:D003924,1,Dichlorodiphenyl Dichloroethylene,0,
MHC class II biosynthetic process,GO:0045342,"Diabetes Mellitus, Type 1",MESH:D003922,0,,1,SLC11A1
microglia development,GO:0014005,Diabetes Mellitus,MESH:D003920,2,Arsenic|Particulate Matter,0,
microglia development,GO:0014005,"Diabetes Mellitus, Experimental",MESH:D003921,2,sodium arsenite|tributyltin,0,
microglia development,GO:0014005,"Diabetes Mellitus, Type 1",MESH:D003922,2,Lipopolysaccharides|sodium arsenite,0,
microglia development,GO:0014005,"Diabetes Mellitus, Type 2",MESH:D003924,2,Arsenic|Particulate Matter,0,
microglia differentiation,GO:0014004,Diabetes Mellitus,MESH:D003920,1,Ozone,0,
microglia differentiation,GO:0014004,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,ENPP1
microglial cell activation,GO:0001774,Diabetes Mellitus,MESH:D003920,14,Air Pollutants|Arsenic|Atrazine|Chlorpyrifos|Copper|Cyclosporine|Dichlorvos|Glyburide|Lead|morroniside|Particulate Matter|Reactive Oxygen Species|Resveratrol|Zinc,0,
microglial cell activation,GO:0001774,"Diabetes Mellitus, Experimental",MESH:D003921,11,astaxanthine|corilagin|Dronabinol|ginsenoside Re|Glyburide|Manganese|Nicotine|Quercetin|Resveratrol|sodium arsenite|Taurine,3,CX3CL1|IFNG|TNF
microglial cell activation,GO:0001774,"Diabetes Mellitus, Type 1",MESH:D003922,6,Dichlorvos|Lipopolysaccharides|Reactive Oxygen Species|Resveratrol|sodium arsenite|Taurine,2,IFNG|TNF
microglial cell activation,GO:0001774,"Diabetes Mellitus, Type 2",MESH:D003924,17,Air Pollutants|Arsenic|astaxanthine|Atrazine|Copper|Ethanol|ginsenoside Re|Glyburide|Lead|Manganese|Nicotine|Particulate Matter|perfluorooctane sulfonic acid|Reactive Oxygen Species|Resveratrol|Vehicle Emissions|Zinc,2,MIR181C|TNF
microglial cell migration,GO:1904124,Diabetes Mellitus,MESH:D003920,3,Air Pollutants|Atrazine|Particulate Matter,0,
microglial cell migration,GO:1904124,"Diabetes Mellitus, Type 2",MESH:D003924,3,Air Pollutants|Atrazine|Particulate Matter,1,ENPP1
microglial cell proliferation,GO:0061518,Diabetes Mellitus,MESH:D003920,5,Air Pollutants|Arsenic|bisphenol A|Particulate Matter|Streptozocin,0,
microglial cell proliferation,GO:0061518,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
microglial cell proliferation,GO:0061518,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Cyclophosphamide|Quercetin|sodium arsenite|Streptozocin,1,CX3CL1
microglial cell proliferation,GO:0061518,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Cyclophosphamide|sodium arsenite|Streptozocin,0,
microglial cell proliferation,GO:0061518,"Diabetes Mellitus, Type 2",MESH:D003924,7,Air Pollutants|Arsenic|bisphenol A|Ethanol|Particulate Matter|Streptozocin|Vehicle Emissions,0,
micronucleus organization,GO:0032125,Diabetes Mellitus,MESH:D003920,14,"2-hydroxyfluorene|2-naphthol|Air Pollutants|Arsenic|arsenite|bisphenol A|Cadmium|Fatty Acids, Omega-3|Insecticides|Mercury|Ozone|Particulate Matter|Pesticides|Plant Extracts",0,
micronucleus organization,GO:0032125,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
micronucleus organization,GO:0032125,"Diabetes Mellitus, Experimental",MESH:D003921,8,"bisphenol A|Cyclophosphamide|Fatty Acids, Omega-3|Hydrogen Peroxide|Nicotine|Plant Extracts|Quercetin|sodium arsenite",0,
micronucleus organization,GO:0032125,"Diabetes Mellitus, Type 1",MESH:D003922,4,bisphenol A|Cyclophosphamide|Mercury|sodium arsenite,0,
micronucleus organization,GO:0032125,"Diabetes Mellitus, Type 2",MESH:D003924,20,Air Pollutants|Arsenic|Ascorbic Acid|bisphenol A|Cadmium|Calcium|coumarin|Diethylnitrosamine|epigallocatechin gallate|Ethanol|Folic Acid|Glutathione|Mercury|Nickel|Nicotine|Particulate Matter|Pesticides|Plant Extracts|Silver|Vehicle Emissions,0,
microtubule anchoring at centrosome,GO:0034454,Diabetes Mellitus,MESH:D003920,1,bisphenol A,0,
microtubule anchoring at centrosome,GO:0034454,"Diabetes Mellitus, Experimental",MESH:D003921,1,bisphenol A,0,
microtubule anchoring at centrosome,GO:0034454,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
microtubule anchoring at centrosome,GO:0034454,"Diabetes Mellitus, Type 2",MESH:D003924,2,bisphenol A|bisphenol S,0,
microtubule-based movement,GO:0007018,Diabetes Mellitus,MESH:D003920,0,,2,KIF1A|KIF5B
microtubule-based process,GO:0007017,Diabetes Mellitus,MESH:D003920,0,,1,KIF5B
microtubule cytoskeleton organization,GO:0000226,Diabetes Mellitus,MESH:D003920,3,"2,4,5-Trichlorophenoxyacetic Acid|Particulate Matter|Reactive Oxygen Species",0,
microtubule cytoskeleton organization,GO:0000226,"Diabetes Mellitus, Experimental",MESH:D003921,2,Hydrogen Peroxide|tributyltin,0,
microtubule cytoskeleton organization,GO:0000226,"Diabetes Mellitus, Type 1",MESH:D003922,1,Reactive Oxygen Species,0,
microtubule cytoskeleton organization,GO:0000226,"Diabetes Mellitus, Type 2",MESH:D003924,2,Particulate Matter|Reactive Oxygen Species,0,
microtubule depolymerization,GO:0007019,"Diabetes Mellitus, Experimental",MESH:D003921,1,Quercetin,0,
microtubule depolymerization,GO:0007019,"Diabetes Mellitus, Type 2",MESH:D003924,1,epigallocatechin gallate,0,
microtubule polymerization,GO:0046785,Diabetes Mellitus,MESH:D003920,1,Resveratrol,0,
microtubule polymerization,GO:0046785,"Diabetes Mellitus, Experimental",MESH:D003921,2,Quercetin|Resveratrol,1,CAV1
microtubule polymerization,GO:0046785,"Diabetes Mellitus, Type 1",MESH:D003922,1,Resveratrol,0,
microtubule polymerization,GO:0046785,"Diabetes Mellitus, Type 2",MESH:D003924,1,Resveratrol,0,
microvillus assembly,GO:0030033,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,PAM
microvillus organization,GO:0032528,Diabetes Mellitus,MESH:D003920,4,Air Pollutants|Particulate Matter|Streptozocin|Zinc,0,
microvillus organization,GO:0032528,"Diabetes Mellitus, Experimental",MESH:D003921,1,Streptozocin,0,
microvillus organization,GO:0032528,"Diabetes Mellitus, Type 1",MESH:D003922,1,Streptozocin,0,
microvillus organization,GO:0032528,"Diabetes Mellitus, Type 2",MESH:D003924,4,Air Pollutants|Particulate Matter|Streptozocin|Zinc,0,
micturition,GO:0060073,Diabetes Mellitus,MESH:D003920,2,Chlorpyrifos|Streptozocin,0,
micturition,GO:0060073,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,Cyclophosphamide,0,
micturition,GO:0060073,"Diabetes Mellitus, Experimental",MESH:D003921,4,2-Hydroxypropyl-beta-cyclodextrin|Cyclophosphamide|Dietary Fats|Streptozocin,0,
micturition,GO:0060073,"Diabetes Mellitus, Type 1",MESH:D003922,2,Cyclophosphamide|Streptozocin,0,
micturition,GO:0060073,"Diabetes Mellitus, Type 2",MESH:D003924,2,Dietary Fats|Streptozocin,0,
midbrain development,GO:0030901,"Diabetes Mellitus, Type 2",MESH:D003924,2,Ethanol|Folic Acid,0,
midbrain dopaminergic neuron differentiation,GO:1904948,Diabetes Mellitus,MESH:D003920,0,,1,RAC1
middle ear morphogenesis,GO:0042474,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,EDN1
middle ear morphogenesis,GO:0042474,"Diabetes Mellitus, Type 2",MESH:D003924,0,,3,EDN1|EDNRA|ENPP1
midgut development,GO:0007494,"Diabetes Mellitus, Type 2",MESH:D003924,0,,1,EGFR
mineralocorticoid metabolic process,GO:0008212,"Diabetes Mellitus, Experimental",MESH:D003921,0,,1,HSD11B1
mineralocorticoid receptor signaling pathway,GO:0031959,Diabetes Mellitus,MESH:D003920,5,"alachlor|Atrazine|DDT|Dichlorodiphenyl Dichloroethylene|o,p'-DDT",0,
mineralocorticoid receptor signaling pathway,GO:0031959,"Diabetes Mellitus, Experimental",MESH:D003921,1,Aldosterone,0,
mineralocorticoid receptor signaling pathway,GO:0031959,"Diabetes Mellitus, Type 2",MESH:D003924,2,Atrazine|Dichlorodiphenyl Dichloroethylene,0,
miRNA-mediated gene silencing,GO:0035195,"Diabetes Mellitus, Type 2",MESH:D003924,0,,52,MIR10B|MIR1226|MIR1249|MIR125B1|MIR126|MIR1260B|MIR127|MIR1296|MIR1306|MIR1307|MIR130B|MIR140|MIR141|MIR142|MIR144|MIR151A|MIR17HG|MIR181C|MIR1908|MIR192|MIR195|MIR200A|MIR203A|MIR204|MIR205|MIR214|MIR215|MIR221|MIR222|MIR27A|MIR30A|MIR3173|MIR335|MIR339|MIR33B|MIR375|MIR377|MIR409|MIR423|MIR432|MIR4516|MIR483|MIR485|MIR487B|MIR532|MIR628|MIR744|MIR885|MIR92B|MIR939|MIR98|MIRLET7D
miRNA-mediated gene silencing by inhibition of translation,GO:0035278,"Diabetes Mellitus, Type 2",MESH:D003924,0,,14,MIR10B|MIR125B1|MIR126|MIR141|MIR144|MIR181C|MIR204|MIR205|MIR214|MIR221|MIR27A|MIR483|MIR939|MIR98
miRNA-mediated gene silencing by mRNA destabilization,GO:0035279,"Diabetes Mellitus, Type 2",MESH:D003924,0,,17,MIR125B1|MIR130B|MIR140|MIR142|MIR151A|MIR181C|MIR192|MIR195|MIR203A|MIR204|MIR214|MIR27A|MIR423|MIR483|MIR485|MIR885|MIR98
miRNA transcription,GO:0061614,Diabetes Mellitus,MESH:D003920,2,Air Pollutants|Particulate Matter,0,
miRNA transcription,GO:0061614,"Diabetes Mellitus, Type 2",MESH:D003924,3,Air Pollutants|Particulate Matter|Vehicle Emissions,0,
miRNA transport,GO:1990428,Diabetes Mellitus,MESH:D003920,2,arsenite|Particulate Matter,0,
miRNA transport,GO:1990428,"Diabetes Mellitus, Experimental",MESH:D003921,2,Dibutyl Phthalate|Diethylhexyl Phthalate,0,
miRNA transport,GO:1990428,"Diabetes Mellitus, Type 2",MESH:D003924,7,Dibutyl Phthalate|Diethylhexyl Phthalate|mono(2-ethyl-5-hydroxyhexyl) phthalate|mono-(2-ethylhexyl)phthalate|Particulate Matter|perfluorooctane sulfonic acid|perfluorooctanoic acid,0,
mismatch repair,GO:0006298,"Diabetes Mellitus, Experimental",MESH:D003921,1,Hydrogen Peroxide,0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,Diabetes Mellitus,MESH:D003920,7,"2,2',4,4'-tetrabromodiphenyl ether|bisphenol A|Cadmium|Lead|Metformin|Pioglitazone|Troglitazone",0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,"Diabetes Mellitus, Experimental",MESH:D003921,5,bisphenol A|Glucose|Metformin|Pioglitazone|Troglitazone,0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,"Diabetes Mellitus, Type 1",MESH:D003922,1,bisphenol A,0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,"Diabetes Mellitus, Type 2",MESH:D003924,7,bisphenol A|Cadmium|Glucose|Lead|Metformin|Pioglitazone|Troglitazone,0,
mitochondrial calcium ion homeostasis,GO:0051560,Diabetes Mellitus,MESH:D003920,4,arsenite|Chlorpyrifos|Cyclosporine|Lead,0,
mitochondrial calcium ion homeostasis,GO:0051560,"Diabetes Mellitus, Experimental",MESH:D003921,4,corilagin|ginsenoside Re|Hydrogen Peroxide|sodium arsenite,0,
mitochondrial calcium ion homeostasis,GO:0051560,"Diabetes Mellitus, Type 1",MESH:D003922,1,sodium arsenite,0,
mitochondrial calcium ion homeostasis,GO:0051560,"Diabetes Mellitus, Type 2",MESH:D003924,5,Calcium|Ethanol|ginsenoside Re|Lead|mono-(2-ethylhexyl)phthalate,0,
mitochondrial cytochrome c oxidase assembly,GO:0033617,Diabetes Mellitus,MESH:D003920,2,Copper|Particulate Matter,0,
mitochondrial cytochrome c oxidase assembly,GO:0033617,"Diabetes Mellitus, Experimental",MESH:D003921,2,Cholesterol|Glucose,0,
mitochondrial cytochrome c oxidase assembly,GO:0033617,"Diabetes Mellitus, Type 2",MESH:D003924,3,Copper|Glucose|Particulate Matter,0,
mitochondrial depolarization,GO:0051882,Diabetes Mellitus,MESH:D003920,21,"Arsenic|Aspirin|bisphenol A|Cadmium|Chlorpyrifos|Chromium|Copper|Cyclosporine|DDT|Iron|Lead|Mercury|Metals, Heavy|Niacin|Particulate Matter|puerarin|Resveratrol|Risperidone|Streptozocin|Trifluoperazine|Zinc",0,
mitochondrial depolarization,GO:0051882,"Diabetes Mellitus, Experimental",MESH:D003921,20,astaxanthine|bisphenol A|Chromium|Dietary Fats|Dronabinol|Fructose|Glucose|honokiol|Hydrogen Peroxide|Imatinib Mesylate|Manganese|mangiferin|methylamine|pterostilbene|puerarin|Resveratrol|sarpogrelate|sodium arsenite|Streptozocin|Taurine,0,
mitochondrial depolarization,GO:0051882,"Diabetes Mellitus, Type 1",MESH:D003922,10,bisphenol A|decabromobiphenyl ether|Imatinib Mesylate|Iron|Lipopolysaccharides|Mercury|Resveratrol|sodium arsenite|Streptozocin|Taurine,0,
mitochondrial depolarization,GO:0051882,"Diabetes Mellitus, Type 2",MESH:D003924,26,alpha-Tocopherol|Arsenic|Ascorbic Acid|astaxanthine|bisphenol A|Cadmium|Chromium|Copper|coumarin|Dietary Fats|epigallocatechin gallate|Ethanol|Fructose|Glucose|Iron|Lead|Manganese|mangiferin|Mercury|Nickel|Particulate Matter|perfluorooctane sulfonic acid|Resveratrol|saxagliptin|Streptozocin|Zinc,0,
mitochondrial DNA catabolic process,GO:0032043,Diabetes Mellitus,MESH:D003920,2,arsenite|puerarin,0,
mitochondrial DNA catabolic process,GO:0032043,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
mitochondrial DNA catabolic process,GO:0032043,"Diabetes Mellitus, Experimental",MESH:D003921,3,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|puerarin|Taurine",0,
mitochondrial DNA catabolic process,GO:0032043,"Diabetes Mellitus, Type 1",MESH:D003922,1,Taurine,0,
mitochondrial DNA metabolic process,GO:0032042,Diabetes Mellitus,MESH:D003920,5,Air Pollutants|Arsenic|Lead|Nitrogen Dioxide|Particulate Matter,0,
mitochondrial DNA metabolic process,GO:0032042,"Diabetes Mellitus, Experimental",MESH:D003921,1,Dietary Fats,0,
mitochondrial DNA metabolic process,GO:0032042,"Diabetes Mellitus, Type 2",MESH:D003924,6,Air Pollutants|Arsenic|Dietary Fats|Folic Acid|Lead|Particulate Matter,0,
mitochondrial DNA repair,GO:0043504,"Diabetes Mellitus, Experimental",MESH:D003921,0,,2,TP53|TRP53
mitochondrial DNA repair,GO:0043504,"Diabetes Mellitus, Type 1",MESH:D003922,1,Thioctic Acid,0,
mitochondrial DNA replication,GO:0006264,Diabetes Mellitus,MESH:D003920,9,"2,4,5,2',4',5'-hexachlorobiphenyl|bisphenol A|Cadmium|Lead|Ozone|Resveratrol|Rosiglitazone|Tetrachlorodibenzodioxin|Tobacco Smoke Pollution",0,
mitochondrial DNA replication,GO:0006264,"Diabetes Mellitus, Congenital Autoimmune",MESH:C565730,1,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",0,
mitochondrial DNA replication,GO:0006264,"Diabetes Mellitus, Experimental",MESH:D003921,10,"bisphenol A|Dibutyl Phthalate|Dietary Fats|Glucose|mangiferin|N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride|Quercetin|Resveratrol|Rosiglitazone|sodium arsenite",0,
mitochondrial DNA replication,GO:0006264,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Lipopolysaccharides|Resveratrol|sodium arsenite|Tetrachlorodibenzodioxin,0,
mitochondrial DNA replication,GO:0006264,"Diabetes Mellitus, Type 2",MESH:D003924,9,bisphenol A|Cadmium|Dibutyl Phthalate|Dietary Fats|Glucose|Lead|mangiferin|Resveratrol|Rosiglitazone,0,
"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,Diabetes Mellitus,MESH:D003920,6,bisphenol A|Copper|Pesticides|Resveratrol|Rosiglitazone|Tetrachlorodibenzodioxin,0,
"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,"Diabetes Mellitus, Experimental",MESH:D003921,8,bisphenol A|Dietary Sucrose|Fructose|Hydrogen Peroxide|Nitric Oxide|Resveratrol|Rosiglitazone|sodium arsenite,1,COX2
"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,"Diabetes Mellitus, Type 1",MESH:D003922,5,bisphenol A|Nitric Oxide|Resveratrol|sodium arsenite|Tetrachlorodibenzodioxin,0,
"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,"Diabetes Mellitus, Type 2",MESH:D003924,8,Ascorbic Acid|bisphenol A|Copper|Curcumin|Fructose|Pesticides|Resveratrol|Rosiglitazone,0,
